data_2dgu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2dgu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.807 0.337 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 68.5 t -82.66 137.22 21.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.552 HD12 ' CE1' ' A' ' 378' ' ' PHE . 56.6 mt -111.48 127.54 55.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -90.65 105.49 17.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.86 128.57 58.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -128.44 175.92 8.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.66 36.4 1.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 31.8 mt -75.1 146.63 41.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -73.19 -179.14 3.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.107 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -85.51 -2.34 58.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 13.1 p -118.49 15.55 13.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 95.7 t -97.25 135.64 30.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.092 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 82.3 p -139.31 175.79 9.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.168 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -54.86 -44.78 74.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -55.53 -44.77 77.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 63.7 mt -68.54 -33.79 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.138 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 89.9 mt -70.75 -27.77 64.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 359' ' ' SER . 72.4 mt-10 -74.21 -71.19 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -41.54 -39.4 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' ALA . . . . . 0.46 ' HB3' ' CE ' ' A' ' 391' ' ' MET . . . -69.77 -56.31 7.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -83.86 14.46 4.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 355' ' ' GLU . 13.4 t -99.22 -56.83 2.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 359' ' ' SER . 27.2 pt20 -37.67 -38.28 0.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.566 ' CD2' ' HB1' ' A' ' 387' ' ' ALA . 84.5 m-85 -63.0 -63.08 1.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.25 167.12 31.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.465 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -52.98 128.83 28.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.444 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 37.5 mt -98.15 157.2 16.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.912 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -106.02 -46.67 4.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -174.9 165.6 3.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 78.4 t -135.41 127.85 47.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.118 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -114.69 113.4 24.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -89.0 142.02 27.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.569 HD23 ' CE2' ' A' ' 373' ' ' TYR . 6.1 mp -126.91 -174.02 3.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.5 OUTLIER -32.28 -67.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.891 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -124.43 -37.7 2.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.569 ' CE2' HD23 ' A' ' 370' ' ' LEU . 9.1 p90 -93.46 179.64 5.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.448 ' HA ' ' CD1' ' A' ' 370' ' ' LEU . . . -158.21 168.22 27.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.131 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -119.02 128.55 54.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 7.2 mm -102.6 114.59 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -92.66 126.67 37.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.552 ' CE1' HD12 ' A' ' 340' ' ' LEU . 21.2 m-85 -109.51 137.73 46.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -54.16 -30.66 50.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -135.87 152.67 51.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.415 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 6.0 tmm_? -60.64 -28.37 68.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.919 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -71.72 -54.08 11.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . 0.408 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -42.97 -30.82 1.08 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -77.74 -59.43 2.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.821 0.343 . . . . 0.0 111.082 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 95.4 t -37.99 -37.75 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.127 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -71.3 -62.81 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.566 ' HB1' ' CD2' ' A' ' 361' ' ' PHE . . . -59.71 -15.67 21.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.562 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.7 ttm -78.75 -62.39 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.426 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.6 mt-10 -74.92 -0.35 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.496 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 14.3 mm-40 -100.03 -38.99 8.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' MET . . . . . 0.467 ' HA ' ' CG ' ' A' ' 394' ' ' LYS . 4.4 mmt -100.96 -27.66 13.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.934 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 388' ' ' MET . 1.5 t-20 -38.05 107.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 78.52 38.61 24.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.467 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 21.3 mmtt -100.06 149.05 23.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 110.884 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -75.57 82.18 2.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.88 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 15.3 tp -89.48 112.6 23.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 62.24 26.63 15.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 88.14 11.31 67.43 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.487 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -130.91 128.91 41.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.888 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.51 98.37 4.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.825 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 20.2 pt -78.1 147.92 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.138 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -109.83 129.72 55.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.464 ' CD1' ' N ' ' A' ' 392' ' ' ASN . 15.5 mt -113.35 124.12 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.095 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 2.9 m -138.62 135.16 43.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.562 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 10.1 m-85 -51.67 106.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.077 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 3.7 pttm . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.878 0.371 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 65.2 t -69.49 133.22 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.072 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.433 ' HB3' ' CG2' ' A' ' 403' ' ' ILE . 51.8 mt -105.28 119.2 38.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -85.32 106.18 16.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 25.4 t -102.1 130.05 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.163 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -131.14 173.29 11.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.73 39.61 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 38.6 mt -81.24 156.95 25.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.921 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -95.08 161.23 14.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.075 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -63.73 -8.0 9.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 24.9 p -98.84 -9.24 24.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.165 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.15 140.48 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.139 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 78.2 p -144.46 163.03 35.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -40.7 -50.46 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -52.08 -52.24 52.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.903 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 75.2 mt -58.95 -29.08 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 96.1 mt -75.54 -30.65 59.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 359' ' ' SER . 51.3 mt-10 -75.58 -64.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -50.14 -38.67 40.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -69.01 -49.69 55.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' PHE . . . . . 0.406 ' CE2' HD13 ' A' ' 403' ' ' ILE . 45.0 m-85 -90.32 14.89 11.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 355' ' ' GLU . 9.0 t -100.06 -51.35 3.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -38.84 -38.7 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.565 ' CD2' ' HB3' ' A' ' 387' ' ' ALA . 94.1 m-85 -64.49 -62.72 1.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -153.65 161.31 29.78 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -47.94 129.06 14.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 40.4 mt -98.31 156.42 16.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -100.55 -50.49 3.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -171.24 165.49 7.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 51.1 t -136.93 129.59 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.82 109.02 16.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 29.5 tptt -82.17 146.16 29.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 371' ' ' LYS . 6.7 mp -128.99 -174.91 3.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.1 OUTLIER -34.4 -67.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -122.3 -37.14 2.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -94.19 -175.11 3.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -166.44 161.41 16.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.138 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -110.94 137.3 48.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.513 HG23 ' CE1' ' A' ' 378' ' ' PHE . 5.3 mm -111.16 109.55 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -89.29 121.32 31.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 19.5 m-85 -101.78 149.08 24.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -69.02 -31.76 70.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.847 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -131.05 154.37 48.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -58.13 -37.71 75.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 384' ' ' ALA . 19.6 t70 -66.2 -57.55 7.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . 0.537 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -35.12 -31.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.507 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 382' ' ' ASP . . . -80.88 -66.93 0.82 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.117 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' A' ' 384' ' ' ALA . 58.0 t -36.0 -35.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 384' ' ' ALA . 12.1 tptm -72.92 -61.03 1.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.565 ' HB3' ' CD2' ' A' ' 361' ' ' PHE . . . -60.51 -16.92 41.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.593 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.7 ttm -76.52 -61.27 2.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.429 ' N ' ' HG2' ' A' ' 388' ' ' MET . 13.1 mt-10 -74.17 -4.22 34.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.872 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.497 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 39.0 mm-40 -100.03 -33.02 10.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' MET . . . . . 0.503 ' O ' ' CG ' ' A' ' 394' ' ' LYS . 38.2 mmm -101.96 -41.0 6.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.473 ' N ' HD11 ' A' ' 403' ' ' ILE . 5.1 t-20 -34.12 116.61 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 76.63 30.05 56.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.46 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.503 ' CG ' ' O ' ' A' ' 391' ' ' MET . 0.0 OUTLIER -100.01 141.97 32.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 0.0 110.896 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.49 99.99 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 20.5 tp -106.36 114.31 28.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.968 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 60.88 27.18 17.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.88 16.86 59.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.479 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -140.04 120.74 14.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.91 100.01 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 25.0 pt -75.68 149.72 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -112.44 128.51 56.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.473 HD11 ' N ' ' A' ' 392' ' ' ASN . 35.6 mt -111.96 128.97 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.124 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 9.9 m -142.32 132.91 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.152 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.593 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 19.2 m-85 -50.87 110.78 0.46 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.814 0.34 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.0 t -85.17 125.68 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.118 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.554 HD13 ' CE1' ' A' ' 378' ' ' PHE . 70.6 mt -103.84 130.35 51.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.946 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -94.74 107.83 19.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 18.7 t -106.15 130.49 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -130.15 168.24 17.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.3 t30 72.22 54.35 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 15.6 mt -96.25 145.91 25.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.929 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -81.08 163.12 23.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.053 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -66.83 -4.47 9.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 24.6 p -104.58 6.31 34.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.442 ' CG1' ' NZ ' ' A' ' 369' ' ' LYS . 58.6 t -94.16 138.09 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.154 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 43.4 p -142.64 159.15 42.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.16 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -42.73 -41.15 3.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -57.92 -46.93 84.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 73.3 mt -65.56 -30.17 49.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.14 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.418 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 83.2 mt -72.94 -31.4 64.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 359' ' ' SER . 21.7 mt-10 -72.07 -67.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -50.3 -39.92 46.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' ALA . . . . . 0.457 ' HB3' ' CE ' ' A' ' 391' ' ' MET . . . -65.71 -51.3 60.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' PHE . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 45.3 m-85 -90.49 14.57 12.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 355' ' ' GLU . 2.1 t -99.8 -57.44 2.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 359' ' ' SER . 19.1 pt20 -35.2 -39.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.565 ' CD2' ' HB3' ' A' ' 387' ' ' ALA . 84.8 m-85 -64.58 -65.23 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -147.4 163.89 28.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.454 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -52.85 130.72 34.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.457 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 34.2 mt -99.77 158.94 15.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.949 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -108.07 -44.5 4.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -174.16 164.41 4.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 54.2 t -135.51 133.75 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 39.7 tptt -119.55 123.76 44.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . 0.442 ' NZ ' ' CG1' ' A' ' 349' ' ' VAL . 24.0 tptt -95.7 146.29 24.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.545 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.8 mp -133.96 -174.74 3.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 370' ' ' LEU . 24.4 tttp -33.57 -68.46 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.886 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.3 -37.13 2.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.545 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.3 p90 -90.94 -175.79 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.968 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -168.15 147.18 4.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.091 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -95.76 142.23 28.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.449 HG21 ' CE1' ' A' ' 378' ' ' PHE . 4.6 mm -118.07 106.18 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -84.44 121.48 27.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.847 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.554 ' CE1' HD13 ' A' ' 340' ' ' LEU . 14.4 m-85 -102.61 151.47 22.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -60.57 -35.77 76.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -140.35 153.12 46.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.418 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 6.5 tmm_? -52.7 -28.43 21.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.877 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 384' ' ' ALA . 12.0 t0 -69.81 -62.21 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . 0.474 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -36.76 -29.62 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.52 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 382' ' ' ASP . . . -79.9 -58.47 3.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 0.0 111.113 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 96.3 t -38.39 -38.63 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -71.93 -64.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.565 ' HB3' ' CD2' ' A' ' 361' ' ' PHE . . . -57.04 -15.48 5.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.602 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 9.0 ttm -79.46 -62.91 1.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.432 ' N ' ' HG2' ' A' ' 388' ' ' MET . 9.9 mt-10 -74.86 -0.97 20.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -100.09 -35.04 9.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' MET . . . . . 0.459 ' HA ' ' CG ' ' A' ' 394' ' ' LYS . 27.7 mmm -103.91 -37.15 7.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.889 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 388' ' ' MET . 4.3 t-20 -34.29 101.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 92.22 29.68 11.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.464 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.459 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 8.7 mmtp -94.99 148.2 22.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 0.0 110.854 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.64 80.66 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 15.6 tp -89.12 115.69 26.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.941 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 62.22 25.02 14.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 86.03 20.18 55.96 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.464 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -139.81 125.28 19.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.92 98.21 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 47.2 pt -74.6 153.32 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -117.09 126.61 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 392' ' ' ASN . 23.2 mt -113.06 124.85 70.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.158 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 10.4 m -137.05 133.35 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.602 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 8.3 m-85 -51.26 110.91 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.068 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 339' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.841 0.353 . . . . 0.0 110.891 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.426 ' N ' ' HD2' ' A' ' 338' ' ' LYS . 86.4 t -77.18 131.34 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.101 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.549 HD12 ' CE1' ' A' ' 378' ' ' PHE . 43.4 mt -108.26 127.37 53.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -91.27 108.61 20.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 14.0 t -103.13 134.73 43.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -134.11 167.13 21.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.84 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.4 t30 73.23 52.38 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 22.5 mt -96.22 131.99 42.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -54.58 -176.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -88.93 5.68 42.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 21.9 p -121.86 13.77 10.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 91.6 t -88.55 138.81 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 67.0 p -144.07 167.05 23.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.159 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -50.45 -43.94 55.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.04 -41.9 75.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.49 -41.48 80.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.37 -32.51 73.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 359' ' ' SER . 46.1 mt-10 -68.21 -73.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -41.48 -39.67 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.957 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' ALA . . . . . 0.425 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -66.7 -54.6 21.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' PHE . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 37.0 m-85 -87.78 14.68 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 355' ' ' GLU . 17.7 t -99.99 -53.25 3.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.848 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -38.68 -38.68 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.563 ' CD2' ' HB2' ' A' ' 387' ' ' ALA . 84.3 m-85 -64.08 -62.71 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -151.87 169.78 31.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.525 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -53.86 132.73 42.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.818 0.342 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.468 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 32.9 mt -101.46 160.49 14.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.949 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -110.33 -48.04 3.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -172.97 163.65 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 71.9 t -134.1 130.07 54.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -111.06 108.41 18.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.866 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . 0.41 ' C ' HD13 ' A' ' 370' ' ' LEU . 19.3 tptp -87.08 137.58 32.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.559 HD21 ' CE2' ' A' ' 373' ' ' TYR . 7.6 mp -126.28 -174.74 3.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 370' ' ' LEU . 30.8 tttm -33.55 -67.73 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.873 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.16 -36.39 2.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.559 ' CE2' HD21 ' A' ' 370' ' ' LEU . 6.5 p90 -93.7 -177.36 4.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -165.79 159.65 16.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.098 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -110.7 131.51 54.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.882 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 3.9 mm -105.26 115.58 47.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -93.54 113.98 26.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.549 ' CE1' HD12 ' A' ' 340' ' ' LEU . 17.4 m-85 -96.06 146.11 24.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.851 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -63.66 -32.81 74.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -131.82 153.31 50.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.415 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 2.0 tmm_? -62.19 -30.66 71.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -71.61 -50.42 30.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -44.8 -31.97 2.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.546 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -76.57 -63.06 1.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.792 0.33 . . . . 0.0 111.138 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 384' ' ' ALA . 61.3 t -34.92 -36.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . 0.428 ' HE3' ' CG ' ' A' ' 390' ' ' GLU . 17.8 tptt -72.68 -66.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.563 ' HB2' ' CD2' ' A' ' 361' ' ' PHE . . . -55.21 -16.87 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.592 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 7.5 ttm -77.65 -61.64 1.93 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.412 ' N ' ' HG2' ' A' ' 388' ' ' MET . 7.3 mt-10 -77.48 -2.06 33.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.492 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 52.9 mm-40 -100.15 -25.89 14.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' MET . . . . . 0.498 ' O ' ' N ' ' A' ' 393' ' ' GLY . 23.4 mmm -112.1 -38.19 4.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.473 ' N ' HD11 ' A' ' 403' ' ' ILE . 7.6 t-20 -35.09 92.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 108.44 23.95 6.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.477 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 391' ' ' MET . 0.3 OUTLIER -90.28 146.9 23.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.774 0.321 . . . . 0.0 110.903 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -78.6 80.26 4.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 19.0 tp -89.19 114.89 26.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.927 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 62.49 27.74 16.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 82.45 20.88 61.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.481 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -140.18 122.51 15.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.891 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.38 95.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 30.4 pt -72.4 148.7 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.193 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -115.79 130.77 56.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.473 HD11 ' N ' ' A' ' 392' ' ' ASN . 19.7 mt -109.74 138.93 35.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.167 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 17.9 m -149.43 134.61 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.073 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.592 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 15.4 m-85 -54.71 108.7 0.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.854 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 179.903 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.806 0.336 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 90.6 t -79.94 135.94 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.403 HD21 ' CB ' ' A' ' 384' ' ' ALA . 16.5 mt -111.62 127.27 55.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -88.54 113.1 23.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.875 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.438 ' CG1' HD13 ' A' ' 401' ' ' ILE . 15.8 t -111.43 135.45 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -132.49 170.61 14.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.5 t30 73.46 43.85 0.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 39.0 mt -83.37 127.59 33.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -49.4 178.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -84.57 -5.34 59.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 25.7 p -117.84 22.46 12.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 64.5 t -96.4 136.64 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.153 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 77.8 p -135.45 178.28 7.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.132 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.87 -40.29 92.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -58.27 -46.54 85.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.86 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.67 -30.82 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 97.0 mt -73.84 -26.87 60.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 359' ' ' SER . 52.6 mt-10 -81.27 -64.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -51.05 -25.37 4.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -83.66 -44.83 14.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' PHE . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 35.9 m-85 -92.03 9.91 31.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 361' ' ' PHE . 92.2 p -95.13 -54.46 3.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.84 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 359' ' ' SER . 26.0 pt20 -34.28 -35.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.57 ' CD2' ' HB2' ' A' ' 387' ' ' ALA . 98.2 m-85 -70.97 -68.27 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -145.61 165.48 27.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.461 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -54.37 131.84 42.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.755 0.312 . . . . 0.0 110.909 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.508 HD21 ' CE2' ' A' ' 378' ' ' PHE . 86.9 mt -101.32 155.63 17.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -100.88 -42.99 6.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.938 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -174.95 170.08 3.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.7 t -140.66 125.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.131 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -112.49 123.14 49.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -97.52 143.52 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.475 ' O ' ' C ' ' A' ' 371' ' ' LYS . 6.9 mp -129.1 -174.62 3.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.1 OUTLIER -32.12 -72.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.932 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -120.04 -35.37 3.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.426 ' CE2' HD22 ' A' ' 370' ' ' LEU . 12.4 p90 -94.99 -179.41 4.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -159.11 167.28 29.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.109 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -118.32 125.39 49.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.465 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 5.3 mm -99.18 110.5 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -91.68 120.75 32.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.827 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.508 ' CE2' HD21 ' A' ' 364' ' ' LEU . 21.0 m-85 -101.02 154.63 18.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.55 -33.96 73.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -132.13 156.58 46.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.414 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 5.6 tmm_? -61.86 -32.71 73.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.15 -52.08 26.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -42.69 -32.84 1.42 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.543 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 386' ' ' LYS . . . -77.73 -64.35 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.789 0.328 . . . . 0.0 111.092 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.43 ' C ' ' O ' ' A' ' 384' ' ' ALA . 68.2 t -35.39 -32.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.122 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 384' ' ' ALA . 15.5 tptm -74.8 -61.89 1.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.57 ' HB2' ' CD2' ' A' ' 361' ' ' PHE . . . -61.07 -14.68 25.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.57 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.4 ttm -78.65 -60.18 2.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.906 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -73.23 -3.15 25.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.462 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 4.4 mm-40 -100.41 -39.43 7.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' MET . . . . . 0.47 ' HB2' ' CD1' ' A' ' 403' ' ' ILE . 49.8 mmm -99.76 -19.73 16.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 388' ' ' MET . 0.8 OUTLIER -43.92 119.46 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 56.36 37.25 73.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.445 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.41 ' HD2' ' C ' ' A' ' 395' ' ' ASP . 0.0 OUTLIER -100.09 150.78 22.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.78 0.324 . . . . 0.0 110.911 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' ASP . . . . . 0.41 ' C ' ' HD2' ' A' ' 394' ' ' LYS . 24.7 t0 -71.12 105.92 3.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 38.4 tp -119.39 115.48 24.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 59.77 36.95 22.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 77.0 9.56 86.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.501 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -135.31 124.39 24.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.893 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.79 106.12 6.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.931 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.438 HD13 ' CG1' ' A' ' 342' ' ' VAL . 21.7 pt -83.12 147.11 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -109.56 128.58 55.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 391' ' ' MET . 44.1 mt -110.71 142.55 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.11 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 9.6 m -157.01 134.12 2.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.57 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 27.0 m-85 -53.32 111.04 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.113 179.934 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.809 0.338 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.425 HG11 ' N ' ' A' ' 340' ' ' LEU . 97.3 t -83.16 136.63 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.101 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.425 ' N ' HG11 ' A' ' 339' ' ' VAL . 53.1 mt -112.9 128.9 56.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -92.59 108.26 19.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.431 ' CG1' HD13 ' A' ' 401' ' ' ILE . 48.7 t -106.0 127.27 61.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.176 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -126.51 173.44 9.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.24 39.19 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 48.7 mt -78.22 121.78 24.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -50.26 172.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.078 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -83.34 15.63 2.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 63.1 p -132.29 19.27 4.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.161 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 350' ' ' THR . 67.0 t -97.71 158.06 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' THR . . . . . 0.458 ' N ' ' CG1' ' A' ' 349' ' ' VAL . 21.2 p -156.19 165.54 36.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -49.69 -44.51 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -56.96 -45.61 82.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 67.0 mt -64.43 -31.81 55.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.121 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 88.6 mt -73.49 -26.09 60.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 359' ' ' SER . 90.6 mt-10 -81.82 -66.88 0.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.899 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -49.72 -23.41 1.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -85.86 -45.75 11.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.078 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -92.49 11.47 26.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 355' ' ' GLU . 95.7 p -100.09 -24.48 14.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.866 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -63.6 -31.71 72.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.562 ' CD2' ' HB1' ' A' ' 387' ' ' ALA . 93.6 m-85 -74.95 -61.95 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.859 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -148.65 162.45 28.87 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.521 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -52.18 129.19 27.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 38.7 mt -97.7 154.63 17.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -101.85 -42.75 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.925 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 366' ' ' ARG . 2.4 ptm85 -174.1 164.89 4.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.859 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 46.3 t -136.53 124.68 34.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -117.79 107.94 14.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . 0.451 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 12.3 tttm -88.17 140.43 29.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.465 ' O ' ' C ' ' A' ' 371' ' ' LYS . 6.4 mp -118.18 -174.21 2.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 370' ' ' LEU . 9.2 ttpt -31.97 -69.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -118.12 -39.32 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -91.61 -174.96 4.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 369' ' ' LYS . . . -162.48 167.96 22.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.103 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -121.92 121.51 37.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.845 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.458 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 6.7 mm -97.06 111.86 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -91.19 124.09 35.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.835 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 387' ' ' ALA . 23.6 m-85 -105.28 152.16 23.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.99 -35.59 80.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -129.65 153.43 48.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.859 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.418 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 5.9 tmm_? -60.08 -32.91 71.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -70.08 -51.36 32.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.843 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -42.82 -33.76 1.71 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.43 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -76.52 -56.94 4.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.812 0.339 . . . . 0.0 111.071 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 80.6 t -38.47 -39.87 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.094 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -70.76 -65.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.562 ' HB1' ' CD2' ' A' ' 361' ' ' PHE . . . -55.05 -16.62 3.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.174 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.597 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.5 ttm -78.54 -62.84 1.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.438 ' N ' ' HG2' ' A' ' 388' ' ' MET . 9.0 mt-10 -75.92 -0.55 21.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.552 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 56.3 mm-40 -100.08 -34.6 10.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' MET . . . . . 0.42 ' O ' ' C ' ' A' ' 392' ' ' ASN . 4.9 mmt -104.52 -31.15 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.904 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 388' ' ' MET . 3.9 t-20 -36.68 97.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 95.46 38.26 4.8 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.522 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -100.1 147.66 25.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.888 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -75.53 75.19 2.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 17.6 tp -79.75 111.17 15.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.933 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 62.4 25.31 15.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . 0.44 ' C ' ' OE1' ' A' ' 399' ' ' GLU . . . 89.77 14.62 59.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.495 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . 0.44 ' OE1' ' C ' ' A' ' 398' ' ' GLY . 15.8 mp0 -133.38 126.15 30.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.808 0.337 . . . . 0.0 110.86 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.72 97.34 2.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.431 HD13 ' CG1' ' A' ' 342' ' ' VAL . 18.1 pt -76.9 151.7 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -114.77 132.18 56.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.463 HD11 ' N ' ' A' ' 392' ' ' ASN . 31.6 mt -115.27 121.34 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.135 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 15.3 m -136.19 132.58 49.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.597 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 7.4 m-85 -51.07 117.47 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.098 179.928 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.789 0.328 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 98.5 t -78.53 133.15 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.079 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.564 HD11 ' CE1' ' A' ' 378' ' ' PHE . 55.1 mt -109.72 128.59 55.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -93.79 102.83 14.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 33.0 t -102.06 133.85 44.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.106 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -132.77 168.79 17.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.865 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 74.76 52.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 41.9 mt -97.38 148.11 23.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -85.79 169.53 13.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.137 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -71.12 -1.98 14.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 40.6 p -106.16 0.51 25.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 86.8 t -93.91 130.45 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.119 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 68.9 p -132.83 165.65 24.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.124 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -47.42 -41.97 21.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -57.39 -47.44 81.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 66.5 mt -65.64 -28.82 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.452 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 95.1 mt -74.58 -28.93 61.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -78.56 -63.32 1.43 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.821 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 35.8 mmtt -53.36 -34.71 58.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' ALA . . . . . 0.434 ' HB3' ' CE ' ' A' ' 391' ' ' MET . . . -71.43 -45.53 62.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -92.64 13.07 21.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 361' ' ' PHE . 1.5 t -97.62 -53.69 3.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 359' ' ' SER . 15.4 pt20 -36.57 -32.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.576 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 90.5 m-85 -71.04 -66.04 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -147.61 179.05 24.8 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -61.95 129.86 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 110.865 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.422 HD21 ' CD2' ' A' ' 378' ' ' PHE . 32.1 mt -101.21 152.12 21.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -100.37 -47.0 5.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -174.31 168.74 3.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 41.9 t -139.56 131.62 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.153 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.14 123.48 44.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -96.19 143.51 27.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.902 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.567 HD21 ' CE2' ' A' ' 373' ' ' TYR . 6.4 mp -127.73 -174.6 3.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.8 OUTLIER -33.31 -66.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -124.51 -36.78 2.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.567 ' CE2' HD21 ' A' ' 370' ' ' LEU . 9.7 p90 -92.86 179.75 5.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -160.32 161.43 33.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -112.2 136.57 51.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 5.0 mm -110.52 109.62 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.128 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -89.43 123.27 33.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.564 ' CE1' HD11 ' A' ' 340' ' ' LEU . 15.6 m-85 -105.56 140.72 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -56.72 -33.98 67.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.842 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -131.42 149.12 52.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.412 ' NH1' ' CG2' ' A' ' 385' ' ' VAL . 0.0 OUTLIER -57.06 -32.89 66.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -69.41 -53.1 21.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -41.29 -32.24 0.67 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.531 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -77.63 -58.78 3.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 111.119 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.412 ' CG2' ' NH1' ' A' ' 381' ' ' ARG . 57.6 t -38.52 -35.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -74.57 -64.32 1.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.551 ' HB3' ' CD2' ' A' ' 361' ' ' PHE . . . -58.25 -15.53 10.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.4 ttm -78.76 -63.07 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.429 ' N ' ' HG2' ' A' ' 388' ' ' MET . 14.6 mt-10 -73.52 1.41 9.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.576 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 43.7 mm-40 -100.12 -41.77 6.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' MET . . . . . 0.489 ' O ' ' N ' ' A' ' 393' ' ' GLY . 8.1 mmm -99.91 -27.39 13.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 388' ' ' MET . 5.1 t-20 -37.19 92.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.849 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 97.7 38.84 4.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.497 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.406 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 24.8 mmtm -100.04 148.29 24.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.739 0.304 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -75.9 77.69 2.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 15.6 tp -82.3 111.5 18.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 62.61 25.42 15.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . 0.43 ' C ' ' OE1' ' A' ' 399' ' ' GLU . . . 90.49 12.83 60.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . 0.43 ' OE1' ' C ' ' A' ' 398' ' ' GLY . 1.8 mp0 -131.76 129.55 40.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.943 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.49 97.43 3.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 20.7 pt -76.16 147.47 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -113.22 130.47 56.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.455 HD12 ' N ' ' A' ' 392' ' ' ASN . 11.7 mt -113.1 126.72 70.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.121 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 30.1 m -140.48 134.03 33.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.064 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 14.3 m-85 -50.95 110.1 0.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.857 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.911 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.415 ' HB3' ' NH1' ' A' ' 381' ' ' ARG . 10.5 ptpt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.829 0.347 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.22 121.87 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.083 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.524 HD13 ' CE1' ' A' ' 378' ' ' PHE . 78.5 mt -98.81 121.75 41.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -88.31 106.56 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 47.2 t -105.16 135.33 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -134.73 167.64 20.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.84 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 24.7 t30 74.59 49.99 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 14.5 mt -92.53 130.24 38.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.06 -179.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.101 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -87.15 6.5 32.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 22.2 p -124.15 15.88 9.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.171 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 55.3 t -91.98 134.93 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.151 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 58.4 p -136.98 161.0 37.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.145 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -47.02 -42.93 19.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -56.76 -40.42 75.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.884 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 83.0 mt -72.17 -29.55 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 85.3 mt -74.73 -28.04 60.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 359' ' ' SER . 45.3 mt-10 -72.26 -70.09 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -42.08 -44.1 3.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' ALA . . . . . 0.421 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -63.38 -57.05 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.097 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' PHE . . . . . 0.408 ' CE2' HD12 ' A' ' 403' ' ' ILE . 41.0 m-85 -85.09 16.08 3.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 355' ' ' GLU . 5.4 t -100.07 -59.27 1.74 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.851 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 359' ' ' SER . 21.7 pt20 -36.82 -40.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.561 ' CD2' ' HB3' ' A' ' 387' ' ' ALA . 92.8 m-85 -62.36 -61.83 2.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.39 161.79 29.59 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.474 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.28 128.63 22.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 0.0 110.876 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.462 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 49.6 mt -98.81 152.95 19.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -101.45 -47.64 4.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -170.17 166.02 9.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.841 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 60.1 t -137.49 123.64 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -105.73 111.34 23.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -91.02 136.48 33.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.565 HD23 ' CE2' ' A' ' 373' ' ' TYR . 6.9 mp -124.73 -174.82 3.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 370' ' ' LEU . 7.9 mmtm -32.9 -71.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.09 -37.88 3.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.565 ' CE2' HD23 ' A' ' 370' ' ' LEU . 8.4 p90 -91.67 -179.8 5.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.951 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -165.55 160.47 17.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.053 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -111.69 135.51 52.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 7.5 mm -108.88 106.97 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.099 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -87.58 120.29 28.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.535 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 23.6 m-85 -99.74 158.6 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -79.91 -32.07 40.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -128.22 152.91 47.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.423 ' HB2' ' NH1' ' A' ' 381' ' ' ARG . 0.0 OUTLIER -59.14 -34.08 71.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.855 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 384' ' ' ALA . 10.3 t70 -70.74 -54.95 9.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -37.81 -30.75 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.449 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -81.28 -65.92 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.419 ' C ' ' O ' ' A' ' 384' ' ' ALA . 58.4 t -36.4 -36.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.124 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -72.88 -61.83 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.561 ' HB3' ' CD2' ' A' ' 361' ' ' PHE . . . -60.3 -15.66 27.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.076 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.5 ttm -77.97 -61.18 2.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.408 ' N ' ' HG2' ' A' ' 388' ' ' MET . 16.4 mt-10 -74.89 -0.73 19.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.504 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 7.4 mm-40 -100.15 -37.41 8.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.839 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' MET . . . . . 0.494 ' O ' ' N ' ' A' ' 393' ' ' GLY . 17.8 mmm -101.66 -34.04 9.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 388' ' ' MET . 5.2 t-20 -34.0 93.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 98.17 39.47 3.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.401 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 2.0 mmmp? -99.92 147.51 25.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.886 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -75.76 69.47 2.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.851 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 14.8 tp -74.93 113.12 11.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 61.94 27.33 16.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 85.31 21.26 55.14 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.533 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -140.1 125.91 19.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.87 0.367 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.37 96.92 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 33.4 pt -74.61 148.36 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -110.35 131.27 55.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.458 HD13 ' N ' ' A' ' 392' ' ' ASN . 36.1 mt -116.06 127.61 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 11.1 m -141.11 134.24 30.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.175 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.591 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 6.3 m-85 -52.49 108.73 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.11 179.926 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 19.2 pttp . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.803 0.335 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.1 122.34 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 48.6 mt -96.52 134.67 39.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -99.19 107.9 20.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.401 ' CG1' HD13 ' A' ' 401' ' ' ILE . 29.8 t -103.71 131.81 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.147 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -130.92 172.39 12.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.901 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.7 t30 72.54 33.27 1.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 17.8 mt -76.63 125.47 29.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.01 176.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.053 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -82.73 9.95 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 20.6 p -125.78 9.7 7.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 90.8 t -92.57 139.17 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 55.5 p -143.89 171.59 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -50.7 -50.98 53.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -50.28 -39.18 44.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 74.2 mt -73.94 -35.71 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 96.7 mt -69.29 -26.26 64.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.47 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 44.9 mt-10 -76.43 -71.49 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -42.43 -35.72 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' ALA . . . . . 0.467 ' HB2' ' CE ' ' A' ' 391' ' ' MET . . . -72.81 -55.72 6.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.145 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' PHE . . . . . 0.403 ' CE2' HD11 ' A' ' 403' ' ' ILE . 41.2 m-85 -84.17 14.12 4.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 355' ' ' GLU . 18.0 t -99.65 -52.95 3.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -39.46 -37.24 0.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.565 ' CD2' ' HB3' ' A' ' 387' ' ' ALA . 93.6 m-85 -66.38 -62.58 1.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -150.53 161.85 29.11 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -53.15 122.77 10.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 110.937 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.47 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 32.0 mt -90.4 166.59 13.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -114.2 -44.78 3.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.485 ' HG3' ' CD2' ' A' ' 377' ' ' HIS . 18.5 ptt180 -173.01 166.53 5.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.414 ' CG1' HD11 ' A' ' 354' ' ' LEU . 89.7 t -139.81 123.83 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.471 ' CE ' HD11 ' A' ' 370' ' ' LEU . 1.6 tmmm? -107.17 120.1 41.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -91.73 142.28 27.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.471 HD11 ' CE ' ' A' ' 368' ' ' LYS . 6.4 mp -129.57 -174.57 3.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 370' ' ' LEU . 1.9 mptp? -33.33 -73.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -119.27 -29.66 5.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.401 ' CE2' HD21 ' A' ' 370' ' ' LEU . 3.8 p90 -97.99 -175.0 3.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.434 ' HA ' ' CD1' ' A' ' 370' ' ' LEU . . . -168.52 153.48 6.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.09 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -100.61 146.12 27.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 6.5 mm -118.87 110.81 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . 0.485 ' CD2' ' HG3' ' A' ' 366' ' ' ARG . 55.1 m-70 -89.46 126.1 35.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.819 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.445 ' CD2' HD23 ' A' ' 364' ' ' LEU . 20.1 m-85 -108.4 139.41 43.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -58.52 -29.44 66.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -134.62 143.76 47.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.42 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 3.8 tmm_? -52.13 -34.56 45.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -67.35 -56.53 9.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . 0.426 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -37.74 -32.47 0.11 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.537 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -77.43 -62.81 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.803 0.335 . . . . 0.0 111.122 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 384' ' ' ALA . 54.8 t -36.72 -39.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.133 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . 0.41 ' HA ' ' NZ ' ' A' ' 386' ' ' LYS . 0.1 OUTLIER -71.23 -65.67 0.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.565 ' HB3' ' CD2' ' A' ' 361' ' ' PHE . . . -53.84 -19.27 4.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.14 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.7 ttm -74.97 -63.74 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.458 ' N ' ' HG2' ' A' ' 388' ' ' MET . 5.5 mt-10 -73.71 1.56 10.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.565 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 3.0 mm-40 -99.67 -39.66 8.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' MET . . . . . 0.467 ' CE ' ' HB2' ' A' ' 357' ' ' ALA . 5.9 mmm -101.36 -29.95 11.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 391' ' ' MET . 4.4 t-20 -34.17 96.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 94.11 38.43 5.13 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.525 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -99.62 147.2 25.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -76.51 76.44 3.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 17.6 tp -81.48 113.92 19.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 61.99 24.92 14.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 88.09 20.23 50.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -140.06 126.6 20.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 110.924 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.6 99.28 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.401 HD13 ' CG1' ' A' ' 342' ' ' VAL . 20.9 pt -77.15 148.59 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -109.95 129.9 55.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.403 HD11 ' CE2' ' A' ' 358' ' ' PHE . 24.3 mt -113.3 129.21 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 34.2 m -146.68 135.27 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.089 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 15.9 m-85 -52.69 120.06 5.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.042 179.998 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 33.2 pttt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.816 0.341 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 77.9 t -74.79 123.24 29.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.107 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 48.9 mt -99.06 123.4 43.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -91.54 106.36 18.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 11.9 t -103.51 138.24 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.152 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -136.03 168.4 19.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 5.9 t30 73.2 54.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 31.1 mt -94.99 137.77 33.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.88 172.52 1.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.107 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -79.38 1.16 26.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 5.7 p -118.04 13.54 13.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.183 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 45.5 t -97.25 140.46 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 64.6 p -140.35 172.48 12.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.151 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -51.49 -45.89 62.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -54.87 -46.62 74.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 72.5 mt -64.32 -28.84 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.156 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 96.4 mt -76.59 -27.61 55.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 359' ' ' SER . 54.2 mt-10 -77.45 -65.69 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -46.47 -37.52 7.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' ALA . . . . . 0.462 ' HB2' ' CE ' ' A' ' 391' ' ' MET . . . -72.17 -49.83 32.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.099 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' PHE . . . . . 0.413 ' C ' HD13 ' A' ' 364' ' ' LEU . 39.6 m-85 -88.17 13.03 12.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 355' ' ' GLU . 5.3 t -98.89 -52.64 3.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . 0.401 ' HG3' ' N ' ' A' ' 361' ' ' PHE . 18.2 pt20 -38.59 -40.14 0.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.565 ' CD2' ' HB1' ' A' ' 387' ' ' ALA . 93.5 m-85 -64.0 -62.44 1.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -149.55 169.36 29.79 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -59.61 127.34 31.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.466 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 81.4 mt -95.99 156.37 16.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -104.99 -41.73 5.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -174.93 165.9 3.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 33.9 t -139.48 124.6 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.155 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -109.5 114.98 29.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . 0.416 ' C ' HD11 ' A' ' 370' ' ' LEU . 19.1 tptp -90.89 144.28 25.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.54 HD22 ' CE2' ' A' ' 373' ' ' TYR . 7.0 mp -130.92 -174.69 3.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 370' ' ' LEU . 16.1 tttm -33.09 -68.02 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.4 -37.56 2.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.54 ' CE2' HD22 ' A' ' 370' ' ' LEU . 9.7 p90 -92.23 179.8 5.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -160.86 161.54 31.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.078 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -112.42 125.37 54.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 6.1 mm -101.32 121.29 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -100.94 124.38 46.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.56 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 26.5 m-85 -106.64 133.78 50.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -53.9 -32.57 53.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -128.51 151.18 49.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -58.41 -36.31 73.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 384' ' ' ALA . 14.6 t70 -68.23 -55.48 12.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -37.97 -31.15 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.506 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -80.87 -63.96 1.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.855 0.359 . . . . 0.0 111.155 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 384' ' ' ALA . 79.7 t -36.82 -35.42 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . 0.411 ' HE2' ' CG ' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -72.02 -60.02 2.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.888 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.565 ' HB1' ' CD2' ' A' ' 361' ' ' PHE . . . -62.21 -17.37 58.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.594 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.1 ttm -75.39 -60.9 2.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.887 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.427 ' N ' ' HG2' ' A' ' 388' ' ' MET . 11.1 mt-10 -74.48 -0.79 18.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.49 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 33.8 mm-40 -99.98 -37.93 8.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.913 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' MET . . . . . 0.477 ' O ' ' CG ' ' A' ' 394' ' ' LYS . 12.3 mmm -99.9 -29.22 12.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 388' ' ' MET . 2.7 t-20 -41.24 111.79 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.845 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 75.49 28.84 60.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.507 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.477 ' CG ' ' O ' ' A' ' 391' ' ' MET . 0.0 OUTLIER -97.71 142.79 29.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -68.73 99.89 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 21.6 tp -105.46 109.67 21.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 61.6 32.63 18.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 83.28 15.99 70.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -139.82 120.09 13.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.871 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.75 106.02 3.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 23.7 pt -79.25 161.08 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.132 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -123.75 125.61 45.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 391' ' ' MET . 25.0 mt -111.16 135.51 50.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.128 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 6.9 m -150.16 130.96 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.132 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.594 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 15.5 m-85 -51.53 108.95 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.064 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 64.7 pttt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.792 0.329 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 95.5 t -81.5 121.13 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.569 HD11 ' CE1' ' A' ' 378' ' ' PHE . 60.5 mt -100.66 121.94 42.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.944 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -85.54 108.25 17.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 43.4 t -106.69 133.64 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.123 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.425 ' HB2' ' NH1' ' A' ' 343' ' ' ARG . 3.0 ptm85 -131.66 172.18 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.835 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.1 t30 72.7 37.45 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 17.5 mt -77.34 144.79 37.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -73.89 179.05 4.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -83.49 2.55 36.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 69.5 p -120.64 11.55 11.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 97.6 t -95.58 132.16 40.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.129 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 70.5 p -139.39 165.57 26.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.164 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -41.2 -44.31 2.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -55.29 -59.21 5.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 80.4 mt -55.73 -31.75 30.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.126 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.401 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 93.1 mt -71.43 -26.15 62.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.496 ' O ' ' CB ' ' A' ' 359' ' ' SER . 27.0 mt-10 -83.71 -53.92 5.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . 0.439 ' O ' ' NE2' ' A' ' 360' ' ' GLN . 74.0 mttt -57.55 -20.44 32.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' ALA . . . . . 0.467 ' HB2' ' CE ' ' A' ' 391' ' ' MET . . . -93.26 -44.45 8.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.111 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' PHE . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 41.2 m-85 -93.25 18.03 10.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 355' ' ' GLU . 3.3 t -100.06 -61.84 1.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 356' ' ' LYS . 2.4 pm0 -37.68 -37.84 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.51 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 70.0 m-85 -62.71 -58.74 6.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -155.46 162.83 31.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.483 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -55.07 123.59 14.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.422 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 60.0 mt -91.36 178.21 6.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -131.76 -44.02 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -173.97 165.96 4.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 64.6 t -138.07 134.48 44.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -118.85 117.72 29.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -93.51 144.29 25.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.481 ' O ' ' C ' ' A' ' 371' ' ' LYS . 8.0 mp -130.87 -174.44 3.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 370' ' ' LEU . 20.8 tttp -31.53 -64.78 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -128.36 -37.26 1.84 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.44 ' CE2' HD23 ' A' ' 370' ' ' LEU . 14.1 p90 -92.53 179.18 5.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -159.1 171.89 19.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.069 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -124.06 127.73 48.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.839 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.401 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.4 mm -101.2 109.31 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.161 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -85.79 110.46 19.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 340' ' ' LEU . 17.9 m-85 -92.95 143.31 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -55.32 -33.1 63.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -141.43 162.66 34.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.408 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 4.0 tmm_? -63.62 -33.0 74.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -65.47 -58.84 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.824 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -42.17 -28.6 0.53 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.452 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -80.18 -60.38 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 0.0 111.092 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 384' ' ' ALA . 60.6 t -37.44 -35.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . 0.417 ' HA ' ' NZ ' ' A' ' 386' ' ' LYS . 0.0 OUTLIER -73.83 -63.25 1.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.65 -14.41 13.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.563 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.7 ttm -80.28 -62.24 1.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.859 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.413 ' N ' ' HG2' ' A' ' 388' ' ' MET . 11.9 mt-10 -75.05 -3.19 31.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.51 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 28.2 mm-40 -100.16 -29.38 12.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.822 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' MET . . . . . 0.501 ' O ' ' N ' ' A' ' 393' ' ' GLY . 5.0 mmt -107.92 -41.98 4.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 388' ' ' MET . 26.2 t-20 -34.21 93.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.856 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 103.64 28.44 5.99 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.51 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 391' ' ' MET . 1.1 mmmm -98.54 146.31 25.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.319 . . . . 0.0 110.918 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -74.35 78.6 1.86 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.872 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 19.0 tp -86.23 113.22 22.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 62.34 25.1 14.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.31 17.98 58.04 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.483 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -138.64 124.26 19.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.28 92.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 20.7 pt -71.56 146.13 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.154 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -111.76 130.84 55.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 392' ' ' ASN . 20.9 mt -115.04 126.47 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.43 136.82 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.132 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.563 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 13.1 m-85 -54.56 110.61 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.825 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.116 179.896 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 17.3 pttp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.857 0.361 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 64.6 t -79.1 123.92 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 72.0 mt -104.19 125.48 50.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -90.04 106.66 18.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 22.3 t -104.31 137.68 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.163 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -136.34 169.25 17.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.3 t30 74.16 46.81 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.901 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 48.5 mt -83.88 135.91 34.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.944 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.3 179.8 0.54 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -85.81 5.97 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 49.8 p -123.43 11.61 9.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 87.5 t -90.81 153.01 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 77.6 p -153.96 173.18 16.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -58.55 -35.85 72.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.6 -40.71 92.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 68.9 mt -69.16 -28.66 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.457 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 94.6 mt -72.39 -31.47 65.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 359' ' ' SER . 64.8 mt-10 -72.18 -74.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -42.05 -34.55 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' ALA . . . . . 0.429 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -73.01 -52.13 15.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -88.06 15.11 7.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 360' ' ' GLN . 82.7 p -97.23 -56.39 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 359' ' ' SER . 26.4 pt20 -35.16 -42.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.524 ' CD2' ' HB1' ' A' ' 387' ' ' ALA . 87.9 m-85 -61.42 -68.36 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -146.51 165.03 28.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.489 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -54.72 127.65 29.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.828 0.347 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 78.7 mt -96.35 156.41 16.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -103.36 -42.42 5.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -174.59 169.43 3.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 48.9 t -140.65 126.02 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.123 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -119.73 104.86 10.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . 0.472 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 20.2 tttm -82.81 152.75 25.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.563 HD21 ' CE2' ' A' ' 373' ' ' TYR . 6.9 mp -130.51 -174.8 3.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 370' ' ' LEU . 16.9 tptm -33.26 -68.8 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -118.66 -39.06 3.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.563 ' CE2' HD21 ' A' ' 370' ' ' LEU . 7.0 p90 -92.9 -178.94 4.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 369' ' ' LYS . . . -158.02 168.16 27.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.061 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -121.28 128.3 52.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 7.4 mm -103.7 113.7 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -92.52 123.71 36.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 387' ' ' ALA . 20.4 m-85 -105.77 145.61 30.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.64 -33.73 74.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -132.29 159.09 40.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.421 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 0.4 OUTLIER -65.24 -28.91 69.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 384' ' ' ALA . 23.5 t0 -70.77 -61.07 1.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -36.89 -30.37 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.509 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 382' ' ' ASP . . . -76.91 -63.22 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.346 . . . . 0.0 111.07 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 384' ' ' ALA . 89.5 t -36.46 -35.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.095 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -63.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.524 ' HB1' ' CD2' ' A' ' 361' ' ' PHE . . . -59.21 -16.16 19.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.515 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.7 ttm -77.75 -61.64 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.413 ' N ' ' HG2' ' A' ' 388' ' ' MET . 14.6 mt-10 -75.22 0.31 16.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.48 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 32.4 mm-40 -100.07 -36.58 9.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' MET . . . . . 0.5 ' O ' ' N ' ' A' ' 393' ' ' GLY . 3.6 mmt -102.95 -30.32 10.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 388' ' ' MET . 7.0 t-20 -42.54 91.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 100.82 30.46 6.09 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.462 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 391' ' ' MET . 22.1 mmtt -100.0 148.43 24.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.743 0.306 . . . . 0.0 110.943 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -74.15 85.49 1.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.905 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 21.8 tp -93.34 112.34 24.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 62.48 26.94 16.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 86.35 18.39 59.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -140.09 126.0 19.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.882 0.373 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.0 93.51 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 25.9 pt -71.02 149.32 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.085 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -113.51 131.7 55.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.429 ' O ' ' ND2' ' A' ' 392' ' ' ASN . 30.9 mt -113.3 133.46 59.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.14 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 5.1 m -145.72 132.83 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.515 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 7.1 m-85 -53.7 109.45 0.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.094 179.909 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.837 0.351 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 58.3 t -80.65 132.74 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.413 HD12 ' CE1' ' A' ' 378' ' ' PHE . 33.4 mt -110.74 127.38 55.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -90.39 114.08 26.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.59 131.62 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -130.0 170.14 14.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.2 t30 74.81 41.21 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 44.1 mt -80.27 133.6 36.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -56.17 -177.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -91.67 11.59 23.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.908 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 51.4 p -135.04 17.71 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 71.4 t -95.48 136.92 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.103 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 76.9 p -135.79 170.52 15.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.133 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -52.49 -46.05 66.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -52.59 -42.97 64.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 77.6 mt -70.94 -27.46 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.178 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.414 HD12 ' CG1' ' A' ' 367' ' ' VAL . 97.8 mt -73.99 -31.5 62.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 359' ' ' SER . 24.4 mt-10 -74.73 -64.83 0.96 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.939 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -44.36 -40.34 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' ALA . . . . . 0.444 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -71.26 -55.79 7.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.092 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' PHE . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 45.3 m-85 -81.77 13.95 2.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.864 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 355' ' ' GLU . 7.2 t -100.03 -54.17 2.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.828 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -39.65 -36.02 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.557 ' CD2' ' HB2' ' A' ' 387' ' ' ALA . 81.1 m-85 -65.52 -63.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.19 168.74 31.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.479 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -53.37 129.12 30.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 110.906 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.512 HD21 ' CD2' ' A' ' 378' ' ' PHE . 32.7 mt -99.54 163.35 12.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -111.93 -48.68 3.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -172.82 165.91 5.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.414 ' CG1' HD12 ' A' ' 354' ' ' LEU . 93.7 t -134.45 127.41 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.147 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -110.83 114.19 27.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -89.97 138.76 31.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.87 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.499 HD22 ' CE2' ' A' ' 373' ' ' TYR . 7.7 mp -125.49 -174.83 3.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 370' ' ' LEU . 3.2 mptp? -33.7 -70.81 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.94 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -119.01 -38.26 3.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.838 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.499 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.9 p90 -91.78 -175.79 4.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.947 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -164.95 158.26 16.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -109.63 133.57 52.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 3.7 mm -107.41 107.48 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -85.5 117.88 24.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.512 ' CD2' HD21 ' A' ' 364' ' ' LEU . 16.2 m-85 -99.42 146.13 26.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -57.72 -36.48 72.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -133.18 160.34 37.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.415 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 1.6 tmm_? -63.92 -35.27 80.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 384' ' ' ALA . 11.5 t0 -65.77 -58.58 5.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -38.62 -30.67 0.1 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.466 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 382' ' ' ASP . . . -76.95 -58.91 3.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.317 . . . . 0.0 111.091 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.4 t -37.9 -37.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.122 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . 0.425 ' HA ' ' NZ ' ' A' ' 386' ' ' LYS . 0.1 OUTLIER -72.3 -65.36 0.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.84 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.557 ' HB2' ' CD2' ' A' ' 361' ' ' PHE . . . -56.14 -16.57 5.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.106 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.535 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.5 ttm -78.52 -64.13 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.455 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.1 mt-10 -73.86 0.83 12.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.478 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 57.5 mm-40 -100.14 -39.91 7.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' MET . . . . . 0.447 ' O ' ' N ' ' A' ' 393' ' ' GLY . 5.9 mmm -100.11 -30.12 12.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 388' ' ' MET . 5.5 t-20 -42.03 94.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 100.61 30.38 6.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.503 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.0 147.74 25.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.329 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' ASP . . . . . 0.414 ' OD1' ' C ' ' A' ' 395' ' ' ASP . 31.2 t0 -75.35 88.63 2.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.875 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 29.2 tp -94.73 110.17 22.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.984 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 63.35 24.95 14.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.47 18.95 51.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.448 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -139.94 125.59 19.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.9 94.05 2.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 20.1 pt -71.5 148.14 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -112.04 130.3 55.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.879 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.436 ' O ' ' ND2' ' A' ' 392' ' ' ASN . 27.2 mt -112.43 131.24 64.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.096 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 22.1 m -144.8 136.58 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.535 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 12.2 m-85 -54.17 116.0 2.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.098 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 40.8 pttt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.783 0.325 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.0 t -79.48 138.98 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.559 HD11 ' CE1' ' A' ' 378' ' ' PHE . 47.4 mt -114.01 130.84 56.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -92.19 107.98 19.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.09 136.36 39.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -135.78 173.36 11.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.0 t30 68.89 52.1 0.54 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 18.0 mt -94.94 121.15 36.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -46.26 173.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -80.78 13.79 2.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 38.6 p -128.19 5.58 5.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 51.0 t -88.92 140.41 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.107 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 68.0 p -143.71 170.56 15.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.134 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -49.47 -41.86 41.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -59.31 -39.0 81.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 77.0 mt -73.64 -29.38 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.451 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 89.7 mt -74.26 -27.48 60.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 359' ' ' SER . 38.0 mt-10 -80.2 -66.87 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -48.7 -25.54 1.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -83.91 -47.47 11.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -90.76 12.89 17.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 355' ' ' GLU . 99.2 p -99.64 -46.93 5.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -41.75 -30.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.567 ' CD2' ' HB3' ' A' ' 387' ' ' ALA . 98.4 m-85 -75.43 -73.92 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -135.56 174.4 21.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.476 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -60.16 133.88 56.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.792 0.33 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.411 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 50.0 mt -103.74 153.36 20.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -103.5 -47.42 4.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -173.47 165.08 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.849 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 51.4 t -136.58 132.57 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.72 107.79 15.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -83.43 143.36 30.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.526 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.2 mp -128.59 -174.27 3.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.941 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 370' ' ' LEU . 21.6 mtpp -32.48 -64.15 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.47 -33.77 2.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.526 ' CE2' HD22 ' A' ' 370' ' ' LEU . 3.8 p90 -93.74 -176.04 3.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.436 ' HA ' ' CD1' ' A' ' 370' ' ' LEU . . . -166.81 160.49 14.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.123 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -111.57 134.85 52.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.489 HG23 ' CE1' ' A' ' 378' ' ' PHE . 3.6 mm -109.76 116.05 51.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -92.13 121.16 33.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.559 ' CE1' HD11 ' A' ' 340' ' ' LEU . 20.0 m-85 -106.57 127.67 53.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -42.52 -35.82 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -134.28 157.6 45.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -34.57 74.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 384' ' ' ALA . 27.1 t0 -65.67 -57.4 8.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . 0.459 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -38.97 -29.15 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 382' ' ' ASP . . . -82.07 -58.86 2.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 111.122 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 94.1 t -38.16 -39.66 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.109 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -68.62 -60.56 2.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.567 ' HB3' ' CD2' ' A' ' 361' ' ' PHE . . . -63.07 -14.35 47.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.085 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 7.6 ttm -79.43 -59.67 2.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -75.09 -3.43 32.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.513 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 6.2 mm-40 -100.07 -37.18 9.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' MET . . . . . 0.498 ' O ' ' CG ' ' A' ' 394' ' ' LYS . 69.8 mmm -99.91 -25.13 14.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 388' ' ' MET . 1.4 t-20 -42.04 118.84 1.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 63.69 32.68 84.98 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.467 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 391' ' ' MET . 0.0 OUTLIER -96.75 145.2 26.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.757 0.313 . . . . 0.0 110.91 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -68.48 108.22 3.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 21.1 tp -119.51 111.45 18.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 62.01 37.06 15.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.893 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 76.72 11.17 85.58 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.492 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -137.27 121.08 17.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.368 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.34 116.04 8.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 17.3 pt -90.99 147.55 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.113 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -111.23 133.13 53.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 391' ' ' MET . 22.6 mt -116.92 134.69 59.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.127 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 3.9 m -144.92 140.59 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 14.9 m-85 -61.0 105.01 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 179.943 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.84 0.352 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.83 130.83 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 403' ' ' ILE . 63.0 mt -106.27 124.62 49.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -88.69 107.28 18.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 20.6 t -101.98 134.73 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.126 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -134.54 170.35 15.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.823 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.1 t30 72.91 39.12 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 31.1 mt -79.93 154.45 28.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -93.08 163.17 13.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -65.51 -7.29 13.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 81.9 p -103.53 -0.13 30.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.135 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 96.0 t -91.97 132.27 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.087 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 67.8 p -134.62 170.3 16.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -50.97 -44.95 60.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -56.61 -41.2 76.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.933 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 73.2 mt -70.46 -30.25 42.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.138 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.433 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 97.2 mt -73.5 -30.13 62.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 359' ' ' SER . 49.4 mt-10 -75.64 -67.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -47.87 -36.44 12.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.848 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' ALA . . . . . 0.464 ' HB3' ' CE ' ' A' ' 391' ' ' MET . . . -70.96 -49.77 41.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -88.9 12.78 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 355' ' ' GLU . 40.4 t -99.26 -53.41 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -37.96 -31.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.55 ' CD2' ' HB1' ' A' ' 387' ' ' ALA . 91.5 m-85 -71.98 -63.11 1.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -149.55 171.12 29.71 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.465 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -58.62 128.26 36.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 0.0 110.917 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.456 HD22 ' CD2' ' A' ' 378' ' ' PHE . 33.7 mt -97.35 171.48 8.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.956 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -120.52 -45.69 2.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -173.84 165.03 4.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.858 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.43 HG11 ' N ' ' A' ' 368' ' ' LYS . 40.4 t -137.12 137.37 46.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.43 ' N ' HG11 ' A' ' 367' ' ' VAL . 7.9 tmtm? -125.07 120.32 31.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.864 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -94.44 140.92 29.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.873 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.462 ' O ' ' C ' ' A' ' 371' ' ' LYS . 6.8 mp -124.47 -174.71 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 370' ' ' LEU . 19.3 tttp -33.11 -65.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -125.67 -37.44 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.864 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -92.41 -174.8 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -164.69 163.66 21.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -116.15 129.6 56.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.901 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.1 mm -104.52 119.45 53.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -98.3 121.89 40.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.493 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 21.5 m-85 -102.75 149.9 24.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.76 -29.19 70.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.858 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -136.23 160.54 38.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.892 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.415 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 7.0 tmm_? -65.05 -29.41 70.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -73.13 -54.09 9.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . 0.493 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -40.17 -30.76 0.28 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -80.13 -63.87 1.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 111.104 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 384' ' ' ALA . 52.6 t -37.08 -35.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.131 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -61.5 1.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.55 ' HB1' ' CD2' ' A' ' 361' ' ' PHE . . . -60.88 -16.12 38.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.098 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.52 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.3 ttm -78.13 -62.21 1.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.436 ' N ' ' HG2' ' A' ' 388' ' ' MET . 18.5 mt-10 -74.5 1.22 12.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.545 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 4.4 mm-40 -100.07 -39.08 8.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' MET . . . . . 0.5 ' O ' ' N ' ' A' ' 393' ' ' GLY . 10.6 mmm -102.7 -30.76 10.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 388' ' ' MET . 5.7 t-20 -34.35 93.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 98.81 37.23 4.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -99.97 148.34 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.328 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -76.06 77.95 2.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.861 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 16.6 tp -83.36 110.54 18.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.979 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 63.04 29.67 16.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 84.18 20.68 58.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -140.09 126.7 20.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.83 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.43 97.84 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 22.2 pt -77.79 146.38 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -112.12 131.69 55.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.882 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.465 HD12 ' N ' ' A' ' 392' ' ' ASN . 13.5 mt -112.04 132.45 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.101 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 13.7 m -145.69 134.06 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.52 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 16.2 m-85 -51.5 111.13 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.844 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.128 179.889 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 23.4 pttt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.856 0.36 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 91.6 t -75.7 124.9 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 91.4 mt -104.97 116.67 32.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -82.79 109.33 16.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.455 ' CG1' HD13 ' A' ' 401' ' ' ILE . 24.4 t -108.3 132.26 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -130.72 177.17 7.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 68.94 43.79 1.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 33.6 mt -83.39 141.26 31.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.41 -178.16 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.095 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -88.87 2.95 52.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 61.4 p -120.08 13.87 12.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.186 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 73.6 t -92.83 150.47 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 75.5 p -149.13 170.04 19.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -52.07 -44.85 64.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -54.61 -52.12 63.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 77.8 mt -58.07 -33.1 45.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 87.4 mt -73.85 -26.63 60.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.918 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.459 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 31.7 mt-10 -78.92 -63.29 1.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -51.35 -41.33 60.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' ALA . . . . . 0.47 ' HB3' ' CE ' ' A' ' 391' ' ' MET . . . -65.85 -49.73 67.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.055 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -89.08 16.82 6.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 360' ' ' GLN . 12.2 t -99.95 -57.15 2.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 359' ' ' SER . 24.0 pt20 -37.68 -39.42 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.914 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.563 ' CD2' ' HB3' ' A' ' 387' ' ' ALA . 71.6 m-85 -62.83 -63.41 1.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -150.88 166.45 30.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.499 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -54.88 125.53 20.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 0.0 110.916 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.459 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 34.3 mt -94.12 154.32 17.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -103.63 -44.9 4.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -174.92 163.6 3.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.445 ' CG2' ' HG2' ' A' ' 355' ' ' GLU . 51.8 t -135.14 124.06 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.34 106.97 13.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . 0.477 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 17.6 tttm -84.14 150.43 25.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.516 HD23 ' CE2' ' A' ' 373' ' ' TYR . 6.4 mp -127.97 -174.33 3.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 370' ' ' LEU . 9.7 ttmt -32.58 -67.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.04 -38.68 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.843 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.516 ' CE2' HD23 ' A' ' 370' ' ' LEU . 4.8 p90 -91.94 -176.39 4.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 369' ' ' LYS . . . -160.88 166.86 27.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -119.53 131.9 55.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.416 HG21 ' CE1' ' A' ' 378' ' ' PHE . 7.2 mm -107.79 110.31 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.132 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -88.9 125.64 35.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.428 ' CZ ' ' HB1' ' A' ' 387' ' ' ALA . 20.0 m-85 -108.8 134.59 51.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.87 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -46.66 -36.55 7.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -133.29 158.84 41.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -62.29 -36.56 82.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 384' ' ' ALA . 26.4 t70 -63.48 -59.5 4.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 382' ' ' ASP . . . -36.89 -31.78 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 382' ' ' ASP . . . -76.06 -61.24 2.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 111.093 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 384' ' ' ALA . 66.7 t -35.79 -33.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.088 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 384' ' ' ALA . 0.0 OUTLIER -75.3 -65.15 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.872 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.563 ' HB3' ' CD2' ' A' ' 361' ' ' PHE . . . -58.0 -14.77 7.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.1 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.59 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.8 ttm -80.23 -62.38 1.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.874 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.413 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.0 mt-10 -75.63 -1.64 25.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.537 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 69.0 mm-40 -100.14 -32.28 10.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' MET . . . . . 0.486 ' O ' ' N ' ' A' ' 393' ' ' GLY . 19.5 mmm -106.2 -37.94 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.896 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 388' ' ' MET . 7.0 t-20 -33.9 93.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.927 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 103.92 27.02 6.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.481 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 391' ' ' MET . 14.1 mmmt -90.76 146.72 23.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.792 0.33 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.72 72.41 3.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.897 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 15.8 tp -75.84 111.82 11.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 62.49 24.99 14.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . 0.446 ' C ' ' OE1' ' A' ' 399' ' ' GLU . . . 89.75 14.39 59.66 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.508 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . 0.446 ' OE1' ' C ' ' A' ' 398' ' ' GLY . 2.5 mp0 -132.88 127.71 34.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.87 0.367 . . . . 0.0 110.849 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.46 96.81 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.455 HD13 ' CG1' ' A' ' 342' ' ' VAL . 20.4 pt -74.67 148.9 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.11 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -112.58 129.71 56.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.461 ' O ' ' ND2' ' A' ' 392' ' ' ASN . 27.3 mt -113.91 126.47 71.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.141 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.65 136.28 46.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.149 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.59 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 9.0 m-85 -54.9 112.61 1.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.104 179.943 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 8.8 pttm . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.8 0.333 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 67.7 t -79.61 118.81 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.147 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 46.1 mt -99.2 131.02 45.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -92.92 105.17 17.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.413 HG21 ' CZ ' ' A' ' 358' ' ' PHE . 20.8 t -104.17 131.83 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -133.21 173.73 11.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 73.06 35.47 0.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 21.4 mt -76.63 139.18 40.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -67.52 -178.93 0.97 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -85.7 -0.26 54.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 17.2 p -117.64 14.94 14.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.159 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 96.0 t -96.52 133.73 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.127 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 39.8 p -134.39 169.01 17.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.116 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -51.7 -41.66 61.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -57.47 -43.87 84.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 66.5 mt -67.7 -29.56 45.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.424 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 96.0 mt -72.78 -32.01 65.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 359' ' ' SER . 16.1 mt-10 -73.14 -69.85 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . 0.481 ' HE3' ' N ' ' A' ' 356' ' ' LYS . 0.7 OUTLIER -43.25 -39.11 2.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' ALA . . . . . 0.47 ' HB2' ' CE ' ' A' ' 391' ' ' MET . . . -69.59 -56.02 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' PHE . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 42.7 m-85 -83.96 14.54 4.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 355' ' ' GLU . 11.7 t -100.01 -52.39 3.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -40.35 -37.63 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.562 ' CD2' ' HB2' ' A' ' 387' ' ' ALA . 79.9 m-85 -65.7 -62.75 1.34 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.94 162.22 29.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.507 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -49.0 130.85 18.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 0.0 110.917 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.469 HD21 ' CD2' ' A' ' 378' ' ' PHE . 36.2 mt -101.21 155.02 18.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -100.12 -47.86 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -173.52 167.44 4.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.407 ' CG2' ' HG2' ' A' ' 355' ' ' GLU . 83.2 t -136.87 133.42 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.4 ' N ' HG13 ' A' ' 367' ' ' VAL . 1.0 OUTLIER -119.34 118.51 31.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 12.9 tptp -92.66 141.33 28.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.458 ' O ' ' C ' ' A' ' 371' ' ' LYS . 6.5 mp -126.39 -174.65 3.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 370' ' ' LEU . 1.3 mppt? -33.51 -68.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -122.27 -37.67 2.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -92.64 -176.39 4.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -163.87 161.84 23.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -112.4 134.68 53.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.7 mm -108.56 109.11 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.151 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -88.42 120.67 30.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.469 ' CD2' HD21 ' A' ' 364' ' ' LEU . 17.9 m-85 -101.92 147.53 26.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.54 -33.7 75.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -132.71 153.97 50.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -61.78 -31.01 71.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.99 -51.18 27.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -43.18 -36.67 2.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.501 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -72.11 -59.32 2.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.865 0.364 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.419 ' C ' ' O ' ' A' ' 384' ' ' ALA . 86.1 t -36.41 -37.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.8 tptt -72.56 -66.01 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' A' ' 361' ' ' PHE . . . -56.3 -15.87 4.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 7.5 ttm -78.94 -60.15 2.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -78.2 -2.5 38.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.518 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 65.0 mm-40 -100.07 -21.62 15.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' MET . . . . . 0.499 ' O ' ' N ' ' A' ' 393' ' ' GLY . 10.9 mmm -116.8 -39.12 3.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 391' ' ' MET . 27.5 t-20 -33.23 93.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 103.73 29.93 5.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 391' ' ' MET . 14.8 mmmt -96.2 146.4 24.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.729 0.299 . . . . 0.0 110.914 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.66 74.05 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 15.6 tp -76.41 110.65 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 62.28 24.96 14.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.66 13.84 57.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.478 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -133.56 130.53 38.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 0.0 110.889 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.3 93.57 2.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 20.2 pt -72.06 145.47 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -108.72 130.2 55.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 391' ' ' MET . 24.7 mt -115.52 127.82 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.1 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.27 140.07 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 7.7 m-85 -58.16 108.95 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 49.9 pttt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.826 0.346 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.95 122.45 27.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.153 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.433 ' HB3' ' CG2' ' A' ' 403' ' ' ILE . 29.3 mt -102.33 122.85 45.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -85.64 111.29 19.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.22 141.51 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.117 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -140.74 168.21 20.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 75.05 45.34 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 54.0 mt -81.08 137.97 35.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.31 -175.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.085 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -89.86 -4.84 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.851 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 80.5 p -118.71 19.26 13.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 81.5 t -94.74 152.57 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.091 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 82.2 p -155.45 175.44 13.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -57.28 -45.82 83.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.926 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -53.4 -43.59 68.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 70.7 mt -67.72 -38.81 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.462 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 88.1 mt -64.28 -25.41 68.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.961 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 359' ' ' SER . 37.2 mt-10 -76.94 -71.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -44.2 -33.17 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -74.39 -52.47 12.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.128 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' PHE . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 41.7 m-85 -88.27 13.57 11.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 355' ' ' GLU . 11.8 t -100.03 -58.22 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 359' ' ' SER . 20.7 pt20 -34.96 -39.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.567 ' CD2' ' HB2' ' A' ' 387' ' ' ALA . 89.6 m-85 -63.41 -63.91 1.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -149.83 166.47 29.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.81 129.98 31.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.917 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 27.8 mt -98.36 161.51 13.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.869 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -109.71 -46.28 3.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -174.32 165.27 4.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.417 ' CG1' HD13 ' A' ' 354' ' ' LEU . 53.2 t -135.75 132.57 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.108 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.77 108.25 10.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . 0.458 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 8.3 tttm -87.77 147.28 25.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 371' ' ' LYS . 5.6 mp -126.33 -173.52 2.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.486 ' C ' ' O ' ' A' ' 370' ' ' LEU . 32.4 ttmt -30.35 -65.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -125.72 -37.96 2.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.861 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.485 ' CE2' HD21 ' A' ' 370' ' ' LEU . 4.5 p90 -90.93 -176.25 4.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.47 ' HA ' ' CD1' ' A' ' 370' ' ' LEU . . . -162.78 160.93 25.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.086 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -116.28 121.86 43.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.462 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 5.3 mm -96.62 122.26 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -100.09 123.19 44.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 358' ' ' PHE . 19.9 m-85 -105.3 147.71 27.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -64.28 -35.01 79.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -130.99 147.46 52.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.457 ' NH1' ' CG2' ' A' ' 385' ' ' VAL . 0.0 OUTLIER -55.54 -32.07 62.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.826 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 384' ' ' ALA . 7.1 t70 -68.74 -60.6 2.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 382' ' ' ASP . . . -36.35 -33.81 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.491 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -74.07 -63.8 1.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 111.065 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.457 ' CG2' ' NH1' ' A' ' 381' ' ' ARG . 92.5 t -35.43 -35.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . 0.468 ' HE3' ' CG ' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -71.92 -60.56 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.567 ' HB2' ' CD2' ' A' ' 361' ' ' PHE . . . -62.1 -17.73 58.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.135 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.585 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 7.4 ttm -75.24 -59.1 2.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -77.69 -3.04 39.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.468 ' CG ' ' HE3' ' A' ' 386' ' ' LYS . 28.5 mm-40 -100.09 -29.21 12.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.884 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' MET . . . . . 0.463 ' O ' ' CG ' ' A' ' 394' ' ' LYS . 7.4 mmm -108.0 -28.92 9.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 388' ' ' MET . 2.6 t-20 -43.74 111.56 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 78.81 24.71 61.67 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 391' ' ' MET . 0.0 OUTLIER -93.62 142.57 27.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 0.0 110.876 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -70.56 103.19 2.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.787 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 19.5 tp -109.83 110.48 21.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 62.04 34.4 16.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 80.8 16.28 75.58 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.518 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -140.03 119.57 13.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.31 104.32 2.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 28.0 pt -79.42 151.06 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -114.81 132.02 56.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.457 HD11 ' N ' ' A' ' 392' ' ' ASN . 22.6 mt -116.05 134.83 58.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.109 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 14.1 m -147.74 130.62 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.585 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 14.5 m-85 -49.52 105.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.072 179.914 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 25.5 pttm . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.801 0.334 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.2 t -79.96 123.01 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.562 HD11 ' CE1' ' A' ' 378' ' ' PHE . 33.5 mt -102.42 131.23 49.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.948 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -94.78 104.7 16.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.468 ' CG1' HD12 ' A' ' 401' ' ' ILE . 33.0 t -104.42 130.78 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -132.33 173.35 11.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . 0.493 ' ND2' ' OE1' ' A' ' 399' ' ' GLU . 0.7 OUTLIER 73.78 40.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.888 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 62.1 mt -78.86 159.11 27.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -86.0 -178.74 6.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.075 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -88.39 4.64 45.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 15.9 p -124.47 15.41 8.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.1 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.87 143.6 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.089 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 73.7 p -143.3 173.11 11.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -52.93 -48.09 67.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -51.77 -46.18 64.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.862 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 77.5 mt -64.7 -35.7 75.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.46 HD13 ' CG1' ' A' ' 367' ' ' VAL . 95.6 mt -69.53 -27.4 65.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.458 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 34.2 mt-10 -77.64 -69.19 0.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -46.21 -32.8 3.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' ALA . . . . . 0.464 ' HB3' ' CE ' ' A' ' 391' ' ' MET . . . -75.77 -49.16 18.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.098 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' PHE . . . . . 0.42 ' CG ' HG21 ' A' ' 376' ' ' ILE . 28.7 m-85 -89.73 15.89 8.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 360' ' ' GLN . 9.9 t -98.9 -57.81 2.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.842 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 359' ' ' SER . 24.2 pt20 -35.97 -39.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.892 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.564 ' CD2' ' HB2' ' A' ' 387' ' ' ALA . 85.1 m-85 -63.78 -63.4 1.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.39 162.52 29.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.434 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -50.12 127.28 16.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.458 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 32.3 mt -97.66 153.97 17.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -102.06 -49.03 4.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -171.31 164.42 7.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.46 ' CG1' HD13 ' A' ' 354' ' ' LEU . 40.6 t -136.4 125.8 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -112.08 118.95 36.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -91.32 140.52 29.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.93 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.455 ' O ' ' C ' ' A' ' 371' ' ' LYS . 6.5 mp -124.24 -174.76 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 370' ' ' LEU . 1.0 OUTLIER -33.69 -69.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -119.6 -38.53 2.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.822 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.438 ' CE2' HD22 ' A' ' 370' ' ' LEU . 5.2 p90 -91.44 -174.95 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -163.83 162.81 23.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.111 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -112.47 139.26 48.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.42 HG21 ' CG ' ' A' ' 358' ' ' PHE . 6.2 mm -114.11 104.31 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.119 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -84.26 122.78 29.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.562 ' CE1' HD11 ' A' ' 340' ' ' LEU . 19.8 m-85 -105.12 148.1 27.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -58.46 -36.85 74.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -134.35 155.79 49.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.879 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . 0.419 ' C ' ' HD3' ' A' ' 381' ' ' ARG . 2.4 tmt_? -59.05 -34.56 72.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 384' ' ' ALA . 23.1 t70 -67.01 -60.03 2.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.831 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -37.06 -32.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.487 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . 0.421 ' CB ' HD21 ' A' ' 340' ' ' LEU . . . -76.82 -54.95 5.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.859 0.361 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 384' ' ' ALA . 65.1 t -36.79 -39.7 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -69.8 -66.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.564 ' HB2' ' CD2' ' A' ' 361' ' ' PHE . . . -53.29 -15.73 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.118 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.56 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.5 ttm -79.6 -63.93 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.445 ' N ' ' HG2' ' A' ' 388' ' ' MET . 6.4 mt-10 -75.2 -0.67 20.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.511 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 28.3 mm-40 -100.19 -35.36 9.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' MET . . . . . 0.466 ' HB2' ' CD1' ' A' ' 403' ' ' ILE . 9.8 mmm -103.47 -34.61 8.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 388' ' ' MET . 3.5 t-20 -37.79 99.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 96.04 28.53 9.23 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.452 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 391' ' ' MET . 34.4 mmtt -95.6 147.26 23.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.779 0.323 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.37 78.02 3.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 21.5 tp -81.87 110.39 17.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 62.19 27.48 16.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.43 21.3 48.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . 0.493 ' OE1' ' ND2' ' A' ' 344' ' ' ASN . 12.7 mm-40 -140.06 126.51 20.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 0.0 110.851 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.47 92.53 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.468 HD12 ' CG1' ' A' ' 342' ' ' VAL . 28.8 pt -72.41 150.54 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.094 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -115.78 131.35 56.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 391' ' ' MET . 28.0 mt -114.87 124.84 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.164 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 30.7 m -138.03 132.33 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.56 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 17.7 m-85 -49.18 114.11 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.124 179.92 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? . . . . . 0 N--CA 1.457 -0.075 0 CA-C-O 120.861 0.362 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 60.2 t -79.86 129.83 36.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.147 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.558 HD12 ' CE1' ' A' ' 378' ' ' PHE . 31.2 mt -110.71 125.03 53.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.47 ' CE1' ' HB3' ' A' ' 343' ' ' ARG . 6.3 t80 -86.04 118.84 25.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.471 ' CG1' HD12 ' A' ' 401' ' ' ILE . 21.2 t -115.73 130.12 70.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.099 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.47 ' HB3' ' CE1' ' A' ' 341' ' ' PHE . 6.9 ptp180 -128.58 -179.91 5.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.7 t30 65.22 41.92 4.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 39.4 mt -84.32 136.33 33.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.28 172.48 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.128 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -81.66 11.92 4.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 18.5 p -129.36 11.19 5.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.562 ' CG1' ' NZ ' ' A' ' 369' ' ' LYS . 84.8 t -85.91 139.61 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.164 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' THR . . . . . 0.457 ' N ' HG12 ' A' ' 349' ' ' VAL . 76.7 p -140.42 157.71 45.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -43.92 -43.9 6.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -54.36 -42.87 70.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 78.1 mt -68.93 -33.37 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.453 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 95.2 mt -69.22 -30.83 69.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 359' ' ' SER . 51.9 mt-10 -72.72 -72.41 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -44.19 -36.91 2.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' ALA . . . . . 0.407 ' HB2' ' CE ' ' A' ' 391' ' ' MET . . . -69.42 -51.87 32.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' PHE . . . . . 0.454 ' CE2' HD13 ' A' ' 403' ' ' ILE . 34.8 m-85 -89.23 15.58 8.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 355' ' ' GLU . 12.3 t -99.66 -51.82 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -40.44 -38.22 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.945 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.562 ' CD2' ' HB2' ' A' ' 387' ' ' ALA . 92.0 m-85 -65.59 -62.35 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.19 170.3 31.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -55.77 138.52 47.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.412 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 55.7 mt -107.95 162.64 13.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -111.46 -48.94 3.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.42 ' HB2' ' NH1' ' A' ' 366' ' ' ARG . 1.3 ptp180 -171.23 166.19 7.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 78.6 t -135.67 130.89 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -116.84 116.81 28.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' LYS . . . . . 0.562 ' NZ ' ' CG1' ' A' ' 349' ' ' VAL . 33.8 tptt -89.12 146.22 24.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.499 HD23 ' CE2' ' A' ' 373' ' ' TYR . 6.5 mp -130.58 -174.86 3.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 370' ' ' LEU . 28.8 mtpt -33.64 -62.49 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -129.38 -36.05 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.499 ' CE2' HD23 ' A' ' 370' ' ' LEU . 3.7 p90 -92.23 -174.94 3.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.403 ' HA ' ' CD1' ' A' ' 370' ' ' LEU . . . -167.35 153.02 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.106 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -103.01 137.95 40.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.9 mm -110.33 110.6 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -88.49 121.46 30.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.558 ' CE1' HD12 ' A' ' 340' ' ' LEU . 17.3 m-85 -103.24 144.12 31.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.92 -27.89 54.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -142.01 156.3 45.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -61.49 -35.22 77.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 384' ' ' ALA . 27.0 t70 -66.89 -58.74 4.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -38.04 -31.1 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.455 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -77.19 -58.61 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.328 . . . . 0.0 111.079 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 384' ' ' ALA . 57.7 t -36.08 -35.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -73.54 -66.09 0.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' A' ' 361' ' ' PHE . . . -55.51 -17.37 5.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.095 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.567 ' HE3' ' CD1' ' A' ' 405' ' ' PHE . 9.0 ttm -77.3 -63.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.875 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.454 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.4 mt-10 -74.81 0.33 15.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.519 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 30.1 mm-40 -100.21 -36.27 9.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 393' ' ' GLY . 4.0 mmt -102.64 -31.27 10.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.468 ' N ' HD11 ' A' ' 403' ' ' ILE . 6.5 t-20 -39.2 92.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 101.38 33.85 4.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.465 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -100.14 147.19 25.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.878 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.09 80.96 2.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 17.8 tp -90.07 113.88 25.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 62.25 26.39 15.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.939 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 84.83 20.33 58.11 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -140.01 122.18 15.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.921 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.38 92.27 0.8 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' ILE . . . . . 0.471 HD12 ' CG1' ' A' ' 342' ' ' VAL . 19.4 pt -71.33 147.46 10.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.123 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -113.05 131.37 55.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.468 HD11 ' N ' ' A' ' 392' ' ' ASN . 55.7 mt -110.78 136.98 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.124 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 20.2 m -151.76 135.13 7.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.567 ' CD1' ' HE3' ' A' ' 388' ' ' MET . 24.0 m-85 -52.58 117.22 2.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 179.912 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 3.2 m -88.55 42.48 1.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.91 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 25.2 m -41.28 -60.89 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 172.68 -132.44 2.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 4.4 t -145.27 137.71 25.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 110.844 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.4 t -143.23 160.38 40.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 179.78 -169.14 39.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.5 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -142.47 124.65 15.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.0 110.933 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -131.38 152.59 50.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.131 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -106.71 46.13 0.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.863 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 87.3 t -102.07 137.95 28.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.128 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -99.2 -27.95 13.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 68.5 t -82.66 137.22 21.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.552 HD12 ' CE1' ' A' ' 378' ' ' PHE . 56.6 mt -111.48 127.54 55.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -90.65 105.49 17.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.86 128.57 58.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -128.44 175.92 8.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.66 36.4 1.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 31.8 mt -75.1 146.63 41.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -73.19 -179.14 3.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.107 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -85.51 -2.34 58.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 13.1 p -118.49 15.55 13.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 95.7 t -97.25 135.64 30.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.092 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 82.3 p -139.31 175.79 9.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.168 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -54.86 -44.78 74.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -55.53 -44.77 77.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 63.7 mt -68.54 -33.79 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.138 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 89.9 mt -70.75 -27.77 64.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 359' ' ' SER . 72.4 mt-10 -74.21 -71.19 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -41.54 -39.4 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' ALA . . . . . 0.46 ' HB3' ' CE ' ' A' ' 391' ' ' MET . . . -69.77 -56.31 7.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -83.86 14.46 4.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 355' ' ' GLU . 13.4 t -99.22 -56.83 2.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 359' ' ' SER . 27.2 pt20 -37.67 -38.28 0.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.566 ' CD2' ' HB1' ' A' ' 387' ' ' ALA . 84.5 m-85 -63.0 -63.08 1.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.25 167.12 31.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.465 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -52.98 128.83 28.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.444 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 37.5 mt -98.15 157.2 16.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.912 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -106.02 -46.67 4.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -174.9 165.6 3.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 78.4 t -135.41 127.85 47.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.118 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -114.69 113.4 24.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -89.0 142.02 27.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.569 HD23 ' CE2' ' A' ' 373' ' ' TYR . 6.1 mp -126.91 -174.02 3.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.5 OUTLIER -32.28 -67.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.891 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -124.43 -37.7 2.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.569 ' CE2' HD23 ' A' ' 370' ' ' LEU . 9.1 p90 -93.46 179.64 5.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.448 ' HA ' ' CD1' ' A' ' 370' ' ' LEU . . . -158.21 168.22 27.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.131 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -119.02 128.55 54.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 7.2 mm -102.6 114.59 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -92.66 126.67 37.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.552 ' CE1' HD12 ' A' ' 340' ' ' LEU . 21.2 m-85 -109.51 137.73 46.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -54.16 -30.66 50.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -135.87 152.67 51.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.415 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 6.0 tmm_? -60.64 -28.37 68.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.919 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -71.72 -54.08 11.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . 0.408 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -42.97 -30.82 1.08 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -77.74 -59.43 2.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.821 0.343 . . . . 0.0 111.082 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 95.4 t -37.99 -37.75 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.127 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -71.3 -62.81 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.566 ' HB1' ' CD2' ' A' ' 361' ' ' PHE . . . -59.71 -15.67 21.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.562 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.7 ttm -78.75 -62.39 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.426 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.6 mt-10 -74.92 -0.35 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.496 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 14.3 mm-40 -100.03 -38.99 8.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' MET . . . . . 0.467 ' HA ' ' CG ' ' A' ' 394' ' ' LYS . 4.4 mmt -100.96 -27.66 13.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.934 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 388' ' ' MET . 1.5 t-20 -38.05 107.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 78.52 38.61 24.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.467 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 21.3 mmtt -100.06 149.05 23.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 110.884 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -75.57 82.18 2.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.88 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 15.3 tp -89.48 112.6 23.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 62.24 26.63 15.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 88.14 11.31 67.43 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.487 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -130.91 128.91 41.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.888 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.51 98.37 4.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.825 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 20.2 pt -78.1 147.92 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.138 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -109.83 129.72 55.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.464 ' CD1' ' N ' ' A' ' 392' ' ' ASN . 15.5 mt -113.35 124.12 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.095 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 2.9 m -138.62 135.16 43.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.562 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 10.1 m-85 -51.67 106.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.82 156.5 36.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.077 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -76.07 145.11 76.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.628 0.727 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 146.68 61.06 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.688 2.259 . . . . 0.0 112.354 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 90.84 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.701 2.267 . . . . 0.0 112.339 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -131.14 101.95 5.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLN . . . . . 0.495 ' OE1' ' N ' ' A' ' 411' ' ' GLN . 0.1 OUTLIER -140.57 149.15 42.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -173.3 164.1 4.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -121.06 89.34 3.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.11 139.58 30.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -170.31 136.95 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 58.0 ttm-85 -164.46 110.74 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.852 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -149.64 162.48 40.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -145.89 105.84 4.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.153 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -158.71 115.92 2.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -156.12 130.9 9.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -169.01 142.66 2.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -140.53 117.99 11.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.072 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -106.24 80.05 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.103 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 3.7 m -65.87 -55.83 14.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 42.04 82.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.489 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 176.08 7.27 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 24.5 p -169.5 161.07 9.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.815 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 70.1 m -133.9 170.05 16.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.891 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.461 -179.952 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 3.3 m -43.76 145.25 0.7 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 1.4 t -107.13 110.64 22.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -101.12 -130.83 7.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 87.5 p -131.23 49.67 2.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.89 0.376 . . . . 0.0 110.822 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 59.8 p -124.51 126.79 46.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 104.48 68.31 0.74 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 5.7 mtp -116.94 116.97 28.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.802 0.334 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 405' ' ' PHE . . . -120.09 140.98 50.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . 0.511 ' CA ' ' NH2' ' A' ' 381' ' ' ARG . 3.8 ptmm? -86.32 36.08 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 406' ' ' ALA . 61.0 t -106.93 134.74 47.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.087 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -91.74 -35.43 14.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.929 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 65.2 t -69.49 133.22 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.072 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.433 ' HB3' ' CG2' ' A' ' 403' ' ' ILE . 51.8 mt -105.28 119.2 38.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -85.32 106.18 16.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 25.4 t -102.1 130.05 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.163 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -131.14 173.29 11.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.73 39.61 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 38.6 mt -81.24 156.95 25.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.921 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -95.08 161.23 14.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.075 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -63.73 -8.0 9.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 24.9 p -98.84 -9.24 24.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.165 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.15 140.48 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.139 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 78.2 p -144.46 163.03 35.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -40.7 -50.46 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -52.08 -52.24 52.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.903 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 75.2 mt -58.95 -29.08 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 96.1 mt -75.54 -30.65 59.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 359' ' ' SER . 51.3 mt-10 -75.58 -64.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -50.14 -38.67 40.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -69.01 -49.69 55.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' PHE . . . . . 0.406 ' CE2' HD13 ' A' ' 403' ' ' ILE . 45.0 m-85 -90.32 14.89 11.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 355' ' ' GLU . 9.0 t -100.06 -51.35 3.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -38.84 -38.7 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.565 ' CD2' ' HB3' ' A' ' 387' ' ' ALA . 94.1 m-85 -64.49 -62.72 1.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -153.65 161.31 29.78 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -47.94 129.06 14.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 40.4 mt -98.31 156.42 16.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -100.55 -50.49 3.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -171.24 165.49 7.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 51.1 t -136.93 129.59 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.82 109.02 16.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 29.5 tptt -82.17 146.16 29.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 371' ' ' LYS . 6.7 mp -128.99 -174.91 3.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.1 OUTLIER -34.4 -67.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -122.3 -37.14 2.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -94.19 -175.11 3.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -166.44 161.41 16.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.138 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -110.94 137.3 48.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.513 HG23 ' CE1' ' A' ' 378' ' ' PHE . 5.3 mm -111.16 109.55 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -89.29 121.32 31.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 19.5 m-85 -101.78 149.08 24.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -69.02 -31.76 70.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.847 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -131.05 154.37 48.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.511 ' NH2' ' CA ' ' A' ' 336' ' ' LYS . 8.4 tpp85 -58.13 -37.71 75.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 384' ' ' ALA . 19.6 t70 -66.2 -57.55 7.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . 0.537 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -35.12 -31.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.507 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 382' ' ' ASP . . . -80.88 -66.93 0.82 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.117 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' A' ' 384' ' ' ALA . 58.0 t -36.0 -35.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 384' ' ' ALA . 12.1 tptm -72.92 -61.03 1.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.565 ' HB3' ' CD2' ' A' ' 361' ' ' PHE . . . -60.51 -16.92 41.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.593 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.7 ttm -76.52 -61.27 2.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.429 ' N ' ' HG2' ' A' ' 388' ' ' MET . 13.1 mt-10 -74.17 -4.22 34.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.872 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.497 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 39.0 mm-40 -100.03 -33.02 10.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' MET . . . . . 0.503 ' O ' ' CG ' ' A' ' 394' ' ' LYS . 38.2 mmm -101.96 -41.0 6.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.473 ' N ' HD11 ' A' ' 403' ' ' ILE . 5.1 t-20 -34.12 116.61 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 76.63 30.05 56.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.46 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.503 ' CG ' ' O ' ' A' ' 391' ' ' MET . 0.0 OUTLIER -100.01 141.97 32.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 0.0 110.896 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.49 99.99 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 20.5 tp -106.36 114.31 28.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.968 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 60.88 27.18 17.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.88 16.86 59.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.479 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -140.04 120.74 14.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.91 100.01 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 25.0 pt -75.68 149.72 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -112.44 128.51 56.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.473 HD11 ' N ' ' A' ' 392' ' ' ASN . 35.6 mt -111.96 128.97 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.124 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 9.9 m -142.32 132.91 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.152 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.593 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 19.2 m-85 -50.87 110.78 0.46 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.445 ' O ' ' CG2' ' A' ' 337' ' ' VAL . . . -68.08 158.32 33.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -96.78 144.98 28.8 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.618 0.723 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 151.01 69.2 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.709 2.273 . . . . 0.0 112.402 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 123.02 9.68 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.631 2.221 . . . . 0.0 112.325 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 6.5 t70 58.84 49.61 9.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -42.14 -45.25 3.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.05 109.1 10.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -69.26 121.68 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -148.34 127.41 12.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -163.18 143.62 9.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -147.54 123.55 10.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -116.88 118.84 33.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -146.31 121.34 10.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.081 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -130.49 173.49 10.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 -164.82 131.38 2.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.844 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -101.41 152.49 20.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -131.79 155.66 47.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.078 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -146.23 166.45 26.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.107 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.1 t -168.29 167.36 12.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -150.29 85.07 0.16 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.488 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 163.49 38.12 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 38.9 t -119.74 -47.71 2.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 429' ' ' GLY . 89.0 p -172.49 156.39 3.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 428' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.494 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 91.7 p -160.54 174.8 13.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.884 0.373 . . . . 0.0 110.853 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 65.8 m -77.65 118.28 19.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.85 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 146.84 65.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.524 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 84.1 p -123.15 149.38 44.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 0.0 110.888 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 34.3 t -167.36 138.75 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.825 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 136.74 131.88 3.02 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.467 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 61.1 mmm -99.96 91.46 4.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.872 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -128.86 157.05 42.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -126.21 58.34 1.37 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.549 ' HB ' ' CD1' ' A' ' 405' ' ' PHE . 58.6 t -90.76 132.32 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.78 -27.79 14.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.0 t -85.17 125.68 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.118 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.554 HD13 ' CE1' ' A' ' 378' ' ' PHE . 70.6 mt -103.84 130.35 51.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.946 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -94.74 107.83 19.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 18.7 t -106.15 130.49 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -130.15 168.24 17.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.3 t30 72.22 54.35 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 15.6 mt -96.25 145.91 25.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.929 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -81.08 163.12 23.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.053 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -66.83 -4.47 9.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 24.6 p -104.58 6.31 34.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.442 ' CG1' ' NZ ' ' A' ' 369' ' ' LYS . 58.6 t -94.16 138.09 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.154 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 43.4 p -142.64 159.15 42.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.16 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -42.73 -41.15 3.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -57.92 -46.93 84.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 73.3 mt -65.56 -30.17 49.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.14 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.418 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 83.2 mt -72.94 -31.4 64.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 359' ' ' SER . 21.7 mt-10 -72.07 -67.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -50.3 -39.92 46.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' ALA . . . . . 0.457 ' HB3' ' CE ' ' A' ' 391' ' ' MET . . . -65.71 -51.3 60.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' PHE . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 45.3 m-85 -90.49 14.57 12.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 355' ' ' GLU . 2.1 t -99.8 -57.44 2.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 359' ' ' SER . 19.1 pt20 -35.2 -39.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.565 ' CD2' ' HB3' ' A' ' 387' ' ' ALA . 84.8 m-85 -64.58 -65.23 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -147.4 163.89 28.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.454 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -52.85 130.72 34.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.457 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 34.2 mt -99.77 158.94 15.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.949 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -108.07 -44.5 4.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -174.16 164.41 4.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 54.2 t -135.51 133.75 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 39.7 tptt -119.55 123.76 44.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . 0.442 ' NZ ' ' CG1' ' A' ' 349' ' ' VAL . 24.0 tptt -95.7 146.29 24.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.545 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.8 mp -133.96 -174.74 3.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 370' ' ' LEU . 24.4 tttp -33.57 -68.46 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.886 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.3 -37.13 2.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.545 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.3 p90 -90.94 -175.79 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.968 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -168.15 147.18 4.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.091 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -95.76 142.23 28.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.449 HG21 ' CE1' ' A' ' 378' ' ' PHE . 4.6 mm -118.07 106.18 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -84.44 121.48 27.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.847 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.554 ' CE1' HD13 ' A' ' 340' ' ' LEU . 14.4 m-85 -102.61 151.47 22.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -60.57 -35.77 76.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -140.35 153.12 46.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.418 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 6.5 tmm_? -52.7 -28.43 21.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.877 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 384' ' ' ALA . 12.0 t0 -69.81 -62.21 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . 0.474 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -36.76 -29.62 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.52 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 382' ' ' ASP . . . -79.9 -58.47 3.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 0.0 111.113 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 96.3 t -38.39 -38.63 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -71.93 -64.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.565 ' HB3' ' CD2' ' A' ' 361' ' ' PHE . . . -57.04 -15.48 5.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.602 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 9.0 ttm -79.46 -62.91 1.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.432 ' N ' ' HG2' ' A' ' 388' ' ' MET . 9.9 mt-10 -74.86 -0.97 20.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -100.09 -35.04 9.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' MET . . . . . 0.459 ' HA ' ' CG ' ' A' ' 394' ' ' LYS . 27.7 mmm -103.91 -37.15 7.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.889 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 388' ' ' MET . 4.3 t-20 -34.29 101.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 92.22 29.68 11.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.464 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.459 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 8.7 mmtp -94.99 148.2 22.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 0.0 110.854 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.64 80.66 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 15.6 tp -89.12 115.69 26.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.941 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 62.22 25.02 14.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 86.03 20.18 55.96 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.464 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -139.81 125.28 19.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.92 98.21 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 47.2 pt -74.6 153.32 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -117.09 126.61 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 392' ' ' ASN . 23.2 mt -113.06 124.85 70.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.158 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 10.4 m -137.05 133.35 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.602 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 8.3 m-85 -51.26 110.91 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.22 175.95 2.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.068 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -102.43 144.21 28.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.528 0.68 . . . . 0.0 110.933 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 160.27 50.32 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.681 2.254 . . . . 0.0 112.328 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -175.52 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.684 2.256 . . . . 0.0 112.354 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.29 92.75 2.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -104.34 86.38 2.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 77.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -86.76 106.09 17.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.855 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -133.93 155.07 50.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -133.97 115.54 14.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.85 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 41.2 ptt85 -168.48 134.35 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -119.14 130.6 55.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -127.31 110.45 12.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.133 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.83 38.62 2.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -131.14 84.87 2.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -119.72 -44.53 2.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 59.28 47.85 10.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -105.16 -48.1 3.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 18.9 m -119.69 85.45 2.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -120.36 -157.35 10.16 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.511 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 89.63 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.732 2.288 . . . . 0.0 112.34 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 5.0 m -122.02 -177.81 3.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 4.6 t -171.11 148.01 2.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.844 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.511 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 39.0 t -164.08 147.65 9.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.916 0.389 . . . . 0.0 110.828 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 25.4 t -160.63 158.89 29.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.857 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 99.21 107.12 2.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.505 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 1.8 t -151.93 156.34 39.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.916 0.389 . . . . 0.0 110.836 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 58.5 m -74.39 155.18 38.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -143.63 61.89 0.51 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.443 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 63.5 mtp -88.43 90.45 8.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.769 0.319 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -138.79 127.37 23.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.133 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -100.29 42.74 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 91.4 t -103.14 138.27 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 339' ' ' VAL . 0.0 OUTLIER -96.8 -31.05 12.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.426 ' N ' ' HD2' ' A' ' 338' ' ' LYS . 86.4 t -77.18 131.34 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.101 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.549 HD12 ' CE1' ' A' ' 378' ' ' PHE . 43.4 mt -108.26 127.37 53.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -91.27 108.61 20.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 14.0 t -103.13 134.73 43.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -134.11 167.13 21.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.84 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.4 t30 73.23 52.38 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 22.5 mt -96.22 131.99 42.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -54.58 -176.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -88.93 5.68 42.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 21.9 p -121.86 13.77 10.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 91.6 t -88.55 138.81 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 67.0 p -144.07 167.05 23.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.159 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -50.45 -43.94 55.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.04 -41.9 75.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.49 -41.48 80.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.37 -32.51 73.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 359' ' ' SER . 46.1 mt-10 -68.21 -73.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -41.48 -39.67 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.957 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' ALA . . . . . 0.425 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -66.7 -54.6 21.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' PHE . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 37.0 m-85 -87.78 14.68 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 355' ' ' GLU . 17.7 t -99.99 -53.25 3.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.848 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -38.68 -38.68 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.563 ' CD2' ' HB2' ' A' ' 387' ' ' ALA . 84.3 m-85 -64.08 -62.71 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -151.87 169.78 31.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.525 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -53.86 132.73 42.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.818 0.342 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.468 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 32.9 mt -101.46 160.49 14.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.949 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -110.33 -48.04 3.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -172.97 163.65 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 71.9 t -134.1 130.07 54.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -111.06 108.41 18.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.866 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . 0.41 ' C ' HD13 ' A' ' 370' ' ' LEU . 19.3 tptp -87.08 137.58 32.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.559 HD21 ' CE2' ' A' ' 373' ' ' TYR . 7.6 mp -126.28 -174.74 3.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 370' ' ' LEU . 30.8 tttm -33.55 -67.73 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.873 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.16 -36.39 2.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.559 ' CE2' HD21 ' A' ' 370' ' ' LEU . 6.5 p90 -93.7 -177.36 4.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -165.79 159.65 16.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.098 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -110.7 131.51 54.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.882 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 3.9 mm -105.26 115.58 47.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -93.54 113.98 26.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.549 ' CE1' HD12 ' A' ' 340' ' ' LEU . 17.4 m-85 -96.06 146.11 24.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.851 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -63.66 -32.81 74.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -131.82 153.31 50.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.415 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 2.0 tmm_? -62.19 -30.66 71.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -71.61 -50.42 30.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -44.8 -31.97 2.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.546 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -76.57 -63.06 1.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.792 0.33 . . . . 0.0 111.138 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 384' ' ' ALA . 61.3 t -34.92 -36.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . 0.428 ' HE3' ' CG ' ' A' ' 390' ' ' GLU . 17.8 tptt -72.68 -66.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.563 ' HB2' ' CD2' ' A' ' 361' ' ' PHE . . . -55.21 -16.87 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.592 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 7.5 ttm -77.65 -61.64 1.93 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.412 ' N ' ' HG2' ' A' ' 388' ' ' MET . 7.3 mt-10 -77.48 -2.06 33.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.492 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 52.9 mm-40 -100.15 -25.89 14.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' MET . . . . . 0.498 ' O ' ' N ' ' A' ' 393' ' ' GLY . 23.4 mmm -112.1 -38.19 4.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.473 ' N ' HD11 ' A' ' 403' ' ' ILE . 7.6 t-20 -35.09 92.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 108.44 23.95 6.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.477 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 391' ' ' MET . 0.3 OUTLIER -90.28 146.9 23.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.774 0.321 . . . . 0.0 110.903 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -78.6 80.26 4.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 19.0 tp -89.19 114.89 26.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.927 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 62.49 27.74 16.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 82.45 20.88 61.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.481 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -140.18 122.51 15.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.891 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.38 95.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 30.4 pt -72.4 148.7 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.193 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -115.79 130.77 56.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.473 HD11 ' N ' ' A' ' 392' ' ' ASN . 19.7 mt -109.74 138.93 35.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.167 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 17.9 m -149.43 134.61 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.073 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.592 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 15.4 m-85 -54.71 108.7 0.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.854 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.9 159.14 34.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -82.19 146.88 55.81 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.602 0.715 . . . . 0.0 110.912 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 163.05 39.74 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.694 2.263 . . . . 0.0 112.315 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 176.02 7.3 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.666 2.244 . . . . 0.0 112.381 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.94 131.83 47.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLN . . . . . 0.415 ' C ' ' HD3' ' A' ' 412' ' ' LYS . 1.4 pt20 -138.15 159.51 41.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 411' ' ' GLN . 0.0 OUTLIER -168.84 135.97 1.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 14.4 mmm-85 -139.47 149.37 43.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . 0.414 ' C ' ' OE2' ' A' ' 415' ' ' GLU . 14.0 pttp -157.95 150.41 22.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.414 ' OE2' ' C ' ' A' ' 414' ' ' LYS . 7.1 mp0 -138.0 134.73 35.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.94 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -132.2 130.46 41.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.94 121.7 36.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -153.41 172.63 16.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -171.68 164.51 6.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . 0.426 ' CG ' ' N ' ' A' ' 421' ' ' GLN . 12.0 ttp-105 -158.15 165.86 33.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . 0.426 ' N ' ' CG ' ' A' ' 420' ' ' ARG . 8.7 tp60 -108.2 117.27 33.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -86.42 168.05 14.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.081 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -155.12 -179.96 8.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.1 t -142.06 173.52 11.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 155.26 145.92 4.3 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.48 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 171.03 15.26 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.62 2.213 . . . . 0.0 112.351 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 67.9 m -124.79 -60.88 1.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.825 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.8 m 53.11 43.01 32.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.48 -179.999 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 69.0 m -131.66 127.46 37.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 110.9 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 39.2 m -70.0 163.8 25.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 121.36 64.6 0.24 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.468 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 34.1 t -104.86 108.02 19.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.904 0.383 . . . . 0.0 110.878 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 47.8 t -50.12 -52.32 35.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.867 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 64.96 58.69 9.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.477 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 7.7 ttt -80.38 -49.1 11.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.8 0.334 . . . . 0.0 110.867 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -135.13 -175.01 3.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.069 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -107.94 42.11 1.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 338' ' ' LYS . 38.9 t -61.11 141.5 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.148 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.455 ' N ' HG13 ' A' ' 337' ' ' VAL . 0.1 OUTLIER -102.76 -32.6 9.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.942 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 90.6 t -79.94 135.94 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.403 HD21 ' CB ' ' A' ' 384' ' ' ALA . 16.5 mt -111.62 127.27 55.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -88.54 113.1 23.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.875 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.438 ' CG1' HD13 ' A' ' 401' ' ' ILE . 15.8 t -111.43 135.45 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -132.49 170.61 14.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.5 t30 73.46 43.85 0.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 39.0 mt -83.37 127.59 33.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -49.4 178.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -84.57 -5.34 59.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 25.7 p -117.84 22.46 12.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 64.5 t -96.4 136.64 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.153 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 77.8 p -135.45 178.28 7.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.132 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.87 -40.29 92.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -58.27 -46.54 85.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.86 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.67 -30.82 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 97.0 mt -73.84 -26.87 60.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 359' ' ' SER . 52.6 mt-10 -81.27 -64.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -51.05 -25.37 4.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -83.66 -44.83 14.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' PHE . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 35.9 m-85 -92.03 9.91 31.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 361' ' ' PHE . 92.2 p -95.13 -54.46 3.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.84 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 359' ' ' SER . 26.0 pt20 -34.28 -35.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.57 ' CD2' ' HB2' ' A' ' 387' ' ' ALA . 98.2 m-85 -70.97 -68.27 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -145.61 165.48 27.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.461 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -54.37 131.84 42.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.755 0.312 . . . . 0.0 110.909 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.508 HD21 ' CE2' ' A' ' 378' ' ' PHE . 86.9 mt -101.32 155.63 17.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -100.88 -42.99 6.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.938 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -174.95 170.08 3.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.7 t -140.66 125.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.131 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -112.49 123.14 49.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -97.52 143.52 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.475 ' O ' ' C ' ' A' ' 371' ' ' LYS . 6.9 mp -129.1 -174.62 3.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.1 OUTLIER -32.12 -72.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.932 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -120.04 -35.37 3.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.426 ' CE2' HD22 ' A' ' 370' ' ' LEU . 12.4 p90 -94.99 -179.41 4.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -159.11 167.28 29.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.109 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -118.32 125.39 49.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.465 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 5.3 mm -99.18 110.5 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -91.68 120.75 32.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.827 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.508 ' CE2' HD21 ' A' ' 364' ' ' LEU . 21.0 m-85 -101.02 154.63 18.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.55 -33.96 73.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -132.13 156.58 46.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.414 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 5.6 tmm_? -61.86 -32.71 73.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.15 -52.08 26.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -42.69 -32.84 1.42 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.543 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 386' ' ' LYS . . . -77.73 -64.35 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.789 0.328 . . . . 0.0 111.092 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.43 ' C ' ' O ' ' A' ' 384' ' ' ALA . 68.2 t -35.39 -32.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.122 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 384' ' ' ALA . 15.5 tptm -74.8 -61.89 1.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.57 ' HB2' ' CD2' ' A' ' 361' ' ' PHE . . . -61.07 -14.68 25.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.57 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.4 ttm -78.65 -60.18 2.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.906 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -73.23 -3.15 25.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.462 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 4.4 mm-40 -100.41 -39.43 7.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' MET . . . . . 0.47 ' HB2' ' CD1' ' A' ' 403' ' ' ILE . 49.8 mmm -99.76 -19.73 16.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 388' ' ' MET . 0.8 OUTLIER -43.92 119.46 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 56.36 37.25 73.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.445 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.41 ' HD2' ' C ' ' A' ' 395' ' ' ASP . 0.0 OUTLIER -100.09 150.78 22.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.78 0.324 . . . . 0.0 110.911 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . 0.41 ' C ' ' HD2' ' A' ' 394' ' ' LYS . 24.7 t0 -71.12 105.92 3.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 38.4 tp -119.39 115.48 24.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 59.77 36.95 22.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 77.0 9.56 86.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.501 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -135.31 124.39 24.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.893 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.79 106.12 6.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.931 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.438 HD13 ' CG1' ' A' ' 342' ' ' VAL . 21.7 pt -83.12 147.11 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -109.56 128.58 55.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 391' ' ' MET . 44.1 mt -110.71 142.55 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.11 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 9.6 m -157.01 134.12 2.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.57 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 27.0 m-85 -53.32 111.04 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.72 157.68 34.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.113 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -89.92 143.89 30.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.54 0.686 . . . . 0.0 110.941 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 147.84 63.75 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.723 2.282 . . . . 0.0 112.342 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -39.38 6.48 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.643 2.228 . . . . 0.0 112.332 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.41 125.25 1.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -87.42 114.99 24.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 412' ' ' LYS . 1.5 pptp? -118.49 155.17 31.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.908 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -173.88 119.3 0.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.83 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -174.61 148.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.932 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.67 -176.41 3.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -146.31 159.15 43.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -95.84 134.17 39.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -93.4 169.44 10.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -147.96 -177.18 5.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.894 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -125.01 171.48 10.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -165.65 114.25 0.99 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -90.19 175.55 7.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.062 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -170.02 172.88 6.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.082 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 26.9 p -172.59 161.98 5.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 173.51 84.63 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.445 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -174.17 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.712 2.275 . . . . 0.0 112.34 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 8.3 t -172.86 176.35 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 83.8 p -146.8 166.48 26.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.507 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 2.0 t -155.58 153.42 30.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.883 0.373 . . . . 0.0 110.844 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 76.1 p -168.71 118.14 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.821 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 54.58 -156.84 7.02 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 42.0 t -123.5 113.23 18.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 0.0 110.875 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 59.9 p -90.64 124.64 35.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.834 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 73.66 50.39 11.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.524 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 12.3 ptp -67.87 128.36 36.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -132.78 157.14 45.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.113 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -120.45 28.37 8.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 58.9 t -83.6 130.51 35.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.081 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.93 -25.14 17.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.425 HG11 ' N ' ' A' ' 340' ' ' LEU . 97.3 t -83.16 136.63 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.101 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.425 ' N ' HG11 ' A' ' 339' ' ' VAL . 53.1 mt -112.9 128.9 56.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -92.59 108.26 19.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.431 ' CG1' HD13 ' A' ' 401' ' ' ILE . 48.7 t -106.0 127.27 61.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.176 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -126.51 173.44 9.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.24 39.19 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 48.7 mt -78.22 121.78 24.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -50.26 172.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.078 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -83.34 15.63 2.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 63.1 p -132.29 19.27 4.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.161 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 350' ' ' THR . 67.0 t -97.71 158.06 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' THR . . . . . 0.458 ' N ' ' CG1' ' A' ' 349' ' ' VAL . 21.2 p -156.19 165.54 36.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -49.69 -44.51 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -56.96 -45.61 82.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 67.0 mt -64.43 -31.81 55.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.121 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 88.6 mt -73.49 -26.09 60.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 359' ' ' SER . 90.6 mt-10 -81.82 -66.88 0.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.899 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -49.72 -23.41 1.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -85.86 -45.75 11.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.078 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -92.49 11.47 26.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 355' ' ' GLU . 95.7 p -100.09 -24.48 14.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.866 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -63.6 -31.71 72.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.562 ' CD2' ' HB1' ' A' ' 387' ' ' ALA . 93.6 m-85 -74.95 -61.95 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.859 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -148.65 162.45 28.87 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.521 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -52.18 129.19 27.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 38.7 mt -97.7 154.63 17.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -101.85 -42.75 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.925 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 366' ' ' ARG . 2.4 ptm85 -174.1 164.89 4.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.859 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 46.3 t -136.53 124.68 34.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -117.79 107.94 14.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . 0.451 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 12.3 tttm -88.17 140.43 29.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.465 ' O ' ' C ' ' A' ' 371' ' ' LYS . 6.4 mp -118.18 -174.21 2.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 370' ' ' LEU . 9.2 ttpt -31.97 -69.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -118.12 -39.32 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -91.61 -174.96 4.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 369' ' ' LYS . . . -162.48 167.96 22.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.103 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -121.92 121.51 37.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.845 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.458 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 6.7 mm -97.06 111.86 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -91.19 124.09 35.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.835 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 387' ' ' ALA . 23.6 m-85 -105.28 152.16 23.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.99 -35.59 80.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -129.65 153.43 48.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.859 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.418 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 5.9 tmm_? -60.08 -32.91 71.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -70.08 -51.36 32.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.843 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -42.82 -33.76 1.71 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.43 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -76.52 -56.94 4.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.812 0.339 . . . . 0.0 111.071 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 80.6 t -38.47 -39.87 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.094 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -70.76 -65.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.562 ' HB1' ' CD2' ' A' ' 361' ' ' PHE . . . -55.05 -16.62 3.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.174 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.597 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.5 ttm -78.54 -62.84 1.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.438 ' N ' ' HG2' ' A' ' 388' ' ' MET . 9.0 mt-10 -75.92 -0.55 21.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.552 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 56.3 mm-40 -100.08 -34.6 10.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' MET . . . . . 0.42 ' O ' ' C ' ' A' ' 392' ' ' ASN . 4.9 mmt -104.52 -31.15 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.904 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 388' ' ' MET . 3.9 t-20 -36.68 97.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 95.46 38.26 4.8 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.522 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -100.1 147.66 25.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.888 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -75.53 75.19 2.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 17.6 tp -79.75 111.17 15.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.933 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 62.4 25.31 15.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . 0.44 ' C ' ' OE1' ' A' ' 399' ' ' GLU . . . 89.77 14.62 59.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.495 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . 0.44 ' OE1' ' C ' ' A' ' 398' ' ' GLY . 15.8 mp0 -133.38 126.15 30.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.808 0.337 . . . . 0.0 110.86 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.72 97.34 2.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.431 HD13 ' CG1' ' A' ' 342' ' ' VAL . 18.1 pt -76.9 151.7 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -114.77 132.18 56.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.463 HD11 ' N ' ' A' ' 392' ' ' ASN . 31.6 mt -115.27 121.34 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.135 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 15.3 m -136.19 132.58 49.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.597 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 7.4 m-85 -51.07 117.47 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -77.21 169.64 17.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.098 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -80.49 154.26 73.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.601 0.715 . . . . 0.0 110.904 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 147.15 62.01 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.729 2.286 . . . . 0.0 112.341 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -3.68 12.51 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.633 2.222 . . . . 0.0 112.352 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -156.31 -179.8 8.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -142.76 138.24 30.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -116.65 118.44 32.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -153.02 116.9 4.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.855 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -170.18 143.78 2.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -163.74 117.93 1.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.4 147.41 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -137.89 178.65 6.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.934 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -156.03 121.88 4.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -123.7 154.06 39.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 8.4 ttm-85 -165.73 105.63 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -138.54 167.93 20.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -165.39 130.69 2.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.107 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -158.6 117.1 3.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.067 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 60.7 p -131.29 126.66 35.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -131.74 83.77 0.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.499 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 427' ' ' SER . 53.2 Cg_endo -69.81 132.39 23.15 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.621 2.214 . . . . 0.0 112.332 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 426' ' ' PRO . 69.4 m 34.79 44.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.853 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 23.2 t -79.64 109.25 13.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.823 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.452 179.979 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 7.2 t -164.5 114.42 1.18 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.876 0.369 . . . . 0.0 110.883 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 7.6 t -151.82 142.2 22.49 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.856 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 154.42 -135.88 4.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 38.2 t -73.12 121.5 20.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 110.841 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 69.6 m -118.17 82.19 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.851 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -122.24 170.47 15.11 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.478 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -64.31 137.59 57.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.804 0.335 . . . . 0.0 110.842 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -112.92 81.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.08 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -69.9 83.91 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 57.4 t -124.59 136.46 60.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -101.39 -32.93 10.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 98.5 t -78.53 133.15 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.079 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.564 HD11 ' CE1' ' A' ' 378' ' ' PHE . 55.1 mt -109.72 128.59 55.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -93.79 102.83 14.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 33.0 t -102.06 133.85 44.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.106 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -132.77 168.79 17.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.865 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 74.76 52.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 41.9 mt -97.38 148.11 23.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -85.79 169.53 13.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.137 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -71.12 -1.98 14.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 40.6 p -106.16 0.51 25.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 86.8 t -93.91 130.45 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.119 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 68.9 p -132.83 165.65 24.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.124 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -47.42 -41.97 21.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -57.39 -47.44 81.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 66.5 mt -65.64 -28.82 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.452 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 95.1 mt -74.58 -28.93 61.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -78.56 -63.32 1.43 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.821 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 35.8 mmtt -53.36 -34.71 58.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' ALA . . . . . 0.434 ' HB3' ' CE ' ' A' ' 391' ' ' MET . . . -71.43 -45.53 62.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -92.64 13.07 21.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 361' ' ' PHE . 1.5 t -97.62 -53.69 3.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 359' ' ' SER . 15.4 pt20 -36.57 -32.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.576 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 90.5 m-85 -71.04 -66.04 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -147.61 179.05 24.8 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -61.95 129.86 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 110.865 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.422 HD21 ' CD2' ' A' ' 378' ' ' PHE . 32.1 mt -101.21 152.12 21.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -100.37 -47.0 5.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -174.31 168.74 3.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 41.9 t -139.56 131.62 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.153 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.14 123.48 44.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -96.19 143.51 27.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.902 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.567 HD21 ' CE2' ' A' ' 373' ' ' TYR . 6.4 mp -127.73 -174.6 3.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.8 OUTLIER -33.31 -66.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -124.51 -36.78 2.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.567 ' CE2' HD21 ' A' ' 370' ' ' LEU . 9.7 p90 -92.86 179.75 5.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -160.32 161.43 33.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -112.2 136.57 51.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 5.0 mm -110.52 109.62 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.128 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -89.43 123.27 33.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.564 ' CE1' HD11 ' A' ' 340' ' ' LEU . 15.6 m-85 -105.56 140.72 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -56.72 -33.98 67.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.842 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -131.42 149.12 52.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.412 ' NH1' ' CG2' ' A' ' 385' ' ' VAL . 0.0 OUTLIER -57.06 -32.89 66.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -69.41 -53.1 21.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -41.29 -32.24 0.67 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.531 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -77.63 -58.78 3.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 111.119 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.412 ' CG2' ' NH1' ' A' ' 381' ' ' ARG . 57.6 t -38.52 -35.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -74.57 -64.32 1.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.551 ' HB3' ' CD2' ' A' ' 361' ' ' PHE . . . -58.25 -15.53 10.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.4 ttm -78.76 -63.07 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.429 ' N ' ' HG2' ' A' ' 388' ' ' MET . 14.6 mt-10 -73.52 1.41 9.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.576 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 43.7 mm-40 -100.12 -41.77 6.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' MET . . . . . 0.489 ' O ' ' N ' ' A' ' 393' ' ' GLY . 8.1 mmm -99.91 -27.39 13.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 388' ' ' MET . 5.1 t-20 -37.19 92.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.849 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 97.7 38.84 4.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.497 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.406 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 24.8 mmtm -100.04 148.29 24.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.739 0.304 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -75.9 77.69 2.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 15.6 tp -82.3 111.5 18.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 62.61 25.42 15.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . 0.43 ' C ' ' OE1' ' A' ' 399' ' ' GLU . . . 90.49 12.83 60.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . 0.43 ' OE1' ' C ' ' A' ' 398' ' ' GLY . 1.8 mp0 -131.76 129.55 40.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.943 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.49 97.43 3.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 20.7 pt -76.16 147.47 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -113.22 130.47 56.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.455 HD12 ' N ' ' A' ' 392' ' ' ASN . 11.7 mt -113.1 126.72 70.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.121 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 30.1 m -140.48 134.03 33.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.064 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 14.3 m-85 -50.95 110.1 0.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.857 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.66 151.38 47.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -76.77 143.81 71.95 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.626 0.726 . . . . 0.0 110.875 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 151.5 69.56 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.697 2.264 . . . . 0.0 112.354 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -40.56 5.12 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.255 . . . . 0.0 112.33 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -40.75 142.26 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.874 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -154.1 129.09 9.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -125.06 128.85 49.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -160.33 106.17 1.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -76.62 99.46 5.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -149.63 169.47 20.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 1.2 ppt_? -159.99 149.75 18.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -172.15 135.63 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -169.93 136.38 1.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -173.66 152.25 2.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.947 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -159.36 152.37 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -172.72 139.74 0.93 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -171.26 163.56 7.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -112.03 179.05 4.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.094 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 11.6 t -160.88 175.58 12.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -129.97 89.73 0.3 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.459 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 125.78 12.55 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.698 2.266 . . . . 0.0 112.315 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 2.3 m -167.99 151.82 6.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.844 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 98.6 p -74.28 160.03 31.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.904 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.516 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 79.0 p -49.47 128.76 17.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 0.0 110.858 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 68.2 m -121.65 141.27 51.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 144.63 -116.67 0.96 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.48 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 34.0 p 43.99 41.21 3.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.369 . . . . 0.0 110.831 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 36.9 t -105.62 93.63 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.845 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -97.06 161.51 21.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.506 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 2.8 ttt -136.12 113.54 10.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.343 . . . . 0.0 110.87 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.541 ' HB2' ' CD2' ' A' ' 405' ' ' PHE . . . -150.33 157.75 43.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -94.75 74.44 3.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' A' ' 405' ' ' PHE . 93.7 t -140.11 138.34 37.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.415 ' HB3' ' NH1' ' A' ' 381' ' ' ARG . 10.5 ptpt -94.15 -33.75 13.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.22 121.87 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.083 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.524 HD13 ' CE1' ' A' ' 378' ' ' PHE . 78.5 mt -98.81 121.75 41.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -88.31 106.56 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 47.2 t -105.16 135.33 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -134.73 167.64 20.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.84 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 24.7 t30 74.59 49.99 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 14.5 mt -92.53 130.24 38.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.06 -179.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.101 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -87.15 6.5 32.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 22.2 p -124.15 15.88 9.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.171 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 55.3 t -91.98 134.93 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.151 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 58.4 p -136.98 161.0 37.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.145 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -47.02 -42.93 19.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -56.76 -40.42 75.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.884 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 83.0 mt -72.17 -29.55 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 85.3 mt -74.73 -28.04 60.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 359' ' ' SER . 45.3 mt-10 -72.26 -70.09 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -42.08 -44.1 3.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' ALA . . . . . 0.421 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -63.38 -57.05 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.097 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' PHE . . . . . 0.408 ' CE2' HD12 ' A' ' 403' ' ' ILE . 41.0 m-85 -85.09 16.08 3.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 355' ' ' GLU . 5.4 t -100.07 -59.27 1.74 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.851 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 359' ' ' SER . 21.7 pt20 -36.82 -40.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.561 ' CD2' ' HB3' ' A' ' 387' ' ' ALA . 92.8 m-85 -62.36 -61.83 2.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.39 161.79 29.59 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.474 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.28 128.63 22.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 0.0 110.876 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.462 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 49.6 mt -98.81 152.95 19.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -101.45 -47.64 4.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -170.17 166.02 9.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.841 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 60.1 t -137.49 123.64 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -105.73 111.34 23.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -91.02 136.48 33.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.565 HD23 ' CE2' ' A' ' 373' ' ' TYR . 6.9 mp -124.73 -174.82 3.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 370' ' ' LEU . 7.9 mmtm -32.9 -71.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.09 -37.88 3.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.565 ' CE2' HD23 ' A' ' 370' ' ' LEU . 8.4 p90 -91.67 -179.8 5.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.951 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -165.55 160.47 17.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.053 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -111.69 135.51 52.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 7.5 mm -108.88 106.97 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.099 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -87.58 120.29 28.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.535 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 23.6 m-85 -99.74 158.6 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -79.91 -32.07 40.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -128.22 152.91 47.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.423 ' HB2' ' NH1' ' A' ' 381' ' ' ARG . 0.0 OUTLIER -59.14 -34.08 71.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.855 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 384' ' ' ALA . 10.3 t70 -70.74 -54.95 9.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -37.81 -30.75 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.449 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -81.28 -65.92 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.419 ' C ' ' O ' ' A' ' 384' ' ' ALA . 58.4 t -36.4 -36.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.124 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -72.88 -61.83 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.561 ' HB3' ' CD2' ' A' ' 361' ' ' PHE . . . -60.3 -15.66 27.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.076 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.5 ttm -77.97 -61.18 2.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.408 ' N ' ' HG2' ' A' ' 388' ' ' MET . 16.4 mt-10 -74.89 -0.73 19.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.504 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 7.4 mm-40 -100.15 -37.41 8.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.839 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' MET . . . . . 0.494 ' O ' ' N ' ' A' ' 393' ' ' GLY . 17.8 mmm -101.66 -34.04 9.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 388' ' ' MET . 5.2 t-20 -34.0 93.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 98.17 39.47 3.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.401 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 2.0 mmmp? -99.92 147.51 25.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.886 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -75.76 69.47 2.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.851 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 14.8 tp -74.93 113.12 11.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 61.94 27.33 16.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 85.31 21.26 55.14 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.533 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -140.1 125.91 19.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.87 0.367 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.37 96.92 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 33.4 pt -74.61 148.36 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -110.35 131.27 55.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.458 HD13 ' N ' ' A' ' 392' ' ' ASN . 36.1 mt -116.06 127.61 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 11.1 m -141.11 134.24 30.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.175 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.591 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 6.3 m-85 -52.49 108.73 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.31 174.86 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.11 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -88.13 143.91 33.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.619 0.723 . . . . 0.0 110.896 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 148.55 65.43 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.681 2.254 . . . . 0.0 112.359 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 151.26 69.13 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.672 2.248 . . . . 0.0 112.392 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.83 92.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -90.71 -53.38 4.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -38.11 151.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -167.24 168.28 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.874 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -170.35 138.03 1.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.17 129.0 7.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.81 134.63 20.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -166.31 157.99 13.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -142.09 119.45 11.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.156 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.39 150.92 12.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.911 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 10.9 tpt85 -166.74 119.16 0.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -153.92 156.2 37.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -174.89 112.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -130.98 140.36 50.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 38.0 m -163.89 177.2 8.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.84 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 180.0 141.38 4.62 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.473 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -175.65 1.21 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.712 2.275 . . . . 0.0 112.379 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 50.4 m -155.73 164.72 38.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.822 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 37.1 p -115.53 -61.22 1.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.511 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 1.9 t -162.92 159.17 23.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 0.0 110.849 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 23.0 t -166.2 145.71 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.813 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -140.49 45.52 0.98 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.487 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 8.3 t -118.33 119.07 33.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.895 0.378 . . . . 0.0 110.888 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.8 t -85.47 93.12 8.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.861 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -143.37 132.45 4.98 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.496 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.47 -21.78 19.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.824 0.345 . . . . 0.0 110.868 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -133.7 174.17 10.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.074 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . 0.407 ' HD2' ' NH1' ' A' ' 381' ' ' ARG . 34.5 mttm -124.79 69.9 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 74.4 t -54.64 139.64 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.19 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -93.15 -32.08 14.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.1 122.34 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 48.6 mt -96.52 134.67 39.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -99.19 107.9 20.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.401 ' CG1' HD13 ' A' ' 401' ' ' ILE . 29.8 t -103.71 131.81 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.147 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -130.92 172.39 12.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.901 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.7 t30 72.54 33.27 1.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 17.8 mt -76.63 125.47 29.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.01 176.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.053 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -82.73 9.95 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 20.6 p -125.78 9.7 7.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 90.8 t -92.57 139.17 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 55.5 p -143.89 171.59 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -50.7 -50.98 53.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -50.28 -39.18 44.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 74.2 mt -73.94 -35.71 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 96.7 mt -69.29 -26.26 64.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.47 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 44.9 mt-10 -76.43 -71.49 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -42.43 -35.72 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' ALA . . . . . 0.467 ' HB2' ' CE ' ' A' ' 391' ' ' MET . . . -72.81 -55.72 6.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.145 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' PHE . . . . . 0.403 ' CE2' HD11 ' A' ' 403' ' ' ILE . 41.2 m-85 -84.17 14.12 4.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 355' ' ' GLU . 18.0 t -99.65 -52.95 3.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -39.46 -37.24 0.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.565 ' CD2' ' HB3' ' A' ' 387' ' ' ALA . 93.6 m-85 -66.38 -62.58 1.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -150.53 161.85 29.11 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -53.15 122.77 10.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 110.937 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.47 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 32.0 mt -90.4 166.59 13.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -114.2 -44.78 3.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.485 ' HG3' ' CD2' ' A' ' 377' ' ' HIS . 18.5 ptt180 -173.01 166.53 5.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.414 ' CG1' HD11 ' A' ' 354' ' ' LEU . 89.7 t -139.81 123.83 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.471 ' CE ' HD11 ' A' ' 370' ' ' LEU . 1.6 tmmm? -107.17 120.1 41.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -91.73 142.28 27.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.471 HD11 ' CE ' ' A' ' 368' ' ' LYS . 6.4 mp -129.57 -174.57 3.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 370' ' ' LEU . 1.9 mptp? -33.33 -73.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -119.27 -29.66 5.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.401 ' CE2' HD21 ' A' ' 370' ' ' LEU . 3.8 p90 -97.99 -175.0 3.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.434 ' HA ' ' CD1' ' A' ' 370' ' ' LEU . . . -168.52 153.48 6.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.09 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -100.61 146.12 27.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 6.5 mm -118.87 110.81 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . 0.485 ' CD2' ' HG3' ' A' ' 366' ' ' ARG . 55.1 m-70 -89.46 126.1 35.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.819 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.445 ' CD2' HD23 ' A' ' 364' ' ' LEU . 20.1 m-85 -108.4 139.41 43.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -58.52 -29.44 66.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -134.62 143.76 47.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.42 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 3.8 tmm_? -52.13 -34.56 45.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -67.35 -56.53 9.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . 0.426 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -37.74 -32.47 0.11 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.537 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -77.43 -62.81 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.803 0.335 . . . . 0.0 111.122 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 384' ' ' ALA . 54.8 t -36.72 -39.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.133 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . 0.41 ' HA ' ' NZ ' ' A' ' 386' ' ' LYS . 0.1 OUTLIER -71.23 -65.67 0.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.565 ' HB3' ' CD2' ' A' ' 361' ' ' PHE . . . -53.84 -19.27 4.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.14 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.7 ttm -74.97 -63.74 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.458 ' N ' ' HG2' ' A' ' 388' ' ' MET . 5.5 mt-10 -73.71 1.56 10.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.565 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 3.0 mm-40 -99.67 -39.66 8.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' MET . . . . . 0.467 ' CE ' ' HB2' ' A' ' 357' ' ' ALA . 5.9 mmm -101.36 -29.95 11.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 391' ' ' MET . 4.4 t-20 -34.17 96.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 94.11 38.43 5.13 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.525 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -99.62 147.2 25.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -76.51 76.44 3.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 17.6 tp -81.48 113.92 19.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 61.99 24.92 14.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 88.09 20.23 50.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -140.06 126.6 20.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 110.924 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.6 99.28 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.401 HD13 ' CG1' ' A' ' 342' ' ' VAL . 20.9 pt -77.15 148.59 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -109.95 129.9 55.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.403 HD11 ' CE2' ' A' ' 358' ' ' PHE . 24.3 mt -113.3 129.21 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 34.2 m -146.68 135.27 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.089 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 15.9 m-85 -52.69 120.06 5.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.83 135.16 36.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.042 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -63.81 146.13 97.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.529 0.68 . . . . 0.0 110.914 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 146.13 59.44 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.672 2.248 . . . . 0.0 112.407 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -6.26 18.14 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.69 2.26 . . . . 0.0 112.377 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -111.31 156.96 20.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -129.13 176.09 8.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -138.13 144.2 40.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . 0.461 ' HD3' ' N ' ' A' ' 413' ' ' ARG . 1.3 mpp_? -107.28 174.12 6.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -142.3 140.38 32.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -128.11 169.47 14.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.34 167.33 23.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -154.58 161.89 41.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -125.65 155.12 41.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.097 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -104.04 -25.26 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? 41.85 52.6 4.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -119.27 142.81 47.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -174.26 178.92 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -170.42 176.03 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.118 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 19.9 m -158.46 175.82 13.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.874 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -162.12 149.15 17.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.487 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -174.89 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.676 2.251 . . . . 0.0 112.361 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 21.3 t -172.91 -176.62 1.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 85.9 p -128.05 -53.82 1.3 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.861 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.471 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 34.8 p -101.25 90.65 4.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.873 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 24.4 m -83.25 113.55 20.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.854 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 70.43 163.1 4.44 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 34.1 t -95.62 145.93 24.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 0.0 110.872 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 2.1 m -134.07 47.1 2.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -91.42 -139.59 8.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.25 127.99 34.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.831 0.348 . . . . 0.0 110.824 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -126.38 -176.89 3.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.132 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . 0.498 ' C ' ' NH2' ' A' ' 381' ' ' ARG . 1.1 mptp? -101.95 79.11 1.86 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.589 ' O ' ' CE1' ' A' ' 405' ' ' PHE . 41.3 t -135.87 138.11 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.14 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -91.22 -33.66 15.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 77.9 t -74.79 123.24 29.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.107 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 48.9 mt -99.06 123.4 43.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -91.54 106.36 18.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 11.9 t -103.51 138.24 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.152 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -136.03 168.4 19.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 5.9 t30 73.2 54.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 31.1 mt -94.99 137.77 33.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.88 172.52 1.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.107 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -79.38 1.16 26.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 5.7 p -118.04 13.54 13.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.183 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 45.5 t -97.25 140.46 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 64.6 p -140.35 172.48 12.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.151 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -51.49 -45.89 62.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -54.87 -46.62 74.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 72.5 mt -64.32 -28.84 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.156 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 96.4 mt -76.59 -27.61 55.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 359' ' ' SER . 54.2 mt-10 -77.45 -65.69 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -46.47 -37.52 7.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' ALA . . . . . 0.462 ' HB2' ' CE ' ' A' ' 391' ' ' MET . . . -72.17 -49.83 32.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.099 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' PHE . . . . . 0.413 ' C ' HD13 ' A' ' 364' ' ' LEU . 39.6 m-85 -88.17 13.03 12.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 355' ' ' GLU . 5.3 t -98.89 -52.64 3.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . 0.401 ' HG3' ' N ' ' A' ' 361' ' ' PHE . 18.2 pt20 -38.59 -40.14 0.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.565 ' CD2' ' HB1' ' A' ' 387' ' ' ALA . 93.5 m-85 -64.0 -62.44 1.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -149.55 169.36 29.79 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -59.61 127.34 31.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.466 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 81.4 mt -95.99 156.37 16.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -104.99 -41.73 5.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -174.93 165.9 3.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 33.9 t -139.48 124.6 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.155 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -109.5 114.98 29.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . 0.416 ' C ' HD11 ' A' ' 370' ' ' LEU . 19.1 tptp -90.89 144.28 25.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.54 HD22 ' CE2' ' A' ' 373' ' ' TYR . 7.0 mp -130.92 -174.69 3.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 370' ' ' LEU . 16.1 tttm -33.09 -68.02 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.4 -37.56 2.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.54 ' CE2' HD22 ' A' ' 370' ' ' LEU . 9.7 p90 -92.23 179.8 5.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -160.86 161.54 31.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.078 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -112.42 125.37 54.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 6.1 mm -101.32 121.29 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -100.94 124.38 46.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.56 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 26.5 m-85 -106.64 133.78 50.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -53.9 -32.57 53.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -128.51 151.18 49.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.498 ' NH2' ' C ' ' A' ' 336' ' ' LYS . 11.5 tpp85 -58.41 -36.31 73.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 384' ' ' ALA . 14.6 t70 -68.23 -55.48 12.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -37.97 -31.15 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.506 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -80.87 -63.96 1.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.855 0.359 . . . . 0.0 111.155 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 384' ' ' ALA . 79.7 t -36.82 -35.42 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . 0.411 ' HE2' ' CG ' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -72.02 -60.02 2.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.888 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.565 ' HB1' ' CD2' ' A' ' 361' ' ' PHE . . . -62.21 -17.37 58.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.594 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.1 ttm -75.39 -60.9 2.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.887 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.427 ' N ' ' HG2' ' A' ' 388' ' ' MET . 11.1 mt-10 -74.48 -0.79 18.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.49 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 33.8 mm-40 -99.98 -37.93 8.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.913 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' MET . . . . . 0.477 ' O ' ' CG ' ' A' ' 394' ' ' LYS . 12.3 mmm -99.9 -29.22 12.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 388' ' ' MET . 2.7 t-20 -41.24 111.79 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.845 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 75.49 28.84 60.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.507 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.477 ' CG ' ' O ' ' A' ' 391' ' ' MET . 0.0 OUTLIER -97.71 142.79 29.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -68.73 99.89 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 21.6 tp -105.46 109.67 21.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 61.6 32.63 18.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 83.28 15.99 70.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -139.82 120.09 13.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.871 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.75 106.02 3.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 23.7 pt -79.25 161.08 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.132 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -123.75 125.61 45.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 391' ' ' MET . 25.0 mt -111.16 135.51 50.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.128 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 6.9 m -150.16 130.96 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.132 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.594 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 15.5 m-85 -51.53 108.95 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -62.95 153.14 34.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.064 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . 0.407 ' HG3' ' N ' ' A' ' 408' ' ' PRO . 4.4 tttp -78.9 142.63 60.68 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.588 0.709 . . . . 0.0 110.891 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.407 ' N ' ' HG3' ' A' ' 407' ' ' LYS . 54.0 Cg_endo -69.71 148.63 65.84 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.737 2.291 . . . . 0.0 112.365 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -19.07 36.48 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.714 2.276 . . . . 0.0 112.294 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -61.98 153.15 30.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.849 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -126.12 164.48 20.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -153.07 122.08 6.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -109.87 121.19 44.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.882 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -120.89 134.85 55.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -116.16 -175.73 2.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -156.07 130.35 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.869 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -80.81 122.23 26.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -112.93 174.17 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.102 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 8.0 pm0 -112.85 -176.57 2.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.945 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -165.96 108.14 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -98.68 153.27 18.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -107.39 178.17 4.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.081 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -173.54 177.42 2.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.105 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.5 t -163.99 153.52 14.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -157.32 144.7 10.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.511 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -172.69 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.678 2.252 . . . . 0.0 112.373 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 86.2 p -150.24 139.11 20.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 23.3 m -70.63 -59.66 2.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.444 179.961 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.474 -0.251 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 29.8 t -47.83 144.16 3.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.881 0.372 . . . . 0.0 110.825 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 84.9 p -147.76 177.17 9.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 173.3 66.99 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.481 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 65.4 m -109.76 120.46 42.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.904 0.383 . . . . 0.0 110.853 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 73.3 m -137.41 117.42 13.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.896 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.6 175.88 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.5 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 15.0 mtt -141.34 157.82 44.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.767 0.318 . . . . 0.0 110.912 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -156.52 132.75 9.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.115 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 88.57 4.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 55.2 t -135.92 127.86 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -93.81 -27.56 16.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 95.5 t -81.5 121.13 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.569 HD11 ' CE1' ' A' ' 378' ' ' PHE . 60.5 mt -100.66 121.94 42.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.944 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -85.54 108.25 17.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 43.4 t -106.69 133.64 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.123 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.425 ' HB2' ' NH1' ' A' ' 343' ' ' ARG . 3.0 ptm85 -131.66 172.18 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.835 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.1 t30 72.7 37.45 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 17.5 mt -77.34 144.79 37.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -73.89 179.05 4.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -83.49 2.55 36.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 69.5 p -120.64 11.55 11.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 97.6 t -95.58 132.16 40.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.129 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 70.5 p -139.39 165.57 26.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.164 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -41.2 -44.31 2.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -55.29 -59.21 5.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 80.4 mt -55.73 -31.75 30.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.126 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.401 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 93.1 mt -71.43 -26.15 62.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.496 ' O ' ' CB ' ' A' ' 359' ' ' SER . 27.0 mt-10 -83.71 -53.92 5.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . 0.439 ' O ' ' NE2' ' A' ' 360' ' ' GLN . 74.0 mttt -57.55 -20.44 32.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' ALA . . . . . 0.467 ' HB2' ' CE ' ' A' ' 391' ' ' MET . . . -93.26 -44.45 8.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.111 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' PHE . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 41.2 m-85 -93.25 18.03 10.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 355' ' ' GLU . 3.3 t -100.06 -61.84 1.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 356' ' ' LYS . 2.4 pm0 -37.68 -37.84 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.51 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 70.0 m-85 -62.71 -58.74 6.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -155.46 162.83 31.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.483 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -55.07 123.59 14.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.422 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 60.0 mt -91.36 178.21 6.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -131.76 -44.02 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -173.97 165.96 4.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 64.6 t -138.07 134.48 44.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -118.85 117.72 29.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -93.51 144.29 25.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.481 ' O ' ' C ' ' A' ' 371' ' ' LYS . 8.0 mp -130.87 -174.44 3.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 370' ' ' LEU . 20.8 tttp -31.53 -64.78 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -128.36 -37.26 1.84 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.44 ' CE2' HD23 ' A' ' 370' ' ' LEU . 14.1 p90 -92.53 179.18 5.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -159.1 171.89 19.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.069 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -124.06 127.73 48.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.839 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.401 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.4 mm -101.2 109.31 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.161 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -85.79 110.46 19.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 340' ' ' LEU . 17.9 m-85 -92.95 143.31 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -55.32 -33.1 63.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -141.43 162.66 34.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.408 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 4.0 tmm_? -63.62 -33.0 74.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -65.47 -58.84 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.824 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -42.17 -28.6 0.53 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.452 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -80.18 -60.38 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 0.0 111.092 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 384' ' ' ALA . 60.6 t -37.44 -35.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . 0.417 ' HA ' ' NZ ' ' A' ' 386' ' ' LYS . 0.0 OUTLIER -73.83 -63.25 1.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.65 -14.41 13.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.563 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.7 ttm -80.28 -62.24 1.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.859 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.413 ' N ' ' HG2' ' A' ' 388' ' ' MET . 11.9 mt-10 -75.05 -3.19 31.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.51 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 28.2 mm-40 -100.16 -29.38 12.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.822 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' MET . . . . . 0.501 ' O ' ' N ' ' A' ' 393' ' ' GLY . 5.0 mmt -107.92 -41.98 4.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 388' ' ' MET . 26.2 t-20 -34.21 93.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.856 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 103.64 28.44 5.99 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.51 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 391' ' ' MET . 1.1 mmmm -98.54 146.31 25.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.319 . . . . 0.0 110.918 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -74.35 78.6 1.86 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.872 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 19.0 tp -86.23 113.22 22.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 62.34 25.1 14.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.31 17.98 58.04 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.483 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -138.64 124.26 19.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.28 92.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 20.7 pt -71.56 146.13 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.154 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -111.76 130.84 55.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 392' ' ' ASN . 20.9 mt -115.04 126.47 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.43 136.82 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.132 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.563 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 13.1 m-85 -54.56 110.61 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.825 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.75 131.98 46.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.116 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -54.15 150.19 16.42 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.585 0.707 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 148.66 65.97 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.657 2.238 . . . . 0.0 112.345 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 93.72 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.701 2.267 . . . . 0.0 112.364 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 38.9 p30 -74.29 175.1 7.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.858 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -162.12 161.94 28.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.27 -64.82 1.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -173.09 157.14 3.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . 0.414 ' C ' ' HD2' ' A' ' 414' ' ' LYS . 1.2 tmmm? -102.59 107.69 18.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.96 141.31 31.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.416 ' C ' ' HD3' ' A' ' 416' ' ' ARG . 0.6 OUTLIER -140.81 163.73 32.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.851 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 25.4 tptt -113.64 158.02 21.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -172.23 120.29 0.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.129 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.03 155.83 42.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -112.67 138.75 49.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.848 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -147.97 149.14 31.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.887 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -147.33 167.6 23.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -160.74 169.11 23.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 68.5 p -163.91 178.88 7.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 179.78 146.0 6.66 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.445 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -176.36 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.758 2.305 . . . . 0.0 112.346 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 83.9 p -133.77 173.81 11.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.809 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.5 t -150.96 175.38 12.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.875 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.435 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 36.4 p -144.94 134.46 23.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 110.856 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 13.6 t -153.29 119.91 5.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 100.47 69.69 0.89 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 36.2 p -73.22 130.19 39.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.883 0.373 . . . . 0.0 110.862 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 t -61.08 -54.67 41.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 76.92 83.54 0.5 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.44 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 8.9 mmt -104.4 -52.65 2.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.754 0.311 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -157.39 131.96 8.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.057 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -75.7 104.82 6.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.939 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.466 ' HB ' ' CD1' ' A' ' 405' ' ' PHE . 55.5 t -133.69 134.93 56.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.137 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -94.29 -31.39 14.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.924 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 64.6 t -79.1 123.92 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 72.0 mt -104.19 125.48 50.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -90.04 106.66 18.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 22.3 t -104.31 137.68 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.163 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -136.34 169.25 17.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.3 t30 74.16 46.81 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.901 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 48.5 mt -83.88 135.91 34.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.944 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.3 179.8 0.54 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -85.81 5.97 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 49.8 p -123.43 11.61 9.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 87.5 t -90.81 153.01 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 77.6 p -153.96 173.18 16.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -58.55 -35.85 72.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.6 -40.71 92.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 68.9 mt -69.16 -28.66 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.457 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 94.6 mt -72.39 -31.47 65.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 359' ' ' SER . 64.8 mt-10 -72.18 -74.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -42.05 -34.55 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' ALA . . . . . 0.429 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -73.01 -52.13 15.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -88.06 15.11 7.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 360' ' ' GLN . 82.7 p -97.23 -56.39 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 359' ' ' SER . 26.4 pt20 -35.16 -42.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.524 ' CD2' ' HB1' ' A' ' 387' ' ' ALA . 87.9 m-85 -61.42 -68.36 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -146.51 165.03 28.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.489 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -54.72 127.65 29.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.828 0.347 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 78.7 mt -96.35 156.41 16.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -103.36 -42.42 5.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -174.59 169.43 3.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 48.9 t -140.65 126.02 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.123 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -119.73 104.86 10.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . 0.472 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 20.2 tttm -82.81 152.75 25.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.563 HD21 ' CE2' ' A' ' 373' ' ' TYR . 6.9 mp -130.51 -174.8 3.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 370' ' ' LEU . 16.9 tptm -33.26 -68.8 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -118.66 -39.06 3.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.563 ' CE2' HD21 ' A' ' 370' ' ' LEU . 7.0 p90 -92.9 -178.94 4.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 369' ' ' LYS . . . -158.02 168.16 27.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.061 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -121.28 128.3 52.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 7.4 mm -103.7 113.7 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -92.52 123.71 36.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 387' ' ' ALA . 20.4 m-85 -105.77 145.61 30.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.64 -33.73 74.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -132.29 159.09 40.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.421 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 0.4 OUTLIER -65.24 -28.91 69.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 384' ' ' ALA . 23.5 t0 -70.77 -61.07 1.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -36.89 -30.37 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.509 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 382' ' ' ASP . . . -76.91 -63.22 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.346 . . . . 0.0 111.07 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 384' ' ' ALA . 89.5 t -36.46 -35.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.095 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -63.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.524 ' HB1' ' CD2' ' A' ' 361' ' ' PHE . . . -59.21 -16.16 19.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.515 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.7 ttm -77.75 -61.64 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.413 ' N ' ' HG2' ' A' ' 388' ' ' MET . 14.6 mt-10 -75.22 0.31 16.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.48 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 32.4 mm-40 -100.07 -36.58 9.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' MET . . . . . 0.5 ' O ' ' N ' ' A' ' 393' ' ' GLY . 3.6 mmt -102.95 -30.32 10.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 388' ' ' MET . 7.0 t-20 -42.54 91.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 100.82 30.46 6.09 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.462 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 391' ' ' MET . 22.1 mmtt -100.0 148.43 24.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.743 0.306 . . . . 0.0 110.943 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -74.15 85.49 1.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.905 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 21.8 tp -93.34 112.34 24.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 62.48 26.94 16.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 86.35 18.39 59.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -140.09 126.0 19.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.882 0.373 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.0 93.51 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 25.9 pt -71.02 149.32 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.085 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -113.51 131.7 55.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.429 ' O ' ' ND2' ' A' ' 392' ' ' ASN . 30.9 mt -113.3 133.46 59.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.14 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 5.1 m -145.72 132.83 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.515 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 7.1 m-85 -53.7 109.45 0.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.63 147.23 47.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.094 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -66.85 145.52 98.94 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.571 0.7 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 113.36 3.34 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.7 2.267 . . . . 0.0 112.341 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 101.87 0.95 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.702 2.268 . . . . 0.0 112.362 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -157.22 137.89 13.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -106.14 101.32 10.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -128.83 145.17 51.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . 0.413 ' HG2' ' N ' ' A' ' 414' ' ' LYS . 50.7 ttp180 -154.94 155.34 34.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . 0.413 ' N ' ' HG2' ' A' ' 413' ' ' ARG . 11.3 tptp -139.97 121.84 15.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -144.54 143.67 30.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.914 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -171.29 151.36 3.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -159.0 139.45 12.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.912 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -155.94 157.27 35.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -134.46 171.56 14.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -135.69 172.45 12.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -110.03 149.09 30.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -97.5 159.83 14.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.031 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -113.13 162.6 15.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.3 p -124.94 168.48 13.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.834 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -173.87 146.44 8.77 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.502 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 117.33 5.02 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.707 2.271 . . . . 0.0 112.322 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 2.9 m -60.37 -55.17 36.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.855 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 9.3 m -99.45 153.7 18.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.466 -179.982 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 45.9 p -55.38 134.0 50.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.866 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 70.6 p -101.67 139.2 37.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -86.12 139.32 16.77 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.448 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 14.0 m -39.36 105.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 110.845 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 45.3 t -39.57 153.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 159.62 99.47 0.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.483 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 27.5 mtt -68.16 119.24 12.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.743 0.306 . . . . 0.0 110.839 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -169.67 148.92 3.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.073 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -122.56 91.33 3.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.4 133.07 69.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.12 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -94.54 -31.4 13.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.891 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 58.3 t -80.65 132.74 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.413 HD12 ' CE1' ' A' ' 378' ' ' PHE . 33.4 mt -110.74 127.38 55.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -90.39 114.08 26.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.59 131.62 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -130.0 170.14 14.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.2 t30 74.81 41.21 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 44.1 mt -80.27 133.6 36.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -56.17 -177.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -91.67 11.59 23.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.908 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 51.4 p -135.04 17.71 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 71.4 t -95.48 136.92 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.103 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 76.9 p -135.79 170.52 15.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.133 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -52.49 -46.05 66.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -52.59 -42.97 64.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 77.6 mt -70.94 -27.46 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.178 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.414 HD12 ' CG1' ' A' ' 367' ' ' VAL . 97.8 mt -73.99 -31.5 62.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 359' ' ' SER . 24.4 mt-10 -74.73 -64.83 0.96 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.939 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -44.36 -40.34 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' ALA . . . . . 0.444 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -71.26 -55.79 7.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.092 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' PHE . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 45.3 m-85 -81.77 13.95 2.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.864 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 355' ' ' GLU . 7.2 t -100.03 -54.17 2.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.828 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -39.65 -36.02 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.557 ' CD2' ' HB2' ' A' ' 387' ' ' ALA . 81.1 m-85 -65.52 -63.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.19 168.74 31.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.479 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -53.37 129.12 30.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 110.906 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.512 HD21 ' CD2' ' A' ' 378' ' ' PHE . 32.7 mt -99.54 163.35 12.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -111.93 -48.68 3.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -172.82 165.91 5.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.414 ' CG1' HD12 ' A' ' 354' ' ' LEU . 93.7 t -134.45 127.41 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.147 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -110.83 114.19 27.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -89.97 138.76 31.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.87 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.499 HD22 ' CE2' ' A' ' 373' ' ' TYR . 7.7 mp -125.49 -174.83 3.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 370' ' ' LEU . 3.2 mptp? -33.7 -70.81 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.94 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -119.01 -38.26 3.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.838 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.499 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.9 p90 -91.78 -175.79 4.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.947 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -164.95 158.26 16.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -109.63 133.57 52.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 3.7 mm -107.41 107.48 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -85.5 117.88 24.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.512 ' CD2' HD21 ' A' ' 364' ' ' LEU . 16.2 m-85 -99.42 146.13 26.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -57.72 -36.48 72.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -133.18 160.34 37.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.415 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 1.6 tmm_? -63.92 -35.27 80.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 384' ' ' ALA . 11.5 t0 -65.77 -58.58 5.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -38.62 -30.67 0.1 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.466 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 382' ' ' ASP . . . -76.95 -58.91 3.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.317 . . . . 0.0 111.091 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.4 t -37.9 -37.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.122 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . 0.425 ' HA ' ' NZ ' ' A' ' 386' ' ' LYS . 0.1 OUTLIER -72.3 -65.36 0.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.84 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.557 ' HB2' ' CD2' ' A' ' 361' ' ' PHE . . . -56.14 -16.57 5.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.106 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.535 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.5 ttm -78.52 -64.13 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.455 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.1 mt-10 -73.86 0.83 12.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.478 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 57.5 mm-40 -100.14 -39.91 7.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' MET . . . . . 0.447 ' O ' ' N ' ' A' ' 393' ' ' GLY . 5.9 mmm -100.11 -30.12 12.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 388' ' ' MET . 5.5 t-20 -42.03 94.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 100.61 30.38 6.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.503 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.0 147.74 25.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.329 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . 0.414 ' OD1' ' C ' ' A' ' 395' ' ' ASP . 31.2 t0 -75.35 88.63 2.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.875 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 29.2 tp -94.73 110.17 22.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.984 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 63.35 24.95 14.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.47 18.95 51.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.448 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -139.94 125.59 19.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.9 94.05 2.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 20.1 pt -71.5 148.14 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -112.04 130.3 55.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.879 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.436 ' O ' ' ND2' ' A' ' 392' ' ' ASN . 27.2 mt -112.43 131.24 64.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.096 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 22.1 m -144.8 136.58 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.535 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 12.2 m-85 -54.17 116.0 2.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.2 147.22 46.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.098 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -77.12 143.95 70.81 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.564 0.697 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 132.37 23.26 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.355 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 172.01 13.38 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.709 2.272 . . . . 0.0 112.349 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -45.69 132.17 8.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.87 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -49.96 144.68 6.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 4.6 tppt? -77.61 -60.66 2.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 9.0 ttm105 -169.54 160.31 8.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.85 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -131.27 123.85 29.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -114.5 156.21 25.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -143.6 141.19 30.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -166.45 149.28 6.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -166.15 149.16 7.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -158.69 138.18 11.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.95 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -91.63 144.25 25.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -86.36 158.71 19.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -141.07 177.28 8.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.105 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -114.82 159.93 20.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 96.0 p -168.37 171.2 9.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -131.29 157.34 22.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.516 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 153.91 68.45 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.721 2.28 . . . . 0.0 112.321 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 1.1 t -163.96 157.88 19.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 13.5 m 57.48 53.45 7.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.48 -179.973 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 12.7 t -109.82 -63.96 1.31 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.902 0.382 . . . . 0.0 110.838 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 32.9 m -113.16 94.93 5.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.894 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -96.88 139.81 14.7 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.465 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 1.9 t -113.26 130.84 56.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.903 0.382 . . . . 0.0 110.855 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 37.6 m -96.54 149.18 22.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -120.84 129.79 7.99 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.494 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' MET . . . . . 0.437 ' O ' ' C ' ' A' ' 335' ' ' ALA . 16.6 mmt -121.05 157.46 29.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 110.884 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 336' ' ' LYS . . . 35.34 37.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.082 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 335' ' ' ALA . 35.2 mtmt 34.48 45.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 58.3 t -48.73 136.89 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.117 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -105.48 -30.09 9.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.0 t -79.48 138.98 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.559 HD11 ' CE1' ' A' ' 378' ' ' PHE . 47.4 mt -114.01 130.84 56.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -92.19 107.98 19.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.09 136.36 39.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -135.78 173.36 11.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.0 t30 68.89 52.1 0.54 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 18.0 mt -94.94 121.15 36.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -46.26 173.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -80.78 13.79 2.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 38.6 p -128.19 5.58 5.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 51.0 t -88.92 140.41 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.107 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 68.0 p -143.71 170.56 15.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.134 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -49.47 -41.86 41.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -59.31 -39.0 81.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 77.0 mt -73.64 -29.38 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.451 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 89.7 mt -74.26 -27.48 60.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 359' ' ' SER . 38.0 mt-10 -80.2 -66.87 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -48.7 -25.54 1.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -83.91 -47.47 11.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -90.76 12.89 17.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 355' ' ' GLU . 99.2 p -99.64 -46.93 5.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -41.75 -30.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.567 ' CD2' ' HB3' ' A' ' 387' ' ' ALA . 98.4 m-85 -75.43 -73.92 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -135.56 174.4 21.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.476 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -60.16 133.88 56.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.792 0.33 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.411 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 50.0 mt -103.74 153.36 20.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -103.5 -47.42 4.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -173.47 165.08 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.849 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 51.4 t -136.58 132.57 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.72 107.79 15.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -83.43 143.36 30.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.526 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.2 mp -128.59 -174.27 3.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.941 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 370' ' ' LEU . 21.6 mtpp -32.48 -64.15 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.47 -33.77 2.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.526 ' CE2' HD22 ' A' ' 370' ' ' LEU . 3.8 p90 -93.74 -176.04 3.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.436 ' HA ' ' CD1' ' A' ' 370' ' ' LEU . . . -166.81 160.49 14.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.123 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -111.57 134.85 52.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.489 HG23 ' CE1' ' A' ' 378' ' ' PHE . 3.6 mm -109.76 116.05 51.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -92.13 121.16 33.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.559 ' CE1' HD11 ' A' ' 340' ' ' LEU . 20.0 m-85 -106.57 127.67 53.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -42.52 -35.82 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -134.28 157.6 45.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -34.57 74.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 384' ' ' ALA . 27.1 t0 -65.67 -57.4 8.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . 0.459 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -38.97 -29.15 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 382' ' ' ASP . . . -82.07 -58.86 2.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 111.122 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 94.1 t -38.16 -39.66 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.109 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -68.62 -60.56 2.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.567 ' HB3' ' CD2' ' A' ' 361' ' ' PHE . . . -63.07 -14.35 47.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.085 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 7.6 ttm -79.43 -59.67 2.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -75.09 -3.43 32.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.513 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 6.2 mm-40 -100.07 -37.18 9.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' MET . . . . . 0.498 ' O ' ' CG ' ' A' ' 394' ' ' LYS . 69.8 mmm -99.91 -25.13 14.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 388' ' ' MET . 1.4 t-20 -42.04 118.84 1.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 63.69 32.68 84.98 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.467 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 391' ' ' MET . 0.0 OUTLIER -96.75 145.2 26.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.757 0.313 . . . . 0.0 110.91 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -68.48 108.22 3.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 21.1 tp -119.51 111.45 18.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 62.01 37.06 15.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.893 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 76.72 11.17 85.58 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.492 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -137.27 121.08 17.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.368 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.34 116.04 8.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 17.3 pt -90.99 147.55 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.113 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -111.23 133.13 53.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 391' ' ' MET . 22.6 mt -116.92 134.69 59.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.127 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 3.9 m -144.92 140.59 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 14.9 m-85 -61.0 105.01 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -62.44 166.47 5.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . 0.464 ' HG3' ' N ' ' A' ' 408' ' ' PRO . 0.2 OUTLIER -72.38 143.73 85.88 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.527 0.68 . . . . 0.0 110.927 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.464 ' N ' ' HG3' ' A' ' 407' ' ' LYS . 53.9 Cg_endo -69.65 153.69 69.11 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.722 2.281 . . . . 0.0 112.382 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -32.37 18.52 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.647 2.231 . . . . 0.0 112.367 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -97.16 132.38 42.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.856 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.93 86.74 2.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -55.67 134.47 51.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -102.01 111.22 23.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -100.56 143.33 30.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -136.02 152.71 51.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -124.64 171.29 10.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.857 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.04 169.39 10.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -131.39 147.07 52.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.092 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -127.93 166.1 18.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.03 116.73 20.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -174.09 118.99 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -168.05 167.02 12.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -163.74 169.17 18.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 93.6 p -168.51 176.72 5.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.54 68.75 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -178.45 2.36 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.685 2.257 . . . . 0.0 112.336 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 1.9 m -166.74 137.18 3.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.913 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.2 m -38.25 154.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.453 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 24.2 t -163.93 147.67 9.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.0 110.908 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 2.5 t -110.08 168.79 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.837 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -118.17 132.74 9.98 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 3.4 m -146.05 176.61 9.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 110.869 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 77.9 p -159.21 152.77 22.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.915 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 79.55 127.3 0.59 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.508 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 1.1 tpt -103.62 89.2 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.78 0.324 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -132.86 166.64 21.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.62 16.42 9.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 56.8 t -50.94 129.2 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -93.86 -31.88 14.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.83 130.83 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 403' ' ' ILE . 63.0 mt -106.27 124.62 49.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -88.69 107.28 18.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 20.6 t -101.98 134.73 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.126 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -134.54 170.35 15.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.823 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.1 t30 72.91 39.12 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 31.1 mt -79.93 154.45 28.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -93.08 163.17 13.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -65.51 -7.29 13.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 81.9 p -103.53 -0.13 30.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.135 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 96.0 t -91.97 132.27 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.087 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 67.8 p -134.62 170.3 16.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -50.97 -44.95 60.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -56.61 -41.2 76.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.933 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 73.2 mt -70.46 -30.25 42.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.138 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.433 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 97.2 mt -73.5 -30.13 62.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 359' ' ' SER . 49.4 mt-10 -75.64 -67.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -47.87 -36.44 12.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.848 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' ALA . . . . . 0.464 ' HB3' ' CE ' ' A' ' 391' ' ' MET . . . -70.96 -49.77 41.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -88.9 12.78 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 355' ' ' GLU . 40.4 t -99.26 -53.41 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -37.96 -31.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.55 ' CD2' ' HB1' ' A' ' 387' ' ' ALA . 91.5 m-85 -71.98 -63.11 1.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -149.55 171.12 29.71 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.465 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -58.62 128.26 36.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 0.0 110.917 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.456 HD22 ' CD2' ' A' ' 378' ' ' PHE . 33.7 mt -97.35 171.48 8.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.956 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -120.52 -45.69 2.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -173.84 165.03 4.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.858 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.43 HG11 ' N ' ' A' ' 368' ' ' LYS . 40.4 t -137.12 137.37 46.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.43 ' N ' HG11 ' A' ' 367' ' ' VAL . 7.9 tmtm? -125.07 120.32 31.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.864 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -94.44 140.92 29.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.873 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.462 ' O ' ' C ' ' A' ' 371' ' ' LYS . 6.8 mp -124.47 -174.71 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 370' ' ' LEU . 19.3 tttp -33.11 -65.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -125.67 -37.44 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.864 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -92.41 -174.8 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -164.69 163.66 21.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -116.15 129.6 56.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.901 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.1 mm -104.52 119.45 53.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -98.3 121.89 40.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.493 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 21.5 m-85 -102.75 149.9 24.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.76 -29.19 70.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.858 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -136.23 160.54 38.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.892 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.415 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 7.0 tmm_? -65.05 -29.41 70.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -73.13 -54.09 9.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . 0.493 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -40.17 -30.76 0.28 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -80.13 -63.87 1.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 111.104 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 384' ' ' ALA . 52.6 t -37.08 -35.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.131 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -61.5 1.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.55 ' HB1' ' CD2' ' A' ' 361' ' ' PHE . . . -60.88 -16.12 38.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.098 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.52 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.3 ttm -78.13 -62.21 1.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.436 ' N ' ' HG2' ' A' ' 388' ' ' MET . 18.5 mt-10 -74.5 1.22 12.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.545 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 4.4 mm-40 -100.07 -39.08 8.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' MET . . . . . 0.5 ' O ' ' N ' ' A' ' 393' ' ' GLY . 10.6 mmm -102.7 -30.76 10.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 388' ' ' MET . 5.7 t-20 -34.35 93.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 98.81 37.23 4.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -99.97 148.34 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.328 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -76.06 77.95 2.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.861 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 16.6 tp -83.36 110.54 18.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.979 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 63.04 29.67 16.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 84.18 20.68 58.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -140.09 126.7 20.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.83 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.43 97.84 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 22.2 pt -77.79 146.38 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -112.12 131.69 55.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.882 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.465 HD12 ' N ' ' A' ' 392' ' ' ASN . 13.5 mt -112.04 132.45 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.101 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 13.7 m -145.69 134.06 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.52 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 16.2 m-85 -51.5 111.13 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.844 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.76 150.26 48.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.128 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -73.33 141.13 80.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.582 0.706 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 160.31 50.17 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.67 2.247 . . . . 0.0 112.375 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 141.29 44.84 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.702 2.268 . . . . 0.0 112.323 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -119.99 128.11 53.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.868 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -152.8 154.67 35.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.943 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -136.48 159.41 41.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.863 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -149.39 156.0 41.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.858 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.63 139.91 1.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -101.49 155.55 18.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.886 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -133.47 134.08 43.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.835 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -137.9 135.38 36.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -144.85 163.34 34.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.132 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -129.3 177.03 7.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 8.6 ptt-85 -149.51 158.18 43.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -144.7 149.01 34.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -129.75 177.56 7.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.094 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -163.09 173.06 13.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.079 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 65.3 m -147.52 176.03 10.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -151.55 145.54 13.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.503 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 172.79 12.0 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.669 2.246 . . . . 0.0 112.349 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 26.6 m -114.17 -56.01 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.859 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 14.5 m 54.38 42.78 31.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.489 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 26.0 m -115.19 172.25 7.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.854 0.359 . . . . 0.0 110.874 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 20.0 t -144.2 131.11 20.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.855 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -96.55 -153.57 29.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.491 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 2.5 m -73.11 171.89 12.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 110.851 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 12.6 t -116.53 110.34 18.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.856 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -111.23 106.38 2.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 32.6 mtt -106.57 41.33 1.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.793 0.33 . . . . 0.0 110.86 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -123.5 175.12 6.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.104 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -108.43 94.2 4.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.935 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 44.6 t -143.94 131.01 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.128 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -92.92 -32.28 14.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 91.6 t -75.7 124.9 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 91.4 mt -104.97 116.67 32.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -82.79 109.33 16.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.455 ' CG1' HD13 ' A' ' 401' ' ' ILE . 24.4 t -108.3 132.26 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -130.72 177.17 7.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 68.94 43.79 1.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 33.6 mt -83.39 141.26 31.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.41 -178.16 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.095 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -88.87 2.95 52.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 61.4 p -120.08 13.87 12.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.186 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 73.6 t -92.83 150.47 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 75.5 p -149.13 170.04 19.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -52.07 -44.85 64.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -54.61 -52.12 63.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 77.8 mt -58.07 -33.1 45.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 87.4 mt -73.85 -26.63 60.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.918 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.459 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 31.7 mt-10 -78.92 -63.29 1.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -51.35 -41.33 60.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' ALA . . . . . 0.47 ' HB3' ' CE ' ' A' ' 391' ' ' MET . . . -65.85 -49.73 67.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.055 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -89.08 16.82 6.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 360' ' ' GLN . 12.2 t -99.95 -57.15 2.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 359' ' ' SER . 24.0 pt20 -37.68 -39.42 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.914 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.563 ' CD2' ' HB3' ' A' ' 387' ' ' ALA . 71.6 m-85 -62.83 -63.41 1.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -150.88 166.45 30.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.499 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -54.88 125.53 20.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 0.0 110.916 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.459 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 34.3 mt -94.12 154.32 17.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -103.63 -44.9 4.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -174.92 163.6 3.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.445 ' CG2' ' HG2' ' A' ' 355' ' ' GLU . 51.8 t -135.14 124.06 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.34 106.97 13.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . 0.477 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 17.6 tttm -84.14 150.43 25.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.516 HD23 ' CE2' ' A' ' 373' ' ' TYR . 6.4 mp -127.97 -174.33 3.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 370' ' ' LEU . 9.7 ttmt -32.58 -67.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.04 -38.68 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.843 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.516 ' CE2' HD23 ' A' ' 370' ' ' LEU . 4.8 p90 -91.94 -176.39 4.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 369' ' ' LYS . . . -160.88 166.86 27.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -119.53 131.9 55.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.416 HG21 ' CE1' ' A' ' 378' ' ' PHE . 7.2 mm -107.79 110.31 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.132 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -88.9 125.64 35.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.428 ' CZ ' ' HB1' ' A' ' 387' ' ' ALA . 20.0 m-85 -108.8 134.59 51.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.87 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -46.66 -36.55 7.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -133.29 158.84 41.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -62.29 -36.56 82.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 384' ' ' ALA . 26.4 t70 -63.48 -59.5 4.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 382' ' ' ASP . . . -36.89 -31.78 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 382' ' ' ASP . . . -76.06 -61.24 2.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 111.093 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 384' ' ' ALA . 66.7 t -35.79 -33.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.088 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 384' ' ' ALA . 0.0 OUTLIER -75.3 -65.15 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.872 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.563 ' HB3' ' CD2' ' A' ' 361' ' ' PHE . . . -58.0 -14.77 7.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.1 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.59 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.8 ttm -80.23 -62.38 1.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.874 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.413 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.0 mt-10 -75.63 -1.64 25.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.537 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 69.0 mm-40 -100.14 -32.28 10.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' MET . . . . . 0.486 ' O ' ' N ' ' A' ' 393' ' ' GLY . 19.5 mmm -106.2 -37.94 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.896 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 388' ' ' MET . 7.0 t-20 -33.9 93.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.927 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 103.92 27.02 6.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.481 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 391' ' ' MET . 14.1 mmmt -90.76 146.72 23.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.792 0.33 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.72 72.41 3.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.897 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 15.8 tp -75.84 111.82 11.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 62.49 24.99 14.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . 0.446 ' C ' ' OE1' ' A' ' 399' ' ' GLU . . . 89.75 14.39 59.66 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.508 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . 0.446 ' OE1' ' C ' ' A' ' 398' ' ' GLY . 2.5 mp0 -132.88 127.71 34.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.87 0.367 . . . . 0.0 110.849 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.46 96.81 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.455 HD13 ' CG1' ' A' ' 342' ' ' VAL . 20.4 pt -74.67 148.9 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.11 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -112.58 129.71 56.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.461 ' O ' ' ND2' ' A' ' 392' ' ' ASN . 27.3 mt -113.91 126.47 71.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.141 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.65 136.28 46.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.149 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.59 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 9.0 m-85 -54.9 112.61 1.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.22 167.93 16.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.104 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.67 149.39 35.66 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.605 0.717 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 129.01 16.88 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.73 2.286 . . . . 0.0 112.32 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -25.59 28.43 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.685 2.257 . . . . 0.0 112.332 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.52 158.85 9.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -152.14 120.79 6.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -172.87 131.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 6.1 ttt-85 -128.99 147.0 50.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -120.29 166.97 12.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -164.79 119.96 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -124.24 176.26 6.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.828 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -167.17 105.7 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -133.25 129.08 37.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.053 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -118.56 139.36 51.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -154.28 146.54 23.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -143.51 166.29 25.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -164.36 169.52 17.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -149.08 142.71 25.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 17.4 t -143.2 146.82 34.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.85 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -154.85 90.62 0.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.513 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -177.29 1.82 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.657 2.238 . . . . 0.0 112.314 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 5.9 t -147.76 164.84 32.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.3 m -81.39 174.01 11.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.859 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.493 179.983 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 21.5 t -108.41 120.9 43.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.89 0.376 . . . . 0.0 110.897 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 6.5 t -137.88 136.54 37.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -105.99 115.51 4.83 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.437 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 84.3 p -80.71 -40.75 24.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 0.0 110.836 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 333' ' ' GLY . 3.8 t -119.84 92.56 3.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 332' ' ' SER . . . 35.43 -113.64 0.14 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.447 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 52.9 mtt -134.08 101.84 5.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.297 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -78.41 172.14 14.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -121.82 111.14 16.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.542 ' HB ' ' CD1' ' A' ' 405' ' ' PHE . 48.2 t -151.04 129.36 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.118 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 8.8 pttm -94.03 -32.6 13.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 67.7 t -79.61 118.81 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.147 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 46.1 mt -99.2 131.02 45.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -92.92 105.17 17.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.413 HG21 ' CZ ' ' A' ' 358' ' ' PHE . 20.8 t -104.17 131.83 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -133.21 173.73 11.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 73.06 35.47 0.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 21.4 mt -76.63 139.18 40.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -67.52 -178.93 0.97 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -85.7 -0.26 54.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 17.2 p -117.64 14.94 14.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.159 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 96.0 t -96.52 133.73 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.127 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 39.8 p -134.39 169.01 17.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.116 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -51.7 -41.66 61.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -57.47 -43.87 84.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 66.5 mt -67.7 -29.56 45.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.424 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 96.0 mt -72.78 -32.01 65.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 359' ' ' SER . 16.1 mt-10 -73.14 -69.85 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . 0.481 ' HE3' ' N ' ' A' ' 356' ' ' LYS . 0.7 OUTLIER -43.25 -39.11 2.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' ALA . . . . . 0.47 ' HB2' ' CE ' ' A' ' 391' ' ' MET . . . -69.59 -56.02 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' PHE . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 42.7 m-85 -83.96 14.54 4.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 355' ' ' GLU . 11.7 t -100.01 -52.39 3.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -40.35 -37.63 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.562 ' CD2' ' HB2' ' A' ' 387' ' ' ALA . 79.9 m-85 -65.7 -62.75 1.34 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.94 162.22 29.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.507 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -49.0 130.85 18.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 0.0 110.917 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.469 HD21 ' CD2' ' A' ' 378' ' ' PHE . 36.2 mt -101.21 155.02 18.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -100.12 -47.86 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -173.52 167.44 4.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.407 ' CG2' ' HG2' ' A' ' 355' ' ' GLU . 83.2 t -136.87 133.42 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.4 ' N ' HG13 ' A' ' 367' ' ' VAL . 1.0 OUTLIER -119.34 118.51 31.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 12.9 tptp -92.66 141.33 28.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.458 ' O ' ' C ' ' A' ' 371' ' ' LYS . 6.5 mp -126.39 -174.65 3.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 370' ' ' LEU . 1.3 mppt? -33.51 -68.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -122.27 -37.67 2.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -92.64 -176.39 4.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -163.87 161.84 23.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -112.4 134.68 53.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.7 mm -108.56 109.11 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.151 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -88.42 120.67 30.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.469 ' CD2' HD21 ' A' ' 364' ' ' LEU . 17.9 m-85 -101.92 147.53 26.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.54 -33.7 75.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -132.71 153.97 50.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -61.78 -31.01 71.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.99 -51.18 27.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -43.18 -36.67 2.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.501 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -72.11 -59.32 2.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.865 0.364 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.419 ' C ' ' O ' ' A' ' 384' ' ' ALA . 86.1 t -36.41 -37.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.8 tptt -72.56 -66.01 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' A' ' 361' ' ' PHE . . . -56.3 -15.87 4.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 7.5 ttm -78.94 -60.15 2.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -78.2 -2.5 38.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.518 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 65.0 mm-40 -100.07 -21.62 15.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' MET . . . . . 0.499 ' O ' ' N ' ' A' ' 393' ' ' GLY . 10.9 mmm -116.8 -39.12 3.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 391' ' ' MET . 27.5 t-20 -33.23 93.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 103.73 29.93 5.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 391' ' ' MET . 14.8 mmmt -96.2 146.4 24.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.729 0.299 . . . . 0.0 110.914 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.66 74.05 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 15.6 tp -76.41 110.65 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 62.28 24.96 14.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.66 13.84 57.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.478 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -133.56 130.53 38.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 0.0 110.889 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.3 93.57 2.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 20.2 pt -72.06 145.47 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -108.72 130.2 55.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 391' ' ' MET . 24.7 mt -115.52 127.82 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.1 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.27 140.07 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 7.7 m-85 -58.16 108.95 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.5 156.49 36.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -81.13 146.54 58.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.549 0.69 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 131.94 22.35 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.723 2.282 . . . . 0.0 112.345 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -35.82 12.05 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.653 2.235 . . . . 0.0 112.361 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.66 113.99 21.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -113.28 79.14 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -108.98 122.06 46.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -73.89 99.04 3.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -121.93 112.84 18.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -149.77 165.81 31.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -140.14 151.3 45.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . 0.413 ' C ' ' HD3' ' A' ' 417' ' ' LYS . 2.5 tmtt? -159.33 129.78 5.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -168.01 143.79 3.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.165 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -165.67 140.46 4.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.884 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -149.94 152.41 34.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -95.25 156.29 16.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.961 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -117.19 172.53 7.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.08 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -172.33 164.56 5.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.2 t -159.27 173.28 16.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 176.72 147.46 6.56 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.486 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 142.64 48.34 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.705 2.27 . . . . 0.0 112.335 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 6.2 m -134.11 -62.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 5.0 m -137.6 140.09 40.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.864 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.488 -179.952 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 77.0 p -107.5 158.42 17.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.883 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 5.5 t 41.94 42.08 2.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -143.28 89.56 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.484 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 1.2 t -170.04 126.66 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.377 . . . . 0.0 110.851 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 48.0 t -104.92 81.55 1.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -135.23 103.73 0.48 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.462 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 29.5 mmt -78.13 121.05 23.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.783 0.325 . . . . 0.0 110.881 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -115.47 122.68 46.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.101 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -85.22 43.91 1.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 94.7 t -93.32 133.3 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.177 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -93.06 -33.27 14.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.95 122.45 27.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.153 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.433 ' HB3' ' CG2' ' A' ' 403' ' ' ILE . 29.3 mt -102.33 122.85 45.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -85.64 111.29 19.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.22 141.51 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.117 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -140.74 168.21 20.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 75.05 45.34 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 54.0 mt -81.08 137.97 35.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.31 -175.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.085 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -89.86 -4.84 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.851 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 80.5 p -118.71 19.26 13.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 81.5 t -94.74 152.57 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.091 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 82.2 p -155.45 175.44 13.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -57.28 -45.82 83.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.926 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -53.4 -43.59 68.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 70.7 mt -67.72 -38.81 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.462 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 88.1 mt -64.28 -25.41 68.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.961 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 359' ' ' SER . 37.2 mt-10 -76.94 -71.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -44.2 -33.17 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -74.39 -52.47 12.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.128 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' PHE . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 41.7 m-85 -88.27 13.57 11.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 355' ' ' GLU . 11.8 t -100.03 -58.22 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 359' ' ' SER . 20.7 pt20 -34.96 -39.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.567 ' CD2' ' HB2' ' A' ' 387' ' ' ALA . 89.6 m-85 -63.41 -63.91 1.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -149.83 166.47 29.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.81 129.98 31.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.917 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 27.8 mt -98.36 161.51 13.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.869 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -109.71 -46.28 3.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -174.32 165.27 4.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.417 ' CG1' HD13 ' A' ' 354' ' ' LEU . 53.2 t -135.75 132.57 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.108 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.77 108.25 10.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . 0.458 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 8.3 tttm -87.77 147.28 25.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 371' ' ' LYS . 5.6 mp -126.33 -173.52 2.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.486 ' C ' ' O ' ' A' ' 370' ' ' LEU . 32.4 ttmt -30.35 -65.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -125.72 -37.96 2.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.861 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.485 ' CE2' HD21 ' A' ' 370' ' ' LEU . 4.5 p90 -90.93 -176.25 4.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.47 ' HA ' ' CD1' ' A' ' 370' ' ' LEU . . . -162.78 160.93 25.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.086 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -116.28 121.86 43.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.462 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 5.3 mm -96.62 122.26 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -100.09 123.19 44.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 358' ' ' PHE . 19.9 m-85 -105.3 147.71 27.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -64.28 -35.01 79.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -130.99 147.46 52.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.457 ' NH1' ' CG2' ' A' ' 385' ' ' VAL . 0.0 OUTLIER -55.54 -32.07 62.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.826 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 384' ' ' ALA . 7.1 t70 -68.74 -60.6 2.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 382' ' ' ASP . . . -36.35 -33.81 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.491 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -74.07 -63.8 1.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 111.065 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.457 ' CG2' ' NH1' ' A' ' 381' ' ' ARG . 92.5 t -35.43 -35.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . 0.468 ' HE3' ' CG ' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -71.92 -60.56 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.567 ' HB2' ' CD2' ' A' ' 361' ' ' PHE . . . -62.1 -17.73 58.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.135 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.585 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 7.4 ttm -75.24 -59.1 2.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -77.69 -3.04 39.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.468 ' CG ' ' HE3' ' A' ' 386' ' ' LYS . 28.5 mm-40 -100.09 -29.21 12.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.884 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' MET . . . . . 0.463 ' O ' ' CG ' ' A' ' 394' ' ' LYS . 7.4 mmm -108.0 -28.92 9.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 388' ' ' MET . 2.6 t-20 -43.74 111.56 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 78.81 24.71 61.67 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 391' ' ' MET . 0.0 OUTLIER -93.62 142.57 27.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 0.0 110.876 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -70.56 103.19 2.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.787 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 19.5 tp -109.83 110.48 21.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 62.04 34.4 16.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 80.8 16.28 75.58 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.518 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -140.03 119.57 13.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.31 104.32 2.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 28.0 pt -79.42 151.06 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -114.81 132.02 56.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.457 HD11 ' N ' ' A' ' 392' ' ' ASN . 22.6 mt -116.05 134.83 58.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.109 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 14.1 m -147.74 130.62 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.585 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 14.5 m-85 -49.52 105.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -64.21 145.37 56.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.072 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -66.49 153.13 93.72 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.616 0.722 . . . . 0.0 110.896 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 127.9 15.27 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.633 2.222 . . . . 0.0 112.374 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -3.55 12.22 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.745 2.297 . . . . 0.0 112.368 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -152.48 159.27 43.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -101.2 94.82 6.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.959 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -98.47 104.74 16.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -142.15 113.58 7.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -127.66 100.81 6.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -56.38 160.66 2.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.63 166.51 21.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.828 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -170.26 144.53 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -121.26 156.23 32.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.082 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -156.95 153.13 27.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -169.1 174.69 6.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.83 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -155.53 142.13 18.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.908 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -128.84 162.25 27.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.1 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -152.76 134.96 14.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.101 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 23.3 t -119.95 171.43 8.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -156.39 145.64 12.55 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.476 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 110.99 2.68 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.723 2.282 . . . . 0.0 112.346 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 1.4 t -82.25 142.43 32.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 5.5 m -77.74 167.77 21.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.486 179.997 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 97.7 p -126.87 -46.8 1.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.856 0.36 . . . . 0.0 110.828 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 34.8 m -136.17 121.1 18.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -171.95 143.44 7.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.492 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 73.2 p -130.8 132.99 45.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.87 0.367 . . . . 0.0 110.855 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.4 m -126.91 110.86 13.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 90.89 -170.54 34.89 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.49 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 9.0 mmt -85.13 162.35 19.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.329 . . . . 0.0 110.844 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -79.61 -55.86 4.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.096 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -76.13 74.83 2.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.516 ' HB ' ' CD1' ' A' ' 405' ' ' PHE . 80.7 t -126.08 133.13 69.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -95.23 -31.8 13.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.913 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.2 t -79.96 123.01 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.562 HD11 ' CE1' ' A' ' 378' ' ' PHE . 33.5 mt -102.42 131.23 49.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.948 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -94.78 104.7 16.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.468 ' CG1' HD12 ' A' ' 401' ' ' ILE . 33.0 t -104.42 130.78 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -132.33 173.35 11.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . 0.493 ' ND2' ' OE1' ' A' ' 399' ' ' GLU . 0.7 OUTLIER 73.78 40.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.888 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 62.1 mt -78.86 159.11 27.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -86.0 -178.74 6.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.075 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -88.39 4.64 45.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 15.9 p -124.47 15.41 8.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.1 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.87 143.6 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.089 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 73.7 p -143.3 173.11 11.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -52.93 -48.09 67.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -51.77 -46.18 64.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.862 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 77.5 mt -64.7 -35.7 75.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.46 HD13 ' CG1' ' A' ' 367' ' ' VAL . 95.6 mt -69.53 -27.4 65.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.458 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 34.2 mt-10 -77.64 -69.19 0.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -46.21 -32.8 3.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' ALA . . . . . 0.464 ' HB3' ' CE ' ' A' ' 391' ' ' MET . . . -75.77 -49.16 18.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.098 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' PHE . . . . . 0.42 ' CG ' HG21 ' A' ' 376' ' ' ILE . 28.7 m-85 -89.73 15.89 8.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 360' ' ' GLN . 9.9 t -98.9 -57.81 2.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.842 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 359' ' ' SER . 24.2 pt20 -35.97 -39.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.892 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.564 ' CD2' ' HB2' ' A' ' 387' ' ' ALA . 85.1 m-85 -63.78 -63.4 1.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.39 162.52 29.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.434 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -50.12 127.28 16.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.458 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 32.3 mt -97.66 153.97 17.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -102.06 -49.03 4.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -171.31 164.42 7.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.46 ' CG1' HD13 ' A' ' 354' ' ' LEU . 40.6 t -136.4 125.8 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -112.08 118.95 36.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -91.32 140.52 29.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.93 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.455 ' O ' ' C ' ' A' ' 371' ' ' LYS . 6.5 mp -124.24 -174.76 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 370' ' ' LEU . 1.0 OUTLIER -33.69 -69.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -119.6 -38.53 2.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.822 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.438 ' CE2' HD22 ' A' ' 370' ' ' LEU . 5.2 p90 -91.44 -174.95 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -163.83 162.81 23.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.111 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -112.47 139.26 48.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.42 HG21 ' CG ' ' A' ' 358' ' ' PHE . 6.2 mm -114.11 104.31 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.119 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -84.26 122.78 29.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.562 ' CE1' HD11 ' A' ' 340' ' ' LEU . 19.8 m-85 -105.12 148.1 27.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -58.46 -36.85 74.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -134.35 155.79 49.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.879 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . 0.419 ' C ' ' HD3' ' A' ' 381' ' ' ARG . 2.4 tmt_? -59.05 -34.56 72.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 384' ' ' ALA . 23.1 t70 -67.01 -60.03 2.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.831 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -37.06 -32.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.487 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . 0.421 ' CB ' HD21 ' A' ' 340' ' ' LEU . . . -76.82 -54.95 5.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.859 0.361 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 384' ' ' ALA . 65.1 t -36.79 -39.7 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -69.8 -66.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.564 ' HB2' ' CD2' ' A' ' 361' ' ' PHE . . . -53.29 -15.73 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.118 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.56 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.5 ttm -79.6 -63.93 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.445 ' N ' ' HG2' ' A' ' 388' ' ' MET . 6.4 mt-10 -75.2 -0.67 20.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.511 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 28.3 mm-40 -100.19 -35.36 9.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' MET . . . . . 0.466 ' HB2' ' CD1' ' A' ' 403' ' ' ILE . 9.8 mmm -103.47 -34.61 8.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 388' ' ' MET . 3.5 t-20 -37.79 99.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 96.04 28.53 9.23 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.452 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 391' ' ' MET . 34.4 mmtt -95.6 147.26 23.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.779 0.323 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.37 78.02 3.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 21.5 tp -81.87 110.39 17.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 62.19 27.48 16.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.43 21.3 48.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . 0.493 ' OE1' ' ND2' ' A' ' 344' ' ' ASN . 12.7 mm-40 -140.06 126.51 20.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 0.0 110.851 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.47 92.53 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.468 HD12 ' CG1' ' A' ' 342' ' ' VAL . 28.8 pt -72.41 150.54 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.094 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -115.78 131.35 56.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 391' ' ' MET . 28.0 mt -114.87 124.84 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.164 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 30.7 m -138.03 132.33 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.56 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 17.7 m-85 -49.18 114.11 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.98 161.84 28.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.124 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -73.85 147.29 86.27 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.546 0.688 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 146.84 61.82 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.686 2.257 . . . . 0.0 112.374 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -17.53 37.23 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.673 2.248 . . . . 0.0 112.33 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -113.88 120.01 39.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -109.59 130.09 55.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.935 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 413' ' ' ARG . 25.3 tptt -69.01 151.81 46.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . 0.423 ' N ' ' HG3' ' A' ' 412' ' ' LYS . 20.0 ptp180 -110.32 149.01 30.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -130.01 154.27 47.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -150.76 118.45 6.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -90.41 155.79 18.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -124.54 -178.32 4.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -137.64 143.74 41.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.074 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -102.21 175.69 5.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 11.2 ptt-85 -97.51 177.09 5.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.04 162.6 40.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.905 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -123.55 172.0 9.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -143.26 167.66 21.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.077 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 69.6 m -129.62 170.8 13.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.849 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -118.04 126.01 6.7 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.489 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -172.21 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.708 2.272 . . . . 0.0 112.356 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 64.8 p -147.96 175.46 10.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 52.8 p -124.63 175.34 7.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.496 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 30.2 p -146.21 131.15 18.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 110.848 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 83.1 p -55.6 168.51 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.903 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -115.9 152.28 18.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.493 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 70.8 m -78.7 150.18 32.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 0.0 110.873 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 2.9 m -90.01 124.57 34.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 58.86 85.6 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.476 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 9.2 ttt -94.47 -54.73 3.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 110.89 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -155.13 140.41 17.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.085 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 75.59 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 86.3 t -133.47 133.1 57.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.198 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -91.69 -28.81 17.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 60.2 t -79.86 129.83 36.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.147 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.558 HD12 ' CE1' ' A' ' 378' ' ' PHE . 31.2 mt -110.71 125.03 53.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.47 ' CE1' ' HB3' ' A' ' 343' ' ' ARG . 6.3 t80 -86.04 118.84 25.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.471 ' CG1' HD12 ' A' ' 401' ' ' ILE . 21.2 t -115.73 130.12 70.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.099 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.47 ' HB3' ' CE1' ' A' ' 341' ' ' PHE . 6.9 ptp180 -128.58 -179.91 5.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.7 t30 65.22 41.92 4.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 39.4 mt -84.32 136.33 33.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.28 172.48 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.128 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -81.66 11.92 4.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 18.5 p -129.36 11.19 5.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.562 ' CG1' ' NZ ' ' A' ' 369' ' ' LYS . 84.8 t -85.91 139.61 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.164 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' THR . . . . . 0.457 ' N ' HG12 ' A' ' 349' ' ' VAL . 76.7 p -140.42 157.71 45.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -43.92 -43.9 6.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -54.36 -42.87 70.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 78.1 mt -68.93 -33.37 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.453 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 95.2 mt -69.22 -30.83 69.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 359' ' ' SER . 51.9 mt-10 -72.72 -72.41 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -44.19 -36.91 2.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' ALA . . . . . 0.407 ' HB2' ' CE ' ' A' ' 391' ' ' MET . . . -69.42 -51.87 32.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' PHE . . . . . 0.454 ' CE2' HD13 ' A' ' 403' ' ' ILE . 34.8 m-85 -89.23 15.58 8.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 355' ' ' GLU . 12.3 t -99.66 -51.82 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -40.44 -38.22 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.945 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.562 ' CD2' ' HB2' ' A' ' 387' ' ' ALA . 92.0 m-85 -65.59 -62.35 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.19 170.3 31.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -55.77 138.52 47.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.412 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 55.7 mt -107.95 162.64 13.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -111.46 -48.94 3.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.42 ' HB2' ' NH1' ' A' ' 366' ' ' ARG . 1.3 ptp180 -171.23 166.19 7.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 78.6 t -135.67 130.89 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -116.84 116.81 28.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' LYS . . . . . 0.562 ' NZ ' ' CG1' ' A' ' 349' ' ' VAL . 33.8 tptt -89.12 146.22 24.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.499 HD23 ' CE2' ' A' ' 373' ' ' TYR . 6.5 mp -130.58 -174.86 3.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 370' ' ' LEU . 28.8 mtpt -33.64 -62.49 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -129.38 -36.05 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.499 ' CE2' HD23 ' A' ' 370' ' ' LEU . 3.7 p90 -92.23 -174.94 3.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.403 ' HA ' ' CD1' ' A' ' 370' ' ' LEU . . . -167.35 153.02 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.106 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -103.01 137.95 40.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.9 mm -110.33 110.6 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -88.49 121.46 30.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.558 ' CE1' HD12 ' A' ' 340' ' ' LEU . 17.3 m-85 -103.24 144.12 31.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.92 -27.89 54.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -142.01 156.3 45.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -61.49 -35.22 77.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 384' ' ' ALA . 27.0 t70 -66.89 -58.74 4.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -38.04 -31.1 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.455 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -77.19 -58.61 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.328 . . . . 0.0 111.079 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 384' ' ' ALA . 57.7 t -36.08 -35.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -73.54 -66.09 0.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' A' ' 361' ' ' PHE . . . -55.51 -17.37 5.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.095 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.567 ' HE3' ' CD1' ' A' ' 405' ' ' PHE . 9.0 ttm -77.3 -63.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.875 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.454 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.4 mt-10 -74.81 0.33 15.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.519 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 30.1 mm-40 -100.21 -36.27 9.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 393' ' ' GLY . 4.0 mmt -102.64 -31.27 10.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.468 ' N ' HD11 ' A' ' 403' ' ' ILE . 6.5 t-20 -39.2 92.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 101.38 33.85 4.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.465 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -100.14 147.19 25.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.878 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.09 80.96 2.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 17.8 tp -90.07 113.88 25.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 62.25 26.39 15.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.939 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 84.83 20.33 58.11 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -140.01 122.18 15.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.921 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.38 92.27 0.8 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.471 HD12 ' CG1' ' A' ' 342' ' ' VAL . 19.4 pt -71.33 147.46 10.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.123 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -113.05 131.37 55.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.468 HD11 ' N ' ' A' ' 392' ' ' ASN . 55.7 mt -110.78 136.98 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.124 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 20.2 m -151.76 135.13 7.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.567 ' CD1' ' HE3' ' A' ' 388' ' ' MET . 24.0 m-85 -52.58 117.22 2.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -74.61 161.36 29.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -89.68 143.83 30.95 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.611 0.719 . . . . 0.0 110.864 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 159.58 52.85 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.678 2.252 . . . . 0.0 112.337 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 150.29 67.94 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.635 2.224 . . . . 0.0 112.328 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -86.03 125.05 33.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -159.82 135.78 8.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -121.24 161.42 21.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . 0.419 ' NH1' ' HB3' ' A' ' 413' ' ' ARG . 4.9 mmm180 -123.07 -52.07 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -52.64 161.44 0.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -161.86 155.93 21.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.866 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -143.82 165.17 28.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . 0.451 ' HG2' ' N ' ' A' ' 418' ' ' ALA . 9.1 ttmm -165.91 145.47 6.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . 0.451 ' N ' ' HG2' ' A' ' 417' ' ' LYS . . . -146.65 171.69 14.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.069 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -169.47 139.27 2.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -122.72 170.1 10.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -127.69 176.14 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -165.57 166.71 17.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.061 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -137.09 152.54 50.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 3.8 m -163.83 162.85 23.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -150.73 146.05 14.63 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.481 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 171.78 13.84 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.724 2.282 . . . . 0.0 112.308 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 53.4 m -98.7 -44.01 6.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.843 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 27.8 m -146.51 166.35 26.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.486 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.807 0.337 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 68.5 t -82.66 137.22 21.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.574 HD22 ' HB2' ' A' ' 388' ' ' MET . 56.6 mt -111.48 127.54 55.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.578 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 71.1 t80 -90.65 105.49 17.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.452 ' CG1' HD12 ' A' ' 401' ' ' ILE . 21.6 t -104.86 128.57 58.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -128.44 175.92 8.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.66 36.4 1.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 31.8 mt -75.1 146.63 41.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.627 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -73.19 -179.14 3.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.107 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -85.51 -2.34 58.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 13.1 p -118.49 15.55 13.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.627 HG23 ' HB3' ' A' ' 346' ' ' ALA . 95.7 t -97.25 135.64 30.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.092 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 82.3 p -139.31 175.79 9.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.168 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -54.86 -44.78 74.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -55.53 -44.77 77.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 63.7 mt -68.54 -33.79 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.138 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.454 ' HB2' HG11 ' A' ' 367' ' ' VAL . 89.9 mt -70.75 -27.77 64.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 359' ' ' SER . 72.4 mt-10 -74.21 -71.19 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -41.54 -39.4 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' ALA . . . . . 0.735 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -69.77 -56.31 7.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -83.86 14.46 4.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 355' ' ' GLU . 13.4 t -99.22 -56.83 2.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 359' ' ' SER . 27.2 pt20 -37.67 -38.28 0.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.496 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 84.5 m-85 -63.0 -63.08 1.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.25 167.12 31.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.465 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -52.98 128.83 28.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.454 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 37.5 mt -98.15 157.2 16.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.912 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -106.02 -46.67 4.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -174.9 165.6 3.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 354' ' ' LEU . 78.4 t -135.41 127.85 47.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.118 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -114.69 113.4 24.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -89.0 142.02 27.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.731 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.1 mp -126.91 -174.02 3.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.5 OUTLIER -32.28 -67.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.891 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -124.43 -37.7 2.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.731 ' CE2' HD22 ' A' ' 370' ' ' LEU . 9.1 p90 -93.46 179.64 5.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.508 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -158.21 168.22 27.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.131 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -119.02 128.55 54.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 7.2 mm -102.6 114.59 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -92.66 126.67 37.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 387' ' ' ALA . 21.2 m-85 -109.51 137.73 46.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -54.16 -30.66 50.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -135.87 152.67 51.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 385' ' ' VAL . 6.0 tmm_? -60.64 -28.37 68.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.919 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -71.72 -54.08 11.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' GLY . . . . . 0.408 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -42.97 -30.82 1.08 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 384' ' ' ALA . . . . . 0.444 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -77.74 -59.43 2.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.821 0.343 . . . . 0.0 111.082 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 381' ' ' ARG . 95.4 t -37.99 -37.75 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.127 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -71.3 -62.81 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -59.71 -15.67 21.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.574 ' HB2' HD22 ' A' ' 340' ' ' LEU . 8.7 ttm -78.75 -62.39 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.436 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.6 mt-10 -74.92 -0.35 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.496 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 14.3 mm-40 -100.03 -38.99 8.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' MET . . . . . 0.735 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 4.4 mmt -100.96 -27.66 13.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.934 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.875 ' N ' HD12 ' A' ' 403' ' ' ILE . 1.5 t-20 -38.05 107.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 78.52 38.61 24.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.479 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 21.3 mmtt -100.06 149.05 23.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 110.884 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -75.57 82.18 2.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.88 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.401 HD22 HD13 ' A' ' 401' ' ' ILE . 15.3 tp -89.48 112.6 23.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 62.24 26.63 15.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 88.14 11.31 67.43 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.487 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -130.91 128.91 41.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.888 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.51 98.37 4.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.825 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.452 HD12 ' CG1' ' A' ' 342' ' ' VAL . 20.2 pt -78.1 147.92 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.138 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -109.83 129.72 55.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.875 HD12 ' N ' ' A' ' 392' ' ' ASN . 15.5 mt -113.35 124.12 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.095 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 2.9 m -138.62 135.16 43.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.562 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 10.1 m-85 -51.67 106.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.578 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.077 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 3.7 pttm . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.878 0.371 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 65.2 t -69.49 133.22 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.072 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.529 HD21 ' HB1' ' A' ' 384' ' ' ALA . 51.8 mt -105.28 119.2 38.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -85.32 106.18 16.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.776 HG22 HG12 ' A' ' 403' ' ' ILE . 25.4 t -102.1 130.05 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.163 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -131.14 173.29 11.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.73 39.61 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.614 HD13 ' NZ ' ' A' ' 369' ' ' LYS . 38.6 mt -81.24 156.95 25.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.921 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -95.08 161.23 14.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.075 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -63.73 -8.0 9.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 24.9 p -98.84 -9.24 24.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.165 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.543 HG12 ' NZ ' ' A' ' 369' ' ' LYS . 57.7 t -83.15 140.48 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.139 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 78.2 p -144.46 163.03 35.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -40.7 -50.46 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -52.08 -52.24 52.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.903 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 75.2 mt -58.95 -29.08 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.5 ' HB2' HG11 ' A' ' 367' ' ' VAL . 96.1 mt -75.54 -30.65 59.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.472 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 51.3 mt-10 -75.58 -64.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -50.14 -38.67 40.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' ALA . . . . . 0.458 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -69.01 -49.69 55.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 358' ' ' PHE . . . . . 0.422 ' C ' HD11 ' A' ' 364' ' ' LEU . 45.0 m-85 -90.32 14.89 11.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 355' ' ' GLU . 9.0 t -100.06 -51.35 3.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -38.84 -38.7 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.497 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 94.1 m-85 -64.49 -62.72 1.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -153.65 161.31 29.78 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -47.94 129.06 14.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.472 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 40.4 mt -98.31 156.42 16.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -100.55 -50.49 3.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -171.24 165.49 7.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 354' ' ' LEU . 51.1 t -136.93 129.59 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.82 109.02 16.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 369' ' ' LYS . . . . . 0.614 ' NZ ' HD13 ' A' ' 345' ' ' LEU . 29.5 tptt -82.17 146.16 29.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.703 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.7 mp -128.99 -174.91 3.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.1 OUTLIER -34.4 -67.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -122.3 -37.14 2.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.703 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.8 p90 -94.19 -175.11 3.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.531 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -166.44 161.41 16.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.138 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -110.94 137.3 48.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 5.3 mm -111.16 109.55 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -89.29 121.32 31.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 19.5 m-85 -101.78 149.08 24.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -69.02 -31.76 70.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.847 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -131.05 154.37 48.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -58.13 -37.71 75.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 384' ' ' ALA . 19.6 t70 -66.2 -57.55 7.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 383' ' ' GLY . . . . . 0.537 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -35.12 -31.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.507 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' ALA . . . . . 0.529 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -80.88 -66.93 0.82 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.117 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' A' ' 384' ' ' ALA . 58.0 t -36.0 -35.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 386' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 384' ' ' ALA . 12.1 tptm -72.92 -61.03 1.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.51 -16.92 41.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.593 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.7 ttm -76.52 -61.27 2.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.436 ' N ' ' HG2' ' A' ' 388' ' ' MET . 13.1 mt-10 -74.17 -4.22 34.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.872 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.497 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 39.0 mm-40 -100.03 -33.02 10.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 391' ' ' MET . . . . . 0.503 ' O ' ' CG ' ' A' ' 394' ' ' LYS . 38.2 mmm -101.96 -41.0 6.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.754 ' N ' HD12 ' A' ' 403' ' ' ILE . 5.1 t-20 -34.12 116.61 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 76.63 30.05 56.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.46 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.734 ' HE3' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -100.01 141.97 32.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 0.0 110.896 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.49 99.99 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.734 HD13 ' HE3' ' A' ' 394' ' ' LYS . 20.5 tp -106.36 114.31 28.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.968 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' GLU . . . . . 0.451 ' HG3' HG22 ' A' ' 349' ' ' VAL . 6.2 mm-40 60.88 27.18 17.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.88 16.86 59.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.479 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -140.04 120.74 14.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.91 100.01 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.567 HD12 ' CG1' ' A' ' 342' ' ' VAL . 25.0 pt -75.68 149.72 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -112.44 128.51 56.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.776 HG12 HG22 ' A' ' 342' ' ' VAL . 35.6 mt -111.96 128.97 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.124 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 9.9 m -142.32 132.91 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.152 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.593 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 19.2 m-85 -50.87 110.78 0.46 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.814 0.34 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.0 t -85.17 125.68 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.118 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.617 HD12 ' CE1' ' A' ' 378' ' ' PHE . 70.6 mt -103.84 130.35 51.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.946 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -94.74 107.83 19.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.59 HG22 HG12 ' A' ' 403' ' ' ILE . 18.7 t -106.15 130.49 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -130.15 168.24 17.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.3 t30 72.22 54.35 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.466 HD21 HG12 ' A' ' 342' ' ' VAL . 15.6 mt -96.25 145.91 25.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.929 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -81.08 163.12 23.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.053 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -66.83 -4.47 9.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 24.6 p -104.58 6.31 34.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.709 HG12 ' NZ ' ' A' ' 369' ' ' LYS . 58.6 t -94.16 138.09 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.154 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 43.4 p -142.64 159.15 42.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.16 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.4 ' HA ' HD12 ' A' ' 354' ' ' LEU . 53.3 mt-10 -42.73 -41.15 3.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -57.92 -46.93 84.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 73.3 mt -65.56 -30.17 49.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.14 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.513 ' HB2' HG11 ' A' ' 367' ' ' VAL . 83.2 mt -72.94 -31.4 64.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 359' ' ' SER . 21.7 mt-10 -72.07 -67.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -50.3 -39.92 46.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' ALA . . . . . 0.463 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -65.71 -51.3 60.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' PHE . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 45.3 m-85 -90.49 14.57 12.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 355' ' ' GLU . 2.1 t -99.8 -57.44 2.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 360' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 359' ' ' SER . 19.1 pt20 -35.2 -39.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -64.58 -65.23 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -147.4 163.89 28.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.454 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -52.85 130.72 34.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.469 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 34.2 mt -99.77 158.94 15.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.949 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -108.07 -44.5 4.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -174.16 164.41 4.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.513 HG11 ' HB2' ' A' ' 354' ' ' LEU . 54.2 t -135.51 133.75 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.443 ' O ' ' HB1' ' A' ' 374' ' ' ALA . 39.7 tptt -119.55 123.76 44.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' LYS . . . . . 0.709 ' NZ ' HG12 ' A' ' 349' ' ' VAL . 24.0 tptt -95.7 146.29 24.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.788 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.8 mp -133.96 -174.74 3.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 370' ' ' LEU . 24.4 tttp -33.57 -68.46 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.886 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.3 -37.13 2.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.788 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.3 p90 -90.94 -175.79 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.968 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 368' ' ' LYS . . . -168.15 147.18 4.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.091 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -95.76 142.23 28.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.6 mm -118.07 106.18 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -84.44 121.48 27.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.847 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.617 ' CE1' HD12 ' A' ' 340' ' ' LEU . 14.4 m-85 -102.61 151.47 22.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -60.57 -35.77 76.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -140.35 153.12 46.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.449 ' O ' HG23 ' A' ' 385' ' ' VAL . 6.5 tmm_? -52.7 -28.43 21.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.877 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 384' ' ' ALA . 12.0 t0 -69.81 -62.21 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' GLY . . . . . 0.474 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -36.76 -29.62 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.52 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 384' ' ' ALA . . . . . 0.506 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -79.9 -58.47 3.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 0.0 111.113 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 381' ' ' ARG . 96.3 t -38.39 -38.63 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.151 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -71.93 -64.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -57.04 -15.48 5.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.602 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 9.0 ttm -79.46 -62.91 1.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.442 ' N ' ' HG2' ' A' ' 388' ' ' MET . 9.9 mt-10 -74.86 -0.97 20.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -100.09 -35.04 9.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' MET . . . . . 0.47 ' HA ' ' CG ' ' A' ' 394' ' ' LYS . 27.7 mmm -103.91 -37.15 7.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.889 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.821 ' N ' HD12 ' A' ' 403' ' ' ILE . 4.3 t-20 -34.29 101.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 92.22 29.68 11.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.464 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.47 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 8.7 mmtp -94.99 148.2 22.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 0.0 110.854 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.64 80.66 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 15.6 tp -89.12 115.69 26.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.941 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 62.22 25.02 14.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 86.03 20.18 55.96 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.464 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -139.81 125.28 19.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.92 98.21 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 47.2 pt -74.6 153.32 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -117.09 126.61 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.821 HD12 ' N ' ' A' ' 392' ' ' ASN . 23.2 mt -113.06 124.85 70.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.158 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 10.4 m -137.05 133.35 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.602 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 8.3 m-85 -51.26 110.91 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.068 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 339' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.841 0.353 . . . . 0.0 110.891 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.427 ' N ' ' HD2' ' A' ' 338' ' ' LYS . 86.4 t -77.18 131.34 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.101 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.878 HD21 ' HB1' ' A' ' 384' ' ' ALA . 43.4 mt -108.26 127.37 53.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.522 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 56.2 t80 -91.27 108.61 20.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.463 HG12 HD21 ' A' ' 345' ' ' LEU . 14.0 t -103.13 134.73 43.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.125 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -134.11 167.13 21.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.84 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ASN . . . . . 0.401 ' O ' HG22 ' A' ' 401' ' ' ILE . 2.0 t-20 73.23 52.38 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.463 HD21 HG12 ' A' ' 342' ' ' VAL . 22.5 mt -96.22 131.99 42.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.452 ' HB3' ' CB ' ' A' ' 397' ' ' GLU . . . -54.58 -176.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -88.93 5.68 42.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 21.9 p -121.86 13.77 10.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 91.6 t -88.55 138.81 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' THR . . . . . 0.432 ' H ' HD12 ' A' ' 353' ' ' ILE . 67.0 p -144.07 167.05 23.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.159 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -50.45 -43.94 55.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.04 -41.9 75.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.432 HD12 ' H ' ' A' ' 350' ' ' THR . 71.3 mt -69.49 -41.48 80.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.557 ' HB2' HG11 ' A' ' 367' ' ' VAL . 92.4 mt -63.37 -32.51 73.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.48 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 46.1 mt-10 -68.21 -73.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -41.48 -39.67 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.957 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' ALA . . . . . 0.652 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -66.7 -54.6 21.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' PHE . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 37.0 m-85 -87.78 14.68 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 355' ' ' GLU . 17.7 t -99.99 -53.25 3.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.848 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -38.68 -38.68 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.505 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 84.3 m-85 -64.08 -62.71 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -151.87 169.78 31.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.525 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -53.86 132.73 42.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.818 0.342 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.48 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 32.9 mt -101.46 160.49 14.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.949 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -110.33 -48.04 3.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -172.97 163.65 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' A' ' 354' ' ' LEU . 71.9 t -134.1 130.07 54.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -111.06 108.41 18.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.866 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' LYS . . . . . 0.407 ' C ' HD12 ' A' ' 370' ' ' LEU . 19.3 tptp -87.08 137.58 32.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.799 HD22 ' CE2' ' A' ' 373' ' ' TYR . 7.6 mp -126.28 -174.74 3.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 370' ' ' LEU . 30.8 tttm -33.55 -67.73 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.873 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.16 -36.39 2.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.799 ' CE2' HD22 ' A' ' 370' ' ' LEU . 6.5 p90 -93.7 -177.36 4.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -165.79 159.65 16.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.098 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -110.7 131.51 54.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.882 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 3.9 mm -105.26 115.58 47.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -93.54 113.98 26.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.429 ' HE1' HD12 ' A' ' 340' ' ' LEU . 17.4 m-85 -96.06 146.11 24.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.851 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -63.66 -32.81 74.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -131.82 153.31 50.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.409 ' C ' ' HD2' ' A' ' 381' ' ' ARG . 2.0 tmm_? -62.19 -30.66 71.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -71.61 -50.42 30.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -44.8 -31.97 2.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.546 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' ALA . . . . . 0.878 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -76.57 -63.06 1.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.792 0.33 . . . . 0.0 111.138 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 384' ' ' ALA . 61.3 t -34.92 -36.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 386' ' ' LYS . . . . . 0.445 ' HE3' ' CG ' ' A' ' 390' ' ' GLU . 17.8 tptt -72.68 -66.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -55.21 -16.87 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.592 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 7.5 ttm -77.65 -61.64 1.93 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.422 ' N ' ' HG2' ' A' ' 388' ' ' MET . 7.3 mt-10 -77.48 -2.06 33.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.505 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 52.9 mm-40 -100.15 -25.89 14.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' MET . . . . . 0.652 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 23.4 mmm -112.1 -38.19 4.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.832 ' N ' HD12 ' A' ' 403' ' ' ILE . 7.6 t-20 -35.09 92.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 108.44 23.95 6.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.477 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 391' ' ' MET . 0.3 OUTLIER -90.28 146.9 23.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.774 0.321 . . . . 0.0 110.903 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -78.6 80.26 4.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 19.0 tp -89.19 114.89 26.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.927 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' GLU . . . . . 0.452 ' CB ' ' HB3' ' A' ' 346' ' ' ALA . 67.4 mm-40 62.49 27.74 16.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 82.45 20.88 61.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.481 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -140.18 122.51 15.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.891 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.38 95.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 344' ' ' ASN . 30.4 pt -72.4 148.7 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.193 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -115.79 130.77 56.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.832 HD12 ' N ' ' A' ' 392' ' ' ASN . 19.7 mt -109.74 138.93 35.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.167 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 17.9 m -149.43 134.61 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.073 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.592 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 15.4 m-85 -54.71 108.7 0.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.854 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.522 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.806 0.336 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 90.6 t -79.94 135.94 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.862 HD21 ' HB1' ' A' ' 384' ' ' ALA . 16.5 mt -111.62 127.27 55.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -88.54 113.1 23.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.875 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.558 HG22 HG12 ' A' ' 403' ' ' ILE . 15.8 t -111.43 135.45 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -132.49 170.61 14.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.5 t30 73.46 43.85 0.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 39.0 mt -83.37 127.59 33.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.612 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -49.4 178.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -84.57 -5.34 59.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 25.7 p -117.84 22.46 12.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.612 HG23 ' HB3' ' A' ' 346' ' ' ALA . 64.5 t -96.4 136.64 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.153 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 77.8 p -135.45 178.28 7.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.132 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.87 -40.29 92.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -58.27 -46.54 85.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.86 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.67 -30.82 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.487 ' HB2' HG11 ' A' ' 367' ' ' VAL . 97.0 mt -73.84 -26.87 60.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 359' ' ' SER . 52.6 mt-10 -81.27 -64.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -51.05 -25.37 4.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -83.66 -44.83 14.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' PHE . . . . . 0.407 ' C ' HD11 ' A' ' 364' ' ' LEU . 35.9 m-85 -92.03 9.91 31.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 361' ' ' PHE . 92.2 p -95.13 -54.46 3.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.84 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 359' ' ' SER . 26.0 pt20 -34.28 -35.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.462 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 98.2 m-85 -70.97 -68.27 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -145.61 165.48 27.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.461 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -54.37 131.84 42.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.755 0.312 . . . . 0.0 110.909 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.407 HD11 ' C ' ' A' ' 358' ' ' PHE . 86.9 mt -101.32 155.63 17.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -100.88 -42.99 6.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.938 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -174.95 170.08 3.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.487 HG11 ' HB2' ' A' ' 354' ' ' LEU . 35.7 t -140.66 125.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.131 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.434 ' O ' ' HB1' ' A' ' 374' ' ' ALA . 8.7 tmtt? -112.49 123.14 49.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' LYS . . . . . 0.402 ' C ' HD12 ' A' ' 370' ' ' LEU . 15.7 tptm -97.52 143.52 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.763 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.9 mp -129.1 -174.62 3.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.1 OUTLIER -32.12 -72.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.932 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -120.04 -35.37 3.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.763 ' CE2' HD22 ' A' ' 370' ' ' LEU . 12.4 p90 -94.99 -179.41 4.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 368' ' ' LYS . . . -159.11 167.28 29.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.109 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -118.32 125.39 49.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 5.3 mm -99.18 110.5 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -91.68 120.75 32.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.827 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 358' ' ' PHE . 21.0 m-85 -101.02 154.63 18.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.55 -33.96 73.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -132.13 156.58 46.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.412 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 5.6 tmm_? -61.86 -32.71 73.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.15 -52.08 26.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -42.69 -32.84 1.42 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.543 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' ALA . . . . . 0.862 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -77.73 -64.35 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.789 0.328 . . . . 0.0 111.092 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.43 ' C ' ' O ' ' A' ' 384' ' ' ALA . 68.2 t -35.39 -32.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.122 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 386' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 384' ' ' ALA . 15.5 tptm -74.8 -61.89 1.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.07 -14.68 25.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.57 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.4 ttm -78.65 -60.18 2.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.906 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -73.23 -3.15 25.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.462 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 4.4 mm-40 -100.41 -39.43 7.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' MET . . . . . 0.513 ' HB2' HD11 ' A' ' 403' ' ' ILE . 49.8 mmm -99.76 -19.73 16.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 388' ' ' MET . 0.8 OUTLIER -43.92 119.46 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 56.36 37.25 73.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.445 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.433 ' HD2' ' C ' ' A' ' 395' ' ' ASP . 0.0 OUTLIER -100.09 150.78 22.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.78 0.324 . . . . 0.0 110.911 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 395' ' ' ASP . . . . . 0.433 ' C ' ' HD2' ' A' ' 394' ' ' LYS . 24.7 t0 -71.12 105.92 3.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 38.4 tp -119.39 115.48 24.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 59.77 36.95 22.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 77.0 9.56 86.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.501 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -135.31 124.39 24.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.893 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.79 106.12 6.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.931 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.497 HD12 ' CG1' ' A' ' 342' ' ' VAL . 21.7 pt -83.12 147.11 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -109.56 128.58 55.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.558 HG12 HG22 ' A' ' 342' ' ' VAL . 44.1 mt -110.71 142.55 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.11 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 403' ' ' ILE . 9.6 m -157.01 134.12 2.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.57 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 27.0 m-85 -53.32 111.04 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.113 179.934 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.809 0.338 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.16 136.63 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.101 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.845 HD21 ' HB1' ' A' ' 384' ' ' ALA . 53.1 mt -112.9 128.9 56.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -92.59 108.26 19.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.66 HG22 HG12 ' A' ' 403' ' ' ILE . 48.7 t -106.0 127.27 61.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.176 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -126.51 173.44 9.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.24 39.19 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.581 HD21 HG12 ' A' ' 342' ' ' VAL . 48.7 mt -78.22 121.78 24.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -50.26 172.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.078 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -83.34 15.63 2.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 63.1 p -132.29 19.27 4.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.161 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 350' ' ' THR . 67.0 t -97.71 158.06 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' THR . . . . . 0.5 ' N ' HG12 ' A' ' 349' ' ' VAL . 21.2 p -156.19 165.54 36.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.411 ' HG2' HG12 ' A' ' 367' ' ' VAL . 58.4 mt-10 -49.69 -44.51 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -56.96 -45.61 82.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 67.0 mt -64.43 -31.81 55.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.121 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.547 ' HB2' HG11 ' A' ' 367' ' ' VAL . 88.6 mt -73.49 -26.09 60.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 359' ' ' SER . 90.6 mt-10 -81.82 -66.88 0.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.899 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -49.72 -23.41 1.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -85.86 -45.75 11.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.078 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' PHE . . . . . 0.429 ' O ' HD21 ' A' ' 364' ' ' LEU . 36.1 m-85 -92.49 11.47 26.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 355' ' ' GLU . 95.7 p -100.09 -24.48 14.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.866 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -63.6 -31.71 72.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.563 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 93.6 m-85 -74.95 -61.95 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.859 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -148.65 162.45 28.87 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.521 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -52.18 129.19 27.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.429 HD21 ' O ' ' A' ' 358' ' ' PHE . 38.7 mt -97.7 154.63 17.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -101.85 -42.75 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.925 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 366' ' ' ARG . 2.4 ptm85 -174.1 164.89 4.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.859 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.547 HG11 ' HB2' ' A' ' 354' ' ' LEU . 46.3 t -136.53 124.68 34.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -117.79 107.94 14.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' LYS . . . . . 0.462 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 12.3 tttm -88.17 140.43 29.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.757 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.4 mp -118.18 -174.21 2.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 370' ' ' LEU . 9.2 ttpt -31.97 -69.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -118.12 -39.32 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.757 ' CE2' HD22 ' A' ' 370' ' ' LEU . 5.4 p90 -91.61 -174.96 4.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.462 ' CB ' ' HA ' ' A' ' 369' ' ' LYS . . . -162.48 167.96 22.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.103 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -121.92 121.51 37.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.845 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.512 HD11 HD22 ' A' ' 354' ' ' LEU . 6.7 mm -97.06 111.86 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -91.19 124.09 35.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.835 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 387' ' ' ALA . 23.6 m-85 -105.28 152.16 23.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.99 -35.59 80.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -129.65 153.43 48.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.859 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.411 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 5.9 tmm_? -60.08 -32.91 71.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -70.08 -51.36 32.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.843 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -42.82 -33.76 1.71 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.43 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' ALA . . . . . 0.845 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -76.52 -56.94 4.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.812 0.339 . . . . 0.0 111.071 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 80.6 t -38.47 -39.87 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.094 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -70.76 -65.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -55.05 -16.62 3.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.174 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.597 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.5 ttm -78.54 -62.84 1.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.448 ' N ' ' HG2' ' A' ' 388' ' ' MET . 9.0 mt-10 -75.92 -0.55 21.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.563 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 56.3 mm-40 -100.08 -34.6 10.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' MET . . . . . 0.43 ' HG2' ' CE2' ' A' ' 361' ' ' PHE . 4.9 mmt -104.52 -31.15 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.904 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.749 ' N ' HD12 ' A' ' 403' ' ' ILE . 3.9 t-20 -36.68 97.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 95.46 38.26 4.8 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.522 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -100.1 147.66 25.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.888 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -75.53 75.19 2.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.451 HD22 HD13 ' A' ' 401' ' ' ILE . 17.6 tp -79.75 111.17 15.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.933 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 62.4 25.31 15.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' GLY . . . . . 0.44 ' C ' ' OE1' ' A' ' 399' ' ' GLU . . . 89.77 14.62 59.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.495 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' GLU . . . . . 0.44 ' OE1' ' C ' ' A' ' 398' ' ' GLY . 15.8 mp0 -133.38 126.15 30.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.808 0.337 . . . . 0.0 110.86 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.72 97.34 2.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.451 HD13 HD22 ' A' ' 396' ' ' LEU . 18.1 pt -76.9 151.7 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -114.77 132.18 56.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.749 HD12 ' N ' ' A' ' 392' ' ' ASN . 31.6 mt -115.27 121.34 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.135 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 15.3 m -136.19 132.58 49.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.597 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 7.4 m-85 -51.07 117.47 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.098 179.928 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.789 0.328 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 98.5 t -78.53 133.15 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.079 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.541 HD21 ' HB1' ' A' ' 384' ' ' ALA . 55.1 mt -109.72 128.59 55.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 75.1 t80 -93.79 102.83 14.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.578 HG22 HG12 ' A' ' 403' ' ' ILE . 33.0 t -102.06 133.85 44.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.106 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -132.77 168.79 17.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.865 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 74.76 52.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.503 HD22 HG11 ' A' ' 349' ' ' VAL . 41.9 mt -97.38 148.11 23.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -85.79 169.53 13.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.137 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -71.12 -1.98 14.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 40.6 p -106.16 0.51 25.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.503 HG11 HD22 ' A' ' 345' ' ' LEU . 86.8 t -93.91 130.45 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.119 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 68.9 p -132.83 165.65 24.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.124 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -47.42 -41.97 21.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -57.39 -47.44 81.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 66.5 mt -65.64 -28.82 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.555 ' HB2' HG11 ' A' ' 367' ' ' VAL . 95.1 mt -74.58 -28.93 61.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -78.56 -63.32 1.43 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.821 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 35.8 mmtt -53.36 -34.71 58.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' ALA . . . . . 0.463 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -71.43 -45.53 62.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -92.64 13.07 21.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 361' ' ' PHE . 1.5 t -97.62 -53.69 3.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 360' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 359' ' ' SER . 15.4 pt20 -36.57 -32.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.576 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 90.5 m-85 -71.04 -66.04 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -147.61 179.05 24.8 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -61.95 129.86 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 110.865 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.453 HD21 ' CZ ' ' A' ' 378' ' ' PHE . 32.1 mt -101.21 152.12 21.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -100.37 -47.0 5.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -174.31 168.74 3.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' A' ' 354' ' ' LEU . 41.9 t -139.56 131.62 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.153 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.14 123.48 44.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -96.19 143.51 27.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.902 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.926 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.4 mp -127.73 -174.6 3.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.8 OUTLIER -33.31 -66.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -124.51 -36.78 2.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.926 ' CE2' HD22 ' A' ' 370' ' ' LEU . 9.7 p90 -92.86 179.75 5.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.439 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -160.32 161.43 33.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -112.2 136.57 51.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 5.0 mm -110.52 109.62 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.128 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -89.43 123.27 33.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.501 ' CE1' HD12 ' A' ' 340' ' ' LEU . 15.6 m-85 -105.56 140.72 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -56.72 -33.98 67.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.842 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -131.42 149.12 52.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.412 ' NH1' ' CG2' ' A' ' 385' ' ' VAL . 0.0 OUTLIER -57.06 -32.89 66.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -69.41 -53.1 21.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -41.29 -32.24 0.67 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.531 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' ALA . . . . . 0.541 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -77.63 -58.78 3.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 111.119 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.412 ' CG2' ' NH1' ' A' ' 381' ' ' ARG . 57.6 t -38.52 -35.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -74.57 -64.32 1.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -58.25 -15.53 10.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.4 ttm -78.76 -63.07 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.439 ' N ' ' HG2' ' A' ' 388' ' ' MET . 14.6 mt-10 -73.52 1.41 9.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.576 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 43.7 mm-40 -100.12 -41.77 6.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' MET . . . . . 0.489 ' O ' ' N ' ' A' ' 393' ' ' GLY . 8.1 mmm -99.91 -27.39 13.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.821 ' N ' HD12 ' A' ' 403' ' ' ILE . 5.1 t-20 -37.19 92.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.849 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 97.7 38.84 4.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.497 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.418 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 24.8 mmtm -100.04 148.29 24.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.739 0.304 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -75.9 77.69 2.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.417 HD22 HD13 ' A' ' 401' ' ' ILE . 15.6 tp -82.3 111.5 18.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 62.61 25.42 15.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' GLY . . . . . 0.43 ' C ' ' OE1' ' A' ' 399' ' ' GLU . . . 90.49 12.83 60.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' GLU . . . . . 0.43 ' OE1' ' C ' ' A' ' 398' ' ' GLY . 1.8 mp0 -131.76 129.55 40.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.943 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.49 97.43 3.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.417 HD13 HD22 ' A' ' 396' ' ' LEU . 20.7 pt -76.16 147.47 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -113.22 130.47 56.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.821 HD12 ' N ' ' A' ' 392' ' ' ASN . 11.7 mt -113.1 126.72 70.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.121 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 30.1 m -140.48 134.03 33.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.064 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 14.3 m-85 -50.95 110.1 0.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.857 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.579 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.412 ' HB3' ' NH1' ' A' ' 381' ' ' ARG . 10.5 ptpt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.829 0.347 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.22 121.87 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.083 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.426 HD21 ' HB1' ' A' ' 384' ' ' ALA . 78.5 mt -98.81 121.75 41.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -88.31 106.56 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.66 HG22 HG12 ' A' ' 403' ' ' ILE . 47.2 t -105.16 135.33 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -134.73 167.64 20.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.84 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 24.7 t30 74.59 49.99 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.49 HD21 HG12 ' A' ' 342' ' ' VAL . 14.5 mt -92.53 130.24 38.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.06 -179.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.101 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -87.15 6.5 32.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 22.2 p -124.15 15.88 9.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.171 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 55.3 t -91.98 134.93 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.151 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 58.4 p -136.98 161.0 37.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.145 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -47.02 -42.93 19.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -56.76 -40.42 75.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.884 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 83.0 mt -72.17 -29.55 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.539 ' HB2' HG11 ' A' ' 367' ' ' VAL . 85.3 mt -74.73 -28.04 60.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 359' ' ' SER . 45.3 mt-10 -72.26 -70.09 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -42.08 -44.1 3.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' ALA . . . . . 0.821 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -63.38 -57.05 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.097 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' PHE . . . . . 0.486 ' O ' HD21 ' A' ' 364' ' ' LEU . 41.0 m-85 -85.09 16.08 3.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 355' ' ' GLU . 5.4 t -100.07 -59.27 1.74 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.851 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 360' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 359' ' ' SER . 21.7 pt20 -36.82 -40.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 92.8 m-85 -62.36 -61.83 2.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.39 161.79 29.59 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.474 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.28 128.63 22.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 0.0 110.876 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.486 HD21 ' O ' ' A' ' 358' ' ' PHE . 49.6 mt -98.81 152.95 19.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -101.45 -47.64 4.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -170.17 166.02 9.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.841 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.539 HG11 ' HB2' ' A' ' 354' ' ' LEU . 60.1 t -137.49 123.64 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -105.73 111.34 23.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -91.02 136.48 33.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.851 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.9 mp -124.73 -174.82 3.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 370' ' ' LEU . 7.9 mmtm -32.9 -71.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.09 -37.88 3.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.851 ' CE2' HD22 ' A' ' 370' ' ' LEU . 8.4 p90 -91.67 -179.8 5.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.951 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -165.55 160.47 17.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.053 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -111.69 135.51 52.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 7.5 mm -108.88 106.97 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.099 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -87.58 120.29 28.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.535 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 23.6 m-85 -99.74 158.6 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -79.91 -32.07 40.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -128.22 152.91 47.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.414 ' HB2' ' NH1' ' A' ' 381' ' ' ARG . 0.0 OUTLIER -59.14 -34.08 71.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.855 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 382' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 384' ' ' ALA . 10.3 t70 -70.74 -54.95 9.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 383' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -37.81 -30.75 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.449 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' ALA . . . . . 0.426 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -81.28 -65.92 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.492 HG22 ' HZ ' ' A' ' 405' ' ' PHE . 58.4 t -36.4 -36.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.124 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -72.88 -61.83 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -60.3 -15.66 27.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.076 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.5 ttm -77.97 -61.18 2.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.417 ' N ' ' HG2' ' A' ' 388' ' ' MET . 16.4 mt-10 -74.89 -0.73 19.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.515 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 7.4 mm-40 -100.15 -37.41 8.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.839 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' MET . . . . . 0.821 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 17.8 mmm -101.66 -34.04 9.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.858 ' N ' HD12 ' A' ' 403' ' ' ILE . 5.2 t-20 -34.0 93.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 98.17 39.47 3.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.414 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 2.0 mmmp? -99.92 147.51 25.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.886 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -75.76 69.47 2.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.851 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.582 HD22 HD13 ' A' ' 401' ' ' ILE . 14.8 tp -74.93 113.12 11.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 61.94 27.33 16.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 85.31 21.26 55.14 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.533 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -140.1 125.91 19.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.87 0.367 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.37 96.92 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.582 HD13 HD22 ' A' ' 396' ' ' LEU . 33.4 pt -74.61 148.36 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -110.35 131.27 55.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.858 HD12 ' N ' ' A' ' 392' ' ' ASN . 36.1 mt -116.06 127.61 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 11.1 m -141.11 134.24 30.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.175 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.591 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 6.3 m-85 -52.49 108.73 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.11 179.926 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 19.2 pttp . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.803 0.335 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.1 122.34 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.641 HD21 ' HB1' ' A' ' 384' ' ' ALA . 48.6 mt -96.52 134.67 39.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -99.19 107.9 20.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.727 HG12 HD21 ' A' ' 345' ' ' LEU . 29.8 t -103.71 131.81 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.147 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -130.92 172.39 12.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.901 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.7 t30 72.54 33.27 1.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.727 HD21 HG12 ' A' ' 342' ' ' VAL . 17.8 mt -76.63 125.47 29.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.01 176.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.053 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -82.73 9.95 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 20.6 p -125.78 9.7 7.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 90.8 t -92.57 139.17 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' THR . . . . . 0.446 ' H ' HD12 ' A' ' 353' ' ' ILE . 55.5 p -143.89 171.59 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -50.7 -50.98 53.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -50.28 -39.18 44.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 350' ' ' THR . 74.2 mt -73.94 -35.71 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.59 ' HB2' HG11 ' A' ' 367' ' ' VAL . 96.7 mt -69.29 -26.26 64.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.481 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 44.9 mt-10 -76.43 -71.49 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -42.43 -35.72 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' ALA . . . . . 0.684 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -72.81 -55.72 6.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.145 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' PHE . . . . . 0.408 ' O ' HD21 ' A' ' 364' ' ' LEU . 41.2 m-85 -84.17 14.12 4.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 355' ' ' GLU . 18.0 t -99.65 -52.95 3.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -39.46 -37.24 0.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.575 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 93.6 m-85 -66.38 -62.58 1.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -150.53 161.85 29.11 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -53.15 122.77 10.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 110.937 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.481 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 32.0 mt -90.4 166.59 13.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -114.2 -44.78 3.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.501 ' HG3' ' CD2' ' A' ' 377' ' ' HIS . 18.5 ptt180 -173.01 166.53 5.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.59 HG11 ' HB2' ' A' ' 354' ' ' LEU . 89.7 t -139.81 123.83 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -107.17 120.1 41.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' LYS . . . . . 0.422 ' C ' HD12 ' A' ' 370' ' ' LEU . 16.1 tptp -91.73 142.28 27.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.768 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.4 mp -129.57 -174.57 3.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 370' ' ' LEU . 1.9 mptp? -33.33 -73.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -119.27 -29.66 5.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.768 ' CE2' HD22 ' A' ' 370' ' ' LEU . 3.8 p90 -97.99 -175.0 3.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.569 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -168.52 153.48 6.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.09 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -100.61 146.12 27.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 6.5 mm -118.87 110.81 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 377' ' ' HIS . . . . . 0.501 ' CD2' ' HG3' ' A' ' 366' ' ' ARG . 55.1 m-70 -89.46 126.1 35.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.819 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.458 ' CZ ' HD21 ' A' ' 364' ' ' LEU . 20.1 m-85 -108.4 139.41 43.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -58.52 -29.44 66.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -134.62 143.76 47.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.402 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 3.8 tmm_? -52.13 -34.56 45.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -67.35 -56.53 9.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' GLY . . . . . 0.426 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -37.74 -32.47 0.11 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.537 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 384' ' ' ALA . . . . . 0.641 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -77.43 -62.81 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.803 0.335 . . . . 0.0 111.122 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 384' ' ' ALA . 54.8 t -36.72 -39.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.133 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 386' ' ' LYS . . . . . 0.416 ' HA ' ' NZ ' ' A' ' 386' ' ' LYS . 0.1 OUTLIER -71.23 -65.67 0.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -53.84 -19.27 4.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.14 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.7 ttm -74.97 -63.74 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.465 ' N ' ' HG2' ' A' ' 388' ' ' MET . 5.5 mt-10 -73.71 1.56 10.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.575 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 3.0 mm-40 -99.67 -39.66 8.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' MET . . . . . 0.684 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 5.9 mmm -101.36 -29.95 11.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.744 ' N ' HD12 ' A' ' 403' ' ' ILE . 4.4 t-20 -34.17 96.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 94.11 38.43 5.13 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.525 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -99.62 147.2 25.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -76.51 76.44 3.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.468 HD22 HD13 ' A' ' 401' ' ' ILE . 17.6 tp -81.48 113.92 19.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 61.99 24.92 14.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 88.09 20.23 50.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -140.06 126.6 20.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 110.924 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.6 99.28 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.468 HD13 HD22 ' A' ' 396' ' ' LEU . 20.9 pt -77.15 148.59 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -109.95 129.9 55.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.744 HD12 ' N ' ' A' ' 392' ' ' ASN . 24.3 mt -113.3 129.21 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 34.2 m -146.68 135.27 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.089 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 15.9 m-85 -52.69 120.06 5.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.042 179.998 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 33.2 pttt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.816 0.341 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 77.9 t -74.79 123.24 29.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.107 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.411 HD21 ' HB1' ' A' ' 384' ' ' ALA . 48.9 mt -99.06 123.4 43.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -91.54 106.36 18.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.66 HG22 HG12 ' A' ' 403' ' ' ILE . 11.9 t -103.51 138.24 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.152 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -136.03 168.4 19.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 5.9 t30 73.2 54.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 31.1 mt -94.99 137.77 33.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.88 172.52 1.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.107 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -79.38 1.16 26.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 5.7 p -118.04 13.54 13.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.183 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 45.5 t -97.25 140.46 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 64.6 p -140.35 172.48 12.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.151 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -51.49 -45.89 62.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -54.87 -46.62 74.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 72.5 mt -64.32 -28.84 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.156 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.512 ' HB2' HG11 ' A' ' 367' ' ' VAL . 96.4 mt -76.59 -27.61 55.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 359' ' ' SER . 54.2 mt-10 -77.45 -65.69 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -46.47 -37.52 7.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' ALA . . . . . 0.692 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -72.17 -49.83 32.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.099 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' PHE . . . . . 0.546 ' O ' HD21 ' A' ' 364' ' ' LEU . 39.6 m-85 -88.17 13.03 12.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 355' ' ' GLU . 5.3 t -98.89 -52.64 3.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 360' ' ' GLN . . . . . 0.411 ' HG3' ' N ' ' A' ' 361' ' ' PHE . 18.2 pt20 -38.59 -40.14 0.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 390' ' ' GLU . 93.5 m-85 -64.0 -62.44 1.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -149.55 169.36 29.79 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -59.61 127.34 31.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 358' ' ' PHE . 81.4 mt -95.99 156.37 16.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -104.99 -41.73 5.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -174.93 165.9 3.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.512 HG11 ' HB2' ' A' ' 354' ' ' LEU . 33.9 t -139.48 124.6 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.155 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -109.5 114.98 29.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' LYS . . . . . 0.443 ' C ' HD12 ' A' ' 370' ' ' LEU . 19.1 tptp -90.89 144.28 25.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.852 HD22 ' CE2' ' A' ' 373' ' ' TYR . 7.0 mp -130.92 -174.69 3.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 370' ' ' LEU . 16.1 tttm -33.09 -68.02 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.4 -37.56 2.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.852 ' CE2' HD22 ' A' ' 370' ' ' LEU . 9.7 p90 -92.23 179.8 5.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -160.86 161.54 31.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.078 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -112.42 125.37 54.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 6.1 mm -101.32 121.29 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -100.94 124.38 46.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.56 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 26.5 m-85 -106.64 133.78 50.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -53.9 -32.57 53.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -128.51 151.18 49.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -58.41 -36.31 73.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 384' ' ' ALA . 14.6 t70 -68.23 -55.48 12.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 383' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -37.97 -31.15 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.506 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 384' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -80.87 -63.96 1.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.855 0.359 . . . . 0.0 111.155 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.53 HG22 ' HZ ' ' A' ' 405' ' ' PHE . 79.7 t -36.82 -35.42 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 386' ' ' LYS . . . . . 0.436 ' HE2' ' CG ' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -72.02 -60.02 2.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.888 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -62.21 -17.37 58.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.594 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.1 ttm -75.39 -60.9 2.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.887 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.435 ' N ' ' HG2' ' A' ' 388' ' ' MET . 11.1 mt-10 -74.48 -0.79 18.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 361' ' ' PHE . 33.8 mm-40 -99.98 -37.93 8.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.913 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' MET . . . . . 0.692 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 12.3 mmm -99.9 -29.22 12.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.751 ' N ' HD12 ' A' ' 403' ' ' ILE . 2.7 t-20 -41.24 111.79 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.845 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 75.49 28.84 60.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.507 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.477 ' CG ' ' O ' ' A' ' 391' ' ' MET . 0.0 OUTLIER -97.71 142.79 29.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -68.73 99.89 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.535 HD22 HD13 ' A' ' 401' ' ' ILE . 21.6 tp -105.46 109.67 21.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 61.6 32.63 18.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 83.28 15.99 70.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -139.82 120.09 13.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.871 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.75 106.02 3.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.535 HD13 HD22 ' A' ' 396' ' ' LEU . 23.7 pt -79.25 161.08 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.132 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -123.75 125.61 45.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.751 HD12 ' N ' ' A' ' 392' ' ' ASN . 25.0 mt -111.16 135.51 50.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.128 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 6.9 m -150.16 130.96 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.132 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.594 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 15.5 m-85 -51.53 108.95 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.064 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 64.7 pttt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.792 0.329 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 95.5 t -81.5 121.13 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.765 HD12 ' CE1' ' A' ' 378' ' ' PHE . 60.5 mt -100.66 121.94 42.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.944 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.402 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 89.2 t80 -85.54 108.25 17.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.829 HG22 HG12 ' A' ' 403' ' ' ILE . 43.4 t -106.69 133.64 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.123 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.437 ' HB2' ' NH1' ' A' ' 343' ' ' ARG . 3.0 ptm85 -131.66 172.18 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.835 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.1 t30 72.7 37.45 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.519 HD21 HG12 ' A' ' 342' ' ' VAL . 17.5 mt -77.34 144.79 37.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.447 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -73.89 179.05 4.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -83.49 2.55 36.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 69.5 p -120.64 11.55 11.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 346' ' ' ALA . 97.6 t -95.58 132.16 40.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.129 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 70.5 p -139.39 165.57 26.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.164 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.4 ' HA ' HG11 ' A' ' 367' ' ' VAL . 41.6 mt-10 -41.2 -44.31 2.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.882 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -55.29 -59.21 5.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 80.4 mt -55.73 -31.75 30.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.126 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.437 HD22 HD11 ' A' ' 376' ' ' ILE . 93.1 mt -71.43 -26.15 62.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.496 ' O ' ' CB ' ' A' ' 359' ' ' SER . 27.0 mt-10 -83.71 -53.92 5.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 356' ' ' LYS . . . . . 0.439 ' O ' ' NE2' ' A' ' 360' ' ' GLN . 74.0 mttt -57.55 -20.44 32.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 357' ' ' ALA . . . . . 0.695 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -93.26 -44.45 8.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.111 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 358' ' ' PHE . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 41.2 m-85 -93.25 18.03 10.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 355' ' ' GLU . 3.3 t -100.06 -61.84 1.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 360' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 356' ' ' LYS . 2.4 pm0 -37.68 -37.84 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.51 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 70.0 m-85 -62.71 -58.74 6.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -155.46 162.83 31.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.483 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -55.07 123.59 14.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.432 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 60.0 mt -91.36 178.21 6.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -131.76 -44.02 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -173.97 165.96 4.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 351' ' ' GLU . 64.6 t -138.07 134.48 44.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.428 ' O ' ' HB1' ' A' ' 374' ' ' ALA . 7.0 tptm -118.85 117.72 29.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 369' ' ' LYS . . . . . 0.518 ' C ' HD12 ' A' ' 370' ' ' LEU . 14.3 tptm -93.51 144.29 25.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.809 HD22 ' CE2' ' A' ' 373' ' ' TYR . 8.0 mp -130.87 -174.44 3.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 370' ' ' LEU . 20.8 tttp -31.53 -64.78 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -128.36 -37.26 1.84 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.809 ' CE2' HD22 ' A' ' 370' ' ' LEU . 14.1 p90 -92.53 179.18 5.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 368' ' ' LYS . . . -159.1 171.89 19.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.069 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -124.06 127.73 48.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.839 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.437 HD11 HD22 ' A' ' 354' ' ' LEU . 4.4 mm -101.2 109.31 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.161 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -85.79 110.46 19.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.765 ' CE1' HD12 ' A' ' 340' ' ' LEU . 17.9 m-85 -92.95 143.31 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -55.32 -33.1 63.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -141.43 162.66 34.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.511 ' O ' HG23 ' A' ' 385' ' ' VAL . 4.0 tmm_? -63.62 -33.0 74.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -65.47 -58.84 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.824 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -42.17 -28.6 0.53 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.452 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -80.18 -60.38 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 0.0 111.092 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 381' ' ' ARG . 60.6 t -37.44 -35.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 386' ' ' LYS . . . . . 0.421 ' HA ' ' NZ ' ' A' ' 386' ' ' LYS . 0.0 OUTLIER -73.83 -63.25 1.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -59.65 -14.41 13.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.563 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.7 ttm -80.28 -62.24 1.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.859 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.422 ' N ' ' HG2' ' A' ' 388' ' ' MET . 11.9 mt-10 -75.05 -3.19 31.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.51 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 28.2 mm-40 -100.16 -29.38 12.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.822 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' MET . . . . . 0.695 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 5.0 mmt -107.92 -41.98 4.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.77 ' N ' HD12 ' A' ' 403' ' ' ILE . 26.2 t-20 -34.21 93.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.856 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 103.64 28.44 5.99 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.51 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 391' ' ' MET . 1.1 mmmm -98.54 146.31 25.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.319 . . . . 0.0 110.918 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -74.35 78.6 1.86 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.872 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.466 HD22 HD13 ' A' ' 401' ' ' ILE . 19.0 tp -86.23 113.22 22.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 62.34 25.1 14.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.31 17.98 58.04 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.483 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -138.64 124.26 19.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.28 92.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.466 HD13 HD22 ' A' ' 396' ' ' LEU . 20.7 pt -71.56 146.13 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.154 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -111.76 130.84 55.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.829 HG12 HG22 ' A' ' 342' ' ' VAL . 20.9 mt -115.04 126.47 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.43 136.82 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.132 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.563 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 13.1 m-85 -54.56 110.61 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.825 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.402 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.116 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 17.3 pttp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.857 0.361 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 64.6 t -79.1 123.92 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 72.0 mt -104.19 125.48 50.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 72.0 t80 -90.04 106.66 18.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.527 HG22 HG12 ' A' ' 403' ' ' ILE . 22.3 t -104.31 137.68 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.163 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -136.34 169.25 17.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 74.16 46.81 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.901 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 48.5 mt -83.88 135.91 34.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.944 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.3 179.8 0.54 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -85.81 5.97 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 49.8 p -123.43 11.61 9.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 350' ' ' THR . 87.5 t -90.81 153.01 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 350' ' ' THR . . . . . 0.415 ' N ' HG12 ' A' ' 349' ' ' VAL . 77.6 p -153.96 173.18 16.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -58.55 -35.85 72.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.6 -40.71 92.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 68.9 mt -69.16 -28.66 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.503 ' HB2' HG11 ' A' ' 367' ' ' VAL . 94.6 mt -72.39 -31.47 65.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 359' ' ' SER . 64.8 mt-10 -72.18 -74.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -42.05 -34.55 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 357' ' ' ALA . . . . . 0.486 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -73.01 -52.13 15.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 358' ' ' PHE . . . . . 0.438 ' C ' HD11 ' A' ' 364' ' ' LEU . 38.3 m-85 -88.06 15.11 7.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 360' ' ' GLN . 82.7 p -97.23 -56.39 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 360' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 359' ' ' SER . 26.4 pt20 -35.16 -42.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 87.9 m-85 -61.42 -68.36 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -146.51 165.03 28.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.489 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -54.72 127.65 29.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.828 0.347 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.438 HD11 ' C ' ' A' ' 358' ' ' PHE . 78.7 mt -96.35 156.41 16.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -103.36 -42.42 5.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -174.59 169.43 3.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 354' ' ' LEU . 48.9 t -140.65 126.02 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.123 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -119.73 104.86 10.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' LYS . . . . . 0.482 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 20.2 tttm -82.81 152.75 25.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.879 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.9 mp -130.51 -174.8 3.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 370' ' ' LEU . 16.9 tptm -33.26 -68.8 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -118.66 -39.06 3.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.879 ' CE2' HD22 ' A' ' 370' ' ' LEU . 7.0 p90 -92.9 -178.94 4.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 369' ' ' LYS . . . -158.02 168.16 27.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.061 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -121.28 128.3 52.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 7.4 mm -103.7 113.7 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -92.52 123.71 36.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 387' ' ' ALA . 20.4 m-85 -105.77 145.61 30.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.64 -33.73 74.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -132.29 159.09 40.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.418 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 0.4 OUTLIER -65.24 -28.91 69.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 382' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 384' ' ' ALA . 23.5 t0 -70.77 -61.07 1.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -36.89 -30.37 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.509 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 382' ' ' ASP . . . -76.91 -63.22 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.346 . . . . 0.0 111.07 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 384' ' ' ALA . 89.5 t -36.46 -35.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.095 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -63.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -59.21 -16.16 19.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.515 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.7 ttm -77.75 -61.64 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.421 ' N ' ' HG2' ' A' ' 388' ' ' MET . 14.6 mt-10 -75.22 0.31 16.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.491 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 32.4 mm-40 -100.07 -36.58 9.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 391' ' ' MET . . . . . 0.5 ' O ' ' N ' ' A' ' 393' ' ' GLY . 3.6 mmt -102.95 -30.32 10.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.812 ' N ' HD12 ' A' ' 403' ' ' ILE . 7.0 t-20 -42.54 91.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 100.82 30.46 6.09 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.462 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 391' ' ' MET . 22.1 mmtt -100.0 148.43 24.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.743 0.306 . . . . 0.0 110.943 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -74.15 85.49 1.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.905 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.558 HD22 HD13 ' A' ' 401' ' ' ILE . 21.8 tp -93.34 112.34 24.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 62.48 26.94 16.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 86.35 18.39 59.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -140.09 126.0 19.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.882 0.373 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.0 93.51 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.558 HD13 HD22 ' A' ' 396' ' ' LEU . 25.9 pt -71.02 149.32 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.085 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -113.51 131.7 55.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.812 HD12 ' N ' ' A' ' 392' ' ' ASN . 30.9 mt -113.3 133.46 59.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.14 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 5.1 m -145.72 132.83 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.515 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 7.1 m-85 -53.7 109.45 0.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.55 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.094 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.837 0.351 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 58.3 t -80.65 132.74 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.649 HD21 ' HB1' ' A' ' 384' ' ' ALA . 33.4 mt -110.74 127.38 55.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -90.39 114.08 26.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.664 HG22 HG12 ' A' ' 403' ' ' ILE . 22.0 t -111.59 131.62 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -130.0 170.14 14.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 74.81 41.21 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.54 HD12 ' NZ ' ' A' ' 369' ' ' LYS . 44.1 mt -80.27 133.6 36.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.551 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -56.17 -177.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.498 ' OD1' HG23 ' A' ' 348' ' ' THR . 11.6 p30 -91.67 11.59 23.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.908 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 348' ' ' THR . . . . . 0.498 HG23 ' OD1' ' A' ' 347' ' ' ASN . 51.4 p -135.04 17.71 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.551 HG23 ' HB3' ' A' ' 346' ' ' ALA . 71.4 t -95.48 136.92 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.103 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 76.9 p -135.79 170.52 15.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.133 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -52.49 -46.05 66.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -52.59 -42.97 64.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 77.6 mt -70.94 -27.46 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.178 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.549 ' HB2' HG11 ' A' ' 367' ' ' VAL . 97.8 mt -73.99 -31.5 62.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 359' ' ' SER . 24.4 mt-10 -74.73 -64.83 0.96 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.939 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -44.36 -40.34 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 357' ' ' ALA . . . . . 0.787 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -71.26 -55.79 7.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.092 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 358' ' ' PHE . . . . . 0.409 ' O ' HD21 ' A' ' 364' ' ' LEU . 45.3 m-85 -81.77 13.95 2.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.864 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 355' ' ' GLU . 7.2 t -100.03 -54.17 2.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.828 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -39.65 -36.02 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 81.1 m-85 -65.52 -63.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.19 168.74 31.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.479 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -53.37 129.12 30.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 110.906 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.476 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 32.7 mt -99.54 163.35 12.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -111.93 -48.68 3.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -172.82 165.91 5.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 354' ' ' LEU . 93.7 t -134.45 127.41 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.147 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -110.83 114.19 27.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' LYS . . . . . 0.54 ' NZ ' HD12 ' A' ' 345' ' ' LEU . 16.3 tptp -89.97 138.76 31.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.87 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.718 HD22 ' CE2' ' A' ' 373' ' ' TYR . 7.7 mp -125.49 -174.83 3.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 370' ' ' LEU . 3.2 mptp? -33.7 -70.81 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.94 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -119.01 -38.26 3.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.838 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.718 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.9 p90 -91.78 -175.79 4.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.947 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -164.95 158.26 16.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -109.63 133.57 52.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 3.7 mm -107.41 107.48 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -85.5 117.88 24.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.562 ' CE1' HD12 ' A' ' 340' ' ' LEU . 16.2 m-85 -99.42 146.13 26.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -57.72 -36.48 72.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -133.18 160.34 37.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.409 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 1.6 tmm_? -63.92 -35.27 80.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 382' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 384' ' ' ALA . 11.5 t0 -65.77 -58.58 5.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -38.62 -30.67 0.1 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.466 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' ALA . . . . . 0.649 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -76.95 -58.91 3.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.317 . . . . 0.0 111.091 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.4 t -37.9 -37.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.122 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' LYS . . . . . 0.431 ' HA ' ' NZ ' ' A' ' 386' ' ' LYS . 0.1 OUTLIER -72.3 -65.36 0.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.84 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -56.14 -16.57 5.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.106 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.535 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.5 ttm -78.52 -64.13 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.465 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.1 mt-10 -73.86 0.83 12.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.489 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 57.5 mm-40 -100.14 -39.91 7.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' MET . . . . . 0.787 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 5.9 mmm -100.11 -30.12 12.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.777 ' N ' HD12 ' A' ' 403' ' ' ILE . 5.5 t-20 -42.03 94.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 100.61 30.38 6.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.503 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.0 147.74 25.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.329 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 395' ' ' ASP . . . . . 0.414 ' OD1' ' C ' ' A' ' 395' ' ' ASP . 31.2 t0 -75.35 88.63 2.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.875 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 29.2 tp -94.73 110.17 22.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.984 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 63.35 24.95 14.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.47 18.95 51.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.448 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -139.94 125.59 19.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.9 94.05 2.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 20.1 pt -71.5 148.14 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -112.04 130.3 55.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.879 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.777 HD12 ' N ' ' A' ' 392' ' ' ASN . 27.2 mt -112.43 131.24 64.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.096 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 22.1 m -144.8 136.58 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.535 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 12.2 m-85 -54.17 116.0 2.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.098 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 40.8 pttt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.783 0.325 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.0 t -79.48 138.98 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.798 HD21 ' HB1' ' A' ' 384' ' ' ALA . 47.4 mt -114.01 130.84 56.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.475 ' HB3' HG23 ' A' ' 404' ' ' VAL . 56.2 t80 -92.19 107.98 19.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.464 HG22 HG12 ' A' ' 403' ' ' ILE . 21.7 t -105.09 136.36 39.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -135.78 173.36 11.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.0 t30 68.89 52.1 0.54 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.434 HD21 HG12 ' A' ' 342' ' ' VAL . 18.0 mt -94.94 121.15 36.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.889 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -46.26 173.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -80.78 13.79 2.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 38.6 p -128.19 5.58 5.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 51.0 t -88.92 140.41 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.107 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 68.0 p -143.71 170.56 15.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.134 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -49.47 -41.86 41.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -59.31 -39.0 81.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 77.0 mt -73.64 -29.38 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.526 ' HB2' HG11 ' A' ' 367' ' ' VAL . 89.7 mt -74.26 -27.48 60.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 359' ' ' SER . 38.0 mt-10 -80.2 -66.87 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -48.7 -25.54 1.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -83.91 -47.47 11.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 358' ' ' PHE . . . . . 0.438 ' O ' HD21 ' A' ' 364' ' ' LEU . 35.4 m-85 -90.76 12.89 17.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 355' ' ' GLU . 99.2 p -99.64 -46.93 5.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -41.75 -30.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.513 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 98.4 m-85 -75.43 -73.92 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -135.56 174.4 21.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.476 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -60.16 133.88 56.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.792 0.33 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.438 HD21 ' O ' ' A' ' 358' ' ' PHE . 50.0 mt -103.74 153.36 20.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -103.5 -47.42 4.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -173.47 165.08 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.849 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' A' ' 354' ' ' LEU . 51.4 t -136.58 132.57 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.72 107.79 15.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 369' ' ' LYS . . . . . 0.4 ' C ' HD12 ' A' ' 370' ' ' LEU . 19.5 tptp -83.43 143.36 30.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.889 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.2 mp -128.59 -174.27 3.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.941 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 370' ' ' LEU . 21.6 mtpp -32.48 -64.15 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.47 -33.77 2.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.889 ' CE2' HD22 ' A' ' 370' ' ' LEU . 3.8 p90 -93.74 -176.04 3.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.508 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -166.81 160.49 14.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.123 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -111.57 134.85 52.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.464 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 3.6 mm -109.76 116.05 51.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -92.13 121.16 33.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 20.0 m-85 -106.57 127.67 53.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -42.52 -35.82 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -134.28 157.6 45.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -34.57 74.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 382' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 384' ' ' ALA . 27.1 t0 -65.67 -57.4 8.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 383' ' ' GLY . . . . . 0.459 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -38.97 -29.15 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 384' ' ' ALA . . . . . 0.798 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -82.07 -58.86 2.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 111.122 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 94.1 t -38.16 -39.66 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.109 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -68.62 -60.56 2.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.07 -14.35 47.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.085 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 7.6 ttm -79.43 -59.67 2.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -75.09 -3.43 32.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.513 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 6.2 mm-40 -100.07 -37.18 9.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' MET . . . . . 0.498 ' O ' ' CG ' ' A' ' 394' ' ' LYS . 69.8 mmm -99.91 -25.13 14.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 388' ' ' MET . 1.4 t-20 -42.04 118.84 1.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 63.69 32.68 84.98 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.467 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 391' ' ' MET . 0.0 OUTLIER -96.75 145.2 26.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.757 0.313 . . . . 0.0 110.91 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -68.48 108.22 3.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.561 HD22 HD13 ' A' ' 401' ' ' ILE . 21.1 tp -119.51 111.45 18.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 62.01 37.06 15.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.893 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 76.72 11.17 85.58 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.492 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -137.27 121.08 17.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.368 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.34 116.04 8.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.561 HD13 HD22 ' A' ' 396' ' ' LEU . 17.3 pt -90.99 147.55 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.113 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.737 ' OE2' HG13 ' A' ' 404' ' ' VAL . 13.9 tm-20 -111.23 133.13 53.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 392' ' ' ASN . 22.6 mt -116.92 134.69 59.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.127 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.737 HG13 ' OE2' ' A' ' 402' ' ' GLU . 3.9 m -144.92 140.59 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 14.9 m-85 -61.0 105.01 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 179.943 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.84 0.352 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.83 130.83 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 388' ' ' MET . 63.0 mt -106.27 124.62 49.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.458 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 46.8 t80 -88.69 107.28 18.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.433 HG12 HD21 ' A' ' 345' ' ' LEU . 20.6 t -101.98 134.73 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.126 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -134.54 170.35 15.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.823 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.1 t30 72.91 39.12 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.433 HD21 HG12 ' A' ' 342' ' ' VAL . 31.1 mt -79.93 154.45 28.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -93.08 163.17 13.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -65.51 -7.29 13.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 81.9 p -103.53 -0.13 30.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.135 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 96.0 t -91.97 132.27 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.087 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' THR . . . . . 0.497 ' H ' HD12 ' A' ' 353' ' ' ILE . 67.8 p -134.62 170.3 16.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -50.97 -44.95 60.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -56.61 -41.2 76.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.933 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.497 HD12 ' H ' ' A' ' 350' ' ' THR . 73.2 mt -70.46 -30.25 42.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.138 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.449 ' HB2' HG11 ' A' ' 367' ' ' VAL . 97.2 mt -73.5 -30.13 62.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 359' ' ' SER . 49.4 mt-10 -75.64 -67.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -47.87 -36.44 12.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.848 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 357' ' ' ALA . . . . . 0.515 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -70.96 -49.77 41.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 358' ' ' PHE . . . . . 0.442 ' O ' HD21 ' A' ' 364' ' ' LEU . 39.6 m-85 -88.9 12.78 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.88 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 355' ' ' GLU . 40.4 t -99.26 -53.41 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -37.96 -31.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 91.5 m-85 -71.98 -63.11 1.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -149.55 171.12 29.71 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.465 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -58.62 128.26 36.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 0.0 110.917 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.442 HD21 ' O ' ' A' ' 358' ' ' PHE . 33.7 mt -97.35 171.48 8.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.956 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -120.52 -45.69 2.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.403 HH11 ' CD2' ' A' ' 377' ' ' HIS . 9.1 ptm180 -173.84 165.03 4.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.858 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.449 HG11 ' HB2' ' A' ' 354' ' ' LEU . 40.4 t -137.12 137.37 46.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.415 ' O ' ' HB1' ' A' ' 374' ' ' ALA . 7.9 tmtm? -125.07 120.32 31.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.864 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -94.44 140.92 29.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.873 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.692 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.8 mp -124.47 -174.71 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 370' ' ' LEU . 19.3 tttp -33.11 -65.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -125.67 -37.44 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.864 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.692 ' CE2' HD22 ' A' ' 370' ' ' LEU . 3.5 p90 -92.41 -174.8 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 368' ' ' LYS . . . -164.69 163.66 21.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -116.15 129.6 56.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.901 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.1 mm -104.52 119.45 53.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 377' ' ' HIS . . . . . 0.403 ' CD2' HH11 ' A' ' 366' ' ' ARG . 75.3 m-70 -98.3 121.89 40.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.493 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 21.5 m-85 -102.75 149.9 24.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.76 -29.19 70.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.858 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -136.23 160.54 38.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.892 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.443 ' O ' HG23 ' A' ' 385' ' ' VAL . 7.0 tmm_? -65.05 -29.41 70.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -73.13 -54.09 9.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' GLY . . . . . 0.493 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -40.17 -30.76 0.28 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 384' ' ' ALA . . . . . 0.45 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -80.13 -63.87 1.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 111.104 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 381' ' ' ARG . 52.6 t -37.08 -35.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.131 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -61.5 1.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -60.88 -16.12 38.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.098 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.52 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.3 ttm -78.13 -62.21 1.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.444 ' N ' ' HG2' ' A' ' 388' ' ' MET . 18.5 mt-10 -74.5 1.22 12.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.554 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 4.4 mm-40 -100.07 -39.08 8.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 391' ' ' MET . . . . . 0.515 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 10.6 mmm -102.7 -30.76 10.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.78 ' N ' HD12 ' A' ' 403' ' ' ILE . 5.7 t-20 -34.35 93.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 98.81 37.23 4.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -99.97 148.34 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.328 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -76.06 77.95 2.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.861 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.509 HD22 HD13 ' A' ' 401' ' ' ILE . 16.6 tp -83.36 110.54 18.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.979 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 63.04 29.67 16.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 84.18 20.68 58.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -140.09 126.7 20.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.83 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.43 97.84 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.509 HD13 HD22 ' A' ' 396' ' ' LEU . 22.2 pt -77.79 146.38 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -112.12 131.69 55.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.882 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.78 HD12 ' N ' ' A' ' 392' ' ' ASN . 13.5 mt -112.04 132.45 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.101 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 13.7 m -145.69 134.06 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.52 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 16.2 m-85 -51.5 111.13 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.844 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.128 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 23.4 pttt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.856 0.36 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 91.6 t -75.7 124.9 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.533 HD21 ' HB1' ' A' ' 384' ' ' ALA . 91.4 mt -104.97 116.67 32.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -82.79 109.33 16.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.723 HG22 HG12 ' A' ' 403' ' ' ILE . 24.4 t -108.3 132.26 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -130.72 177.17 7.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 68.94 43.79 1.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 33.6 mt -83.39 141.26 31.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.41 -178.16 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.095 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -88.87 2.95 52.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 61.4 p -120.08 13.87 12.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.186 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 73.6 t -92.83 150.47 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 75.5 p -149.13 170.04 19.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -52.07 -44.85 64.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -54.61 -52.12 63.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 77.8 mt -58.07 -33.1 45.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.521 ' HB2' HG11 ' A' ' 367' ' ' VAL . 87.4 mt -73.85 -26.63 60.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.918 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.47 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 31.7 mt-10 -78.92 -63.29 1.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -51.35 -41.33 60.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 357' ' ' ALA . . . . . 0.581 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -65.85 -49.73 67.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.055 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 358' ' ' PHE . . . . . 0.444 ' O ' HD21 ' A' ' 364' ' ' LEU . 41.2 m-85 -89.08 16.82 6.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.888 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 360' ' ' GLN . 12.2 t -99.95 -57.15 2.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 360' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 359' ' ' SER . 24.0 pt20 -37.68 -39.42 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.914 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.548 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 71.6 m-85 -62.83 -63.41 1.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -150.88 166.45 30.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.499 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -54.88 125.53 20.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 0.0 110.916 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.47 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 34.3 mt -94.12 154.32 17.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -103.63 -44.9 4.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -174.92 163.6 3.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.521 HG11 ' HB2' ' A' ' 354' ' ' LEU . 51.8 t -135.14 124.06 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.34 106.97 13.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 369' ' ' LYS . . . . . 0.487 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 17.6 tttm -84.14 150.43 25.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.879 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.4 mp -127.97 -174.33 3.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 370' ' ' LEU . 9.7 ttmt -32.58 -67.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.04 -38.68 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.843 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.879 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.8 p90 -91.94 -176.39 4.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.487 ' CB ' ' HA ' ' A' ' 369' ' ' LYS . . . -160.88 166.86 27.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -119.53 131.9 55.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.41 HD11 HD22 ' A' ' 354' ' ' LEU . 7.2 mm -107.79 110.31 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.132 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -88.9 125.64 35.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.517 ' CE1' HD12 ' A' ' 340' ' ' LEU . 20.0 m-85 -108.8 134.59 51.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.87 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -46.66 -36.55 7.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -133.29 158.84 41.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -62.29 -36.56 82.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 384' ' ' ALA . 26.4 t70 -63.48 -59.5 4.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 383' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 382' ' ' ASP . . . -36.89 -31.78 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 384' ' ' ALA . . . . . 0.533 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -76.06 -61.24 2.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 111.093 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 384' ' ' ALA . 66.7 t -35.79 -33.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.088 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 386' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 384' ' ' ALA . 0.0 OUTLIER -75.3 -65.15 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.872 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -58.0 -14.77 7.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.1 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.59 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.8 ttm -80.23 -62.38 1.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.874 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.423 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.0 mt-10 -75.63 -1.64 25.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.548 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 69.0 mm-40 -100.14 -32.28 10.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 391' ' ' MET . . . . . 0.581 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 19.5 mmm -106.2 -37.94 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.896 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.863 ' N ' HD12 ' A' ' 403' ' ' ILE . 7.0 t-20 -33.9 93.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.927 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 103.92 27.02 6.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.481 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 391' ' ' MET . 14.1 mmmt -90.76 146.72 23.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.792 0.33 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.72 72.41 3.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.897 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 15.8 tp -75.84 111.82 11.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 62.49 24.99 14.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' GLY . . . . . 0.446 ' C ' ' OE1' ' A' ' 399' ' ' GLU . . . 89.75 14.39 59.66 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.508 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 399' ' ' GLU . . . . . 0.446 ' OE1' ' C ' ' A' ' 398' ' ' GLY . 2.5 mp0 -132.88 127.71 34.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.87 0.367 . . . . 0.0 110.849 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.46 96.81 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 20.4 pt -74.67 148.9 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.11 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -112.58 129.71 56.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.863 HD12 ' N ' ' A' ' 392' ' ' ASN . 27.3 mt -113.91 126.47 71.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.141 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.65 136.28 46.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.149 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.59 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 9.0 m-85 -54.9 112.61 1.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.104 179.943 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 8.8 pttm . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.8 0.333 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 67.7 t -79.61 118.81 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.147 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.572 HD21 ' HB1' ' A' ' 384' ' ' ALA . 46.1 mt -99.2 131.02 45.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -92.92 105.17 17.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.53 HG22 HG12 ' A' ' 403' ' ' ILE . 20.8 t -104.17 131.83 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -133.21 173.73 11.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 73.06 35.47 0.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.427 HD21 HG12 ' A' ' 342' ' ' VAL . 21.4 mt -76.63 139.18 40.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.428 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -67.52 -178.93 0.97 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -85.7 -0.26 54.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 17.2 p -117.64 14.94 14.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.159 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.428 HG23 ' HB3' ' A' ' 346' ' ' ALA . 96.0 t -96.52 133.73 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.127 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 39.8 p -134.39 169.01 17.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.116 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -51.7 -41.66 61.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -57.47 -43.87 84.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 66.5 mt -67.7 -29.56 45.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.55 ' HB2' HG11 ' A' ' 367' ' ' VAL . 96.0 mt -72.78 -32.01 65.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.477 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 16.1 mt-10 -73.14 -69.85 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 356' ' ' LYS . . . . . 0.471 ' HE3' ' N ' ' A' ' 356' ' ' LYS . 0.7 OUTLIER -43.25 -39.11 2.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 357' ' ' ALA . . . . . 0.561 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -69.59 -56.02 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 358' ' ' PHE . . . . . 0.426 ' O ' HD21 ' A' ' 364' ' ' LEU . 42.7 m-85 -83.96 14.54 4.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 355' ' ' GLU . 11.7 t -100.01 -52.39 3.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -40.35 -37.63 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.533 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 79.9 m-85 -65.7 -62.75 1.34 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.94 162.22 29.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.507 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -49.0 130.85 18.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 0.0 110.917 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.477 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 36.2 mt -101.21 155.02 18.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -100.12 -47.86 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -173.52 167.44 4.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.55 HG11 ' HB2' ' A' ' 354' ' ' LEU . 83.2 t -136.87 133.42 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.34 118.51 31.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 12.9 tptp -92.66 141.33 28.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.758 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.5 mp -126.39 -174.65 3.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 370' ' ' LEU . 1.3 mppt? -33.51 -68.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -122.27 -37.67 2.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.758 ' CE2' HD22 ' A' ' 370' ' ' LEU . 6.7 p90 -92.64 -176.39 4.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.503 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -163.87 161.84 23.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -112.4 134.68 53.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.7 mm -108.56 109.11 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.151 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -88.42 120.67 30.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.508 ' CE1' HD12 ' A' ' 340' ' ' LEU . 17.9 m-85 -101.92 147.53 26.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.54 -33.7 75.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -132.71 153.97 50.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -61.78 -31.01 71.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.99 -51.18 27.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -43.18 -36.67 2.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.501 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 384' ' ' ALA . . . . . 0.572 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -72.11 -59.32 2.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.865 0.364 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.478 HG22 ' HZ ' ' A' ' 405' ' ' PHE . 86.1 t -36.41 -37.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.8 tptt -72.56 -66.01 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -56.3 -15.87 4.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 7.5 ttm -78.94 -60.15 2.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -78.2 -2.5 38.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.533 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 65.0 mm-40 -100.07 -21.62 15.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 391' ' ' MET . . . . . 0.561 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 10.9 mmm -116.8 -39.12 3.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.845 ' N ' HD12 ' A' ' 403' ' ' ILE . 27.5 t-20 -33.23 93.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 393' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 103.73 29.93 5.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 391' ' ' MET . 14.8 mmmt -96.2 146.4 24.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.729 0.299 . . . . 0.0 110.914 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.66 74.05 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.625 HD22 HD13 ' A' ' 401' ' ' ILE . 15.6 tp -76.41 110.65 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 62.28 24.96 14.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.66 13.84 57.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.478 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -133.56 130.53 38.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 0.0 110.889 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.3 93.57 2.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.625 HD13 HD22 ' A' ' 396' ' ' LEU . 20.2 pt -72.06 145.47 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -108.72 130.2 55.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.845 HD12 ' N ' ' A' ' 392' ' ' ASN . 24.7 mt -115.52 127.82 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.1 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.27 140.07 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 7.7 m-85 -58.16 108.95 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 49.9 pttt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.826 0.346 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.95 122.45 27.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.153 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.645 HD21 ' HB1' ' A' ' 384' ' ' ALA . 29.3 mt -102.33 122.85 45.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 52.7 t80 -85.64 111.29 19.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.608 HG22 HG12 ' A' ' 403' ' ' ILE . 46.3 t -106.22 141.51 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.117 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -140.74 168.21 20.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 75.05 45.34 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 54.0 mt -81.08 137.97 35.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.655 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -62.31 -175.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.085 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -89.86 -4.84 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.851 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 80.5 p -118.71 19.26 13.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.655 HG23 ' HB3' ' A' ' 346' ' ' ALA . 81.5 t -94.74 152.57 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.091 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 350' ' ' THR . . . . . 0.403 ' N ' HG12 ' A' ' 349' ' ' VAL . 82.2 p -155.45 175.44 13.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -57.28 -45.82 83.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.926 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -53.4 -43.59 68.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 349' ' ' VAL . 70.7 mt -67.72 -38.81 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.498 HD22 HD11 ' A' ' 376' ' ' ILE . 88.1 mt -64.28 -25.41 68.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.961 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 359' ' ' SER . 37.2 mt-10 -76.94 -71.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -44.2 -33.17 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' ALA . . . . . 0.621 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -74.39 -52.47 12.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.128 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 358' ' ' PHE . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 41.7 m-85 -88.27 13.57 11.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 355' ' ' GLU . 11.8 t -100.03 -58.22 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 360' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 359' ' ' SER . 20.7 pt20 -34.96 -39.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 89.6 m-85 -63.41 -63.91 1.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -149.83 166.47 29.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.81 129.98 31.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.917 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.418 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 27.8 mt -98.36 161.51 13.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.869 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -109.71 -46.28 3.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -174.32 165.27 4.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.471 HG11 ' HB2' ' A' ' 354' ' ' LEU . 53.2 t -135.75 132.57 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.108 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.77 108.25 10.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 369' ' ' LYS . . . . . 0.467 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 8.3 tttm -87.77 147.28 25.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.774 HD22 ' CE2' ' A' ' 373' ' ' TYR . 5.6 mp -126.33 -173.52 2.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.486 ' C ' ' O ' ' A' ' 370' ' ' LEU . 32.4 ttmt -30.35 -65.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -125.72 -37.96 2.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.861 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.774 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.5 p90 -90.93 -176.25 4.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 370' ' ' LEU . . . -162.78 160.93 25.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.086 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 375' ' ' PHE . . . . . 0.401 ' CZ ' ' HD1' ' A' ' 341' ' ' PHE . 12.7 m-85 -116.28 121.86 43.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.498 HD11 HD22 ' A' ' 354' ' ' LEU . 5.3 mm -96.62 122.26 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -100.09 123.19 44.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 358' ' ' PHE . 19.9 m-85 -105.3 147.71 27.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -64.28 -35.01 79.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -130.99 147.46 52.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.457 ' NH1' ' CG2' ' A' ' 385' ' ' VAL . 0.0 OUTLIER -55.54 -32.07 62.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.826 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 382' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 384' ' ' ALA . 7.1 t70 -68.74 -60.6 2.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 383' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 382' ' ' ASP . . . -36.35 -33.81 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.491 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 384' ' ' ALA . . . . . 0.645 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -74.07 -63.8 1.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 111.065 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.457 ' CG2' ' NH1' ' A' ' 381' ' ' ARG . 92.5 t -35.43 -35.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 386' ' ' LYS . . . . . 0.48 ' HE3' ' CG ' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -71.92 -60.56 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -62.1 -17.73 58.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.135 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.585 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 7.4 ttm -75.24 -59.1 2.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.401 ' N ' ' HG2' ' A' ' 388' ' ' MET . 7.3 mt-10 -77.69 -3.04 39.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.48 ' CG ' ' HE3' ' A' ' 386' ' ' LYS . 28.5 mm-40 -100.09 -29.21 12.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.884 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' MET . . . . . 0.621 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 7.4 mmm -108.0 -28.92 9.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.663 ' N ' HD12 ' A' ' 403' ' ' ILE . 2.6 t-20 -43.74 111.56 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 78.81 24.71 61.67 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 391' ' ' MET . 0.0 OUTLIER -93.62 142.57 27.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 0.0 110.876 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -70.56 103.19 2.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.787 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.494 HD22 HD13 ' A' ' 401' ' ' ILE . 19.5 tp -109.83 110.48 21.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 62.04 34.4 16.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 80.8 16.28 75.58 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.518 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -140.03 119.57 13.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.31 104.32 2.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.494 HD13 HD22 ' A' ' 396' ' ' LEU . 28.0 pt -79.42 151.06 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.559 ' OE1' HG13 ' A' ' 404' ' ' VAL . 9.6 tm-20 -114.81 132.02 56.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.663 HD12 ' N ' ' A' ' 392' ' ' ASN . 22.6 mt -116.05 134.83 58.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.109 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.559 HG13 ' OE1' ' A' ' 402' ' ' GLU . 14.1 m -147.74 130.62 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.585 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 14.5 m-85 -49.52 105.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.556 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.072 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 25.5 pttm . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.801 0.334 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.2 t -79.96 123.01 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.865 HD21 ' HB1' ' A' ' 384' ' ' ALA . 33.5 mt -102.42 131.23 49.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.948 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.462 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 76.9 t80 -94.78 104.7 16.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.805 HG22 HG12 ' A' ' 403' ' ' ILE . 33.0 t -104.42 130.78 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -132.33 173.35 11.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' ASN . . . . . 0.49 ' ND2' ' OE1' ' A' ' 399' ' ' GLU . 0.7 OUTLIER 73.78 40.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.888 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 62.1 mt -78.86 159.11 27.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -86.0 -178.74 6.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.075 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -88.39 4.64 45.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 15.9 p -124.47 15.41 8.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.1 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.87 143.6 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.089 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 350' ' ' THR . . . . . 0.409 ' H ' HD12 ' A' ' 353' ' ' ILE . 73.7 p -143.3 173.11 11.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -52.93 -48.09 67.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -51.77 -46.18 64.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.862 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.409 HD12 ' H ' ' A' ' 350' ' ' THR . 77.5 mt -64.7 -35.7 75.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.591 ' HB2' HG11 ' A' ' 367' ' ' VAL . 95.6 mt -69.53 -27.4 65.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.469 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 34.2 mt-10 -77.64 -69.19 0.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -46.21 -32.8 3.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 357' ' ' ALA . . . . . 0.564 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -75.77 -49.16 18.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.098 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 358' ' ' PHE . . . . . 0.446 ' C ' HD11 ' A' ' 364' ' ' LEU . 28.7 m-85 -89.73 15.89 8.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 360' ' ' GLN . 9.9 t -98.9 -57.81 2.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.842 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 360' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 359' ' ' SER . 24.2 pt20 -35.97 -39.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.892 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.522 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 85.1 m-85 -63.78 -63.4 1.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.39 162.52 29.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.434 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -50.12 127.28 16.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.499 HD21 ' CZ ' ' A' ' 378' ' ' PHE . 32.3 mt -97.66 153.97 17.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -102.06 -49.03 4.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -171.31 164.42 7.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.591 HG11 ' HB2' ' A' ' 354' ' ' LEU . 40.6 t -136.4 125.8 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -112.08 118.95 36.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -91.32 140.52 29.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.93 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.781 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.5 mp -124.24 -174.76 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 370' ' ' LEU . 1.0 OUTLIER -33.69 -69.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -119.6 -38.53 2.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.822 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.781 ' CE2' HD22 ' A' ' 370' ' ' LEU . 5.2 p90 -91.44 -174.95 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.474 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -163.83 162.81 23.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.111 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -112.47 139.26 48.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 6.2 mm -114.11 104.31 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.119 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -84.26 122.78 29.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.499 ' CZ ' HD21 ' A' ' 364' ' ' LEU . 19.8 m-85 -105.12 148.1 27.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -58.46 -36.85 74.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -134.35 155.79 49.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.879 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' ARG . . . . . 0.416 ' C ' ' HD3' ' A' ' 381' ' ' ARG . 2.4 tmt_? -59.05 -34.56 72.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 382' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 384' ' ' ALA . 23.1 t70 -67.01 -60.03 2.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.831 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -37.06 -32.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.487 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' ALA . . . . . 0.865 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -76.82 -54.95 5.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.859 0.361 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 381' ' ' ARG . 65.1 t -36.79 -39.7 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -69.8 -66.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -53.29 -15.73 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.118 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.56 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.5 ttm -79.6 -63.93 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.457 ' N ' ' HG2' ' A' ' 388' ' ' MET . 6.4 mt-10 -75.2 -0.67 20.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.522 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 28.3 mm-40 -100.19 -35.36 9.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' MET . . . . . 0.564 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 9.8 mmm -103.47 -34.61 8.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.679 ' N ' HD12 ' A' ' 403' ' ' ILE . 3.5 t-20 -37.79 99.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 96.04 28.53 9.23 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.452 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 391' ' ' MET . 34.4 mmtt -95.6 147.26 23.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.779 0.323 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.37 78.02 3.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.457 HD22 HD13 ' A' ' 401' ' ' ILE . 21.5 tp -81.87 110.39 17.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 62.19 27.48 16.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.43 21.3 48.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' GLU . . . . . 0.49 ' OE1' ' ND2' ' A' ' 344' ' ' ASN . 12.7 mm-40 -140.06 126.51 20.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 0.0 110.851 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.47 92.53 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 401' ' ' ILE . . . . . 0.457 HD13 HD22 ' A' ' 396' ' ' LEU . 28.8 pt -72.41 150.54 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.094 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -115.78 131.35 56.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.805 HG12 HG22 ' A' ' 342' ' ' VAL . 28.0 mt -114.87 124.84 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.164 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 30.7 m -138.03 132.33 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.56 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 17.7 m-85 -49.18 114.11 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.124 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? . . . . . 0 N--CA 1.457 -0.075 0 CA-C-O 120.861 0.362 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 60.2 t -79.86 129.83 36.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.147 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.534 HD21 ' HB1' ' A' ' 384' ' ' ALA . 31.2 mt -110.71 125.03 53.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' A' ' 343' ' ' ARG . 6.3 t80 -86.04 118.84 25.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 403' ' ' ILE . 21.2 t -115.73 130.12 70.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.099 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.473 ' HB3' ' CE1' ' A' ' 341' ' ' PHE . 6.9 ptp180 -128.58 -179.91 5.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 65.22 41.92 4.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.606 HD13 ' NZ ' ' A' ' 369' ' ' LYS . 39.4 mt -84.32 136.33 33.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.28 172.48 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.128 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -81.66 11.92 4.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 18.5 p -129.36 11.19 5.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.742 HG12 ' NZ ' ' A' ' 369' ' ' LYS . 84.8 t -85.91 139.61 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.164 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 76.7 p -140.42 157.71 45.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.446 ' HG2' HG12 ' A' ' 367' ' ' VAL . 35.5 mt-10 -43.92 -43.9 6.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -54.36 -42.87 70.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 78.1 mt -68.93 -33.37 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.462 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 95.2 mt -69.22 -30.83 69.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 359' ' ' SER . 51.9 mt-10 -72.72 -72.41 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -44.19 -36.91 2.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 357' ' ' ALA . . . . . 0.467 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -69.42 -51.87 32.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 358' ' ' PHE . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 34.8 m-85 -89.23 15.58 8.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 355' ' ' GLU . 12.3 t -99.66 -51.82 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -40.44 -38.22 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.945 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.531 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 92.0 m-85 -65.59 -62.35 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.19 170.3 31.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -55.77 138.52 47.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.422 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 55.7 mt -107.95 162.64 13.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -111.46 -48.94 3.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.434 ' HB2' ' NH1' ' A' ' 366' ' ' ARG . 1.3 ptp180 -171.23 166.19 7.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.446 HG12 ' HG2' ' A' ' 351' ' ' GLU . 78.6 t -135.67 130.89 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -116.84 116.81 28.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 369' ' ' LYS . . . . . 0.742 ' NZ ' HG12 ' A' ' 349' ' ' VAL . 33.8 tptt -89.12 146.22 24.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.845 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.5 mp -130.58 -174.86 3.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 370' ' ' LEU . 28.8 mtpt -33.64 -62.49 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.488 ' O ' HD12 ' A' ' 345' ' ' LEU . 3.9 m-20 -129.38 -36.05 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.845 ' CE2' HD22 ' A' ' 370' ' ' LEU . 3.7 p90 -92.23 -174.94 3.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.532 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -167.35 153.02 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.106 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -103.01 137.95 40.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.462 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.9 mm -110.33 110.6 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -88.49 121.46 30.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 358' ' ' PHE . 17.3 m-85 -103.24 144.12 31.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.92 -27.89 54.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -142.01 156.3 45.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -61.49 -35.22 77.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 384' ' ' ALA . 27.0 t70 -66.89 -58.74 4.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -38.04 -31.1 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.455 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' ALA . . . . . 0.534 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -77.19 -58.61 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.328 . . . . 0.0 111.079 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 384' ' ' ALA . 57.7 t -36.08 -35.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -73.54 -66.09 0.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -55.51 -17.37 5.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.095 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.561 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.0 ttm -77.3 -63.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.875 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.463 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.4 mt-10 -74.81 0.33 15.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.531 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 30.1 mm-40 -100.21 -36.27 9.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 391' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 393' ' ' GLY . 4.0 mmt -102.64 -31.27 10.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.65 ' N ' HD12 ' A' ' 403' ' ' ILE . 6.5 t-20 -39.2 92.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 393' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 101.38 33.85 4.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.465 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -100.14 147.19 25.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.878 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.09 80.96 2.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 17.8 tp -90.07 113.88 25.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 62.25 26.39 15.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.939 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 84.83 20.33 58.11 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -140.01 122.18 15.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.921 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.38 92.27 0.8 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 19.4 pt -71.33 147.46 10.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.123 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -113.05 131.37 55.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.656 HG12 HG22 ' A' ' 342' ' ' VAL . 55.7 mt -110.78 136.98 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.124 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 20.2 m -151.76 135.13 7.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.561 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 24.0 m-85 -52.58 117.22 2.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 179.912 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 3.2 m -88.55 42.48 1.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.91 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 25.2 m -41.28 -60.89 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 172.68 -132.44 2.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 4.4 t -145.27 137.71 25.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 110.844 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.4 t -143.23 160.38 40.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 179.78 -169.14 39.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.5 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -142.47 124.65 15.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.0 110.933 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -131.38 152.59 50.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.131 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -106.71 46.13 0.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.863 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 87.3 t -102.07 137.95 28.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.128 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -99.2 -27.95 13.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 68.5 t -82.66 137.22 21.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.574 HD22 ' HB2' ' A' ' 388' ' ' MET . 56.6 mt -111.48 127.54 55.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.578 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 71.1 t80 -90.65 105.49 17.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.452 ' CG1' HD12 ' A' ' 401' ' ' ILE . 21.6 t -104.86 128.57 58.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -128.44 175.92 8.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.66 36.4 1.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 31.8 mt -75.1 146.63 41.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.627 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -73.19 -179.14 3.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.107 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -85.51 -2.34 58.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 13.1 p -118.49 15.55 13.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.627 HG23 ' HB3' ' A' ' 346' ' ' ALA . 95.7 t -97.25 135.64 30.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.092 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 82.3 p -139.31 175.79 9.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.168 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -54.86 -44.78 74.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -55.53 -44.77 77.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 63.7 mt -68.54 -33.79 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.138 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.454 ' HB2' HG11 ' A' ' 367' ' ' VAL . 89.9 mt -70.75 -27.77 64.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 359' ' ' SER . 72.4 mt-10 -74.21 -71.19 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -41.54 -39.4 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' ALA . . . . . 0.735 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -69.77 -56.31 7.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -83.86 14.46 4.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 355' ' ' GLU . 13.4 t -99.22 -56.83 2.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 359' ' ' SER . 27.2 pt20 -37.67 -38.28 0.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.496 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 84.5 m-85 -63.0 -63.08 1.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.25 167.12 31.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.465 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -52.98 128.83 28.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.454 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 37.5 mt -98.15 157.2 16.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.912 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -106.02 -46.67 4.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -174.9 165.6 3.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 354' ' ' LEU . 78.4 t -135.41 127.85 47.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.118 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -114.69 113.4 24.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -89.0 142.02 27.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.731 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.1 mp -126.91 -174.02 3.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.5 OUTLIER -32.28 -67.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.891 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -124.43 -37.7 2.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.731 ' CE2' HD22 ' A' ' 370' ' ' LEU . 9.1 p90 -93.46 179.64 5.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.508 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -158.21 168.22 27.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.131 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -119.02 128.55 54.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 7.2 mm -102.6 114.59 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -92.66 126.67 37.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 387' ' ' ALA . 21.2 m-85 -109.51 137.73 46.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -54.16 -30.66 50.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -135.87 152.67 51.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 385' ' ' VAL . 6.0 tmm_? -60.64 -28.37 68.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.919 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -71.72 -54.08 11.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' GLY . . . . . 0.408 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -42.97 -30.82 1.08 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.444 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -77.74 -59.43 2.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.821 0.343 . . . . 0.0 111.082 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 381' ' ' ARG . 95.4 t -37.99 -37.75 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.127 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -71.3 -62.81 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -59.71 -15.67 21.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.574 ' HB2' HD22 ' A' ' 340' ' ' LEU . 8.7 ttm -78.75 -62.39 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.436 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.6 mt-10 -74.92 -0.35 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.496 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 14.3 mm-40 -100.03 -38.99 8.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' MET . . . . . 0.735 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 4.4 mmt -100.96 -27.66 13.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.934 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.875 ' N ' HD12 ' A' ' 403' ' ' ILE . 1.5 t-20 -38.05 107.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 78.52 38.61 24.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.479 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 21.3 mmtt -100.06 149.05 23.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 110.884 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -75.57 82.18 2.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.88 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.401 HD22 HD13 ' A' ' 401' ' ' ILE . 15.3 tp -89.48 112.6 23.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 62.24 26.63 15.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 88.14 11.31 67.43 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.487 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -130.91 128.91 41.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.888 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.51 98.37 4.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.825 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.452 HD12 ' CG1' ' A' ' 342' ' ' VAL . 20.2 pt -78.1 147.92 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.138 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -109.83 129.72 55.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.875 HD12 ' N ' ' A' ' 392' ' ' ASN . 15.5 mt -113.35 124.12 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.095 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 2.9 m -138.62 135.16 43.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.562 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 10.1 m-85 -51.67 106.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.578 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . -67.82 156.5 36.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.077 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -76.07 145.11 76.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.628 0.727 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 146.68 61.06 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.688 2.259 . . . . 0.0 112.354 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 90.84 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.701 2.267 . . . . 0.0 112.339 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -131.14 101.95 5.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLN . . . . . 0.495 ' OE1' ' N ' ' A' ' 411' ' ' GLN . 0.1 OUTLIER -140.57 149.15 42.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -173.3 164.1 4.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -121.06 89.34 3.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.11 139.58 30.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -170.31 136.95 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 58.0 ttm-85 -164.46 110.74 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.852 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -149.64 162.48 40.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -145.89 105.84 4.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.153 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -158.71 115.92 2.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -156.12 130.9 9.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -169.01 142.66 2.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -140.53 117.99 11.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.072 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -106.24 80.05 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.103 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 3.7 m -65.87 -55.83 14.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 42.04 82.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.489 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 176.08 7.27 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 24.5 p -169.5 161.07 9.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.815 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 70.1 m -133.9 170.05 16.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.891 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.461 -179.952 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 3.3 m -43.76 145.25 0.7 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 1.4 t -107.13 110.64 22.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -101.12 -130.83 7.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 87.5 p -131.23 49.67 2.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.89 0.376 . . . . 0.0 110.822 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 59.8 p -124.51 126.79 46.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 104.48 68.31 0.74 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 5.7 mtp -116.94 116.97 28.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.802 0.334 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.516 ' HB3' ' CD2' ' A' ' 405' ' ' PHE . . . -120.09 140.98 50.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.511 ' CA ' ' NH2' ' A' ' 381' ' ' ARG . 3.8 ptmm? -86.32 36.08 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.819 HG21 ' O ' ' A' ' 406' ' ' ALA . 61.0 t -106.93 134.74 47.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.087 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -91.74 -35.43 14.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.929 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 65.2 t -69.49 133.22 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.072 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.529 HD21 ' HB1' ' A' ' 384' ' ' ALA . 51.8 mt -105.28 119.2 38.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -85.32 106.18 16.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.776 HG22 HG12 ' A' ' 403' ' ' ILE . 25.4 t -102.1 130.05 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.163 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -131.14 173.29 11.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.73 39.61 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.614 HD13 ' NZ ' ' A' ' 369' ' ' LYS . 38.6 mt -81.24 156.95 25.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.921 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -95.08 161.23 14.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.075 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -63.73 -8.0 9.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 24.9 p -98.84 -9.24 24.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.165 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.543 HG12 ' NZ ' ' A' ' 369' ' ' LYS . 57.7 t -83.15 140.48 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.139 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 78.2 p -144.46 163.03 35.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -40.7 -50.46 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -52.08 -52.24 52.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.903 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 75.2 mt -58.95 -29.08 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.5 ' HB2' HG11 ' A' ' 367' ' ' VAL . 96.1 mt -75.54 -30.65 59.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.472 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 51.3 mt-10 -75.58 -64.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -50.14 -38.67 40.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' ALA . . . . . 0.458 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -69.01 -49.69 55.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' PHE . . . . . 0.422 ' C ' HD11 ' A' ' 364' ' ' LEU . 45.0 m-85 -90.32 14.89 11.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 355' ' ' GLU . 9.0 t -100.06 -51.35 3.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -38.84 -38.7 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.497 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 94.1 m-85 -64.49 -62.72 1.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -153.65 161.31 29.78 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -47.94 129.06 14.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.472 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 40.4 mt -98.31 156.42 16.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -100.55 -50.49 3.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -171.24 165.49 7.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 354' ' ' LEU . 51.1 t -136.93 129.59 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.82 109.02 16.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' LYS . . . . . 0.614 ' NZ ' HD13 ' A' ' 345' ' ' LEU . 29.5 tptt -82.17 146.16 29.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.703 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.7 mp -128.99 -174.91 3.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.1 OUTLIER -34.4 -67.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -122.3 -37.14 2.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.703 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.8 p90 -94.19 -175.11 3.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.531 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -166.44 161.41 16.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.138 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -110.94 137.3 48.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 5.3 mm -111.16 109.55 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -89.29 121.32 31.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 19.5 m-85 -101.78 149.08 24.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -69.02 -31.76 70.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.847 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -131.05 154.37 48.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.511 ' NH2' ' CA ' ' A' ' 336' ' ' LYS . 8.4 tpp85 -58.13 -37.71 75.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 384' ' ' ALA . 19.6 t70 -66.2 -57.55 7.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' GLY . . . . . 0.537 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -35.12 -31.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.507 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.529 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -80.88 -66.93 0.82 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.117 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' A' ' 384' ' ' ALA . 58.0 t -36.0 -35.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 384' ' ' ALA . 12.1 tptm -72.92 -61.03 1.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.51 -16.92 41.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.593 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.7 ttm -76.52 -61.27 2.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.436 ' N ' ' HG2' ' A' ' 388' ' ' MET . 13.1 mt-10 -74.17 -4.22 34.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.872 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.497 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 39.0 mm-40 -100.03 -33.02 10.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' MET . . . . . 0.503 ' O ' ' CG ' ' A' ' 394' ' ' LYS . 38.2 mmm -101.96 -41.0 6.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.754 ' N ' HD12 ' A' ' 403' ' ' ILE . 5.1 t-20 -34.12 116.61 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 76.63 30.05 56.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.46 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.734 ' HE3' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -100.01 141.97 32.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 0.0 110.896 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.49 99.99 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.734 HD13 ' HE3' ' A' ' 394' ' ' LYS . 20.5 tp -106.36 114.31 28.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.968 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' GLU . . . . . 0.451 ' HG3' HG22 ' A' ' 349' ' ' VAL . 6.2 mm-40 60.88 27.18 17.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.88 16.86 59.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.479 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -140.04 120.74 14.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.91 100.01 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.567 HD12 ' CG1' ' A' ' 342' ' ' VAL . 25.0 pt -75.68 149.72 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -112.44 128.51 56.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.776 HG12 HG22 ' A' ' 342' ' ' VAL . 35.6 mt -111.96 128.97 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.124 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 9.9 m -142.32 132.91 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.152 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.593 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 19.2 m-85 -50.87 110.78 0.46 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.819 ' O ' HG21 ' A' ' 337' ' ' VAL . . . -68.08 158.32 33.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -96.78 144.98 28.8 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.618 0.723 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 151.01 69.2 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.709 2.273 . . . . 0.0 112.402 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 123.02 9.68 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.631 2.221 . . . . 0.0 112.325 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 6.5 t70 58.84 49.61 9.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -42.14 -45.25 3.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.05 109.1 10.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -69.26 121.68 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -148.34 127.41 12.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -163.18 143.62 9.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -147.54 123.55 10.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -116.88 118.84 33.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -146.31 121.34 10.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.081 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -130.49 173.49 10.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 -164.82 131.38 2.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.844 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -101.41 152.49 20.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -131.79 155.66 47.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.078 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -146.23 166.45 26.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.107 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.1 t -168.29 167.36 12.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -150.29 85.07 0.16 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.488 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 163.49 38.12 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 38.9 t -119.74 -47.71 2.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 429' ' ' GLY . 89.0 p -172.49 156.39 3.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 429' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 428' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.494 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 91.7 p -160.54 174.8 13.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.884 0.373 . . . . 0.0 110.853 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 65.8 m -77.65 118.28 19.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.85 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 146.84 65.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.524 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 84.1 p -123.15 149.38 44.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 0.0 110.888 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 34.3 t -167.36 138.75 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.825 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 136.74 131.88 3.02 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.467 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 61.1 mmm -99.96 91.46 4.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.872 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -128.86 157.05 42.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -126.21 58.34 1.37 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.558 ' HB ' ' CD1' ' A' ' 405' ' ' PHE . 58.6 t -90.76 132.32 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.78 -27.79 14.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.0 t -85.17 125.68 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.118 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.617 HD12 ' CE1' ' A' ' 378' ' ' PHE . 70.6 mt -103.84 130.35 51.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.946 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -94.74 107.83 19.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.59 HG22 HG12 ' A' ' 403' ' ' ILE . 18.7 t -106.15 130.49 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -130.15 168.24 17.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.3 t30 72.22 54.35 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.466 HD21 HG12 ' A' ' 342' ' ' VAL . 15.6 mt -96.25 145.91 25.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.929 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -81.08 163.12 23.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.053 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -66.83 -4.47 9.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 24.6 p -104.58 6.31 34.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.709 HG12 ' NZ ' ' A' ' 369' ' ' LYS . 58.6 t -94.16 138.09 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.154 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 43.4 p -142.64 159.15 42.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.16 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.4 ' HA ' HD12 ' A' ' 354' ' ' LEU . 53.3 mt-10 -42.73 -41.15 3.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -57.92 -46.93 84.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 73.3 mt -65.56 -30.17 49.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.14 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.513 ' HB2' HG11 ' A' ' 367' ' ' VAL . 83.2 mt -72.94 -31.4 64.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 359' ' ' SER . 21.7 mt-10 -72.07 -67.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -50.3 -39.92 46.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' ALA . . . . . 0.463 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -65.71 -51.3 60.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' PHE . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 45.3 m-85 -90.49 14.57 12.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 355' ' ' GLU . 2.1 t -99.8 -57.44 2.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 359' ' ' SER . 19.1 pt20 -35.2 -39.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -64.58 -65.23 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -147.4 163.89 28.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.454 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -52.85 130.72 34.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.469 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 34.2 mt -99.77 158.94 15.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.949 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -108.07 -44.5 4.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -174.16 164.41 4.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.513 HG11 ' HB2' ' A' ' 354' ' ' LEU . 54.2 t -135.51 133.75 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.443 ' O ' ' HB1' ' A' ' 374' ' ' ALA . 39.7 tptt -119.55 123.76 44.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' LYS . . . . . 0.709 ' NZ ' HG12 ' A' ' 349' ' ' VAL . 24.0 tptt -95.7 146.29 24.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.788 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.8 mp -133.96 -174.74 3.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 370' ' ' LEU . 24.4 tttp -33.57 -68.46 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.886 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.3 -37.13 2.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.788 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.3 p90 -90.94 -175.79 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.968 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 368' ' ' LYS . . . -168.15 147.18 4.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.091 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -95.76 142.23 28.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.6 mm -118.07 106.18 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -84.44 121.48 27.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.847 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.617 ' CE1' HD12 ' A' ' 340' ' ' LEU . 14.4 m-85 -102.61 151.47 22.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -60.57 -35.77 76.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -140.35 153.12 46.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.449 ' O ' HG23 ' A' ' 385' ' ' VAL . 6.5 tmm_? -52.7 -28.43 21.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.877 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 384' ' ' ALA . 12.0 t0 -69.81 -62.21 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' GLY . . . . . 0.474 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -36.76 -29.62 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.52 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.506 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -79.9 -58.47 3.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 0.0 111.113 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 381' ' ' ARG . 96.3 t -38.39 -38.63 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.151 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -71.93 -64.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -57.04 -15.48 5.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.602 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 9.0 ttm -79.46 -62.91 1.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.442 ' N ' ' HG2' ' A' ' 388' ' ' MET . 9.9 mt-10 -74.86 -0.97 20.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -100.09 -35.04 9.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' MET . . . . . 0.47 ' HA ' ' CG ' ' A' ' 394' ' ' LYS . 27.7 mmm -103.91 -37.15 7.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.889 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.821 ' N ' HD12 ' A' ' 403' ' ' ILE . 4.3 t-20 -34.29 101.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 92.22 29.68 11.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.464 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.47 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 8.7 mmtp -94.99 148.2 22.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 0.0 110.854 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.64 80.66 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 15.6 tp -89.12 115.69 26.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.941 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 62.22 25.02 14.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 86.03 20.18 55.96 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.464 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -139.81 125.28 19.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.92 98.21 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 47.2 pt -74.6 153.32 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -117.09 126.61 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.821 HD12 ' N ' ' A' ' 392' ' ' ASN . 23.2 mt -113.06 124.85 70.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.158 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 10.4 m -137.05 133.35 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.602 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 8.3 m-85 -51.26 110.91 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.22 175.95 2.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.068 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -102.43 144.21 28.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.528 0.68 . . . . 0.0 110.933 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 160.27 50.32 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.681 2.254 . . . . 0.0 112.328 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -175.52 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.684 2.256 . . . . 0.0 112.354 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.29 92.75 2.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -104.34 86.38 2.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 77.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -86.76 106.09 17.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.855 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -133.93 155.07 50.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -133.97 115.54 14.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.85 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 41.2 ptt85 -168.48 134.35 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -119.14 130.6 55.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -127.31 110.45 12.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.133 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.83 38.62 2.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -131.14 84.87 2.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -119.72 -44.53 2.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 59.28 47.85 10.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -105.16 -48.1 3.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 18.9 m -119.69 85.45 2.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -120.36 -157.35 10.16 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.511 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 89.63 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.732 2.288 . . . . 0.0 112.34 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 5.0 m -122.02 -177.81 3.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 4.6 t -171.11 148.01 2.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.844 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.511 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 39.0 t -164.08 147.65 9.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.916 0.389 . . . . 0.0 110.828 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 25.4 t -160.63 158.89 29.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.857 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 99.21 107.12 2.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.505 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 1.8 t -151.93 156.34 39.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.916 0.389 . . . . 0.0 110.836 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 58.5 m -74.39 155.18 38.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -143.63 61.89 0.51 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.443 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 63.5 mtp -88.43 90.45 8.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.769 0.319 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -138.79 127.37 23.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.133 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -100.29 42.74 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 91.4 t -103.14 138.27 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 339' ' ' VAL . 0.0 OUTLIER -96.8 -31.05 12.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.427 ' N ' ' HD2' ' A' ' 338' ' ' LYS . 86.4 t -77.18 131.34 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.101 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.878 HD21 ' HB1' ' A' ' 384' ' ' ALA . 43.4 mt -108.26 127.37 53.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.522 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 56.2 t80 -91.27 108.61 20.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.463 HG12 HD21 ' A' ' 345' ' ' LEU . 14.0 t -103.13 134.73 43.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.125 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -134.11 167.13 21.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.84 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ASN . . . . . 0.401 ' O ' HG22 ' A' ' 401' ' ' ILE . 2.0 t-20 73.23 52.38 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.463 HD21 HG12 ' A' ' 342' ' ' VAL . 22.5 mt -96.22 131.99 42.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.452 ' HB3' ' CB ' ' A' ' 397' ' ' GLU . . . -54.58 -176.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -88.93 5.68 42.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 21.9 p -121.86 13.77 10.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 91.6 t -88.55 138.81 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' THR . . . . . 0.432 ' H ' HD12 ' A' ' 353' ' ' ILE . 67.0 p -144.07 167.05 23.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.159 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -50.45 -43.94 55.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.04 -41.9 75.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.432 HD12 ' H ' ' A' ' 350' ' ' THR . 71.3 mt -69.49 -41.48 80.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.557 ' HB2' HG11 ' A' ' 367' ' ' VAL . 92.4 mt -63.37 -32.51 73.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.48 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 46.1 mt-10 -68.21 -73.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -41.48 -39.67 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.957 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' ALA . . . . . 0.652 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -66.7 -54.6 21.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' PHE . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 37.0 m-85 -87.78 14.68 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 355' ' ' GLU . 17.7 t -99.99 -53.25 3.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.848 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -38.68 -38.68 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.505 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 84.3 m-85 -64.08 -62.71 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -151.87 169.78 31.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.525 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -53.86 132.73 42.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.818 0.342 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.48 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 32.9 mt -101.46 160.49 14.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.949 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -110.33 -48.04 3.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -172.97 163.65 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' A' ' 354' ' ' LEU . 71.9 t -134.1 130.07 54.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -111.06 108.41 18.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.866 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' LYS . . . . . 0.407 ' C ' HD12 ' A' ' 370' ' ' LEU . 19.3 tptp -87.08 137.58 32.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.799 HD22 ' CE2' ' A' ' 373' ' ' TYR . 7.6 mp -126.28 -174.74 3.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 370' ' ' LEU . 30.8 tttm -33.55 -67.73 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.873 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.16 -36.39 2.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.799 ' CE2' HD22 ' A' ' 370' ' ' LEU . 6.5 p90 -93.7 -177.36 4.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -165.79 159.65 16.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.098 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -110.7 131.51 54.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.882 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 3.9 mm -105.26 115.58 47.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -93.54 113.98 26.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.429 ' HE1' HD12 ' A' ' 340' ' ' LEU . 17.4 m-85 -96.06 146.11 24.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.851 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -63.66 -32.81 74.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -131.82 153.31 50.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.409 ' C ' ' HD2' ' A' ' 381' ' ' ARG . 2.0 tmm_? -62.19 -30.66 71.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -71.61 -50.42 30.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -44.8 -31.97 2.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.546 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.878 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -76.57 -63.06 1.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.792 0.33 . . . . 0.0 111.138 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 384' ' ' ALA . 61.3 t -34.92 -36.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' LYS . . . . . 0.445 ' HE3' ' CG ' ' A' ' 390' ' ' GLU . 17.8 tptt -72.68 -66.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -55.21 -16.87 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.592 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 7.5 ttm -77.65 -61.64 1.93 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.422 ' N ' ' HG2' ' A' ' 388' ' ' MET . 7.3 mt-10 -77.48 -2.06 33.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.505 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 52.9 mm-40 -100.15 -25.89 14.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' MET . . . . . 0.652 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 23.4 mmm -112.1 -38.19 4.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.832 ' N ' HD12 ' A' ' 403' ' ' ILE . 7.6 t-20 -35.09 92.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 108.44 23.95 6.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.477 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 391' ' ' MET . 0.3 OUTLIER -90.28 146.9 23.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.774 0.321 . . . . 0.0 110.903 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -78.6 80.26 4.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 19.0 tp -89.19 114.89 26.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.927 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' GLU . . . . . 0.452 ' CB ' ' HB3' ' A' ' 346' ' ' ALA . 67.4 mm-40 62.49 27.74 16.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 82.45 20.88 61.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.481 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -140.18 122.51 15.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.891 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.38 95.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 344' ' ' ASN . 30.4 pt -72.4 148.7 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.193 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -115.79 130.77 56.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.832 HD12 ' N ' ' A' ' 392' ' ' ASN . 19.7 mt -109.74 138.93 35.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.167 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 17.9 m -149.43 134.61 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.073 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.592 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 15.4 m-85 -54.71 108.7 0.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.854 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.522 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . -69.9 159.14 34.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -82.19 146.88 55.81 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.602 0.715 . . . . 0.0 110.912 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 163.05 39.74 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.694 2.263 . . . . 0.0 112.315 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 176.02 7.3 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.666 2.244 . . . . 0.0 112.381 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.94 131.83 47.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLN . . . . . 0.425 ' C ' ' HD3' ' A' ' 412' ' ' LYS . 1.4 pt20 -138.15 159.51 41.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.425 ' HD3' ' C ' ' A' ' 411' ' ' GLN . 0.0 OUTLIER -168.84 135.97 1.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 14.4 mmm-85 -139.47 149.37 43.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.414 ' C ' ' OE2' ' A' ' 415' ' ' GLU . 14.0 pttp -157.95 150.41 22.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.414 ' OE2' ' C ' ' A' ' 414' ' ' LYS . 7.1 mp0 -138.0 134.73 35.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.94 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -132.2 130.46 41.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.94 121.7 36.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -153.41 172.63 16.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -171.68 164.51 6.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' ARG . . . . . 0.426 ' CG ' ' N ' ' A' ' 421' ' ' GLN . 12.0 ttp-105 -158.15 165.86 33.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' GLN . . . . . 0.426 ' N ' ' CG ' ' A' ' 420' ' ' ARG . 8.7 tp60 -108.2 117.27 33.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -86.42 168.05 14.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.081 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -155.12 -179.96 8.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.1 t -142.06 173.52 11.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 155.26 145.92 4.3 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.48 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 171.03 15.26 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.62 2.213 . . . . 0.0 112.351 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 67.9 m -124.79 -60.88 1.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.825 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.8 m 53.11 43.01 32.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.48 -179.999 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 69.0 m -131.66 127.46 37.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 110.9 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 39.2 m -70.0 163.8 25.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 121.36 64.6 0.24 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.468 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 34.1 t -104.86 108.02 19.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.904 0.383 . . . . 0.0 110.878 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 47.8 t -50.12 -52.32 35.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.867 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 64.96 58.69 9.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.477 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 7.7 ttt -80.38 -49.1 11.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.8 0.334 . . . . 0.0 110.867 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -135.13 -175.01 3.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.069 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -107.94 42.11 1.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.11 141.5 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.148 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.76 -32.6 9.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.942 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 90.6 t -79.94 135.94 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.862 HD21 ' HB1' ' A' ' 384' ' ' ALA . 16.5 mt -111.62 127.27 55.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -88.54 113.1 23.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.875 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.558 HG22 HG12 ' A' ' 403' ' ' ILE . 15.8 t -111.43 135.45 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -132.49 170.61 14.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.5 t30 73.46 43.85 0.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 39.0 mt -83.37 127.59 33.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.612 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -49.4 178.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -84.57 -5.34 59.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 25.7 p -117.84 22.46 12.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.612 HG23 ' HB3' ' A' ' 346' ' ' ALA . 64.5 t -96.4 136.64 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.153 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 77.8 p -135.45 178.28 7.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.132 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.87 -40.29 92.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -58.27 -46.54 85.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.86 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.67 -30.82 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.487 ' HB2' HG11 ' A' ' 367' ' ' VAL . 97.0 mt -73.84 -26.87 60.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 359' ' ' SER . 52.6 mt-10 -81.27 -64.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -51.05 -25.37 4.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -83.66 -44.83 14.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' PHE . . . . . 0.407 ' C ' HD11 ' A' ' 364' ' ' LEU . 35.9 m-85 -92.03 9.91 31.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 361' ' ' PHE . 92.2 p -95.13 -54.46 3.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.84 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 359' ' ' SER . 26.0 pt20 -34.28 -35.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.462 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 98.2 m-85 -70.97 -68.27 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -145.61 165.48 27.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.461 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -54.37 131.84 42.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.755 0.312 . . . . 0.0 110.909 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.407 HD11 ' C ' ' A' ' 358' ' ' PHE . 86.9 mt -101.32 155.63 17.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -100.88 -42.99 6.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.938 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -174.95 170.08 3.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.487 HG11 ' HB2' ' A' ' 354' ' ' LEU . 35.7 t -140.66 125.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.131 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.434 ' O ' ' HB1' ' A' ' 374' ' ' ALA . 8.7 tmtt? -112.49 123.14 49.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' LYS . . . . . 0.402 ' C ' HD12 ' A' ' 370' ' ' LEU . 15.7 tptm -97.52 143.52 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.763 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.9 mp -129.1 -174.62 3.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.1 OUTLIER -32.12 -72.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.932 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -120.04 -35.37 3.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.763 ' CE2' HD22 ' A' ' 370' ' ' LEU . 12.4 p90 -94.99 -179.41 4.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 368' ' ' LYS . . . -159.11 167.28 29.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.109 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -118.32 125.39 49.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 5.3 mm -99.18 110.5 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -91.68 120.75 32.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.827 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 358' ' ' PHE . 21.0 m-85 -101.02 154.63 18.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.55 -33.96 73.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -132.13 156.58 46.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.412 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 5.6 tmm_? -61.86 -32.71 73.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.15 -52.08 26.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -42.69 -32.84 1.42 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.543 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.862 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -77.73 -64.35 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.789 0.328 . . . . 0.0 111.092 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.43 ' C ' ' O ' ' A' ' 384' ' ' ALA . 68.2 t -35.39 -32.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.122 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 386' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 384' ' ' ALA . 15.5 tptm -74.8 -61.89 1.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.07 -14.68 25.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.57 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.4 ttm -78.65 -60.18 2.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.906 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -73.23 -3.15 25.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.462 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 4.4 mm-40 -100.41 -39.43 7.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' MET . . . . . 0.513 ' HB2' HD11 ' A' ' 403' ' ' ILE . 49.8 mmm -99.76 -19.73 16.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 388' ' ' MET . 0.8 OUTLIER -43.92 119.46 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 56.36 37.25 73.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.445 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.433 ' HD2' ' C ' ' A' ' 395' ' ' ASP . 0.0 OUTLIER -100.09 150.78 22.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.78 0.324 . . . . 0.0 110.911 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 395' ' ' ASP . . . . . 0.433 ' C ' ' HD2' ' A' ' 394' ' ' LYS . 24.7 t0 -71.12 105.92 3.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 38.4 tp -119.39 115.48 24.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 59.77 36.95 22.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 77.0 9.56 86.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.501 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -135.31 124.39 24.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.893 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.79 106.12 6.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.931 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.497 HD12 ' CG1' ' A' ' 342' ' ' VAL . 21.7 pt -83.12 147.11 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -109.56 128.58 55.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.558 HG12 HG22 ' A' ' 342' ' ' VAL . 44.1 mt -110.71 142.55 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.11 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 403' ' ' ILE . 9.6 m -157.01 134.12 2.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.57 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 27.0 m-85 -53.32 111.04 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.72 157.68 34.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.113 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -89.92 143.89 30.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.54 0.686 . . . . 0.0 110.941 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 147.84 63.75 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.723 2.282 . . . . 0.0 112.342 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -39.38 6.48 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.643 2.228 . . . . 0.0 112.332 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.41 125.25 1.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -87.42 114.99 24.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 412' ' ' LYS . 1.5 pptp? -118.49 155.17 31.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.908 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -173.88 119.3 0.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.83 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -174.61 148.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.932 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.67 -176.41 3.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -146.31 159.15 43.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -95.84 134.17 39.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -93.4 169.44 10.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -147.96 -177.18 5.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.894 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -125.01 171.48 10.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -165.65 114.25 0.99 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -90.19 175.55 7.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.062 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -170.02 172.88 6.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.082 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 26.9 p -172.59 161.98 5.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 173.51 84.63 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.445 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -174.17 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.712 2.275 . . . . 0.0 112.34 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 8.3 t -172.86 176.35 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 83.8 p -146.8 166.48 26.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.507 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 2.0 t -155.58 153.42 30.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.883 0.373 . . . . 0.0 110.844 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 76.1 p -168.71 118.14 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.821 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 54.58 -156.84 7.02 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 42.0 t -123.5 113.23 18.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 0.0 110.875 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 59.9 p -90.64 124.64 35.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.834 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 73.66 50.39 11.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.524 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 12.3 ptp -67.87 128.36 36.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -132.78 157.14 45.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.113 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -120.45 28.37 8.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 58.9 t -83.6 130.51 35.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.081 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.93 -25.14 17.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.16 136.63 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.101 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.845 HD21 ' HB1' ' A' ' 384' ' ' ALA . 53.1 mt -112.9 128.9 56.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -92.59 108.26 19.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.66 HG22 HG12 ' A' ' 403' ' ' ILE . 48.7 t -106.0 127.27 61.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.176 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -126.51 173.44 9.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.24 39.19 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.581 HD21 HG12 ' A' ' 342' ' ' VAL . 48.7 mt -78.22 121.78 24.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -50.26 172.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.078 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -83.34 15.63 2.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 63.1 p -132.29 19.27 4.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.161 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 350' ' ' THR . 67.0 t -97.71 158.06 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' THR . . . . . 0.5 ' N ' HG12 ' A' ' 349' ' ' VAL . 21.2 p -156.19 165.54 36.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.411 ' HG2' HG12 ' A' ' 367' ' ' VAL . 58.4 mt-10 -49.69 -44.51 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -56.96 -45.61 82.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 67.0 mt -64.43 -31.81 55.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.121 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.547 ' HB2' HG11 ' A' ' 367' ' ' VAL . 88.6 mt -73.49 -26.09 60.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 359' ' ' SER . 90.6 mt-10 -81.82 -66.88 0.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.899 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -49.72 -23.41 1.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -85.86 -45.75 11.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.078 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' PHE . . . . . 0.429 ' O ' HD21 ' A' ' 364' ' ' LEU . 36.1 m-85 -92.49 11.47 26.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 355' ' ' GLU . 95.7 p -100.09 -24.48 14.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.866 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -63.6 -31.71 72.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.563 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 93.6 m-85 -74.95 -61.95 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.859 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -148.65 162.45 28.87 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.521 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -52.18 129.19 27.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.429 HD21 ' O ' ' A' ' 358' ' ' PHE . 38.7 mt -97.7 154.63 17.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -101.85 -42.75 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.925 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 366' ' ' ARG . 2.4 ptm85 -174.1 164.89 4.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.859 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.547 HG11 ' HB2' ' A' ' 354' ' ' LEU . 46.3 t -136.53 124.68 34.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -117.79 107.94 14.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' LYS . . . . . 0.462 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 12.3 tttm -88.17 140.43 29.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.757 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.4 mp -118.18 -174.21 2.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 370' ' ' LEU . 9.2 ttpt -31.97 -69.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -118.12 -39.32 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.757 ' CE2' HD22 ' A' ' 370' ' ' LEU . 5.4 p90 -91.61 -174.96 4.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.462 ' CB ' ' HA ' ' A' ' 369' ' ' LYS . . . -162.48 167.96 22.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.103 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -121.92 121.51 37.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.845 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.512 HD11 HD22 ' A' ' 354' ' ' LEU . 6.7 mm -97.06 111.86 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -91.19 124.09 35.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.835 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 387' ' ' ALA . 23.6 m-85 -105.28 152.16 23.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.99 -35.59 80.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -129.65 153.43 48.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.859 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.411 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 5.9 tmm_? -60.08 -32.91 71.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -70.08 -51.36 32.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.843 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -42.82 -33.76 1.71 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.43 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.845 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -76.52 -56.94 4.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.812 0.339 . . . . 0.0 111.071 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 80.6 t -38.47 -39.87 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.094 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -70.76 -65.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -55.05 -16.62 3.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.174 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.597 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.5 ttm -78.54 -62.84 1.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.448 ' N ' ' HG2' ' A' ' 388' ' ' MET . 9.0 mt-10 -75.92 -0.55 21.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.563 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 56.3 mm-40 -100.08 -34.6 10.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' MET . . . . . 0.43 ' HG2' ' CE2' ' A' ' 361' ' ' PHE . 4.9 mmt -104.52 -31.15 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.904 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.749 ' N ' HD12 ' A' ' 403' ' ' ILE . 3.9 t-20 -36.68 97.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 95.46 38.26 4.8 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.522 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -100.1 147.66 25.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.888 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -75.53 75.19 2.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.451 HD22 HD13 ' A' ' 401' ' ' ILE . 17.6 tp -79.75 111.17 15.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.933 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 62.4 25.31 15.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' GLY . . . . . 0.44 ' C ' ' OE1' ' A' ' 399' ' ' GLU . . . 89.77 14.62 59.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.495 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' GLU . . . . . 0.44 ' OE1' ' C ' ' A' ' 398' ' ' GLY . 15.8 mp0 -133.38 126.15 30.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.808 0.337 . . . . 0.0 110.86 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.72 97.34 2.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.451 HD13 HD22 ' A' ' 396' ' ' LEU . 18.1 pt -76.9 151.7 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -114.77 132.18 56.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.749 HD12 ' N ' ' A' ' 392' ' ' ASN . 31.6 mt -115.27 121.34 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.135 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 15.3 m -136.19 132.58 49.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.597 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 7.4 m-85 -51.07 117.47 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -77.21 169.64 17.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.098 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -80.49 154.26 73.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.601 0.715 . . . . 0.0 110.904 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 147.15 62.01 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.729 2.286 . . . . 0.0 112.341 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -3.68 12.51 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.633 2.222 . . . . 0.0 112.352 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -156.31 -179.8 8.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -142.76 138.24 30.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -116.65 118.44 32.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -153.02 116.9 4.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.855 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -170.18 143.78 2.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -163.74 117.93 1.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.4 147.41 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -137.89 178.65 6.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.934 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -156.03 121.88 4.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -123.7 154.06 39.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 8.4 ttm-85 -165.73 105.63 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -138.54 167.93 20.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -165.39 130.69 2.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.107 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -158.6 117.1 3.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.067 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 60.7 p -131.29 126.66 35.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -131.74 83.77 0.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.499 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 427' ' ' SER . 53.2 Cg_endo -69.81 132.39 23.15 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.621 2.214 . . . . 0.0 112.332 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 427' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 426' ' ' PRO . 69.4 m 34.79 44.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.853 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 23.2 t -79.64 109.25 13.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.823 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.452 179.979 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 7.2 t -164.5 114.42 1.18 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.876 0.369 . . . . 0.0 110.883 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 7.6 t -151.82 142.2 22.49 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.856 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 154.42 -135.88 4.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 38.2 t -73.12 121.5 20.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 110.841 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 69.6 m -118.17 82.19 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.851 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -122.24 170.47 15.11 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.478 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -64.31 137.59 57.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.804 0.335 . . . . 0.0 110.842 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -112.92 81.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.08 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -69.9 83.91 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 57.4 t -124.59 136.46 60.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -101.39 -32.93 10.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 98.5 t -78.53 133.15 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.079 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.541 HD21 ' HB1' ' A' ' 384' ' ' ALA . 55.1 mt -109.72 128.59 55.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 75.1 t80 -93.79 102.83 14.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.578 HG22 HG12 ' A' ' 403' ' ' ILE . 33.0 t -102.06 133.85 44.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.106 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -132.77 168.79 17.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.865 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 74.76 52.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.503 HD22 HG11 ' A' ' 349' ' ' VAL . 41.9 mt -97.38 148.11 23.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -85.79 169.53 13.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.137 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -71.12 -1.98 14.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 40.6 p -106.16 0.51 25.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.503 HG11 HD22 ' A' ' 345' ' ' LEU . 86.8 t -93.91 130.45 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.119 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 68.9 p -132.83 165.65 24.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.124 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -47.42 -41.97 21.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -57.39 -47.44 81.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 66.5 mt -65.64 -28.82 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.555 ' HB2' HG11 ' A' ' 367' ' ' VAL . 95.1 mt -74.58 -28.93 61.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -78.56 -63.32 1.43 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.821 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 35.8 mmtt -53.36 -34.71 58.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' ALA . . . . . 0.463 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -71.43 -45.53 62.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -92.64 13.07 21.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 361' ' ' PHE . 1.5 t -97.62 -53.69 3.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 359' ' ' SER . 15.4 pt20 -36.57 -32.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.576 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 90.5 m-85 -71.04 -66.04 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -147.61 179.05 24.8 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -61.95 129.86 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 110.865 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.453 HD21 ' CZ ' ' A' ' 378' ' ' PHE . 32.1 mt -101.21 152.12 21.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -100.37 -47.0 5.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -174.31 168.74 3.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' A' ' 354' ' ' LEU . 41.9 t -139.56 131.62 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.153 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.14 123.48 44.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -96.19 143.51 27.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.902 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.926 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.4 mp -127.73 -174.6 3.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.8 OUTLIER -33.31 -66.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -124.51 -36.78 2.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.926 ' CE2' HD22 ' A' ' 370' ' ' LEU . 9.7 p90 -92.86 179.75 5.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.439 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -160.32 161.43 33.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -112.2 136.57 51.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 5.0 mm -110.52 109.62 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.128 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -89.43 123.27 33.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.501 ' CE1' HD12 ' A' ' 340' ' ' LEU . 15.6 m-85 -105.56 140.72 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -56.72 -33.98 67.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.842 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -131.42 149.12 52.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.412 ' NH1' ' CG2' ' A' ' 385' ' ' VAL . 0.0 OUTLIER -57.06 -32.89 66.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -69.41 -53.1 21.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -41.29 -32.24 0.67 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.531 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.541 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -77.63 -58.78 3.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 111.119 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.412 ' CG2' ' NH1' ' A' ' 381' ' ' ARG . 57.6 t -38.52 -35.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -74.57 -64.32 1.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -58.25 -15.53 10.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.4 ttm -78.76 -63.07 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.439 ' N ' ' HG2' ' A' ' 388' ' ' MET . 14.6 mt-10 -73.52 1.41 9.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.576 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 43.7 mm-40 -100.12 -41.77 6.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' MET . . . . . 0.489 ' O ' ' N ' ' A' ' 393' ' ' GLY . 8.1 mmm -99.91 -27.39 13.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.821 ' N ' HD12 ' A' ' 403' ' ' ILE . 5.1 t-20 -37.19 92.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.849 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 97.7 38.84 4.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.497 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.418 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 24.8 mmtm -100.04 148.29 24.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.739 0.304 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -75.9 77.69 2.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.417 HD22 HD13 ' A' ' 401' ' ' ILE . 15.6 tp -82.3 111.5 18.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 62.61 25.42 15.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' GLY . . . . . 0.43 ' C ' ' OE1' ' A' ' 399' ' ' GLU . . . 90.49 12.83 60.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' GLU . . . . . 0.43 ' OE1' ' C ' ' A' ' 398' ' ' GLY . 1.8 mp0 -131.76 129.55 40.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.943 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.49 97.43 3.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.417 HD13 HD22 ' A' ' 396' ' ' LEU . 20.7 pt -76.16 147.47 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -113.22 130.47 56.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.821 HD12 ' N ' ' A' ' 392' ' ' ASN . 11.7 mt -113.1 126.72 70.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.121 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 30.1 m -140.48 134.03 33.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.064 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 14.3 m-85 -50.95 110.1 0.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.857 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.579 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . -66.66 151.38 47.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -76.77 143.81 71.95 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.626 0.726 . . . . 0.0 110.875 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 151.5 69.56 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.697 2.264 . . . . 0.0 112.354 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -40.56 5.12 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.255 . . . . 0.0 112.33 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -40.75 142.26 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.874 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -154.1 129.09 9.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -125.06 128.85 49.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -160.33 106.17 1.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -76.62 99.46 5.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -149.63 169.47 20.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 1.2 ppt_? -159.99 149.75 18.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -172.15 135.63 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -169.93 136.38 1.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -173.66 152.25 2.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.947 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -159.36 152.37 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -172.72 139.74 0.93 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -171.26 163.56 7.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -112.03 179.05 4.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.094 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 11.6 t -160.88 175.58 12.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -129.97 89.73 0.3 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.459 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 125.78 12.55 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.698 2.266 . . . . 0.0 112.315 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 2.3 m -167.99 151.82 6.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.844 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 98.6 p -74.28 160.03 31.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.904 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.516 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 79.0 p -49.47 128.76 17.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 0.0 110.858 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 68.2 m -121.65 141.27 51.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 144.63 -116.67 0.96 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.48 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 34.0 p 43.99 41.21 3.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.369 . . . . 0.0 110.831 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 36.9 t -105.62 93.63 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.845 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -97.06 161.51 21.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.506 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 2.8 ttt -136.12 113.54 10.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.343 . . . . 0.0 110.87 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.521 ' HB3' ' CD2' ' A' ' 405' ' ' PHE . . . -150.33 157.75 43.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -94.75 74.44 3.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 406' ' ' ALA . 93.7 t -140.11 138.34 37.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.412 ' HB3' ' NH1' ' A' ' 381' ' ' ARG . 10.5 ptpt -94.15 -33.75 13.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.22 121.87 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.083 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.426 HD21 ' HB1' ' A' ' 384' ' ' ALA . 78.5 mt -98.81 121.75 41.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -88.31 106.56 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.66 HG22 HG12 ' A' ' 403' ' ' ILE . 47.2 t -105.16 135.33 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -134.73 167.64 20.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.84 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 24.7 t30 74.59 49.99 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.49 HD21 HG12 ' A' ' 342' ' ' VAL . 14.5 mt -92.53 130.24 38.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.06 -179.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.101 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -87.15 6.5 32.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 22.2 p -124.15 15.88 9.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.171 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 55.3 t -91.98 134.93 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.151 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 58.4 p -136.98 161.0 37.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.145 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -47.02 -42.93 19.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -56.76 -40.42 75.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.884 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 83.0 mt -72.17 -29.55 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.539 ' HB2' HG11 ' A' ' 367' ' ' VAL . 85.3 mt -74.73 -28.04 60.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 359' ' ' SER . 45.3 mt-10 -72.26 -70.09 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -42.08 -44.1 3.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' ALA . . . . . 0.821 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -63.38 -57.05 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.097 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' PHE . . . . . 0.486 ' O ' HD21 ' A' ' 364' ' ' LEU . 41.0 m-85 -85.09 16.08 3.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 355' ' ' GLU . 5.4 t -100.07 -59.27 1.74 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.851 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 360' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 359' ' ' SER . 21.7 pt20 -36.82 -40.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 92.8 m-85 -62.36 -61.83 2.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.39 161.79 29.59 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.474 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.28 128.63 22.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 0.0 110.876 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.486 HD21 ' O ' ' A' ' 358' ' ' PHE . 49.6 mt -98.81 152.95 19.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -101.45 -47.64 4.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -170.17 166.02 9.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.841 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.539 HG11 ' HB2' ' A' ' 354' ' ' LEU . 60.1 t -137.49 123.64 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -105.73 111.34 23.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -91.02 136.48 33.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.851 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.9 mp -124.73 -174.82 3.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 370' ' ' LEU . 7.9 mmtm -32.9 -71.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.09 -37.88 3.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.851 ' CE2' HD22 ' A' ' 370' ' ' LEU . 8.4 p90 -91.67 -179.8 5.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.951 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -165.55 160.47 17.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.053 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -111.69 135.51 52.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 7.5 mm -108.88 106.97 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.099 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -87.58 120.29 28.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.535 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 23.6 m-85 -99.74 158.6 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -79.91 -32.07 40.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -128.22 152.91 47.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.414 ' HB2' ' NH1' ' A' ' 381' ' ' ARG . 0.0 OUTLIER -59.14 -34.08 71.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.855 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 382' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 384' ' ' ALA . 10.3 t70 -70.74 -54.95 9.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -37.81 -30.75 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.449 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.426 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -81.28 -65.92 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.492 HG22 ' HZ ' ' A' ' 405' ' ' PHE . 58.4 t -36.4 -36.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.124 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -72.88 -61.83 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -60.3 -15.66 27.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.076 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.5 ttm -77.97 -61.18 2.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.417 ' N ' ' HG2' ' A' ' 388' ' ' MET . 16.4 mt-10 -74.89 -0.73 19.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.515 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 7.4 mm-40 -100.15 -37.41 8.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.839 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' MET . . . . . 0.821 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 17.8 mmm -101.66 -34.04 9.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.858 ' N ' HD12 ' A' ' 403' ' ' ILE . 5.2 t-20 -34.0 93.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 98.17 39.47 3.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.414 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 2.0 mmmp? -99.92 147.51 25.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.886 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -75.76 69.47 2.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.851 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.582 HD22 HD13 ' A' ' 401' ' ' ILE . 14.8 tp -74.93 113.12 11.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 61.94 27.33 16.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 85.31 21.26 55.14 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.533 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -140.1 125.91 19.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.87 0.367 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.37 96.92 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.582 HD13 HD22 ' A' ' 396' ' ' LEU . 33.4 pt -74.61 148.36 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -110.35 131.27 55.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.858 HD12 ' N ' ' A' ' 392' ' ' ASN . 36.1 mt -116.06 127.61 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 11.1 m -141.11 134.24 30.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.175 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.591 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 6.3 m-85 -52.49 108.73 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.464 ' O ' HG21 ' A' ' 337' ' ' VAL . . . -63.31 174.86 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.11 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -88.13 143.91 33.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.619 0.723 . . . . 0.0 110.896 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 148.55 65.43 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.681 2.254 . . . . 0.0 112.359 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 151.26 69.13 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.672 2.248 . . . . 0.0 112.392 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.83 92.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -90.71 -53.38 4.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -38.11 151.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -167.24 168.28 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.874 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -170.35 138.03 1.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.17 129.0 7.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.81 134.63 20.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -166.31 157.99 13.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -142.09 119.45 11.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.156 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.39 150.92 12.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.911 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 10.9 tpt85 -166.74 119.16 0.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -153.92 156.2 37.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -174.89 112.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -130.98 140.36 50.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 38.0 m -163.89 177.2 8.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.84 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 180.0 141.38 4.62 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.473 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -175.65 1.21 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.712 2.275 . . . . 0.0 112.379 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 50.4 m -155.73 164.72 38.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.822 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 37.1 p -115.53 -61.22 1.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.511 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 1.9 t -162.92 159.17 23.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 0.0 110.849 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 23.0 t -166.2 145.71 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.813 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -140.49 45.52 0.98 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.487 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 8.3 t -118.33 119.07 33.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.895 0.378 . . . . 0.0 110.888 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.8 t -85.47 93.12 8.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.861 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -143.37 132.45 4.98 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.496 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.47 -21.78 19.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.824 0.345 . . . . 0.0 110.868 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -133.7 174.17 10.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.074 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.432 ' HD2' ' NH1' ' A' ' 381' ' ' ARG . 34.5 mttm -124.79 69.9 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.534 HG11 ' O ' ' A' ' 406' ' ' ALA . 74.4 t -54.64 139.64 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.19 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -93.15 -32.08 14.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.1 122.34 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.641 HD21 ' HB1' ' A' ' 384' ' ' ALA . 48.6 mt -96.52 134.67 39.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -99.19 107.9 20.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.727 HG12 HD21 ' A' ' 345' ' ' LEU . 29.8 t -103.71 131.81 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.147 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -130.92 172.39 12.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.901 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.7 t30 72.54 33.27 1.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.727 HD21 HG12 ' A' ' 342' ' ' VAL . 17.8 mt -76.63 125.47 29.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.01 176.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.053 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -82.73 9.95 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 20.6 p -125.78 9.7 7.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 90.8 t -92.57 139.17 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' THR . . . . . 0.446 ' H ' HD12 ' A' ' 353' ' ' ILE . 55.5 p -143.89 171.59 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -50.7 -50.98 53.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -50.28 -39.18 44.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 350' ' ' THR . 74.2 mt -73.94 -35.71 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.59 ' HB2' HG11 ' A' ' 367' ' ' VAL . 96.7 mt -69.29 -26.26 64.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.481 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 44.9 mt-10 -76.43 -71.49 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -42.43 -35.72 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' ALA . . . . . 0.684 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -72.81 -55.72 6.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.145 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' PHE . . . . . 0.408 ' O ' HD21 ' A' ' 364' ' ' LEU . 41.2 m-85 -84.17 14.12 4.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 355' ' ' GLU . 18.0 t -99.65 -52.95 3.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -39.46 -37.24 0.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.575 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 93.6 m-85 -66.38 -62.58 1.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -150.53 161.85 29.11 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -53.15 122.77 10.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 110.937 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.481 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 32.0 mt -90.4 166.59 13.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -114.2 -44.78 3.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.501 ' HG3' ' CD2' ' A' ' 377' ' ' HIS . 18.5 ptt180 -173.01 166.53 5.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.59 HG11 ' HB2' ' A' ' 354' ' ' LEU . 89.7 t -139.81 123.83 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -107.17 120.1 41.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' LYS . . . . . 0.422 ' C ' HD12 ' A' ' 370' ' ' LEU . 16.1 tptp -91.73 142.28 27.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.768 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.4 mp -129.57 -174.57 3.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 370' ' ' LEU . 1.9 mptp? -33.33 -73.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -119.27 -29.66 5.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.768 ' CE2' HD22 ' A' ' 370' ' ' LEU . 3.8 p90 -97.99 -175.0 3.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.569 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -168.52 153.48 6.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.09 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -100.61 146.12 27.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 6.5 mm -118.87 110.81 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' HIS . . . . . 0.501 ' CD2' ' HG3' ' A' ' 366' ' ' ARG . 55.1 m-70 -89.46 126.1 35.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.819 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.458 ' CZ ' HD21 ' A' ' 364' ' ' LEU . 20.1 m-85 -108.4 139.41 43.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -58.52 -29.44 66.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -134.62 143.76 47.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.432 ' NH1' ' HD2' ' A' ' 336' ' ' LYS . 3.8 tmm_? -52.13 -34.56 45.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -67.35 -56.53 9.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' GLY . . . . . 0.426 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -37.74 -32.47 0.11 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.537 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.641 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -77.43 -62.81 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.803 0.335 . . . . 0.0 111.122 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 384' ' ' ALA . 54.8 t -36.72 -39.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.133 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 386' ' ' LYS . . . . . 0.416 ' HA ' ' NZ ' ' A' ' 386' ' ' LYS . 0.1 OUTLIER -71.23 -65.67 0.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -53.84 -19.27 4.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.14 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.7 ttm -74.97 -63.74 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.465 ' N ' ' HG2' ' A' ' 388' ' ' MET . 5.5 mt-10 -73.71 1.56 10.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.575 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 3.0 mm-40 -99.67 -39.66 8.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' MET . . . . . 0.684 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 5.9 mmm -101.36 -29.95 11.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.744 ' N ' HD12 ' A' ' 403' ' ' ILE . 4.4 t-20 -34.17 96.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 94.11 38.43 5.13 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.525 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -99.62 147.2 25.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -76.51 76.44 3.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.468 HD22 HD13 ' A' ' 401' ' ' ILE . 17.6 tp -81.48 113.92 19.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 61.99 24.92 14.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 88.09 20.23 50.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -140.06 126.6 20.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 110.924 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.6 99.28 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.468 HD13 HD22 ' A' ' 396' ' ' LEU . 20.9 pt -77.15 148.59 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -109.95 129.9 55.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.744 HD12 ' N ' ' A' ' 392' ' ' ASN . 24.3 mt -113.3 129.21 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 34.2 m -146.68 135.27 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.089 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 15.9 m-85 -52.69 120.06 5.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.534 ' O ' HG11 ' A' ' 337' ' ' VAL . . . -79.83 135.16 36.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.042 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -63.81 146.13 97.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.529 0.68 . . . . 0.0 110.914 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 146.13 59.44 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.672 2.248 . . . . 0.0 112.407 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -6.26 18.14 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.69 2.26 . . . . 0.0 112.377 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -111.31 156.96 20.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -129.13 176.09 8.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -138.13 144.2 40.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ARG . . . . . 0.46 ' HD3' ' N ' ' A' ' 413' ' ' ARG . 1.3 mpp_? -107.28 174.12 6.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -142.3 140.38 32.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -128.11 169.47 14.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.34 167.33 23.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -154.58 161.89 41.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -125.65 155.12 41.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.097 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -104.04 -25.26 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? 41.85 52.6 4.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -119.27 142.81 47.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -174.26 178.92 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -170.42 176.03 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.118 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 19.9 m -158.46 175.82 13.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.874 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -162.12 149.15 17.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.487 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -174.89 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.676 2.251 . . . . 0.0 112.361 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 21.3 t -172.91 -176.62 1.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 85.9 p -128.05 -53.82 1.3 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.861 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.471 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 34.8 p -101.25 90.65 4.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.873 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 24.4 m -83.25 113.55 20.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.854 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 70.43 163.1 4.44 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 34.1 t -95.62 145.93 24.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 0.0 110.872 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 2.1 m -134.07 47.1 2.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -91.42 -139.59 8.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.25 127.99 34.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.831 0.348 . . . . 0.0 110.824 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -126.38 -176.89 3.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.132 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.498 ' C ' ' NH2' ' A' ' 381' ' ' ARG . 1.1 mptp? -101.95 79.11 1.86 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.589 ' O ' ' CE1' ' A' ' 405' ' ' PHE . 41.3 t -135.87 138.11 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.14 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -91.22 -33.66 15.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 77.9 t -74.79 123.24 29.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.107 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.411 HD21 ' HB1' ' A' ' 384' ' ' ALA . 48.9 mt -99.06 123.4 43.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -91.54 106.36 18.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.66 HG22 HG12 ' A' ' 403' ' ' ILE . 11.9 t -103.51 138.24 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.152 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -136.03 168.4 19.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 5.9 t30 73.2 54.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 31.1 mt -94.99 137.77 33.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.88 172.52 1.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.107 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -79.38 1.16 26.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 5.7 p -118.04 13.54 13.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.183 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 45.5 t -97.25 140.46 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 64.6 p -140.35 172.48 12.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.151 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -51.49 -45.89 62.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -54.87 -46.62 74.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 72.5 mt -64.32 -28.84 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.156 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.512 ' HB2' HG11 ' A' ' 367' ' ' VAL . 96.4 mt -76.59 -27.61 55.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 359' ' ' SER . 54.2 mt-10 -77.45 -65.69 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -46.47 -37.52 7.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' ALA . . . . . 0.692 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -72.17 -49.83 32.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.099 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' PHE . . . . . 0.546 ' O ' HD21 ' A' ' 364' ' ' LEU . 39.6 m-85 -88.17 13.03 12.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 355' ' ' GLU . 5.3 t -98.89 -52.64 3.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' GLN . . . . . 0.411 ' HG3' ' N ' ' A' ' 361' ' ' PHE . 18.2 pt20 -38.59 -40.14 0.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 390' ' ' GLU . 93.5 m-85 -64.0 -62.44 1.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -149.55 169.36 29.79 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -59.61 127.34 31.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 358' ' ' PHE . 81.4 mt -95.99 156.37 16.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -104.99 -41.73 5.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -174.93 165.9 3.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.512 HG11 ' HB2' ' A' ' 354' ' ' LEU . 33.9 t -139.48 124.6 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.155 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -109.5 114.98 29.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' LYS . . . . . 0.443 ' C ' HD12 ' A' ' 370' ' ' LEU . 19.1 tptp -90.89 144.28 25.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.852 HD22 ' CE2' ' A' ' 373' ' ' TYR . 7.0 mp -130.92 -174.69 3.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 370' ' ' LEU . 16.1 tttm -33.09 -68.02 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.4 -37.56 2.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.852 ' CE2' HD22 ' A' ' 370' ' ' LEU . 9.7 p90 -92.23 179.8 5.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -160.86 161.54 31.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.078 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -112.42 125.37 54.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 6.1 mm -101.32 121.29 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -100.94 124.38 46.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.56 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 26.5 m-85 -106.64 133.78 50.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -53.9 -32.57 53.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -128.51 151.18 49.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.498 ' NH2' ' C ' ' A' ' 336' ' ' LYS . 11.5 tpp85 -58.41 -36.31 73.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 384' ' ' ALA . 14.6 t70 -68.23 -55.48 12.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -37.97 -31.15 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.506 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -80.87 -63.96 1.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.855 0.359 . . . . 0.0 111.155 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.53 HG22 ' HZ ' ' A' ' 405' ' ' PHE . 79.7 t -36.82 -35.42 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 386' ' ' LYS . . . . . 0.436 ' HE2' ' CG ' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -72.02 -60.02 2.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.888 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -62.21 -17.37 58.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.594 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.1 ttm -75.39 -60.9 2.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.887 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.435 ' N ' ' HG2' ' A' ' 388' ' ' MET . 11.1 mt-10 -74.48 -0.79 18.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 361' ' ' PHE . 33.8 mm-40 -99.98 -37.93 8.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.913 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' MET . . . . . 0.692 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 12.3 mmm -99.9 -29.22 12.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.751 ' N ' HD12 ' A' ' 403' ' ' ILE . 2.7 t-20 -41.24 111.79 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.845 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 75.49 28.84 60.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.507 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.477 ' CG ' ' O ' ' A' ' 391' ' ' MET . 0.0 OUTLIER -97.71 142.79 29.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -68.73 99.89 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.535 HD22 HD13 ' A' ' 401' ' ' ILE . 21.6 tp -105.46 109.67 21.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 61.6 32.63 18.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 83.28 15.99 70.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -139.82 120.09 13.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.871 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.75 106.02 3.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.535 HD13 HD22 ' A' ' 396' ' ' LEU . 23.7 pt -79.25 161.08 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.132 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -123.75 125.61 45.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.751 HD12 ' N ' ' A' ' 392' ' ' ASN . 25.0 mt -111.16 135.51 50.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.128 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 6.9 m -150.16 130.96 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.132 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.594 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 15.5 m-85 -51.53 108.95 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.512 ' O ' HG11 ' A' ' 337' ' ' VAL . . . -62.95 153.14 34.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.064 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' LYS . . . . . 0.421 ' HG3' ' N ' ' A' ' 408' ' ' PRO . 4.4 tttp -78.9 142.63 60.68 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.588 0.709 . . . . 0.0 110.891 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 408' ' ' PRO . . . . . 0.421 ' N ' ' HG3' ' A' ' 407' ' ' LYS . 54.0 Cg_endo -69.71 148.63 65.84 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.737 2.291 . . . . 0.0 112.365 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -19.07 36.48 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.714 2.276 . . . . 0.0 112.294 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -61.98 153.15 30.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.849 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -126.12 164.48 20.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -153.07 122.08 6.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -109.87 121.19 44.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.882 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -120.89 134.85 55.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -116.16 -175.73 2.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -156.07 130.35 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.869 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -80.81 122.23 26.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -112.93 174.17 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.102 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 8.0 pm0 -112.85 -176.57 2.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.945 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -165.96 108.14 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -98.68 153.27 18.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -107.39 178.17 4.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.081 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -173.54 177.42 2.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.105 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.5 t -163.99 153.52 14.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -157.32 144.7 10.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.511 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -172.69 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.678 2.252 . . . . 0.0 112.373 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 86.2 p -150.24 139.11 20.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 23.3 m -70.63 -59.66 2.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.444 179.961 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.474 -0.251 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 29.8 t -47.83 144.16 3.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.881 0.372 . . . . 0.0 110.825 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 84.9 p -147.76 177.17 9.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 173.3 66.99 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.481 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 65.4 m -109.76 120.46 42.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.904 0.383 . . . . 0.0 110.853 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 73.3 m -137.41 117.42 13.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.896 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.6 175.88 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.5 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 15.0 mtt -141.34 157.82 44.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.767 0.318 . . . . 0.0 110.912 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -156.52 132.75 9.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.115 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 88.57 4.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 55.2 t -135.92 127.86 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -93.81 -27.56 16.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 95.5 t -81.5 121.13 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.765 HD12 ' CE1' ' A' ' 378' ' ' PHE . 60.5 mt -100.66 121.94 42.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.944 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.402 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 89.2 t80 -85.54 108.25 17.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.829 HG22 HG12 ' A' ' 403' ' ' ILE . 43.4 t -106.69 133.64 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.123 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.437 ' HB2' ' NH1' ' A' ' 343' ' ' ARG . 3.0 ptm85 -131.66 172.18 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.835 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.1 t30 72.7 37.45 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.519 HD21 HG12 ' A' ' 342' ' ' VAL . 17.5 mt -77.34 144.79 37.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.447 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -73.89 179.05 4.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -83.49 2.55 36.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 69.5 p -120.64 11.55 11.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 346' ' ' ALA . 97.6 t -95.58 132.16 40.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.129 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 70.5 p -139.39 165.57 26.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.164 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.4 ' HA ' HG11 ' A' ' 367' ' ' VAL . 41.6 mt-10 -41.2 -44.31 2.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.882 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -55.29 -59.21 5.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 80.4 mt -55.73 -31.75 30.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.126 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.437 HD22 HD11 ' A' ' 376' ' ' ILE . 93.1 mt -71.43 -26.15 62.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.496 ' O ' ' CB ' ' A' ' 359' ' ' SER . 27.0 mt-10 -83.71 -53.92 5.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 356' ' ' LYS . . . . . 0.439 ' O ' ' NE2' ' A' ' 360' ' ' GLN . 74.0 mttt -57.55 -20.44 32.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 357' ' ' ALA . . . . . 0.695 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -93.26 -44.45 8.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.111 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' PHE . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 41.2 m-85 -93.25 18.03 10.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 355' ' ' GLU . 3.3 t -100.06 -61.84 1.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 360' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 356' ' ' LYS . 2.4 pm0 -37.68 -37.84 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.51 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 70.0 m-85 -62.71 -58.74 6.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -155.46 162.83 31.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.483 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -55.07 123.59 14.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.432 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 60.0 mt -91.36 178.21 6.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -131.76 -44.02 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -173.97 165.96 4.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 351' ' ' GLU . 64.6 t -138.07 134.48 44.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.428 ' O ' ' HB1' ' A' ' 374' ' ' ALA . 7.0 tptm -118.85 117.72 29.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 369' ' ' LYS . . . . . 0.518 ' C ' HD12 ' A' ' 370' ' ' LEU . 14.3 tptm -93.51 144.29 25.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.809 HD22 ' CE2' ' A' ' 373' ' ' TYR . 8.0 mp -130.87 -174.44 3.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 370' ' ' LEU . 20.8 tttp -31.53 -64.78 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -128.36 -37.26 1.84 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.809 ' CE2' HD22 ' A' ' 370' ' ' LEU . 14.1 p90 -92.53 179.18 5.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 368' ' ' LYS . . . -159.1 171.89 19.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.069 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -124.06 127.73 48.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.839 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.437 HD11 HD22 ' A' ' 354' ' ' LEU . 4.4 mm -101.2 109.31 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.161 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -85.79 110.46 19.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.765 ' CE1' HD12 ' A' ' 340' ' ' LEU . 17.9 m-85 -92.95 143.31 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -55.32 -33.1 63.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -141.43 162.66 34.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.511 ' O ' HG23 ' A' ' 385' ' ' VAL . 4.0 tmm_? -63.62 -33.0 74.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -65.47 -58.84 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.824 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -42.17 -28.6 0.53 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.452 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -80.18 -60.38 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 0.0 111.092 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 381' ' ' ARG . 60.6 t -37.44 -35.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 386' ' ' LYS . . . . . 0.421 ' HA ' ' NZ ' ' A' ' 386' ' ' LYS . 0.0 OUTLIER -73.83 -63.25 1.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -59.65 -14.41 13.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.563 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.7 ttm -80.28 -62.24 1.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.859 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.422 ' N ' ' HG2' ' A' ' 388' ' ' MET . 11.9 mt-10 -75.05 -3.19 31.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.51 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 28.2 mm-40 -100.16 -29.38 12.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.822 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' MET . . . . . 0.695 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 5.0 mmt -107.92 -41.98 4.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.77 ' N ' HD12 ' A' ' 403' ' ' ILE . 26.2 t-20 -34.21 93.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.856 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 103.64 28.44 5.99 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.51 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 391' ' ' MET . 1.1 mmmm -98.54 146.31 25.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.319 . . . . 0.0 110.918 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -74.35 78.6 1.86 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.872 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.466 HD22 HD13 ' A' ' 401' ' ' ILE . 19.0 tp -86.23 113.22 22.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 62.34 25.1 14.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.31 17.98 58.04 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.483 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -138.64 124.26 19.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.28 92.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.466 HD13 HD22 ' A' ' 396' ' ' LEU . 20.7 pt -71.56 146.13 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.154 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -111.76 130.84 55.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.829 HG12 HG22 ' A' ' 342' ' ' VAL . 20.9 mt -115.04 126.47 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.43 136.82 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.132 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.563 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 13.1 m-85 -54.56 110.61 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.825 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.402 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . -68.75 131.98 46.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.116 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -54.15 150.19 16.42 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.585 0.707 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 148.66 65.97 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.657 2.238 . . . . 0.0 112.345 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 93.72 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.701 2.267 . . . . 0.0 112.364 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 38.9 p30 -74.29 175.1 7.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.858 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -162.12 161.94 28.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.27 -64.82 1.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -173.09 157.14 3.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.404 ' C ' ' HD2' ' A' ' 414' ' ' LYS . 1.2 tmmm? -102.59 107.69 18.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.96 141.31 31.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.408 ' C ' ' HD3' ' A' ' 416' ' ' ARG . 0.6 OUTLIER -140.81 163.73 32.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.851 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 25.4 tptt -113.64 158.02 21.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -172.23 120.29 0.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.129 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.03 155.83 42.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -112.67 138.75 49.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.848 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -147.97 149.14 31.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.887 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -147.33 167.6 23.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -160.74 169.11 23.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 68.5 p -163.91 178.88 7.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 179.78 146.0 6.66 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.445 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -176.36 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.758 2.305 . . . . 0.0 112.346 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 83.9 p -133.77 173.81 11.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.809 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.5 t -150.96 175.38 12.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.875 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.435 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 36.4 p -144.94 134.46 23.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 110.856 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 13.6 t -153.29 119.91 5.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 100.47 69.69 0.89 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 36.2 p -73.22 130.19 39.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.883 0.373 . . . . 0.0 110.862 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 t -61.08 -54.67 41.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 76.92 83.54 0.5 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.44 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 8.9 mmt -104.4 -52.65 2.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.754 0.311 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -157.39 131.96 8.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.057 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -75.7 104.82 6.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.939 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.474 ' HB ' ' CD1' ' A' ' 405' ' ' PHE . 55.5 t -133.69 134.93 56.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.137 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -94.29 -31.39 14.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.924 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 64.6 t -79.1 123.92 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 72.0 mt -104.19 125.48 50.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 72.0 t80 -90.04 106.66 18.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.527 HG22 HG12 ' A' ' 403' ' ' ILE . 22.3 t -104.31 137.68 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.163 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -136.34 169.25 17.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 74.16 46.81 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.901 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 48.5 mt -83.88 135.91 34.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.944 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.3 179.8 0.54 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -85.81 5.97 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 49.8 p -123.43 11.61 9.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 350' ' ' THR . 87.5 t -90.81 153.01 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 350' ' ' THR . . . . . 0.415 ' N ' HG12 ' A' ' 349' ' ' VAL . 77.6 p -153.96 173.18 16.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -58.55 -35.85 72.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.6 -40.71 92.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 68.9 mt -69.16 -28.66 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.503 ' HB2' HG11 ' A' ' 367' ' ' VAL . 94.6 mt -72.39 -31.47 65.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 359' ' ' SER . 64.8 mt-10 -72.18 -74.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -42.05 -34.55 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' ALA . . . . . 0.486 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -73.01 -52.13 15.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' PHE . . . . . 0.438 ' C ' HD11 ' A' ' 364' ' ' LEU . 38.3 m-85 -88.06 15.11 7.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 360' ' ' GLN . 82.7 p -97.23 -56.39 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 360' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 359' ' ' SER . 26.4 pt20 -35.16 -42.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 87.9 m-85 -61.42 -68.36 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -146.51 165.03 28.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.489 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -54.72 127.65 29.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.828 0.347 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.438 HD11 ' C ' ' A' ' 358' ' ' PHE . 78.7 mt -96.35 156.41 16.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -103.36 -42.42 5.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -174.59 169.43 3.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 354' ' ' LEU . 48.9 t -140.65 126.02 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.123 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -119.73 104.86 10.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' LYS . . . . . 0.482 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 20.2 tttm -82.81 152.75 25.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.879 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.9 mp -130.51 -174.8 3.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 370' ' ' LEU . 16.9 tptm -33.26 -68.8 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -118.66 -39.06 3.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.879 ' CE2' HD22 ' A' ' 370' ' ' LEU . 7.0 p90 -92.9 -178.94 4.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 369' ' ' LYS . . . -158.02 168.16 27.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.061 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -121.28 128.3 52.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 7.4 mm -103.7 113.7 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -92.52 123.71 36.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 387' ' ' ALA . 20.4 m-85 -105.77 145.61 30.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.64 -33.73 74.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -132.29 159.09 40.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.418 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 0.4 OUTLIER -65.24 -28.91 69.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 382' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 384' ' ' ALA . 23.5 t0 -70.77 -61.07 1.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -36.89 -30.37 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.509 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 382' ' ' ASP . . . -76.91 -63.22 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.346 . . . . 0.0 111.07 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 384' ' ' ALA . 89.5 t -36.46 -35.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.095 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -63.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -59.21 -16.16 19.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.515 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.7 ttm -77.75 -61.64 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.421 ' N ' ' HG2' ' A' ' 388' ' ' MET . 14.6 mt-10 -75.22 0.31 16.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.491 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 32.4 mm-40 -100.07 -36.58 9.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' MET . . . . . 0.5 ' O ' ' N ' ' A' ' 393' ' ' GLY . 3.6 mmt -102.95 -30.32 10.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.812 ' N ' HD12 ' A' ' 403' ' ' ILE . 7.0 t-20 -42.54 91.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 100.82 30.46 6.09 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.462 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 391' ' ' MET . 22.1 mmtt -100.0 148.43 24.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.743 0.306 . . . . 0.0 110.943 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -74.15 85.49 1.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.905 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.558 HD22 HD13 ' A' ' 401' ' ' ILE . 21.8 tp -93.34 112.34 24.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 62.48 26.94 16.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 86.35 18.39 59.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -140.09 126.0 19.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.882 0.373 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.0 93.51 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.558 HD13 HD22 ' A' ' 396' ' ' LEU . 25.9 pt -71.02 149.32 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.085 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -113.51 131.7 55.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.812 HD12 ' N ' ' A' ' 392' ' ' ASN . 30.9 mt -113.3 133.46 59.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.14 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 5.1 m -145.72 132.83 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.515 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 7.1 m-85 -53.7 109.45 0.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.55 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . -71.63 147.23 47.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.094 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -66.85 145.52 98.94 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.571 0.7 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' PRO . . . . . 0.413 ' HA ' ' HD2' ' A' ' 409' ' ' PRO . 53.6 Cg_endo -69.71 113.36 3.34 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.7 2.267 . . . . 0.0 112.341 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 408' ' ' PRO . 54.1 Cg_endo -69.7 101.87 0.95 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.702 2.268 . . . . 0.0 112.362 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -157.22 137.89 13.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -106.14 101.32 10.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -128.83 145.17 51.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' ARG . . . . . 0.424 ' HG2' ' N ' ' A' ' 414' ' ' LYS . 50.7 ttp180 -154.94 155.34 34.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.424 ' N ' ' HG2' ' A' ' 413' ' ' ARG . 11.3 tptp -139.97 121.84 15.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -144.54 143.67 30.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.914 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -171.29 151.36 3.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -159.0 139.45 12.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.912 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -155.94 157.27 35.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -134.46 171.56 14.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -135.69 172.45 12.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -110.03 149.09 30.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -97.5 159.83 14.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.031 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -113.13 162.6 15.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.3 p -124.94 168.48 13.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.834 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -173.87 146.44 8.77 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.502 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 117.33 5.02 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.707 2.271 . . . . 0.0 112.322 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 2.9 m -60.37 -55.17 36.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.855 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 9.3 m -99.45 153.7 18.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.466 -179.982 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 45.9 p -55.38 134.0 50.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.866 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 70.6 p -101.67 139.2 37.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -86.12 139.32 16.77 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.448 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 14.0 m -39.36 105.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 110.845 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 45.3 t -39.57 153.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 159.62 99.47 0.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.483 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 27.5 mtt -68.16 119.24 12.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.743 0.306 . . . . 0.0 110.839 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -169.67 148.92 3.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.073 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -122.56 91.33 3.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.4 133.07 69.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.12 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -94.54 -31.4 13.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.891 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 58.3 t -80.65 132.74 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.649 HD21 ' HB1' ' A' ' 384' ' ' ALA . 33.4 mt -110.74 127.38 55.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -90.39 114.08 26.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.664 HG22 HG12 ' A' ' 403' ' ' ILE . 22.0 t -111.59 131.62 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -130.0 170.14 14.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 74.81 41.21 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.54 HD12 ' NZ ' ' A' ' 369' ' ' LYS . 44.1 mt -80.27 133.6 36.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.551 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -56.17 -177.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.498 ' OD1' HG23 ' A' ' 348' ' ' THR . 11.6 p30 -91.67 11.59 23.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.908 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' THR . . . . . 0.498 HG23 ' OD1' ' A' ' 347' ' ' ASN . 51.4 p -135.04 17.71 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.551 HG23 ' HB3' ' A' ' 346' ' ' ALA . 71.4 t -95.48 136.92 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.103 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 76.9 p -135.79 170.52 15.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.133 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -52.49 -46.05 66.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -52.59 -42.97 64.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 77.6 mt -70.94 -27.46 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.178 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.549 ' HB2' HG11 ' A' ' 367' ' ' VAL . 97.8 mt -73.99 -31.5 62.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 359' ' ' SER . 24.4 mt-10 -74.73 -64.83 0.96 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.939 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -44.36 -40.34 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' ALA . . . . . 0.787 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -71.26 -55.79 7.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.092 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' PHE . . . . . 0.409 ' O ' HD21 ' A' ' 364' ' ' LEU . 45.3 m-85 -81.77 13.95 2.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.864 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 355' ' ' GLU . 7.2 t -100.03 -54.17 2.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.828 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -39.65 -36.02 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 81.1 m-85 -65.52 -63.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.19 168.74 31.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.479 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -53.37 129.12 30.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 110.906 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.476 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 32.7 mt -99.54 163.35 12.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -111.93 -48.68 3.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -172.82 165.91 5.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 354' ' ' LEU . 93.7 t -134.45 127.41 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.147 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -110.83 114.19 27.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' LYS . . . . . 0.54 ' NZ ' HD12 ' A' ' 345' ' ' LEU . 16.3 tptp -89.97 138.76 31.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.87 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.718 HD22 ' CE2' ' A' ' 373' ' ' TYR . 7.7 mp -125.49 -174.83 3.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 370' ' ' LEU . 3.2 mptp? -33.7 -70.81 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.94 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -119.01 -38.26 3.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.838 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.718 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.9 p90 -91.78 -175.79 4.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.947 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -164.95 158.26 16.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -109.63 133.57 52.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 3.7 mm -107.41 107.48 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -85.5 117.88 24.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.562 ' CE1' HD12 ' A' ' 340' ' ' LEU . 16.2 m-85 -99.42 146.13 26.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -57.72 -36.48 72.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -133.18 160.34 37.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.409 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 1.6 tmm_? -63.92 -35.27 80.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 384' ' ' ALA . 11.5 t0 -65.77 -58.58 5.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -38.62 -30.67 0.1 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.466 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.649 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -76.95 -58.91 3.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.317 . . . . 0.0 111.091 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.4 t -37.9 -37.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.122 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' LYS . . . . . 0.431 ' HA ' ' NZ ' ' A' ' 386' ' ' LYS . 0.1 OUTLIER -72.3 -65.36 0.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.84 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -56.14 -16.57 5.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.106 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.535 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.5 ttm -78.52 -64.13 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.465 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.1 mt-10 -73.86 0.83 12.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.489 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 57.5 mm-40 -100.14 -39.91 7.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' MET . . . . . 0.787 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 5.9 mmm -100.11 -30.12 12.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.777 ' N ' HD12 ' A' ' 403' ' ' ILE . 5.5 t-20 -42.03 94.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 100.61 30.38 6.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.503 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.0 147.74 25.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.329 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' ASP . . . . . 0.414 ' OD1' ' C ' ' A' ' 395' ' ' ASP . 31.2 t0 -75.35 88.63 2.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.875 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 29.2 tp -94.73 110.17 22.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.984 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 63.35 24.95 14.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.47 18.95 51.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.448 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -139.94 125.59 19.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.9 94.05 2.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 20.1 pt -71.5 148.14 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -112.04 130.3 55.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.879 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.777 HD12 ' N ' ' A' ' 392' ' ' ASN . 27.2 mt -112.43 131.24 64.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.096 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 22.1 m -144.8 136.58 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.535 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 12.2 m-85 -54.17 116.0 2.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.2 147.22 46.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.098 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -77.12 143.95 70.81 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.564 0.697 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 132.37 23.26 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.355 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 172.01 13.38 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.709 2.272 . . . . 0.0 112.349 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -45.69 132.17 8.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.87 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -49.96 144.68 6.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 4.6 tppt? -77.61 -60.66 2.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 9.0 ttm105 -169.54 160.31 8.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.85 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -131.27 123.85 29.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -114.5 156.21 25.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -143.6 141.19 30.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -166.45 149.28 6.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -166.15 149.16 7.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -158.69 138.18 11.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.95 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -91.63 144.25 25.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -86.36 158.71 19.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -141.07 177.28 8.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.105 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -114.82 159.93 20.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 96.0 p -168.37 171.2 9.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -131.29 157.34 22.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.516 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 153.91 68.45 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.721 2.28 . . . . 0.0 112.321 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 1.1 t -163.96 157.88 19.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 13.5 m 57.48 53.45 7.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.48 -179.973 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 12.7 t -109.82 -63.96 1.31 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.902 0.382 . . . . 0.0 110.838 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 32.9 m -113.16 94.93 5.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.894 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -96.88 139.81 14.7 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.465 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 1.9 t -113.26 130.84 56.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.903 0.382 . . . . 0.0 110.855 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 37.6 m -96.54 149.18 22.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -120.84 129.79 7.99 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.494 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' MET . . . . . 0.752 ' O ' HG23 ' A' ' 337' ' ' VAL . 16.6 mmt -121.05 157.46 29.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 110.884 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 336' ' ' LYS . . . 35.34 37.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.082 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 335' ' ' ALA . 35.2 mtmt 34.48 45.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 334' ' ' MET . 58.3 t -48.73 136.89 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.117 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -105.48 -30.09 9.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.0 t -79.48 138.98 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.798 HD21 ' HB1' ' A' ' 384' ' ' ALA . 47.4 mt -114.01 130.84 56.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.475 ' HB3' HG23 ' A' ' 404' ' ' VAL . 56.2 t80 -92.19 107.98 19.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.464 HG22 HG12 ' A' ' 403' ' ' ILE . 21.7 t -105.09 136.36 39.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -135.78 173.36 11.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.0 t30 68.89 52.1 0.54 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.434 HD21 HG12 ' A' ' 342' ' ' VAL . 18.0 mt -94.94 121.15 36.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.889 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -46.26 173.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -80.78 13.79 2.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 38.6 p -128.19 5.58 5.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 51.0 t -88.92 140.41 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.107 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 68.0 p -143.71 170.56 15.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.134 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -49.47 -41.86 41.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -59.31 -39.0 81.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 77.0 mt -73.64 -29.38 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.526 ' HB2' HG11 ' A' ' 367' ' ' VAL . 89.7 mt -74.26 -27.48 60.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 359' ' ' SER . 38.0 mt-10 -80.2 -66.87 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -48.7 -25.54 1.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -83.91 -47.47 11.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' PHE . . . . . 0.438 ' O ' HD21 ' A' ' 364' ' ' LEU . 35.4 m-85 -90.76 12.89 17.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 355' ' ' GLU . 99.2 p -99.64 -46.93 5.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -41.75 -30.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.513 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 98.4 m-85 -75.43 -73.92 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -135.56 174.4 21.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.476 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -60.16 133.88 56.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.792 0.33 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.438 HD21 ' O ' ' A' ' 358' ' ' PHE . 50.0 mt -103.74 153.36 20.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -103.5 -47.42 4.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -173.47 165.08 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.849 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' A' ' 354' ' ' LEU . 51.4 t -136.58 132.57 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.72 107.79 15.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 369' ' ' LYS . . . . . 0.4 ' C ' HD12 ' A' ' 370' ' ' LEU . 19.5 tptp -83.43 143.36 30.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.889 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.2 mp -128.59 -174.27 3.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.941 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 370' ' ' LEU . 21.6 mtpp -32.48 -64.15 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.47 -33.77 2.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.889 ' CE2' HD22 ' A' ' 370' ' ' LEU . 3.8 p90 -93.74 -176.04 3.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.508 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -166.81 160.49 14.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.123 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -111.57 134.85 52.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.464 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 3.6 mm -109.76 116.05 51.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -92.13 121.16 33.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 20.0 m-85 -106.57 127.67 53.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -42.52 -35.82 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -134.28 157.6 45.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -34.57 74.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 382' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 384' ' ' ALA . 27.1 t0 -65.67 -57.4 8.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' GLY . . . . . 0.459 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -38.97 -29.15 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.798 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -82.07 -58.86 2.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 111.122 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 94.1 t -38.16 -39.66 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.109 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -68.62 -60.56 2.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.07 -14.35 47.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.085 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 7.6 ttm -79.43 -59.67 2.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -75.09 -3.43 32.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.513 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 6.2 mm-40 -100.07 -37.18 9.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' MET . . . . . 0.498 ' O ' ' CG ' ' A' ' 394' ' ' LYS . 69.8 mmm -99.91 -25.13 14.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 388' ' ' MET . 1.4 t-20 -42.04 118.84 1.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 63.69 32.68 84.98 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.467 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 391' ' ' MET . 0.0 OUTLIER -96.75 145.2 26.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.757 0.313 . . . . 0.0 110.91 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -68.48 108.22 3.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.561 HD22 HD13 ' A' ' 401' ' ' ILE . 21.1 tp -119.51 111.45 18.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 62.01 37.06 15.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.893 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 76.72 11.17 85.58 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.492 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -137.27 121.08 17.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.368 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.34 116.04 8.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.561 HD13 HD22 ' A' ' 396' ' ' LEU . 17.3 pt -90.99 147.55 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.113 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.737 ' OE2' HG13 ' A' ' 404' ' ' VAL . 13.9 tm-20 -111.23 133.13 53.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 392' ' ' ASN . 22.6 mt -116.92 134.69 59.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.127 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.737 HG13 ' OE2' ' A' ' 402' ' ' GLU . 3.9 m -144.92 140.59 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 14.9 m-85 -61.0 105.01 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -62.44 166.47 5.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 408' ' ' PRO . 0.2 OUTLIER -72.38 143.73 85.88 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.527 0.68 . . . . 0.0 110.927 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 408' ' ' PRO . . . . . 0.474 ' N ' ' HG3' ' A' ' 407' ' ' LYS . 53.9 Cg_endo -69.65 153.69 69.11 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.722 2.281 . . . . 0.0 112.382 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -32.37 18.52 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.647 2.231 . . . . 0.0 112.367 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -97.16 132.38 42.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.856 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.93 86.74 2.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -55.67 134.47 51.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -102.01 111.22 23.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -100.56 143.33 30.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -136.02 152.71 51.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -124.64 171.29 10.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.857 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.04 169.39 10.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -131.39 147.07 52.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.092 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -127.93 166.1 18.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.03 116.73 20.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -174.09 118.99 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -168.05 167.02 12.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -163.74 169.17 18.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 93.6 p -168.51 176.72 5.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.54 68.75 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -178.45 2.36 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.685 2.257 . . . . 0.0 112.336 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 1.9 m -166.74 137.18 3.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.913 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.2 m -38.25 154.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.453 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 24.2 t -163.93 147.67 9.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.0 110.908 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 2.5 t -110.08 168.79 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.837 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -118.17 132.74 9.98 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 3.4 m -146.05 176.61 9.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 110.869 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 77.9 p -159.21 152.77 22.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.915 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 79.55 127.3 0.59 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.508 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 1.1 tpt -103.62 89.2 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.78 0.324 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -132.86 166.64 21.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.62 16.42 9.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 56.8 t -50.94 129.2 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -93.86 -31.88 14.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.83 130.83 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 388' ' ' MET . 63.0 mt -106.27 124.62 49.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.458 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 46.8 t80 -88.69 107.28 18.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.433 HG12 HD21 ' A' ' 345' ' ' LEU . 20.6 t -101.98 134.73 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.126 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -134.54 170.35 15.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.823 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.1 t30 72.91 39.12 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.433 HD21 HG12 ' A' ' 342' ' ' VAL . 31.1 mt -79.93 154.45 28.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -93.08 163.17 13.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -65.51 -7.29 13.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 81.9 p -103.53 -0.13 30.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.135 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 96.0 t -91.97 132.27 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.087 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' THR . . . . . 0.497 ' H ' HD12 ' A' ' 353' ' ' ILE . 67.8 p -134.62 170.3 16.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -50.97 -44.95 60.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -56.61 -41.2 76.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.933 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.497 HD12 ' H ' ' A' ' 350' ' ' THR . 73.2 mt -70.46 -30.25 42.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.138 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.449 ' HB2' HG11 ' A' ' 367' ' ' VAL . 97.2 mt -73.5 -30.13 62.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 359' ' ' SER . 49.4 mt-10 -75.64 -67.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -47.87 -36.44 12.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.848 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' ALA . . . . . 0.515 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -70.96 -49.77 41.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' PHE . . . . . 0.442 ' O ' HD21 ' A' ' 364' ' ' LEU . 39.6 m-85 -88.9 12.78 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.88 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 355' ' ' GLU . 40.4 t -99.26 -53.41 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -37.96 -31.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 91.5 m-85 -71.98 -63.11 1.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -149.55 171.12 29.71 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.465 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -58.62 128.26 36.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 0.0 110.917 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.442 HD21 ' O ' ' A' ' 358' ' ' PHE . 33.7 mt -97.35 171.48 8.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.956 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -120.52 -45.69 2.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.403 HH11 ' CD2' ' A' ' 377' ' ' HIS . 9.1 ptm180 -173.84 165.03 4.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.858 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.449 HG11 ' HB2' ' A' ' 354' ' ' LEU . 40.4 t -137.12 137.37 46.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.415 ' O ' ' HB1' ' A' ' 374' ' ' ALA . 7.9 tmtm? -125.07 120.32 31.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.864 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -94.44 140.92 29.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.873 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.692 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.8 mp -124.47 -174.71 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 370' ' ' LEU . 19.3 tttp -33.11 -65.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -125.67 -37.44 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.864 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.692 ' CE2' HD22 ' A' ' 370' ' ' LEU . 3.5 p90 -92.41 -174.8 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 368' ' ' LYS . . . -164.69 163.66 21.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -116.15 129.6 56.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.901 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.1 mm -104.52 119.45 53.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 377' ' ' HIS . . . . . 0.403 ' CD2' HH11 ' A' ' 366' ' ' ARG . 75.3 m-70 -98.3 121.89 40.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.493 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 21.5 m-85 -102.75 149.9 24.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.76 -29.19 70.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.858 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -136.23 160.54 38.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.892 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.443 ' O ' HG23 ' A' ' 385' ' ' VAL . 7.0 tmm_? -65.05 -29.41 70.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -73.13 -54.09 9.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' GLY . . . . . 0.493 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -40.17 -30.76 0.28 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.45 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -80.13 -63.87 1.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 111.104 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 381' ' ' ARG . 52.6 t -37.08 -35.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.131 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -61.5 1.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -60.88 -16.12 38.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.098 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.52 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.3 ttm -78.13 -62.21 1.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.444 ' N ' ' HG2' ' A' ' 388' ' ' MET . 18.5 mt-10 -74.5 1.22 12.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.554 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 4.4 mm-40 -100.07 -39.08 8.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 391' ' ' MET . . . . . 0.515 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 10.6 mmm -102.7 -30.76 10.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.78 ' N ' HD12 ' A' ' 403' ' ' ILE . 5.7 t-20 -34.35 93.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 98.81 37.23 4.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -99.97 148.34 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.328 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -76.06 77.95 2.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.861 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.509 HD22 HD13 ' A' ' 401' ' ' ILE . 16.6 tp -83.36 110.54 18.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.979 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 63.04 29.67 16.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 84.18 20.68 58.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -140.09 126.7 20.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.83 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.43 97.84 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.509 HD13 HD22 ' A' ' 396' ' ' LEU . 22.2 pt -77.79 146.38 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -112.12 131.69 55.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.882 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.78 HD12 ' N ' ' A' ' 392' ' ' ASN . 13.5 mt -112.04 132.45 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.101 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 13.7 m -145.69 134.06 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.52 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 16.2 m-85 -51.5 111.13 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.844 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . -65.76 150.26 48.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.128 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -73.33 141.13 80.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.582 0.706 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 160.31 50.17 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.67 2.247 . . . . 0.0 112.375 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 141.29 44.84 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.702 2.268 . . . . 0.0 112.323 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -119.99 128.11 53.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.868 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -152.8 154.67 35.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.943 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -136.48 159.41 41.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.863 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -149.39 156.0 41.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.858 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.63 139.91 1.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -101.49 155.55 18.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.886 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -133.47 134.08 43.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.835 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -137.9 135.38 36.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -144.85 163.34 34.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.132 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -129.3 177.03 7.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 8.6 ptt-85 -149.51 158.18 43.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -144.7 149.01 34.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -129.75 177.56 7.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.094 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -163.09 173.06 13.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.079 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 65.3 m -147.52 176.03 10.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -151.55 145.54 13.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.503 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 172.79 12.0 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.669 2.246 . . . . 0.0 112.349 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 26.6 m -114.17 -56.01 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.859 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 14.5 m 54.38 42.78 31.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.489 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 26.0 m -115.19 172.25 7.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.854 0.359 . . . . 0.0 110.874 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 20.0 t -144.2 131.11 20.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.855 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -96.55 -153.57 29.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.491 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 2.5 m -73.11 171.89 12.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 110.851 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 12.6 t -116.53 110.34 18.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.856 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -111.23 106.38 2.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 32.6 mtt -106.57 41.33 1.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.793 0.33 . . . . 0.0 110.86 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -123.5 175.12 6.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.104 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -108.43 94.2 4.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.935 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 44.6 t -143.94 131.01 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.128 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -92.92 -32.28 14.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 91.6 t -75.7 124.9 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.533 HD21 ' HB1' ' A' ' 384' ' ' ALA . 91.4 mt -104.97 116.67 32.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -82.79 109.33 16.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.723 HG22 HG12 ' A' ' 403' ' ' ILE . 24.4 t -108.3 132.26 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -130.72 177.17 7.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 68.94 43.79 1.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 33.6 mt -83.39 141.26 31.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.41 -178.16 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.095 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -88.87 2.95 52.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 61.4 p -120.08 13.87 12.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.186 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 73.6 t -92.83 150.47 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 75.5 p -149.13 170.04 19.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -52.07 -44.85 64.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -54.61 -52.12 63.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 77.8 mt -58.07 -33.1 45.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.521 ' HB2' HG11 ' A' ' 367' ' ' VAL . 87.4 mt -73.85 -26.63 60.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.918 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.47 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 31.7 mt-10 -78.92 -63.29 1.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -51.35 -41.33 60.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' ALA . . . . . 0.581 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -65.85 -49.73 67.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.055 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' PHE . . . . . 0.444 ' O ' HD21 ' A' ' 364' ' ' LEU . 41.2 m-85 -89.08 16.82 6.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.888 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 360' ' ' GLN . 12.2 t -99.95 -57.15 2.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 360' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 359' ' ' SER . 24.0 pt20 -37.68 -39.42 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.914 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.548 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 71.6 m-85 -62.83 -63.41 1.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -150.88 166.45 30.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.499 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -54.88 125.53 20.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 0.0 110.916 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.47 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 34.3 mt -94.12 154.32 17.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -103.63 -44.9 4.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -174.92 163.6 3.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.521 HG11 ' HB2' ' A' ' 354' ' ' LEU . 51.8 t -135.14 124.06 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.34 106.97 13.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 369' ' ' LYS . . . . . 0.487 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 17.6 tttm -84.14 150.43 25.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.879 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.4 mp -127.97 -174.33 3.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 370' ' ' LEU . 9.7 ttmt -32.58 -67.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.04 -38.68 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.843 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.879 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.8 p90 -91.94 -176.39 4.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.487 ' CB ' ' HA ' ' A' ' 369' ' ' LYS . . . -160.88 166.86 27.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -119.53 131.9 55.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.41 HD11 HD22 ' A' ' 354' ' ' LEU . 7.2 mm -107.79 110.31 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.132 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -88.9 125.64 35.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.517 ' CE1' HD12 ' A' ' 340' ' ' LEU . 20.0 m-85 -108.8 134.59 51.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.87 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -46.66 -36.55 7.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -133.29 158.84 41.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -62.29 -36.56 82.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 384' ' ' ALA . 26.4 t70 -63.48 -59.5 4.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 382' ' ' ASP . . . -36.89 -31.78 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.533 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -76.06 -61.24 2.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 111.093 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 384' ' ' ALA . 66.7 t -35.79 -33.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.088 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 386' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 384' ' ' ALA . 0.0 OUTLIER -75.3 -65.15 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.872 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -58.0 -14.77 7.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.1 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.59 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.8 ttm -80.23 -62.38 1.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.874 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.423 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.0 mt-10 -75.63 -1.64 25.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.548 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 69.0 mm-40 -100.14 -32.28 10.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' MET . . . . . 0.581 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 19.5 mmm -106.2 -37.94 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.896 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.863 ' N ' HD12 ' A' ' 403' ' ' ILE . 7.0 t-20 -33.9 93.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.927 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 103.92 27.02 6.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.481 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 391' ' ' MET . 14.1 mmmt -90.76 146.72 23.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.792 0.33 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.72 72.41 3.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.897 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 15.8 tp -75.84 111.82 11.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 62.49 24.99 14.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' GLY . . . . . 0.446 ' C ' ' OE1' ' A' ' 399' ' ' GLU . . . 89.75 14.39 59.66 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.508 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' GLU . . . . . 0.446 ' OE1' ' C ' ' A' ' 398' ' ' GLY . 2.5 mp0 -132.88 127.71 34.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.87 0.367 . . . . 0.0 110.849 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.46 96.81 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 20.4 pt -74.67 148.9 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.11 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -112.58 129.71 56.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.863 HD12 ' N ' ' A' ' 392' ' ' ASN . 27.3 mt -113.91 126.47 71.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.141 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.65 136.28 46.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.149 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.59 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 9.0 m-85 -54.9 112.61 1.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.22 167.93 16.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.104 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.67 149.39 35.66 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.605 0.717 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 129.01 16.88 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.73 2.286 . . . . 0.0 112.32 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -25.59 28.43 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.685 2.257 . . . . 0.0 112.332 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.52 158.85 9.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -152.14 120.79 6.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -172.87 131.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 6.1 ttt-85 -128.99 147.0 50.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -120.29 166.97 12.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -164.79 119.96 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -124.24 176.26 6.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.828 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -167.17 105.7 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -133.25 129.08 37.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.053 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -118.56 139.36 51.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -154.28 146.54 23.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -143.51 166.29 25.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -164.36 169.52 17.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -149.08 142.71 25.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 17.4 t -143.2 146.82 34.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.85 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -154.85 90.62 0.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.513 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -177.29 1.82 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.657 2.238 . . . . 0.0 112.314 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 5.9 t -147.76 164.84 32.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.3 m -81.39 174.01 11.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.859 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.493 179.983 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 21.5 t -108.41 120.9 43.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.89 0.376 . . . . 0.0 110.897 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 6.5 t -137.88 136.54 37.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -105.99 115.51 4.83 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.437 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 84.3 p -80.71 -40.75 24.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 0.0 110.836 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 333' ' ' GLY . 3.8 t -119.84 92.56 3.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 332' ' ' SER . . . 35.43 -113.64 0.14 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.447 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 52.9 mtt -134.08 101.84 5.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.297 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -78.41 172.14 14.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -121.82 111.14 16.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.552 ' HB ' ' CD1' ' A' ' 405' ' ' PHE . 48.2 t -151.04 129.36 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.118 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 8.8 pttm -94.03 -32.6 13.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 67.7 t -79.61 118.81 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.147 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.572 HD21 ' HB1' ' A' ' 384' ' ' ALA . 46.1 mt -99.2 131.02 45.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -92.92 105.17 17.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.53 HG22 HG12 ' A' ' 403' ' ' ILE . 20.8 t -104.17 131.83 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -133.21 173.73 11.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 73.06 35.47 0.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.427 HD21 HG12 ' A' ' 342' ' ' VAL . 21.4 mt -76.63 139.18 40.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.428 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -67.52 -178.93 0.97 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -85.7 -0.26 54.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 17.2 p -117.64 14.94 14.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.159 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.428 HG23 ' HB3' ' A' ' 346' ' ' ALA . 96.0 t -96.52 133.73 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.127 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 39.8 p -134.39 169.01 17.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.116 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -51.7 -41.66 61.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -57.47 -43.87 84.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 66.5 mt -67.7 -29.56 45.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.55 ' HB2' HG11 ' A' ' 367' ' ' VAL . 96.0 mt -72.78 -32.01 65.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.477 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 16.1 mt-10 -73.14 -69.85 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 356' ' ' LYS . . . . . 0.471 ' HE3' ' N ' ' A' ' 356' ' ' LYS . 0.7 OUTLIER -43.25 -39.11 2.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 357' ' ' ALA . . . . . 0.561 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -69.59 -56.02 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' PHE . . . . . 0.426 ' O ' HD21 ' A' ' 364' ' ' LEU . 42.7 m-85 -83.96 14.54 4.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 355' ' ' GLU . 11.7 t -100.01 -52.39 3.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -40.35 -37.63 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.533 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 79.9 m-85 -65.7 -62.75 1.34 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.94 162.22 29.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.507 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -49.0 130.85 18.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 0.0 110.917 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.477 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 36.2 mt -101.21 155.02 18.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -100.12 -47.86 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -173.52 167.44 4.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.55 HG11 ' HB2' ' A' ' 354' ' ' LEU . 83.2 t -136.87 133.42 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.34 118.51 31.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 12.9 tptp -92.66 141.33 28.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.758 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.5 mp -126.39 -174.65 3.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 370' ' ' LEU . 1.3 mppt? -33.51 -68.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -122.27 -37.67 2.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.758 ' CE2' HD22 ' A' ' 370' ' ' LEU . 6.7 p90 -92.64 -176.39 4.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.503 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -163.87 161.84 23.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -112.4 134.68 53.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.7 mm -108.56 109.11 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.151 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -88.42 120.67 30.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.508 ' CE1' HD12 ' A' ' 340' ' ' LEU . 17.9 m-85 -101.92 147.53 26.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.54 -33.7 75.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -132.71 153.97 50.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -61.78 -31.01 71.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.99 -51.18 27.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -43.18 -36.67 2.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.501 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.572 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -72.11 -59.32 2.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.865 0.364 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.478 HG22 ' HZ ' ' A' ' 405' ' ' PHE . 86.1 t -36.41 -37.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.8 tptt -72.56 -66.01 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -56.3 -15.87 4.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 7.5 ttm -78.94 -60.15 2.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -78.2 -2.5 38.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.533 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 65.0 mm-40 -100.07 -21.62 15.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' MET . . . . . 0.561 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 10.9 mmm -116.8 -39.12 3.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.845 ' N ' HD12 ' A' ' 403' ' ' ILE . 27.5 t-20 -33.23 93.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 103.73 29.93 5.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 391' ' ' MET . 14.8 mmmt -96.2 146.4 24.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.729 0.299 . . . . 0.0 110.914 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.66 74.05 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.625 HD22 HD13 ' A' ' 401' ' ' ILE . 15.6 tp -76.41 110.65 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 62.28 24.96 14.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.66 13.84 57.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.478 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -133.56 130.53 38.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 0.0 110.889 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.3 93.57 2.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.625 HD13 HD22 ' A' ' 396' ' ' LEU . 20.2 pt -72.06 145.47 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -108.72 130.2 55.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.845 HD12 ' N ' ' A' ' 392' ' ' ASN . 24.7 mt -115.52 127.82 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.1 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.27 140.07 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 7.7 m-85 -58.16 108.95 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.5 156.49 36.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -81.13 146.54 58.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.549 0.69 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 131.94 22.35 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.723 2.282 . . . . 0.0 112.345 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -35.82 12.05 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.653 2.235 . . . . 0.0 112.361 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.66 113.99 21.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -113.28 79.14 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -108.98 122.06 46.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -73.89 99.04 3.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -121.93 112.84 18.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -149.77 165.81 31.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -140.14 151.3 45.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' LYS . . . . . 0.415 ' C ' ' HD3' ' A' ' 417' ' ' LYS . 2.5 tmtt? -159.33 129.78 5.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -168.01 143.79 3.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.165 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -165.67 140.46 4.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.884 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -149.94 152.41 34.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -95.25 156.29 16.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.961 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -117.19 172.53 7.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.08 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -172.33 164.56 5.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.2 t -159.27 173.28 16.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 176.72 147.46 6.56 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.486 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 142.64 48.34 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.705 2.27 . . . . 0.0 112.335 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 6.2 m -134.11 -62.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 5.0 m -137.6 140.09 40.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.864 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.488 -179.952 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 77.0 p -107.5 158.42 17.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.883 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 5.5 t 41.94 42.08 2.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -143.28 89.56 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.484 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 1.2 t -170.04 126.66 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.377 . . . . 0.0 110.851 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 48.0 t -104.92 81.55 1.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -135.23 103.73 0.48 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.462 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 29.5 mmt -78.13 121.05 23.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.783 0.325 . . . . 0.0 110.881 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -115.47 122.68 46.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.101 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -85.22 43.91 1.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 406' ' ' ALA . 94.7 t -93.32 133.3 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.177 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -93.06 -33.27 14.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.95 122.45 27.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.153 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.645 HD21 ' HB1' ' A' ' 384' ' ' ALA . 29.3 mt -102.33 122.85 45.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 52.7 t80 -85.64 111.29 19.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.608 HG22 HG12 ' A' ' 403' ' ' ILE . 46.3 t -106.22 141.51 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.117 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -140.74 168.21 20.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 75.05 45.34 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 54.0 mt -81.08 137.97 35.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.655 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -62.31 -175.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.085 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -89.86 -4.84 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.851 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 80.5 p -118.71 19.26 13.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.655 HG23 ' HB3' ' A' ' 346' ' ' ALA . 81.5 t -94.74 152.57 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.091 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 350' ' ' THR . . . . . 0.403 ' N ' HG12 ' A' ' 349' ' ' VAL . 82.2 p -155.45 175.44 13.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -57.28 -45.82 83.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.926 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -53.4 -43.59 68.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 349' ' ' VAL . 70.7 mt -67.72 -38.81 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.498 HD22 HD11 ' A' ' 376' ' ' ILE . 88.1 mt -64.28 -25.41 68.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.961 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 359' ' ' SER . 37.2 mt-10 -76.94 -71.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -44.2 -33.17 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' ALA . . . . . 0.621 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -74.39 -52.47 12.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.128 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' PHE . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 41.7 m-85 -88.27 13.57 11.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 355' ' ' GLU . 11.8 t -100.03 -58.22 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 360' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 359' ' ' SER . 20.7 pt20 -34.96 -39.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 89.6 m-85 -63.41 -63.91 1.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -149.83 166.47 29.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.81 129.98 31.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.917 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.418 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 27.8 mt -98.36 161.51 13.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.869 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -109.71 -46.28 3.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -174.32 165.27 4.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.471 HG11 ' HB2' ' A' ' 354' ' ' LEU . 53.2 t -135.75 132.57 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.108 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.77 108.25 10.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' LYS . . . . . 0.467 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 8.3 tttm -87.77 147.28 25.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.774 HD22 ' CE2' ' A' ' 373' ' ' TYR . 5.6 mp -126.33 -173.52 2.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.486 ' C ' ' O ' ' A' ' 370' ' ' LEU . 32.4 ttmt -30.35 -65.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -125.72 -37.96 2.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.861 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.774 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.5 p90 -90.93 -176.25 4.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 370' ' ' LEU . . . -162.78 160.93 25.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.086 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.401 ' CZ ' ' HD1' ' A' ' 341' ' ' PHE . 12.7 m-85 -116.28 121.86 43.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.498 HD11 HD22 ' A' ' 354' ' ' LEU . 5.3 mm -96.62 122.26 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -100.09 123.19 44.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 358' ' ' PHE . 19.9 m-85 -105.3 147.71 27.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -64.28 -35.01 79.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -130.99 147.46 52.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.457 ' NH1' ' CG2' ' A' ' 385' ' ' VAL . 0.0 OUTLIER -55.54 -32.07 62.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.826 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 382' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 384' ' ' ALA . 7.1 t70 -68.74 -60.6 2.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 382' ' ' ASP . . . -36.35 -33.81 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.491 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.645 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -74.07 -63.8 1.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 111.065 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.457 ' CG2' ' NH1' ' A' ' 381' ' ' ARG . 92.5 t -35.43 -35.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' LYS . . . . . 0.48 ' HE3' ' CG ' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -71.92 -60.56 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -62.1 -17.73 58.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.135 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.585 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 7.4 ttm -75.24 -59.1 2.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.401 ' N ' ' HG2' ' A' ' 388' ' ' MET . 7.3 mt-10 -77.69 -3.04 39.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.48 ' CG ' ' HE3' ' A' ' 386' ' ' LYS . 28.5 mm-40 -100.09 -29.21 12.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.884 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' MET . . . . . 0.621 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 7.4 mmm -108.0 -28.92 9.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.663 ' N ' HD12 ' A' ' 403' ' ' ILE . 2.6 t-20 -43.74 111.56 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 78.81 24.71 61.67 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 391' ' ' MET . 0.0 OUTLIER -93.62 142.57 27.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 0.0 110.876 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -70.56 103.19 2.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.787 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.494 HD22 HD13 ' A' ' 401' ' ' ILE . 19.5 tp -109.83 110.48 21.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 62.04 34.4 16.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 80.8 16.28 75.58 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.518 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -140.03 119.57 13.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.31 104.32 2.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.494 HD13 HD22 ' A' ' 396' ' ' LEU . 28.0 pt -79.42 151.06 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.559 ' OE1' HG13 ' A' ' 404' ' ' VAL . 9.6 tm-20 -114.81 132.02 56.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.663 HD12 ' N ' ' A' ' 392' ' ' ASN . 22.6 mt -116.05 134.83 58.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.109 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.559 HG13 ' OE1' ' A' ' 402' ' ' GLU . 14.1 m -147.74 130.62 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.585 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 14.5 m-85 -49.52 105.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.556 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . -64.21 145.37 56.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.072 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -66.49 153.13 93.72 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.616 0.722 . . . . 0.0 110.896 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 127.9 15.27 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.633 2.222 . . . . 0.0 112.374 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -3.55 12.22 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.745 2.297 . . . . 0.0 112.368 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -152.48 159.27 43.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -101.2 94.82 6.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.959 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -98.47 104.74 16.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -142.15 113.58 7.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -127.66 100.81 6.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -56.38 160.66 2.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.63 166.51 21.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.828 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -170.26 144.53 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -121.26 156.23 32.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.082 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -156.95 153.13 27.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -169.1 174.69 6.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.83 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -155.53 142.13 18.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.908 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -128.84 162.25 27.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.1 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -152.76 134.96 14.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.101 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 23.3 t -119.95 171.43 8.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -156.39 145.64 12.55 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.476 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 110.99 2.68 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.723 2.282 . . . . 0.0 112.346 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 1.4 t -82.25 142.43 32.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 5.5 m -77.74 167.77 21.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.486 179.997 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 97.7 p -126.87 -46.8 1.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.856 0.36 . . . . 0.0 110.828 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 34.8 m -136.17 121.1 18.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -171.95 143.44 7.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.492 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 73.2 p -130.8 132.99 45.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.87 0.367 . . . . 0.0 110.855 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.4 m -126.91 110.86 13.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 90.89 -170.54 34.89 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.49 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 9.0 mmt -85.13 162.35 19.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.329 . . . . 0.0 110.844 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -79.61 -55.86 4.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.096 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -76.13 74.83 2.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.525 ' HB ' ' CD1' ' A' ' 405' ' ' PHE . 80.7 t -126.08 133.13 69.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -95.23 -31.8 13.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.913 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.2 t -79.96 123.01 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.865 HD21 ' HB1' ' A' ' 384' ' ' ALA . 33.5 mt -102.42 131.23 49.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.948 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.462 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 76.9 t80 -94.78 104.7 16.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.805 HG22 HG12 ' A' ' 403' ' ' ILE . 33.0 t -104.42 130.78 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -132.33 173.35 11.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' ASN . . . . . 0.49 ' ND2' ' OE1' ' A' ' 399' ' ' GLU . 0.7 OUTLIER 73.78 40.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.888 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 62.1 mt -78.86 159.11 27.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -86.0 -178.74 6.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.075 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -88.39 4.64 45.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 15.9 p -124.47 15.41 8.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.1 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.87 143.6 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.089 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' THR . . . . . 0.409 ' H ' HD12 ' A' ' 353' ' ' ILE . 73.7 p -143.3 173.11 11.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -52.93 -48.09 67.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -51.77 -46.18 64.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.862 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.409 HD12 ' H ' ' A' ' 350' ' ' THR . 77.5 mt -64.7 -35.7 75.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.591 ' HB2' HG11 ' A' ' 367' ' ' VAL . 95.6 mt -69.53 -27.4 65.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.469 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 34.2 mt-10 -77.64 -69.19 0.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -46.21 -32.8 3.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' ALA . . . . . 0.564 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -75.77 -49.16 18.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.098 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 358' ' ' PHE . . . . . 0.446 ' C ' HD11 ' A' ' 364' ' ' LEU . 28.7 m-85 -89.73 15.89 8.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 360' ' ' GLN . 9.9 t -98.9 -57.81 2.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.842 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 360' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 359' ' ' SER . 24.2 pt20 -35.97 -39.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.892 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.522 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 85.1 m-85 -63.78 -63.4 1.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.39 162.52 29.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.434 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -50.12 127.28 16.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.499 HD21 ' CZ ' ' A' ' 378' ' ' PHE . 32.3 mt -97.66 153.97 17.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -102.06 -49.03 4.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -171.31 164.42 7.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.591 HG11 ' HB2' ' A' ' 354' ' ' LEU . 40.6 t -136.4 125.8 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -112.08 118.95 36.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -91.32 140.52 29.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.93 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.781 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.5 mp -124.24 -174.76 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 370' ' ' LEU . 1.0 OUTLIER -33.69 -69.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -119.6 -38.53 2.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.822 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.781 ' CE2' HD22 ' A' ' 370' ' ' LEU . 5.2 p90 -91.44 -174.95 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.474 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -163.83 162.81 23.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.111 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -112.47 139.26 48.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 6.2 mm -114.11 104.31 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.119 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -84.26 122.78 29.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.499 ' CZ ' HD21 ' A' ' 364' ' ' LEU . 19.8 m-85 -105.12 148.1 27.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -58.46 -36.85 74.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -134.35 155.79 49.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.879 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' ARG . . . . . 0.416 ' C ' ' HD3' ' A' ' 381' ' ' ARG . 2.4 tmt_? -59.05 -34.56 72.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 384' ' ' ALA . 23.1 t70 -67.01 -60.03 2.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.831 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -37.06 -32.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.487 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.865 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -76.82 -54.95 5.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.859 0.361 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 381' ' ' ARG . 65.1 t -36.79 -39.7 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -69.8 -66.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -53.29 -15.73 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.118 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.56 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.5 ttm -79.6 -63.93 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.457 ' N ' ' HG2' ' A' ' 388' ' ' MET . 6.4 mt-10 -75.2 -0.67 20.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.522 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 28.3 mm-40 -100.19 -35.36 9.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' MET . . . . . 0.564 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 9.8 mmm -103.47 -34.61 8.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.679 ' N ' HD12 ' A' ' 403' ' ' ILE . 3.5 t-20 -37.79 99.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 96.04 28.53 9.23 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.452 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 391' ' ' MET . 34.4 mmtt -95.6 147.26 23.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.779 0.323 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.37 78.02 3.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.457 HD22 HD13 ' A' ' 401' ' ' ILE . 21.5 tp -81.87 110.39 17.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 62.19 27.48 16.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.43 21.3 48.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' GLU . . . . . 0.49 ' OE1' ' ND2' ' A' ' 344' ' ' ASN . 12.7 mm-40 -140.06 126.51 20.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 0.0 110.851 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.47 92.53 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.457 HD13 HD22 ' A' ' 396' ' ' LEU . 28.8 pt -72.41 150.54 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.094 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -115.78 131.35 56.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.805 HG12 HG22 ' A' ' 342' ' ' VAL . 28.0 mt -114.87 124.84 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.164 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 30.7 m -138.03 132.33 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.56 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 17.7 m-85 -49.18 114.11 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . -75.98 161.84 28.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.124 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -73.85 147.29 86.27 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.546 0.688 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 146.84 61.82 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.686 2.257 . . . . 0.0 112.374 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -17.53 37.23 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.673 2.248 . . . . 0.0 112.33 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -113.88 120.01 39.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -109.59 130.09 55.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.935 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.407 ' HG3' ' N ' ' A' ' 413' ' ' ARG . 25.3 tptt -69.01 151.81 46.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 413' ' ' ARG . . . . . 0.407 ' N ' ' HG3' ' A' ' 412' ' ' LYS . 20.0 ptp180 -110.32 149.01 30.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -130.01 154.27 47.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -150.76 118.45 6.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -90.41 155.79 18.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -124.54 -178.32 4.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -137.64 143.74 41.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.074 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -102.21 175.69 5.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 11.2 ptt-85 -97.51 177.09 5.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.04 162.6 40.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.905 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -123.55 172.0 9.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -143.26 167.66 21.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.077 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 69.6 m -129.62 170.8 13.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.849 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -118.04 126.01 6.7 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.489 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -172.21 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.708 2.272 . . . . 0.0 112.356 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 64.8 p -147.96 175.46 10.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 52.8 p -124.63 175.34 7.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.496 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 30.2 p -146.21 131.15 18.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 110.848 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 83.1 p -55.6 168.51 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.903 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -115.9 152.28 18.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.493 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 70.8 m -78.7 150.18 32.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 0.0 110.873 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 2.9 m -90.01 124.57 34.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 58.86 85.6 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.476 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 9.2 ttt -94.47 -54.73 3.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 110.89 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -155.13 140.41 17.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.085 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 75.59 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 86.3 t -133.47 133.1 57.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.198 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -91.69 -28.81 17.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 60.2 t -79.86 129.83 36.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.147 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.534 HD21 ' HB1' ' A' ' 384' ' ' ALA . 31.2 mt -110.71 125.03 53.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' A' ' 343' ' ' ARG . 6.3 t80 -86.04 118.84 25.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 403' ' ' ILE . 21.2 t -115.73 130.12 70.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.099 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.473 ' HB3' ' CE1' ' A' ' 341' ' ' PHE . 6.9 ptp180 -128.58 -179.91 5.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 65.22 41.92 4.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.606 HD13 ' NZ ' ' A' ' 369' ' ' LYS . 39.4 mt -84.32 136.33 33.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.28 172.48 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.128 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -81.66 11.92 4.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 18.5 p -129.36 11.19 5.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.742 HG12 ' NZ ' ' A' ' 369' ' ' LYS . 84.8 t -85.91 139.61 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.164 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 76.7 p -140.42 157.71 45.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.446 ' HG2' HG12 ' A' ' 367' ' ' VAL . 35.5 mt-10 -43.92 -43.9 6.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -54.36 -42.87 70.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 78.1 mt -68.93 -33.37 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.462 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 95.2 mt -69.22 -30.83 69.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 359' ' ' SER . 51.9 mt-10 -72.72 -72.41 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -44.19 -36.91 2.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' ALA . . . . . 0.467 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -69.42 -51.87 32.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' PHE . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 34.8 m-85 -89.23 15.58 8.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 355' ' ' GLU . 12.3 t -99.66 -51.82 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -40.44 -38.22 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.945 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.531 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 92.0 m-85 -65.59 -62.35 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.19 170.3 31.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -55.77 138.52 47.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.422 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 55.7 mt -107.95 162.64 13.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -111.46 -48.94 3.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.434 ' HB2' ' NH1' ' A' ' 366' ' ' ARG . 1.3 ptp180 -171.23 166.19 7.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.446 HG12 ' HG2' ' A' ' 351' ' ' GLU . 78.6 t -135.67 130.89 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -116.84 116.81 28.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' LYS . . . . . 0.742 ' NZ ' HG12 ' A' ' 349' ' ' VAL . 33.8 tptt -89.12 146.22 24.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.845 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.5 mp -130.58 -174.86 3.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 370' ' ' LEU . 28.8 mtpt -33.64 -62.49 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.488 ' O ' HD12 ' A' ' 345' ' ' LEU . 3.9 m-20 -129.38 -36.05 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.845 ' CE2' HD22 ' A' ' 370' ' ' LEU . 3.7 p90 -92.23 -174.94 3.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.532 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -167.35 153.02 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.106 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -103.01 137.95 40.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.462 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.9 mm -110.33 110.6 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -88.49 121.46 30.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 358' ' ' PHE . 17.3 m-85 -103.24 144.12 31.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.92 -27.89 54.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -142.01 156.3 45.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -61.49 -35.22 77.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 384' ' ' ALA . 27.0 t70 -66.89 -58.74 4.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -38.04 -31.1 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.455 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.534 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -77.19 -58.61 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.328 . . . . 0.0 111.079 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 384' ' ' ALA . 57.7 t -36.08 -35.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -73.54 -66.09 0.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -55.51 -17.37 5.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.095 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.561 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.0 ttm -77.3 -63.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.875 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.463 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.4 mt-10 -74.81 0.33 15.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.531 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 30.1 mm-40 -100.21 -36.27 9.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 391' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 393' ' ' GLY . 4.0 mmt -102.64 -31.27 10.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.65 ' N ' HD12 ' A' ' 403' ' ' ILE . 6.5 t-20 -39.2 92.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 101.38 33.85 4.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.465 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -100.14 147.19 25.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.878 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.09 80.96 2.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 17.8 tp -90.07 113.88 25.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 62.25 26.39 15.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.939 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 84.83 20.33 58.11 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -140.01 122.18 15.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.921 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.38 92.27 0.8 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 19.4 pt -71.33 147.46 10.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.123 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -113.05 131.37 55.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.656 HG12 HG22 ' A' ' 342' ' ' VAL . 55.7 mt -110.78 136.98 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.124 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 20.2 m -151.76 135.13 7.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.561 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 24.0 m-85 -52.58 117.22 2.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -74.61 161.36 29.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -89.68 143.83 30.95 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.611 0.719 . . . . 0.0 110.864 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 159.58 52.85 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.678 2.252 . . . . 0.0 112.337 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 150.29 67.94 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.635 2.224 . . . . 0.0 112.328 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -86.03 125.05 33.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -159.82 135.78 8.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -121.24 161.42 21.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' ARG . . . . . 0.413 ' NH1' ' HB3' ' A' ' 413' ' ' ARG . 4.9 mmm180 -123.07 -52.07 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -52.64 161.44 0.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -161.86 155.93 21.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.866 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -143.82 165.17 28.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' LYS . . . . . 0.457 ' HG2' ' N ' ' A' ' 418' ' ' ALA . 9.1 ttmm -165.91 145.47 6.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.457 ' N ' ' HG2' ' A' ' 417' ' ' LYS . . . -146.65 171.69 14.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.069 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -169.47 139.27 2.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -122.72 170.1 10.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -127.69 176.14 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -165.57 166.71 17.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.061 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -137.09 152.54 50.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 3.8 m -163.83 162.85 23.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -150.73 146.05 14.63 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.481 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 171.78 13.84 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.724 2.282 . . . . 0.0 112.308 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 53.4 m -98.7 -44.01 6.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.843 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 27.8 m -146.51 166.35 26.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.486 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.807 0.337 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 68.5 t -82.66 137.22 21.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.574 HD22 ' HB2' ' A' ' 388' ' ' MET . 56.6 mt -111.48 127.54 55.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.578 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 71.1 t80 -90.65 105.49 17.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.452 ' CG1' HD12 ' A' ' 401' ' ' ILE . 21.6 t -104.86 128.57 58.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -128.44 175.92 8.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.66 36.4 1.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 31.8 mt -75.1 146.63 41.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.627 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -73.19 -179.14 3.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.107 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -85.51 -2.34 58.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 13.1 p -118.49 15.55 13.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.627 HG23 ' HB3' ' A' ' 346' ' ' ALA . 95.7 t -97.25 135.64 30.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.092 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 82.3 p -139.31 175.79 9.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.168 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -54.86 -44.78 74.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -55.53 -44.77 77.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 63.7 mt -68.54 -33.79 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.138 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.454 ' HB2' HG11 ' A' ' 367' ' ' VAL . 89.9 mt -70.75 -27.77 64.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 359' ' ' SER . 72.4 mt-10 -74.21 -71.19 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -41.54 -39.4 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' ALA . . . . . 0.735 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -69.77 -56.31 7.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -83.86 14.46 4.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 355' ' ' GLU . 13.4 t -99.22 -56.83 2.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 359' ' ' SER . 27.2 pt20 -37.67 -38.28 0.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.496 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 84.5 m-85 -63.0 -63.08 1.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.25 167.12 31.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.465 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -52.98 128.83 28.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.454 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 37.5 mt -98.15 157.2 16.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.912 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -106.02 -46.67 4.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -174.9 165.6 3.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 354' ' ' LEU . 78.4 t -135.41 127.85 47.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.118 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -114.69 113.4 24.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -89.0 142.02 27.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.731 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.1 mp -126.91 -174.02 3.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.5 OUTLIER -32.28 -67.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.891 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -124.43 -37.7 2.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.731 ' CE2' HD22 ' A' ' 370' ' ' LEU . 9.1 p90 -93.46 179.64 5.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.508 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -158.21 168.22 27.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.131 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -119.02 128.55 54.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 7.2 mm -102.6 114.59 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -92.66 126.67 37.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 387' ' ' ALA . 21.2 m-85 -109.51 137.73 46.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -54.16 -30.66 50.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -135.87 152.67 51.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 385' ' ' VAL . 6.0 tmm_? -60.64 -28.37 68.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.919 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -71.72 -54.08 11.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . 0.408 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -42.97 -30.82 1.08 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . 0.444 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -77.74 -59.43 2.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.821 0.343 . . . . 0.0 111.082 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 381' ' ' ARG . 95.4 t -37.99 -37.75 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.127 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -71.3 -62.81 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -59.71 -15.67 21.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.574 ' HB2' HD22 ' A' ' 340' ' ' LEU . 8.7 ttm -78.75 -62.39 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.436 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.6 mt-10 -74.92 -0.35 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.496 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 14.3 mm-40 -100.03 -38.99 8.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . 0.735 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 4.4 mmt -100.96 -27.66 13.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.934 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.875 ' N ' HD12 ' A' ' 403' ' ' ILE . 1.5 t-20 -38.05 107.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 78.52 38.61 24.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.479 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 21.3 mmtt -100.06 149.05 23.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 110.884 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -75.57 82.18 2.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.88 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.401 HD22 HD13 ' A' ' 401' ' ' ILE . 15.3 tp -89.48 112.6 23.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 62.24 26.63 15.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 88.14 11.31 67.43 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.487 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -130.91 128.91 41.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.888 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.51 98.37 4.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.825 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.452 HD12 ' CG1' ' A' ' 342' ' ' VAL . 20.2 pt -78.1 147.92 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.138 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -109.83 129.72 55.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.875 HD12 ' N ' ' A' ' 392' ' ' ASN . 15.5 mt -113.35 124.12 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.095 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 2.9 m -138.62 135.16 43.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.562 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 10.1 m-85 -51.67 106.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.578 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.077 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 3.7 pttm . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.878 0.371 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 65.2 t -69.49 133.22 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.072 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.529 HD21 ' HB1' ' A' ' 384' ' ' ALA . 51.8 mt -105.28 119.2 38.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -85.32 106.18 16.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.776 HG22 HG12 ' A' ' 403' ' ' ILE . 25.4 t -102.1 130.05 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.163 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -131.14 173.29 11.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.73 39.61 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.614 HD13 ' NZ ' ' A' ' 369' ' ' LYS . 38.6 mt -81.24 156.95 25.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.921 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -95.08 161.23 14.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.075 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -63.73 -8.0 9.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 24.9 p -98.84 -9.24 24.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.165 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.543 HG12 ' NZ ' ' A' ' 369' ' ' LYS . 57.7 t -83.15 140.48 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.139 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 78.2 p -144.46 163.03 35.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -40.7 -50.46 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -52.08 -52.24 52.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.903 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 75.2 mt -58.95 -29.08 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.5 ' HB2' HG11 ' A' ' 367' ' ' VAL . 96.1 mt -75.54 -30.65 59.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.472 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 51.3 mt-10 -75.58 -64.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -50.14 -38.67 40.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' ALA . . . . . 0.458 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -69.01 -49.69 55.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' PHE . . . . . 0.422 ' C ' HD11 ' A' ' 364' ' ' LEU . 45.0 m-85 -90.32 14.89 11.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 355' ' ' GLU . 9.0 t -100.06 -51.35 3.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -38.84 -38.7 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.497 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 94.1 m-85 -64.49 -62.72 1.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -153.65 161.31 29.78 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -47.94 129.06 14.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.472 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 40.4 mt -98.31 156.42 16.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -100.55 -50.49 3.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -171.24 165.49 7.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 354' ' ' LEU . 51.1 t -136.93 129.59 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.82 109.02 16.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . 0.614 ' NZ ' HD13 ' A' ' 345' ' ' LEU . 29.5 tptt -82.17 146.16 29.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.703 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.7 mp -128.99 -174.91 3.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.1 OUTLIER -34.4 -67.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -122.3 -37.14 2.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.703 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.8 p90 -94.19 -175.11 3.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.531 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -166.44 161.41 16.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.138 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -110.94 137.3 48.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 5.3 mm -111.16 109.55 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -89.29 121.32 31.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 19.5 m-85 -101.78 149.08 24.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -69.02 -31.76 70.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.847 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -131.05 154.37 48.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -58.13 -37.71 75.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 384' ' ' ALA . 19.6 t70 -66.2 -57.55 7.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . 0.537 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -35.12 -31.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.507 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . 0.529 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -80.88 -66.93 0.82 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.117 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' A' ' 384' ' ' ALA . 58.0 t -36.0 -35.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 384' ' ' ALA . 12.1 tptm -72.92 -61.03 1.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.51 -16.92 41.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.593 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.7 ttm -76.52 -61.27 2.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.436 ' N ' ' HG2' ' A' ' 388' ' ' MET . 13.1 mt-10 -74.17 -4.22 34.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.872 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.497 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 39.0 mm-40 -100.03 -33.02 10.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . 0.503 ' O ' ' CG ' ' A' ' 394' ' ' LYS . 38.2 mmm -101.96 -41.0 6.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.754 ' N ' HD12 ' A' ' 403' ' ' ILE . 5.1 t-20 -34.12 116.61 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 76.63 30.05 56.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.46 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.734 ' HE3' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -100.01 141.97 32.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 0.0 110.896 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.49 99.99 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.734 HD13 ' HE3' ' A' ' 394' ' ' LYS . 20.5 tp -106.36 114.31 28.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.968 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . 0.451 ' HG3' HG22 ' A' ' 349' ' ' VAL . 6.2 mm-40 60.88 27.18 17.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.88 16.86 59.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.479 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -140.04 120.74 14.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.91 100.01 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.567 HD12 ' CG1' ' A' ' 342' ' ' VAL . 25.0 pt -75.68 149.72 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -112.44 128.51 56.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.776 HG12 HG22 ' A' ' 342' ' ' VAL . 35.6 mt -111.96 128.97 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.124 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 9.9 m -142.32 132.91 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.152 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.593 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 19.2 m-85 -50.87 110.78 0.46 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.814 0.34 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.0 t -85.17 125.68 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.118 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.617 HD12 ' CE1' ' A' ' 378' ' ' PHE . 70.6 mt -103.84 130.35 51.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.946 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -94.74 107.83 19.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.59 HG22 HG12 ' A' ' 403' ' ' ILE . 18.7 t -106.15 130.49 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -130.15 168.24 17.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.3 t30 72.22 54.35 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.466 HD21 HG12 ' A' ' 342' ' ' VAL . 15.6 mt -96.25 145.91 25.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.929 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -81.08 163.12 23.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.053 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -66.83 -4.47 9.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 24.6 p -104.58 6.31 34.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.709 HG12 ' NZ ' ' A' ' 369' ' ' LYS . 58.6 t -94.16 138.09 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.154 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 43.4 p -142.64 159.15 42.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.16 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.4 ' HA ' HD12 ' A' ' 354' ' ' LEU . 53.3 mt-10 -42.73 -41.15 3.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -57.92 -46.93 84.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 73.3 mt -65.56 -30.17 49.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.14 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.513 ' HB2' HG11 ' A' ' 367' ' ' VAL . 83.2 mt -72.94 -31.4 64.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 359' ' ' SER . 21.7 mt-10 -72.07 -67.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -50.3 -39.92 46.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' ALA . . . . . 0.463 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -65.71 -51.3 60.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' PHE . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 45.3 m-85 -90.49 14.57 12.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 355' ' ' GLU . 2.1 t -99.8 -57.44 2.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 359' ' ' SER . 19.1 pt20 -35.2 -39.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -64.58 -65.23 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -147.4 163.89 28.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.454 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -52.85 130.72 34.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.469 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 34.2 mt -99.77 158.94 15.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.949 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -108.07 -44.5 4.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -174.16 164.41 4.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.513 HG11 ' HB2' ' A' ' 354' ' ' LEU . 54.2 t -135.51 133.75 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.443 ' O ' ' HB1' ' A' ' 374' ' ' ALA . 39.7 tptt -119.55 123.76 44.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . 0.709 ' NZ ' HG12 ' A' ' 349' ' ' VAL . 24.0 tptt -95.7 146.29 24.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.788 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.8 mp -133.96 -174.74 3.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 370' ' ' LEU . 24.4 tttp -33.57 -68.46 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.886 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.3 -37.13 2.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.788 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.3 p90 -90.94 -175.79 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.968 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 368' ' ' LYS . . . -168.15 147.18 4.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.091 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -95.76 142.23 28.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.6 mm -118.07 106.18 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -84.44 121.48 27.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.847 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.617 ' CE1' HD12 ' A' ' 340' ' ' LEU . 14.4 m-85 -102.61 151.47 22.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -60.57 -35.77 76.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -140.35 153.12 46.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.449 ' O ' HG23 ' A' ' 385' ' ' VAL . 6.5 tmm_? -52.7 -28.43 21.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.877 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 384' ' ' ALA . 12.0 t0 -69.81 -62.21 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . 0.474 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -36.76 -29.62 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.52 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . 0.506 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -79.9 -58.47 3.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 0.0 111.113 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 381' ' ' ARG . 96.3 t -38.39 -38.63 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.151 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -71.93 -64.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -57.04 -15.48 5.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.602 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 9.0 ttm -79.46 -62.91 1.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.442 ' N ' ' HG2' ' A' ' 388' ' ' MET . 9.9 mt-10 -74.86 -0.97 20.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -100.09 -35.04 9.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . 0.47 ' HA ' ' CG ' ' A' ' 394' ' ' LYS . 27.7 mmm -103.91 -37.15 7.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.889 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.821 ' N ' HD12 ' A' ' 403' ' ' ILE . 4.3 t-20 -34.29 101.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 92.22 29.68 11.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.464 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.47 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 8.7 mmtp -94.99 148.2 22.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 0.0 110.854 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.64 80.66 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 15.6 tp -89.12 115.69 26.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.941 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 62.22 25.02 14.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 86.03 20.18 55.96 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.464 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -139.81 125.28 19.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.92 98.21 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 47.2 pt -74.6 153.32 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -117.09 126.61 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.821 HD12 ' N ' ' A' ' 392' ' ' ASN . 23.2 mt -113.06 124.85 70.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.158 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 10.4 m -137.05 133.35 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.602 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 8.3 m-85 -51.26 110.91 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.068 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 339' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.841 0.353 . . . . 0.0 110.891 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.427 ' N ' ' HD2' ' A' ' 338' ' ' LYS . 86.4 t -77.18 131.34 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.101 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.878 HD21 ' HB1' ' A' ' 384' ' ' ALA . 43.4 mt -108.26 127.37 53.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.522 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 56.2 t80 -91.27 108.61 20.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.463 HG12 HD21 ' A' ' 345' ' ' LEU . 14.0 t -103.13 134.73 43.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.125 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -134.11 167.13 21.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.84 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . 0.401 ' O ' HG22 ' A' ' 401' ' ' ILE . 3.4 t30 73.23 52.38 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.463 HD21 HG12 ' A' ' 342' ' ' VAL . 22.5 mt -96.22 131.99 42.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.452 ' HB3' ' CB ' ' A' ' 397' ' ' GLU . . . -54.58 -176.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -88.93 5.68 42.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 21.9 p -121.86 13.77 10.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 91.6 t -88.55 138.81 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . 0.432 ' H ' HD12 ' A' ' 353' ' ' ILE . 67.0 p -144.07 167.05 23.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.159 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -50.45 -43.94 55.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.04 -41.9 75.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.432 HD12 ' H ' ' A' ' 350' ' ' THR . 71.3 mt -69.49 -41.48 80.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.557 ' HB2' HG11 ' A' ' 367' ' ' VAL . 92.4 mt -63.37 -32.51 73.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.48 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 46.1 mt-10 -68.21 -73.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -41.48 -39.67 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.957 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' ALA . . . . . 0.652 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -66.7 -54.6 21.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' PHE . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 37.0 m-85 -87.78 14.68 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 355' ' ' GLU . 17.7 t -99.99 -53.25 3.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.848 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -38.68 -38.68 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.505 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 84.3 m-85 -64.08 -62.71 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -151.87 169.78 31.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.525 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -53.86 132.73 42.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.818 0.342 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.48 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 32.9 mt -101.46 160.49 14.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.949 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -110.33 -48.04 3.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -172.97 163.65 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' A' ' 354' ' ' LEU . 71.9 t -134.1 130.07 54.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -111.06 108.41 18.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.866 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . 0.407 ' C ' HD12 ' A' ' 370' ' ' LEU . 19.3 tptp -87.08 137.58 32.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.799 HD22 ' CE2' ' A' ' 373' ' ' TYR . 7.6 mp -126.28 -174.74 3.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 370' ' ' LEU . 30.8 tttm -33.55 -67.73 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.873 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.16 -36.39 2.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.799 ' CE2' HD22 ' A' ' 370' ' ' LEU . 6.5 p90 -93.7 -177.36 4.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -165.79 159.65 16.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.098 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -110.7 131.51 54.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.882 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 3.9 mm -105.26 115.58 47.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -93.54 113.98 26.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.429 ' HE1' HD12 ' A' ' 340' ' ' LEU . 17.4 m-85 -96.06 146.11 24.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.851 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -63.66 -32.81 74.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -131.82 153.31 50.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.409 ' C ' ' HD2' ' A' ' 381' ' ' ARG . 2.0 tmm_? -62.19 -30.66 71.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -71.61 -50.42 30.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -44.8 -31.97 2.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.546 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . 0.878 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -76.57 -63.06 1.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.792 0.33 . . . . 0.0 111.138 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 384' ' ' ALA . 61.3 t -34.92 -36.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . 0.445 ' HE3' ' CG ' ' A' ' 390' ' ' GLU . 17.8 tptt -72.68 -66.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -55.21 -16.87 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.592 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 7.5 ttm -77.65 -61.64 1.93 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.422 ' N ' ' HG2' ' A' ' 388' ' ' MET . 7.3 mt-10 -77.48 -2.06 33.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.505 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 52.9 mm-40 -100.15 -25.89 14.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . 0.652 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 23.4 mmm -112.1 -38.19 4.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.832 ' N ' HD12 ' A' ' 403' ' ' ILE . 7.6 t-20 -35.09 92.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 108.44 23.95 6.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.477 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 391' ' ' MET . 0.3 OUTLIER -90.28 146.9 23.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.774 0.321 . . . . 0.0 110.903 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -78.6 80.26 4.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 19.0 tp -89.19 114.89 26.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.927 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . 0.452 ' CB ' ' HB3' ' A' ' 346' ' ' ALA . 67.4 mm-40 62.49 27.74 16.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 82.45 20.88 61.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.481 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -140.18 122.51 15.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.891 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.38 95.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 344' ' ' ASN . 30.4 pt -72.4 148.7 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.193 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -115.79 130.77 56.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.832 HD12 ' N ' ' A' ' 392' ' ' ASN . 19.7 mt -109.74 138.93 35.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.167 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 17.9 m -149.43 134.61 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.073 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.592 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 15.4 m-85 -54.71 108.7 0.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.854 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.522 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.806 0.336 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 90.6 t -79.94 135.94 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.862 HD21 ' HB1' ' A' ' 384' ' ' ALA . 16.5 mt -111.62 127.27 55.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -88.54 113.1 23.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.875 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.558 HG22 HG12 ' A' ' 403' ' ' ILE . 15.8 t -111.43 135.45 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -132.49 170.61 14.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.5 t30 73.46 43.85 0.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 39.0 mt -83.37 127.59 33.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.612 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -49.4 178.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -84.57 -5.34 59.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 25.7 p -117.84 22.46 12.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.612 HG23 ' HB3' ' A' ' 346' ' ' ALA . 64.5 t -96.4 136.64 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.153 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 77.8 p -135.45 178.28 7.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.132 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.87 -40.29 92.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -58.27 -46.54 85.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.86 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.67 -30.82 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.487 ' HB2' HG11 ' A' ' 367' ' ' VAL . 97.0 mt -73.84 -26.87 60.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 359' ' ' SER . 52.6 mt-10 -81.27 -64.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -51.05 -25.37 4.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -83.66 -44.83 14.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' PHE . . . . . 0.407 ' C ' HD11 ' A' ' 364' ' ' LEU . 35.9 m-85 -92.03 9.91 31.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 361' ' ' PHE . 92.2 p -95.13 -54.46 3.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.84 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 359' ' ' SER . 26.0 pt20 -34.28 -35.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.462 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 98.2 m-85 -70.97 -68.27 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -145.61 165.48 27.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.461 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -54.37 131.84 42.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.755 0.312 . . . . 0.0 110.909 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.407 HD11 ' C ' ' A' ' 358' ' ' PHE . 86.9 mt -101.32 155.63 17.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -100.88 -42.99 6.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.938 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -174.95 170.08 3.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.487 HG11 ' HB2' ' A' ' 354' ' ' LEU . 35.7 t -140.66 125.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.131 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.434 ' O ' ' HB1' ' A' ' 374' ' ' ALA . 8.7 tmtt? -112.49 123.14 49.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . 0.402 ' C ' HD12 ' A' ' 370' ' ' LEU . 15.7 tptm -97.52 143.52 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.763 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.9 mp -129.1 -174.62 3.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.1 OUTLIER -32.12 -72.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.932 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -120.04 -35.37 3.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.763 ' CE2' HD22 ' A' ' 370' ' ' LEU . 12.4 p90 -94.99 -179.41 4.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 368' ' ' LYS . . . -159.11 167.28 29.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.109 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -118.32 125.39 49.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 5.3 mm -99.18 110.5 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -91.68 120.75 32.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.827 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 358' ' ' PHE . 21.0 m-85 -101.02 154.63 18.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.55 -33.96 73.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -132.13 156.58 46.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.412 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 5.6 tmm_? -61.86 -32.71 73.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.15 -52.08 26.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -42.69 -32.84 1.42 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.543 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . 0.862 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -77.73 -64.35 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.789 0.328 . . . . 0.0 111.092 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.43 ' C ' ' O ' ' A' ' 384' ' ' ALA . 68.2 t -35.39 -32.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.122 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 384' ' ' ALA . 15.5 tptm -74.8 -61.89 1.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.07 -14.68 25.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.57 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.4 ttm -78.65 -60.18 2.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.906 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -73.23 -3.15 25.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.462 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 4.4 mm-40 -100.41 -39.43 7.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . 0.513 ' HB2' HD11 ' A' ' 403' ' ' ILE . 49.8 mmm -99.76 -19.73 16.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 388' ' ' MET . 0.8 OUTLIER -43.92 119.46 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 56.36 37.25 73.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.445 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.433 ' HD2' ' C ' ' A' ' 395' ' ' ASP . 0.0 OUTLIER -100.09 150.78 22.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.78 0.324 . . . . 0.0 110.911 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' ASP . . . . . 0.433 ' C ' ' HD2' ' A' ' 394' ' ' LYS . 24.7 t0 -71.12 105.92 3.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 38.4 tp -119.39 115.48 24.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 59.77 36.95 22.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 77.0 9.56 86.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.501 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -135.31 124.39 24.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.893 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.79 106.12 6.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.931 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.497 HD12 ' CG1' ' A' ' 342' ' ' VAL . 21.7 pt -83.12 147.11 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -109.56 128.58 55.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.558 HG12 HG22 ' A' ' 342' ' ' VAL . 44.1 mt -110.71 142.55 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.11 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 403' ' ' ILE . 9.6 m -157.01 134.12 2.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.57 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 27.0 m-85 -53.32 111.04 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.113 179.934 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.809 0.338 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.16 136.63 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.101 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.845 HD21 ' HB1' ' A' ' 384' ' ' ALA . 53.1 mt -112.9 128.9 56.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -92.59 108.26 19.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.66 HG22 HG12 ' A' ' 403' ' ' ILE . 48.7 t -106.0 127.27 61.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.176 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -126.51 173.44 9.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.24 39.19 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.581 HD21 HG12 ' A' ' 342' ' ' VAL . 48.7 mt -78.22 121.78 24.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -50.26 172.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.078 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -83.34 15.63 2.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 63.1 p -132.29 19.27 4.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.161 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 350' ' ' THR . 67.0 t -97.71 158.06 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . 0.5 ' N ' HG12 ' A' ' 349' ' ' VAL . 21.2 p -156.19 165.54 36.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.411 ' HG2' HG12 ' A' ' 367' ' ' VAL . 58.4 mt-10 -49.69 -44.51 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -56.96 -45.61 82.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 67.0 mt -64.43 -31.81 55.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.121 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.547 ' HB2' HG11 ' A' ' 367' ' ' VAL . 88.6 mt -73.49 -26.09 60.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 359' ' ' SER . 90.6 mt-10 -81.82 -66.88 0.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.899 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -49.72 -23.41 1.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -85.86 -45.75 11.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.078 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' PHE . . . . . 0.429 ' O ' HD21 ' A' ' 364' ' ' LEU . 36.1 m-85 -92.49 11.47 26.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 355' ' ' GLU . 95.7 p -100.09 -24.48 14.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.866 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -63.6 -31.71 72.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.563 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 93.6 m-85 -74.95 -61.95 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.859 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -148.65 162.45 28.87 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.521 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -52.18 129.19 27.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.429 HD21 ' O ' ' A' ' 358' ' ' PHE . 38.7 mt -97.7 154.63 17.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -101.85 -42.75 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.925 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.477 ' CZ ' ' HB2' ' A' ' 366' ' ' ARG . 2.4 ptm85 -174.1 164.89 4.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.859 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.547 HG11 ' HB2' ' A' ' 354' ' ' LEU . 46.3 t -136.53 124.68 34.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -117.79 107.94 14.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . 0.462 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 12.3 tttm -88.17 140.43 29.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.757 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.4 mp -118.18 -174.21 2.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 370' ' ' LEU . 9.2 ttpt -31.97 -69.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -118.12 -39.32 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.757 ' CE2' HD22 ' A' ' 370' ' ' LEU . 5.4 p90 -91.61 -174.96 4.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.462 ' CB ' ' HA ' ' A' ' 369' ' ' LYS . . . -162.48 167.96 22.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.103 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -121.92 121.51 37.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.845 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.512 HD11 HD22 ' A' ' 354' ' ' LEU . 6.7 mm -97.06 111.86 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -91.19 124.09 35.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.835 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 387' ' ' ALA . 23.6 m-85 -105.28 152.16 23.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.99 -35.59 80.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -129.65 153.43 48.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.859 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.411 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 5.9 tmm_? -60.08 -32.91 71.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -70.08 -51.36 32.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.843 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -42.82 -33.76 1.71 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.43 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . 0.845 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -76.52 -56.94 4.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.812 0.339 . . . . 0.0 111.071 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 80.6 t -38.47 -39.87 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.094 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -70.76 -65.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -55.05 -16.62 3.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.174 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.597 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.5 ttm -78.54 -62.84 1.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.448 ' N ' ' HG2' ' A' ' 388' ' ' MET . 9.0 mt-10 -75.92 -0.55 21.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.563 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 56.3 mm-40 -100.08 -34.6 10.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . 0.43 ' HG2' ' CE2' ' A' ' 361' ' ' PHE . 4.9 mmt -104.52 -31.15 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.904 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.749 ' N ' HD12 ' A' ' 403' ' ' ILE . 3.9 t-20 -36.68 97.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 95.46 38.26 4.8 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.522 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -100.1 147.66 25.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.888 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -75.53 75.19 2.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.451 HD22 HD13 ' A' ' 401' ' ' ILE . 17.6 tp -79.75 111.17 15.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.933 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 62.4 25.31 15.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . 0.44 ' C ' ' OE1' ' A' ' 399' ' ' GLU . . . 89.77 14.62 59.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.495 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . 0.44 ' OE1' ' C ' ' A' ' 398' ' ' GLY . 15.8 mp0 -133.38 126.15 30.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.808 0.337 . . . . 0.0 110.86 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.72 97.34 2.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.451 HD13 HD22 ' A' ' 396' ' ' LEU . 18.1 pt -76.9 151.7 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -114.77 132.18 56.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.749 HD12 ' N ' ' A' ' 392' ' ' ASN . 31.6 mt -115.27 121.34 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.135 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 15.3 m -136.19 132.58 49.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.597 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 7.4 m-85 -51.07 117.47 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.098 179.928 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.789 0.328 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 98.5 t -78.53 133.15 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.079 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.541 HD21 ' HB1' ' A' ' 384' ' ' ALA . 55.1 mt -109.72 128.59 55.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 75.1 t80 -93.79 102.83 14.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.578 HG22 HG12 ' A' ' 403' ' ' ILE . 33.0 t -102.06 133.85 44.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.106 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -132.77 168.79 17.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.865 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 74.76 52.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.503 HD22 HG11 ' A' ' 349' ' ' VAL . 41.9 mt -97.38 148.11 23.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -85.79 169.53 13.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.137 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -71.12 -1.98 14.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 40.6 p -106.16 0.51 25.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.503 HG11 HD22 ' A' ' 345' ' ' LEU . 86.8 t -93.91 130.45 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.119 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 68.9 p -132.83 165.65 24.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.124 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -47.42 -41.97 21.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -57.39 -47.44 81.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 66.5 mt -65.64 -28.82 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.555 ' HB2' HG11 ' A' ' 367' ' ' VAL . 95.1 mt -74.58 -28.93 61.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -78.56 -63.32 1.43 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.821 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 35.8 mmtt -53.36 -34.71 58.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' ALA . . . . . 0.463 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -71.43 -45.53 62.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -92.64 13.07 21.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 361' ' ' PHE . 1.5 t -97.62 -53.69 3.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 359' ' ' SER . 15.4 pt20 -36.57 -32.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.576 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 90.5 m-85 -71.04 -66.04 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -147.61 179.05 24.8 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -61.95 129.86 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 110.865 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.453 HD21 ' CZ ' ' A' ' 378' ' ' PHE . 32.1 mt -101.21 152.12 21.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -100.37 -47.0 5.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -174.31 168.74 3.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' A' ' 354' ' ' LEU . 41.9 t -139.56 131.62 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.153 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.14 123.48 44.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -96.19 143.51 27.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.902 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.926 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.4 mp -127.73 -174.6 3.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.8 OUTLIER -33.31 -66.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -124.51 -36.78 2.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.926 ' CE2' HD22 ' A' ' 370' ' ' LEU . 9.7 p90 -92.86 179.75 5.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.439 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -160.32 161.43 33.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -112.2 136.57 51.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 5.0 mm -110.52 109.62 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.128 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -89.43 123.27 33.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.501 ' CE1' HD12 ' A' ' 340' ' ' LEU . 15.6 m-85 -105.56 140.72 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -56.72 -33.98 67.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.842 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -131.42 149.12 52.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.412 ' NH1' ' CG2' ' A' ' 385' ' ' VAL . 0.0 OUTLIER -57.06 -32.89 66.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -69.41 -53.1 21.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -41.29 -32.24 0.67 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.531 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . 0.541 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -77.63 -58.78 3.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 111.119 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.412 ' CG2' ' NH1' ' A' ' 381' ' ' ARG . 57.6 t -38.52 -35.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -74.57 -64.32 1.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -58.25 -15.53 10.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.4 ttm -78.76 -63.07 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.439 ' N ' ' HG2' ' A' ' 388' ' ' MET . 14.6 mt-10 -73.52 1.41 9.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.576 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 43.7 mm-40 -100.12 -41.77 6.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . 0.489 ' O ' ' N ' ' A' ' 393' ' ' GLY . 8.1 mmm -99.91 -27.39 13.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.821 ' N ' HD12 ' A' ' 403' ' ' ILE . 5.1 t-20 -37.19 92.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.849 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 97.7 38.84 4.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.497 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.418 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 24.8 mmtm -100.04 148.29 24.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.739 0.304 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -75.9 77.69 2.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.417 HD22 HD13 ' A' ' 401' ' ' ILE . 15.6 tp -82.3 111.5 18.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 62.61 25.42 15.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . 0.43 ' C ' ' OE1' ' A' ' 399' ' ' GLU . . . 90.49 12.83 60.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . 0.43 ' OE1' ' C ' ' A' ' 398' ' ' GLY . 1.8 mp0 -131.76 129.55 40.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.943 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.49 97.43 3.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.417 HD13 HD22 ' A' ' 396' ' ' LEU . 20.7 pt -76.16 147.47 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -113.22 130.47 56.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.821 HD12 ' N ' ' A' ' 392' ' ' ASN . 11.7 mt -113.1 126.72 70.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.121 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 30.1 m -140.48 134.03 33.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.064 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 14.3 m-85 -50.95 110.1 0.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.857 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.579 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.412 ' HB3' ' NH1' ' A' ' 381' ' ' ARG . 10.5 ptpt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.829 0.347 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.22 121.87 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.083 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.426 HD21 ' HB1' ' A' ' 384' ' ' ALA . 78.5 mt -98.81 121.75 41.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -88.31 106.56 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.66 HG22 HG12 ' A' ' 403' ' ' ILE . 47.2 t -105.16 135.33 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -134.73 167.64 20.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.84 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 24.7 t30 74.59 49.99 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.49 HD21 HG12 ' A' ' 342' ' ' VAL . 14.5 mt -92.53 130.24 38.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.06 -179.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.101 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -87.15 6.5 32.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 22.2 p -124.15 15.88 9.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.171 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 55.3 t -91.98 134.93 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.151 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 58.4 p -136.98 161.0 37.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.145 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -47.02 -42.93 19.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -56.76 -40.42 75.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.884 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 83.0 mt -72.17 -29.55 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.539 ' HB2' HG11 ' A' ' 367' ' ' VAL . 85.3 mt -74.73 -28.04 60.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 359' ' ' SER . 45.3 mt-10 -72.26 -70.09 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -42.08 -44.1 3.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' ALA . . . . . 0.821 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -63.38 -57.05 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.097 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' PHE . . . . . 0.486 ' O ' HD21 ' A' ' 364' ' ' LEU . 41.0 m-85 -85.09 16.08 3.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 355' ' ' GLU . 5.4 t -100.07 -59.27 1.74 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.851 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 359' ' ' SER . 21.7 pt20 -36.82 -40.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 92.8 m-85 -62.36 -61.83 2.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.39 161.79 29.59 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.474 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.28 128.63 22.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 0.0 110.876 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.486 HD21 ' O ' ' A' ' 358' ' ' PHE . 49.6 mt -98.81 152.95 19.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -101.45 -47.64 4.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -170.17 166.02 9.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.841 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.539 HG11 ' HB2' ' A' ' 354' ' ' LEU . 60.1 t -137.49 123.64 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -105.73 111.34 23.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -91.02 136.48 33.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.851 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.9 mp -124.73 -174.82 3.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 370' ' ' LEU . 7.9 mmtm -32.9 -71.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.09 -37.88 3.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.851 ' CE2' HD22 ' A' ' 370' ' ' LEU . 8.4 p90 -91.67 -179.8 5.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.951 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -165.55 160.47 17.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.053 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -111.69 135.51 52.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 7.5 mm -108.88 106.97 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.099 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -87.58 120.29 28.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.535 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 23.6 m-85 -99.74 158.6 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -79.91 -32.07 40.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -128.22 152.91 47.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.414 ' HB2' ' NH1' ' A' ' 381' ' ' ARG . 0.0 OUTLIER -59.14 -34.08 71.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.855 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 384' ' ' ALA . 10.3 t70 -70.74 -54.95 9.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -37.81 -30.75 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.449 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . 0.426 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -81.28 -65.92 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.492 HG22 ' HZ ' ' A' ' 405' ' ' PHE . 58.4 t -36.4 -36.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.124 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -72.88 -61.83 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -60.3 -15.66 27.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.076 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.5 ttm -77.97 -61.18 2.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.417 ' N ' ' HG2' ' A' ' 388' ' ' MET . 16.4 mt-10 -74.89 -0.73 19.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.515 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 7.4 mm-40 -100.15 -37.41 8.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.839 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . 0.821 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 17.8 mmm -101.66 -34.04 9.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.858 ' N ' HD12 ' A' ' 403' ' ' ILE . 5.2 t-20 -34.0 93.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 98.17 39.47 3.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.414 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 2.0 mmmp? -99.92 147.51 25.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.886 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -75.76 69.47 2.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.851 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.582 HD22 HD13 ' A' ' 401' ' ' ILE . 14.8 tp -74.93 113.12 11.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 61.94 27.33 16.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 85.31 21.26 55.14 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.533 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -140.1 125.91 19.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.87 0.367 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.37 96.92 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.582 HD13 HD22 ' A' ' 396' ' ' LEU . 33.4 pt -74.61 148.36 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -110.35 131.27 55.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.858 HD12 ' N ' ' A' ' 392' ' ' ASN . 36.1 mt -116.06 127.61 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 11.1 m -141.11 134.24 30.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.175 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.591 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 6.3 m-85 -52.49 108.73 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.11 179.926 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 19.2 pttp . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.803 0.335 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.1 122.34 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.641 HD21 ' HB1' ' A' ' 384' ' ' ALA . 48.6 mt -96.52 134.67 39.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -99.19 107.9 20.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.727 HG12 HD21 ' A' ' 345' ' ' LEU . 29.8 t -103.71 131.81 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.147 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -130.92 172.39 12.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.901 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.7 t30 72.54 33.27 1.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.727 HD21 HG12 ' A' ' 342' ' ' VAL . 17.8 mt -76.63 125.47 29.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.01 176.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.053 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -82.73 9.95 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 20.6 p -125.78 9.7 7.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 90.8 t -92.57 139.17 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . 0.446 ' H ' HD12 ' A' ' 353' ' ' ILE . 55.5 p -143.89 171.59 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -50.7 -50.98 53.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -50.28 -39.18 44.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 350' ' ' THR . 74.2 mt -73.94 -35.71 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.59 ' HB2' HG11 ' A' ' 367' ' ' VAL . 96.7 mt -69.29 -26.26 64.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.481 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 44.9 mt-10 -76.43 -71.49 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -42.43 -35.72 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' ALA . . . . . 0.684 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -72.81 -55.72 6.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.145 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' PHE . . . . . 0.408 ' O ' HD21 ' A' ' 364' ' ' LEU . 41.2 m-85 -84.17 14.12 4.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 355' ' ' GLU . 18.0 t -99.65 -52.95 3.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -39.46 -37.24 0.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.575 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 93.6 m-85 -66.38 -62.58 1.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -150.53 161.85 29.11 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -53.15 122.77 10.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 110.937 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.481 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 32.0 mt -90.4 166.59 13.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -114.2 -44.78 3.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.501 ' HG3' ' CD2' ' A' ' 377' ' ' HIS . 18.5 ptt180 -173.01 166.53 5.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.59 HG11 ' HB2' ' A' ' 354' ' ' LEU . 89.7 t -139.81 123.83 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -107.17 120.1 41.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . 0.422 ' C ' HD12 ' A' ' 370' ' ' LEU . 16.1 tptp -91.73 142.28 27.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.768 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.4 mp -129.57 -174.57 3.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 370' ' ' LEU . 1.9 mptp? -33.33 -73.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -119.27 -29.66 5.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.768 ' CE2' HD22 ' A' ' 370' ' ' LEU . 3.8 p90 -97.99 -175.0 3.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.569 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -168.52 153.48 6.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.09 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -100.61 146.12 27.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 6.5 mm -118.87 110.81 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . 0.501 ' CD2' ' HG3' ' A' ' 366' ' ' ARG . 55.1 m-70 -89.46 126.1 35.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.819 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.458 ' CZ ' HD21 ' A' ' 364' ' ' LEU . 20.1 m-85 -108.4 139.41 43.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -58.52 -29.44 66.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -134.62 143.76 47.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.402 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 3.8 tmm_? -52.13 -34.56 45.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -67.35 -56.53 9.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . 0.426 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -37.74 -32.47 0.11 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.537 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . 0.641 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -77.43 -62.81 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.803 0.335 . . . . 0.0 111.122 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 384' ' ' ALA . 54.8 t -36.72 -39.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.133 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . 0.416 ' HA ' ' NZ ' ' A' ' 386' ' ' LYS . 0.1 OUTLIER -71.23 -65.67 0.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -53.84 -19.27 4.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.14 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.7 ttm -74.97 -63.74 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.465 ' N ' ' HG2' ' A' ' 388' ' ' MET . 5.5 mt-10 -73.71 1.56 10.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.575 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 3.0 mm-40 -99.67 -39.66 8.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . 0.684 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 5.9 mmm -101.36 -29.95 11.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.744 ' N ' HD12 ' A' ' 403' ' ' ILE . 4.4 t-20 -34.17 96.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 94.11 38.43 5.13 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.525 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -99.62 147.2 25.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -76.51 76.44 3.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.468 HD22 HD13 ' A' ' 401' ' ' ILE . 17.6 tp -81.48 113.92 19.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 61.99 24.92 14.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 88.09 20.23 50.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -140.06 126.6 20.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 110.924 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.6 99.28 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.468 HD13 HD22 ' A' ' 396' ' ' LEU . 20.9 pt -77.15 148.59 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -109.95 129.9 55.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.744 HD12 ' N ' ' A' ' 392' ' ' ASN . 24.3 mt -113.3 129.21 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 34.2 m -146.68 135.27 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.089 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 15.9 m-85 -52.69 120.06 5.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.042 179.998 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 33.2 pttt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.816 0.341 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 77.9 t -74.79 123.24 29.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.107 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.411 HD21 ' HB1' ' A' ' 384' ' ' ALA . 48.9 mt -99.06 123.4 43.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -91.54 106.36 18.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.66 HG22 HG12 ' A' ' 403' ' ' ILE . 11.9 t -103.51 138.24 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.152 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -136.03 168.4 19.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 5.9 t30 73.2 54.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 31.1 mt -94.99 137.77 33.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.88 172.52 1.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.107 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -79.38 1.16 26.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 5.7 p -118.04 13.54 13.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.183 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 45.5 t -97.25 140.46 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 64.6 p -140.35 172.48 12.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.151 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -51.49 -45.89 62.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -54.87 -46.62 74.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 72.5 mt -64.32 -28.84 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.156 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.512 ' HB2' HG11 ' A' ' 367' ' ' VAL . 96.4 mt -76.59 -27.61 55.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 359' ' ' SER . 54.2 mt-10 -77.45 -65.69 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -46.47 -37.52 7.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' ALA . . . . . 0.692 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -72.17 -49.83 32.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.099 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' PHE . . . . . 0.546 ' O ' HD21 ' A' ' 364' ' ' LEU . 39.6 m-85 -88.17 13.03 12.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 355' ' ' GLU . 5.3 t -98.89 -52.64 3.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . 0.411 ' HG3' ' N ' ' A' ' 361' ' ' PHE . 18.2 pt20 -38.59 -40.14 0.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 390' ' ' GLU . 93.5 m-85 -64.0 -62.44 1.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -149.55 169.36 29.79 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -59.61 127.34 31.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 358' ' ' PHE . 81.4 mt -95.99 156.37 16.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -104.99 -41.73 5.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -174.93 165.9 3.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.512 HG11 ' HB2' ' A' ' 354' ' ' LEU . 33.9 t -139.48 124.6 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.155 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -109.5 114.98 29.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . 0.443 ' C ' HD12 ' A' ' 370' ' ' LEU . 19.1 tptp -90.89 144.28 25.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.852 HD22 ' CE2' ' A' ' 373' ' ' TYR . 7.0 mp -130.92 -174.69 3.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 370' ' ' LEU . 16.1 tttm -33.09 -68.02 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.4 -37.56 2.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.852 ' CE2' HD22 ' A' ' 370' ' ' LEU . 9.7 p90 -92.23 179.8 5.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -160.86 161.54 31.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.078 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -112.42 125.37 54.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 6.1 mm -101.32 121.29 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -100.94 124.38 46.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.56 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 26.5 m-85 -106.64 133.78 50.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -53.9 -32.57 53.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -128.51 151.18 49.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -58.41 -36.31 73.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 384' ' ' ALA . 14.6 t70 -68.23 -55.48 12.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -37.97 -31.15 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.506 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -80.87 -63.96 1.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.855 0.359 . . . . 0.0 111.155 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.53 HG22 ' HZ ' ' A' ' 405' ' ' PHE . 79.7 t -36.82 -35.42 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . 0.436 ' HE2' ' CG ' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -72.02 -60.02 2.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.888 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -62.21 -17.37 58.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.594 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.1 ttm -75.39 -60.9 2.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.887 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.435 ' N ' ' HG2' ' A' ' 388' ' ' MET . 11.1 mt-10 -74.48 -0.79 18.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 361' ' ' PHE . 33.8 mm-40 -99.98 -37.93 8.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.913 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . 0.692 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 12.3 mmm -99.9 -29.22 12.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.751 ' N ' HD12 ' A' ' 403' ' ' ILE . 2.7 t-20 -41.24 111.79 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.845 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 75.49 28.84 60.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.507 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.477 ' CG ' ' O ' ' A' ' 391' ' ' MET . 0.0 OUTLIER -97.71 142.79 29.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -68.73 99.89 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.535 HD22 HD13 ' A' ' 401' ' ' ILE . 21.6 tp -105.46 109.67 21.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 61.6 32.63 18.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 83.28 15.99 70.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -139.82 120.09 13.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.871 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.75 106.02 3.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.535 HD13 HD22 ' A' ' 396' ' ' LEU . 23.7 pt -79.25 161.08 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.132 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -123.75 125.61 45.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.751 HD12 ' N ' ' A' ' 392' ' ' ASN . 25.0 mt -111.16 135.51 50.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.128 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 6.9 m -150.16 130.96 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.132 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.594 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 15.5 m-85 -51.53 108.95 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.064 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 64.7 pttt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.792 0.329 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 95.5 t -81.5 121.13 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.765 HD12 ' CE1' ' A' ' 378' ' ' PHE . 60.5 mt -100.66 121.94 42.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.944 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.402 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 89.2 t80 -85.54 108.25 17.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.829 HG22 HG12 ' A' ' 403' ' ' ILE . 43.4 t -106.69 133.64 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.123 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.437 ' NH1' ' HB2' ' A' ' 343' ' ' ARG . 3.0 ptm85 -131.66 172.18 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.835 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.1 t30 72.7 37.45 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.519 HD21 HG12 ' A' ' 342' ' ' VAL . 17.5 mt -77.34 144.79 37.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.447 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -73.89 179.05 4.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -83.49 2.55 36.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 69.5 p -120.64 11.55 11.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 346' ' ' ALA . 97.6 t -95.58 132.16 40.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.129 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 70.5 p -139.39 165.57 26.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.164 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.4 ' HA ' HG11 ' A' ' 367' ' ' VAL . 41.6 mt-10 -41.2 -44.31 2.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.882 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -55.29 -59.21 5.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 80.4 mt -55.73 -31.75 30.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.126 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.437 HD22 HD11 ' A' ' 376' ' ' ILE . 93.1 mt -71.43 -26.15 62.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.496 ' O ' ' CB ' ' A' ' 359' ' ' SER . 27.0 mt-10 -83.71 -53.92 5.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . 0.439 ' O ' ' NE2' ' A' ' 360' ' ' GLN . 74.0 mttt -57.55 -20.44 32.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' ALA . . . . . 0.695 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -93.26 -44.45 8.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.111 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' PHE . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 41.2 m-85 -93.25 18.03 10.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 355' ' ' GLU . 3.3 t -100.06 -61.84 1.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 356' ' ' LYS . 2.4 pm0 -37.68 -37.84 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.51 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 70.0 m-85 -62.71 -58.74 6.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -155.46 162.83 31.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.483 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -55.07 123.59 14.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.432 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 60.0 mt -91.36 178.21 6.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -131.76 -44.02 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -173.97 165.96 4.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 351' ' ' GLU . 64.6 t -138.07 134.48 44.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.428 ' O ' ' HB1' ' A' ' 374' ' ' ALA . 7.0 tptm -118.85 117.72 29.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . 0.518 ' C ' HD12 ' A' ' 370' ' ' LEU . 14.3 tptm -93.51 144.29 25.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.809 HD22 ' CE2' ' A' ' 373' ' ' TYR . 8.0 mp -130.87 -174.44 3.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 370' ' ' LEU . 20.8 tttp -31.53 -64.78 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -128.36 -37.26 1.84 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.809 ' CE2' HD22 ' A' ' 370' ' ' LEU . 14.1 p90 -92.53 179.18 5.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 368' ' ' LYS . . . -159.1 171.89 19.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.069 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -124.06 127.73 48.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.839 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.437 HD11 HD22 ' A' ' 354' ' ' LEU . 4.4 mm -101.2 109.31 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.161 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -85.79 110.46 19.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.765 ' CE1' HD12 ' A' ' 340' ' ' LEU . 17.9 m-85 -92.95 143.31 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -55.32 -33.1 63.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -141.43 162.66 34.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.511 ' O ' HG23 ' A' ' 385' ' ' VAL . 4.0 tmm_? -63.62 -33.0 74.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -65.47 -58.84 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.824 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -42.17 -28.6 0.53 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.452 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -80.18 -60.38 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 0.0 111.092 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 381' ' ' ARG . 60.6 t -37.44 -35.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . 0.421 ' HA ' ' NZ ' ' A' ' 386' ' ' LYS . 0.0 OUTLIER -73.83 -63.25 1.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -59.65 -14.41 13.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.563 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.7 ttm -80.28 -62.24 1.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.859 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.422 ' N ' ' HG2' ' A' ' 388' ' ' MET . 11.9 mt-10 -75.05 -3.19 31.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.51 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 28.2 mm-40 -100.16 -29.38 12.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.822 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . 0.695 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 5.0 mmt -107.92 -41.98 4.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.77 ' N ' HD12 ' A' ' 403' ' ' ILE . 26.2 t-20 -34.21 93.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.856 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 103.64 28.44 5.99 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.51 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 391' ' ' MET . 1.1 mmmm -98.54 146.31 25.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.319 . . . . 0.0 110.918 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -74.35 78.6 1.86 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.872 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.466 HD22 HD13 ' A' ' 401' ' ' ILE . 19.0 tp -86.23 113.22 22.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 62.34 25.1 14.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.31 17.98 58.04 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.483 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -138.64 124.26 19.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.28 92.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.466 HD13 HD22 ' A' ' 396' ' ' LEU . 20.7 pt -71.56 146.13 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.154 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -111.76 130.84 55.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.829 HG12 HG22 ' A' ' 342' ' ' VAL . 20.9 mt -115.04 126.47 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.43 136.82 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.132 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.563 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 13.1 m-85 -54.56 110.61 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.825 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.402 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.116 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 17.3 pttp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.857 0.361 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 64.6 t -79.1 123.92 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 72.0 mt -104.19 125.48 50.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 72.0 t80 -90.04 106.66 18.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.527 HG22 HG12 ' A' ' 403' ' ' ILE . 22.3 t -104.31 137.68 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.163 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -136.34 169.25 17.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.3 t30 74.16 46.81 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.901 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 48.5 mt -83.88 135.91 34.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.944 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.3 179.8 0.54 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -85.81 5.97 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 49.8 p -123.43 11.61 9.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 350' ' ' THR . 87.5 t -90.81 153.01 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . 0.415 ' N ' HG12 ' A' ' 349' ' ' VAL . 77.6 p -153.96 173.18 16.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -58.55 -35.85 72.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.6 -40.71 92.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 68.9 mt -69.16 -28.66 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.503 ' HB2' HG11 ' A' ' 367' ' ' VAL . 94.6 mt -72.39 -31.47 65.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 359' ' ' SER . 64.8 mt-10 -72.18 -74.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -42.05 -34.55 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' ALA . . . . . 0.486 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -73.01 -52.13 15.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' PHE . . . . . 0.438 ' C ' HD11 ' A' ' 364' ' ' LEU . 38.3 m-85 -88.06 15.11 7.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 360' ' ' GLN . 82.7 p -97.23 -56.39 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 359' ' ' SER . 26.4 pt20 -35.16 -42.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 87.9 m-85 -61.42 -68.36 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -146.51 165.03 28.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.489 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -54.72 127.65 29.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.828 0.347 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.438 HD11 ' C ' ' A' ' 358' ' ' PHE . 78.7 mt -96.35 156.41 16.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -103.36 -42.42 5.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -174.59 169.43 3.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 354' ' ' LEU . 48.9 t -140.65 126.02 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.123 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -119.73 104.86 10.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . 0.482 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 20.2 tttm -82.81 152.75 25.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.879 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.9 mp -130.51 -174.8 3.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 370' ' ' LEU . 16.9 tptm -33.26 -68.8 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -118.66 -39.06 3.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.879 ' CE2' HD22 ' A' ' 370' ' ' LEU . 7.0 p90 -92.9 -178.94 4.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 369' ' ' LYS . . . -158.02 168.16 27.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.061 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -121.28 128.3 52.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 7.4 mm -103.7 113.7 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -92.52 123.71 36.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 387' ' ' ALA . 20.4 m-85 -105.77 145.61 30.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.64 -33.73 74.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -132.29 159.09 40.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.418 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 0.4 OUTLIER -65.24 -28.91 69.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 384' ' ' ALA . 23.5 t0 -70.77 -61.07 1.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -36.89 -30.37 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.509 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 382' ' ' ASP . . . -76.91 -63.22 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.346 . . . . 0.0 111.07 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 384' ' ' ALA . 89.5 t -36.46 -35.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.095 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -63.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -59.21 -16.16 19.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.515 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.7 ttm -77.75 -61.64 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.421 ' N ' ' HG2' ' A' ' 388' ' ' MET . 14.6 mt-10 -75.22 0.31 16.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.491 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 32.4 mm-40 -100.07 -36.58 9.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . 0.5 ' O ' ' N ' ' A' ' 393' ' ' GLY . 3.6 mmt -102.95 -30.32 10.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.812 ' N ' HD12 ' A' ' 403' ' ' ILE . 7.0 t-20 -42.54 91.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 100.82 30.46 6.09 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.462 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 391' ' ' MET . 22.1 mmtt -100.0 148.43 24.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.743 0.306 . . . . 0.0 110.943 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -74.15 85.49 1.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.905 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.558 HD22 HD13 ' A' ' 401' ' ' ILE . 21.8 tp -93.34 112.34 24.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 62.48 26.94 16.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 86.35 18.39 59.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -140.09 126.0 19.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.882 0.373 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.0 93.51 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.558 HD13 HD22 ' A' ' 396' ' ' LEU . 25.9 pt -71.02 149.32 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.085 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -113.51 131.7 55.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.812 HD12 ' N ' ' A' ' 392' ' ' ASN . 30.9 mt -113.3 133.46 59.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.14 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 5.1 m -145.72 132.83 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.515 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 7.1 m-85 -53.7 109.45 0.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.55 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.094 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.837 0.351 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 58.3 t -80.65 132.74 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.649 HD21 ' HB1' ' A' ' 384' ' ' ALA . 33.4 mt -110.74 127.38 55.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -90.39 114.08 26.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.664 HG22 HG12 ' A' ' 403' ' ' ILE . 22.0 t -111.59 131.62 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -130.0 170.14 14.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.2 t30 74.81 41.21 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.54 HD12 ' NZ ' ' A' ' 369' ' ' LYS . 44.1 mt -80.27 133.6 36.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.551 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -56.17 -177.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.498 ' OD1' HG23 ' A' ' 348' ' ' THR . 11.6 p30 -91.67 11.59 23.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.908 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . 0.498 HG23 ' OD1' ' A' ' 347' ' ' ASN . 51.4 p -135.04 17.71 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.551 HG23 ' HB3' ' A' ' 346' ' ' ALA . 71.4 t -95.48 136.92 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.103 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 76.9 p -135.79 170.52 15.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.133 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -52.49 -46.05 66.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -52.59 -42.97 64.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 77.6 mt -70.94 -27.46 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.178 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.549 ' HB2' HG11 ' A' ' 367' ' ' VAL . 97.8 mt -73.99 -31.5 62.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 359' ' ' SER . 24.4 mt-10 -74.73 -64.83 0.96 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.939 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -44.36 -40.34 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' ALA . . . . . 0.787 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -71.26 -55.79 7.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.092 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' PHE . . . . . 0.409 ' O ' HD21 ' A' ' 364' ' ' LEU . 45.3 m-85 -81.77 13.95 2.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.864 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 355' ' ' GLU . 7.2 t -100.03 -54.17 2.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.828 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -39.65 -36.02 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 81.1 m-85 -65.52 -63.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.19 168.74 31.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.479 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -53.37 129.12 30.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 110.906 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.476 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 32.7 mt -99.54 163.35 12.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -111.93 -48.68 3.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -172.82 165.91 5.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 354' ' ' LEU . 93.7 t -134.45 127.41 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.147 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -110.83 114.19 27.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . 0.54 ' NZ ' HD12 ' A' ' 345' ' ' LEU . 16.3 tptp -89.97 138.76 31.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.87 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.718 HD22 ' CE2' ' A' ' 373' ' ' TYR . 7.7 mp -125.49 -174.83 3.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 370' ' ' LEU . 3.2 mptp? -33.7 -70.81 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.94 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -119.01 -38.26 3.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.838 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.718 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.9 p90 -91.78 -175.79 4.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.947 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -164.95 158.26 16.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -109.63 133.57 52.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 3.7 mm -107.41 107.48 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -85.5 117.88 24.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.562 ' CE1' HD12 ' A' ' 340' ' ' LEU . 16.2 m-85 -99.42 146.13 26.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -57.72 -36.48 72.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -133.18 160.34 37.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.409 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 1.6 tmm_? -63.92 -35.27 80.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 384' ' ' ALA . 11.5 t0 -65.77 -58.58 5.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -38.62 -30.67 0.1 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.466 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . 0.649 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -76.95 -58.91 3.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.317 . . . . 0.0 111.091 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.4 t -37.9 -37.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.122 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . 0.431 ' HA ' ' NZ ' ' A' ' 386' ' ' LYS . 0.1 OUTLIER -72.3 -65.36 0.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.84 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -56.14 -16.57 5.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.106 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.535 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.5 ttm -78.52 -64.13 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.465 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.1 mt-10 -73.86 0.83 12.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.489 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 57.5 mm-40 -100.14 -39.91 7.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . 0.787 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 5.9 mmm -100.11 -30.12 12.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.777 ' N ' HD12 ' A' ' 403' ' ' ILE . 5.5 t-20 -42.03 94.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 100.61 30.38 6.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.503 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.0 147.74 25.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.329 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' ASP . . . . . 0.414 ' C ' ' OD1' ' A' ' 395' ' ' ASP . 31.2 t0 -75.35 88.63 2.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.875 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 29.2 tp -94.73 110.17 22.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.984 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 63.35 24.95 14.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.47 18.95 51.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.448 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -139.94 125.59 19.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.9 94.05 2.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 20.1 pt -71.5 148.14 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -112.04 130.3 55.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.879 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.777 HD12 ' N ' ' A' ' 392' ' ' ASN . 27.2 mt -112.43 131.24 64.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.096 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 22.1 m -144.8 136.58 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.535 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 12.2 m-85 -54.17 116.0 2.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.098 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 40.8 pttt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.783 0.325 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.0 t -79.48 138.98 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.798 HD21 ' HB1' ' A' ' 384' ' ' ALA . 47.4 mt -114.01 130.84 56.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.475 ' HB3' HG23 ' A' ' 404' ' ' VAL . 56.2 t80 -92.19 107.98 19.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.464 HG22 HG12 ' A' ' 403' ' ' ILE . 21.7 t -105.09 136.36 39.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -135.78 173.36 11.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.0 t30 68.89 52.1 0.54 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.434 HD21 HG12 ' A' ' 342' ' ' VAL . 18.0 mt -94.94 121.15 36.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.889 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -46.26 173.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -80.78 13.79 2.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 38.6 p -128.19 5.58 5.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 51.0 t -88.92 140.41 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.107 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 68.0 p -143.71 170.56 15.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.134 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -49.47 -41.86 41.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -59.31 -39.0 81.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 77.0 mt -73.64 -29.38 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.526 ' HB2' HG11 ' A' ' 367' ' ' VAL . 89.7 mt -74.26 -27.48 60.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 359' ' ' SER . 38.0 mt-10 -80.2 -66.87 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -48.7 -25.54 1.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -83.91 -47.47 11.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' PHE . . . . . 0.438 ' O ' HD21 ' A' ' 364' ' ' LEU . 35.4 m-85 -90.76 12.89 17.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 355' ' ' GLU . 99.2 p -99.64 -46.93 5.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -41.75 -30.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.513 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 98.4 m-85 -75.43 -73.92 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -135.56 174.4 21.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.476 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -60.16 133.88 56.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.792 0.33 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.438 HD21 ' O ' ' A' ' 358' ' ' PHE . 50.0 mt -103.74 153.36 20.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -103.5 -47.42 4.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -173.47 165.08 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.849 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' A' ' 354' ' ' LEU . 51.4 t -136.58 132.57 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.72 107.79 15.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . 0.4 ' C ' HD12 ' A' ' 370' ' ' LEU . 19.5 tptp -83.43 143.36 30.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.889 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.2 mp -128.59 -174.27 3.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.941 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 370' ' ' LEU . 21.6 mtpp -32.48 -64.15 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.47 -33.77 2.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.889 ' CE2' HD22 ' A' ' 370' ' ' LEU . 3.8 p90 -93.74 -176.04 3.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.508 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -166.81 160.49 14.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.123 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -111.57 134.85 52.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.464 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 3.6 mm -109.76 116.05 51.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -92.13 121.16 33.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 20.0 m-85 -106.57 127.67 53.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -42.52 -35.82 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -134.28 157.6 45.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -34.57 74.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 384' ' ' ALA . 27.1 t0 -65.67 -57.4 8.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . 0.459 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -38.97 -29.15 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . 0.798 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -82.07 -58.86 2.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 111.122 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 94.1 t -38.16 -39.66 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.109 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -68.62 -60.56 2.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.07 -14.35 47.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.085 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 7.6 ttm -79.43 -59.67 2.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -75.09 -3.43 32.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.513 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 6.2 mm-40 -100.07 -37.18 9.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . 0.498 ' O ' ' CG ' ' A' ' 394' ' ' LYS . 69.8 mmm -99.91 -25.13 14.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 388' ' ' MET . 1.4 t-20 -42.04 118.84 1.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 63.69 32.68 84.98 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.467 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 391' ' ' MET . 0.0 OUTLIER -96.75 145.2 26.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.757 0.313 . . . . 0.0 110.91 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -68.48 108.22 3.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.561 HD22 HD13 ' A' ' 401' ' ' ILE . 21.1 tp -119.51 111.45 18.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 62.01 37.06 15.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.893 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 76.72 11.17 85.58 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.492 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -137.27 121.08 17.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.368 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.34 116.04 8.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.561 HD13 HD22 ' A' ' 396' ' ' LEU . 17.3 pt -90.99 147.55 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.113 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.737 ' OE2' HG13 ' A' ' 404' ' ' VAL . 13.9 tm-20 -111.23 133.13 53.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 392' ' ' ASN . 22.6 mt -116.92 134.69 59.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.127 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.737 HG13 ' OE2' ' A' ' 402' ' ' GLU . 3.9 m -144.92 140.59 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 14.9 m-85 -61.0 105.01 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 179.943 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.84 0.352 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.83 130.83 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 388' ' ' MET . 63.0 mt -106.27 124.62 49.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.458 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 46.8 t80 -88.69 107.28 18.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.433 HG12 HD21 ' A' ' 345' ' ' LEU . 20.6 t -101.98 134.73 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.126 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -134.54 170.35 15.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.823 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.1 t30 72.91 39.12 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.433 HD21 HG12 ' A' ' 342' ' ' VAL . 31.1 mt -79.93 154.45 28.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -93.08 163.17 13.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -65.51 -7.29 13.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 81.9 p -103.53 -0.13 30.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.135 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 96.0 t -91.97 132.27 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.087 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . 0.497 ' H ' HD12 ' A' ' 353' ' ' ILE . 67.8 p -134.62 170.3 16.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -50.97 -44.95 60.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -56.61 -41.2 76.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.933 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.497 HD12 ' H ' ' A' ' 350' ' ' THR . 73.2 mt -70.46 -30.25 42.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.138 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.449 ' HB2' HG11 ' A' ' 367' ' ' VAL . 97.2 mt -73.5 -30.13 62.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 359' ' ' SER . 49.4 mt-10 -75.64 -67.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -47.87 -36.44 12.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.848 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' ALA . . . . . 0.515 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -70.96 -49.77 41.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' PHE . . . . . 0.442 ' O ' HD21 ' A' ' 364' ' ' LEU . 39.6 m-85 -88.9 12.78 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.88 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 355' ' ' GLU . 40.4 t -99.26 -53.41 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -37.96 -31.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 91.5 m-85 -71.98 -63.11 1.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -149.55 171.12 29.71 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.465 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -58.62 128.26 36.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 0.0 110.917 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.442 HD21 ' O ' ' A' ' 358' ' ' PHE . 33.7 mt -97.35 171.48 8.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.956 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -120.52 -45.69 2.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.403 HH11 ' CD2' ' A' ' 377' ' ' HIS . 9.1 ptm180 -173.84 165.03 4.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.858 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.449 HG11 ' HB2' ' A' ' 354' ' ' LEU . 40.4 t -137.12 137.37 46.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.415 ' O ' ' HB1' ' A' ' 374' ' ' ALA . 7.9 tmtm? -125.07 120.32 31.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.864 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -94.44 140.92 29.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.873 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.692 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.8 mp -124.47 -174.71 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 370' ' ' LEU . 19.3 tttp -33.11 -65.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -125.67 -37.44 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.864 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.692 ' CE2' HD22 ' A' ' 370' ' ' LEU . 3.5 p90 -92.41 -174.8 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 368' ' ' LYS . . . -164.69 163.66 21.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -116.15 129.6 56.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.901 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.1 mm -104.52 119.45 53.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . 0.403 ' CD2' HH11 ' A' ' 366' ' ' ARG . 75.3 m-70 -98.3 121.89 40.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.493 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 21.5 m-85 -102.75 149.9 24.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.76 -29.19 70.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.858 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -136.23 160.54 38.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.892 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.443 ' O ' HG23 ' A' ' 385' ' ' VAL . 7.0 tmm_? -65.05 -29.41 70.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -73.13 -54.09 9.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . 0.493 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -40.17 -30.76 0.28 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . 0.45 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -80.13 -63.87 1.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 111.104 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 381' ' ' ARG . 52.6 t -37.08 -35.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.131 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -61.5 1.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -60.88 -16.12 38.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.098 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.52 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.3 ttm -78.13 -62.21 1.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.444 ' N ' ' HG2' ' A' ' 388' ' ' MET . 18.5 mt-10 -74.5 1.22 12.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.554 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 4.4 mm-40 -100.07 -39.08 8.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . 0.515 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 10.6 mmm -102.7 -30.76 10.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.78 ' N ' HD12 ' A' ' 403' ' ' ILE . 5.7 t-20 -34.35 93.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 98.81 37.23 4.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -99.97 148.34 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.328 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -76.06 77.95 2.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.861 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.509 HD22 HD13 ' A' ' 401' ' ' ILE . 16.6 tp -83.36 110.54 18.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.979 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 63.04 29.67 16.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 84.18 20.68 58.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -140.09 126.7 20.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.83 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.43 97.84 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.509 HD13 HD22 ' A' ' 396' ' ' LEU . 22.2 pt -77.79 146.38 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -112.12 131.69 55.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.882 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.78 HD12 ' N ' ' A' ' 392' ' ' ASN . 13.5 mt -112.04 132.45 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.101 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 13.7 m -145.69 134.06 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.52 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 16.2 m-85 -51.5 111.13 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.844 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.128 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 23.4 pttt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.856 0.36 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 91.6 t -75.7 124.9 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.533 HD21 ' HB1' ' A' ' 384' ' ' ALA . 91.4 mt -104.97 116.67 32.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -82.79 109.33 16.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.723 HG22 HG12 ' A' ' 403' ' ' ILE . 24.4 t -108.3 132.26 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -130.72 177.17 7.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 68.94 43.79 1.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 33.6 mt -83.39 141.26 31.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.41 -178.16 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.095 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -88.87 2.95 52.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 61.4 p -120.08 13.87 12.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.186 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 73.6 t -92.83 150.47 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 75.5 p -149.13 170.04 19.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -52.07 -44.85 64.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -54.61 -52.12 63.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 77.8 mt -58.07 -33.1 45.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.521 ' HB2' HG11 ' A' ' 367' ' ' VAL . 87.4 mt -73.85 -26.63 60.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.918 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.47 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 31.7 mt-10 -78.92 -63.29 1.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -51.35 -41.33 60.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' ALA . . . . . 0.581 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -65.85 -49.73 67.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.055 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' PHE . . . . . 0.444 ' O ' HD21 ' A' ' 364' ' ' LEU . 41.2 m-85 -89.08 16.82 6.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.888 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 360' ' ' GLN . 12.2 t -99.95 -57.15 2.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 359' ' ' SER . 24.0 pt20 -37.68 -39.42 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.914 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.548 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 71.6 m-85 -62.83 -63.41 1.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -150.88 166.45 30.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.499 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -54.88 125.53 20.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 0.0 110.916 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.47 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 34.3 mt -94.12 154.32 17.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -103.63 -44.9 4.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -174.92 163.6 3.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.521 HG11 ' HB2' ' A' ' 354' ' ' LEU . 51.8 t -135.14 124.06 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.34 106.97 13.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . 0.487 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 17.6 tttm -84.14 150.43 25.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.879 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.4 mp -127.97 -174.33 3.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 370' ' ' LEU . 9.7 ttmt -32.58 -67.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.04 -38.68 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.843 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.879 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.8 p90 -91.94 -176.39 4.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.487 ' CB ' ' HA ' ' A' ' 369' ' ' LYS . . . -160.88 166.86 27.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -119.53 131.9 55.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.41 HD11 HD22 ' A' ' 354' ' ' LEU . 7.2 mm -107.79 110.31 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.132 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -88.9 125.64 35.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.517 ' CE1' HD12 ' A' ' 340' ' ' LEU . 20.0 m-85 -108.8 134.59 51.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.87 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -46.66 -36.55 7.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -133.29 158.84 41.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -62.29 -36.56 82.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 384' ' ' ALA . 26.4 t70 -63.48 -59.5 4.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 382' ' ' ASP . . . -36.89 -31.78 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . 0.533 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -76.06 -61.24 2.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 111.093 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 384' ' ' ALA . 66.7 t -35.79 -33.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.088 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 384' ' ' ALA . 0.0 OUTLIER -75.3 -65.15 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -58.0 -14.77 7.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.1 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.59 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.8 ttm -80.23 -62.38 1.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.874 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.423 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.0 mt-10 -75.63 -1.64 25.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.548 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 69.0 mm-40 -100.14 -32.28 10.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . 0.581 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 19.5 mmm -106.2 -37.94 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.896 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.863 ' N ' HD12 ' A' ' 403' ' ' ILE . 7.0 t-20 -33.9 93.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.927 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 103.92 27.02 6.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.481 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 391' ' ' MET . 14.1 mmmt -90.76 146.72 23.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.792 0.33 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.72 72.41 3.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.897 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 15.8 tp -75.84 111.82 11.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 62.49 24.99 14.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . 0.446 ' C ' ' OE1' ' A' ' 399' ' ' GLU . . . 89.75 14.39 59.66 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.508 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . 0.446 ' OE1' ' C ' ' A' ' 398' ' ' GLY . 2.5 mp0 -132.88 127.71 34.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.87 0.367 . . . . 0.0 110.849 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.46 96.81 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 20.4 pt -74.67 148.9 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.11 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -112.58 129.71 56.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.863 HD12 ' N ' ' A' ' 392' ' ' ASN . 27.3 mt -113.91 126.47 71.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.141 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.65 136.28 46.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.149 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.59 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 9.0 m-85 -54.9 112.61 1.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.104 179.943 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 8.8 pttm . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.8 0.333 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 67.7 t -79.61 118.81 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.147 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.572 HD21 ' HB1' ' A' ' 384' ' ' ALA . 46.1 mt -99.2 131.02 45.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -92.92 105.17 17.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.53 HG22 HG12 ' A' ' 403' ' ' ILE . 20.8 t -104.17 131.83 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -133.21 173.73 11.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 73.06 35.47 0.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.427 HD21 HG12 ' A' ' 342' ' ' VAL . 21.4 mt -76.63 139.18 40.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.428 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -67.52 -178.93 0.97 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -85.7 -0.26 54.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 17.2 p -117.64 14.94 14.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.159 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.428 HG23 ' HB3' ' A' ' 346' ' ' ALA . 96.0 t -96.52 133.73 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.127 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 39.8 p -134.39 169.01 17.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.116 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -51.7 -41.66 61.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -57.47 -43.87 84.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 66.5 mt -67.7 -29.56 45.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.55 ' HB2' HG11 ' A' ' 367' ' ' VAL . 96.0 mt -72.78 -32.01 65.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.477 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 16.1 mt-10 -73.14 -69.85 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . 0.471 ' HE3' ' N ' ' A' ' 356' ' ' LYS . 0.7 OUTLIER -43.25 -39.11 2.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' ALA . . . . . 0.561 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -69.59 -56.02 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' PHE . . . . . 0.426 ' O ' HD21 ' A' ' 364' ' ' LEU . 42.7 m-85 -83.96 14.54 4.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 355' ' ' GLU . 11.7 t -100.01 -52.39 3.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -40.35 -37.63 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.533 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 79.9 m-85 -65.7 -62.75 1.34 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.94 162.22 29.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.507 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -49.0 130.85 18.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 0.0 110.917 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.477 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 36.2 mt -101.21 155.02 18.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -100.12 -47.86 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -173.52 167.44 4.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.55 HG11 ' HB2' ' A' ' 354' ' ' LEU . 83.2 t -136.87 133.42 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.34 118.51 31.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 12.9 tptp -92.66 141.33 28.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.758 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.5 mp -126.39 -174.65 3.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 370' ' ' LEU . 1.3 mppt? -33.51 -68.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -122.27 -37.67 2.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.758 ' CE2' HD22 ' A' ' 370' ' ' LEU . 6.7 p90 -92.64 -176.39 4.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.503 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -163.87 161.84 23.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -112.4 134.68 53.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.7 mm -108.56 109.11 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.151 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -88.42 120.67 30.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.508 ' CE1' HD12 ' A' ' 340' ' ' LEU . 17.9 m-85 -101.92 147.53 26.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.54 -33.7 75.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -132.71 153.97 50.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -61.78 -31.01 71.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.99 -51.18 27.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -43.18 -36.67 2.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.501 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . 0.572 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -72.11 -59.32 2.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.865 0.364 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.478 HG22 ' HZ ' ' A' ' 405' ' ' PHE . 86.1 t -36.41 -37.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.8 tptt -72.56 -66.01 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -56.3 -15.87 4.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 7.5 ttm -78.94 -60.15 2.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -78.2 -2.5 38.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.533 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 65.0 mm-40 -100.07 -21.62 15.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . 0.561 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 10.9 mmm -116.8 -39.12 3.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.845 ' N ' HD12 ' A' ' 403' ' ' ILE . 27.5 t-20 -33.23 93.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 103.73 29.93 5.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 391' ' ' MET . 14.8 mmmt -96.2 146.4 24.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.729 0.299 . . . . 0.0 110.914 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.66 74.05 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.625 HD22 HD13 ' A' ' 401' ' ' ILE . 15.6 tp -76.41 110.65 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 62.28 24.96 14.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.66 13.84 57.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.478 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -133.56 130.53 38.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 0.0 110.889 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.3 93.57 2.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.625 HD13 HD22 ' A' ' 396' ' ' LEU . 20.2 pt -72.06 145.47 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -108.72 130.2 55.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.845 HD12 ' N ' ' A' ' 392' ' ' ASN . 24.7 mt -115.52 127.82 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.1 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.27 140.07 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 7.7 m-85 -58.16 108.95 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 49.9 pttt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.826 0.346 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.95 122.45 27.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.153 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.645 HD21 ' HB1' ' A' ' 384' ' ' ALA . 29.3 mt -102.33 122.85 45.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 52.7 t80 -85.64 111.29 19.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.608 HG22 HG12 ' A' ' 403' ' ' ILE . 46.3 t -106.22 141.51 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.117 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -140.74 168.21 20.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 75.05 45.34 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 54.0 mt -81.08 137.97 35.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.655 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -62.31 -175.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.085 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -89.86 -4.84 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.851 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 80.5 p -118.71 19.26 13.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.655 HG23 ' HB3' ' A' ' 346' ' ' ALA . 81.5 t -94.74 152.57 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.091 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . 0.403 ' N ' HG12 ' A' ' 349' ' ' VAL . 82.2 p -155.45 175.44 13.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -57.28 -45.82 83.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.926 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -53.4 -43.59 68.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 349' ' ' VAL . 70.7 mt -67.72 -38.81 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.498 HD22 HD11 ' A' ' 376' ' ' ILE . 88.1 mt -64.28 -25.41 68.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.961 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 359' ' ' SER . 37.2 mt-10 -76.94 -71.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -44.2 -33.17 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' ALA . . . . . 0.621 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -74.39 -52.47 12.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.128 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' PHE . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 41.7 m-85 -88.27 13.57 11.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 355' ' ' GLU . 11.8 t -100.03 -58.22 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 359' ' ' SER . 20.7 pt20 -34.96 -39.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 89.6 m-85 -63.41 -63.91 1.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -149.83 166.47 29.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.81 129.98 31.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.917 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.418 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 27.8 mt -98.36 161.51 13.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.869 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -109.71 -46.28 3.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -174.32 165.27 4.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.471 HG11 ' HB2' ' A' ' 354' ' ' LEU . 53.2 t -135.75 132.57 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.108 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.77 108.25 10.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . 0.467 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 8.3 tttm -87.77 147.28 25.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.774 HD22 ' CE2' ' A' ' 373' ' ' TYR . 5.6 mp -126.33 -173.52 2.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.486 ' C ' ' O ' ' A' ' 370' ' ' LEU . 32.4 ttmt -30.35 -65.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -125.72 -37.96 2.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.861 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.774 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.5 p90 -90.93 -176.25 4.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 370' ' ' LEU . . . -162.78 160.93 25.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.086 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . 0.401 ' CZ ' ' HD1' ' A' ' 341' ' ' PHE . 12.7 m-85 -116.28 121.86 43.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.498 HD11 HD22 ' A' ' 354' ' ' LEU . 5.3 mm -96.62 122.26 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -100.09 123.19 44.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 358' ' ' PHE . 19.9 m-85 -105.3 147.71 27.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -64.28 -35.01 79.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -130.99 147.46 52.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.457 ' NH1' ' CG2' ' A' ' 385' ' ' VAL . 0.0 OUTLIER -55.54 -32.07 62.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.826 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 384' ' ' ALA . 7.1 t70 -68.74 -60.6 2.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 382' ' ' ASP . . . -36.35 -33.81 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.491 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . 0.645 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -74.07 -63.8 1.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 111.065 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.457 ' CG2' ' NH1' ' A' ' 381' ' ' ARG . 92.5 t -35.43 -35.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . 0.48 ' HE3' ' CG ' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -71.92 -60.56 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -62.1 -17.73 58.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.135 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.585 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 7.4 ttm -75.24 -59.1 2.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.401 ' N ' ' HG2' ' A' ' 388' ' ' MET . 7.3 mt-10 -77.69 -3.04 39.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.48 ' CG ' ' HE3' ' A' ' 386' ' ' LYS . 28.5 mm-40 -100.09 -29.21 12.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.884 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . 0.621 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 7.4 mmm -108.0 -28.92 9.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.663 ' N ' HD12 ' A' ' 403' ' ' ILE . 2.6 t-20 -43.74 111.56 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 78.81 24.71 61.67 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 391' ' ' MET . 0.0 OUTLIER -93.62 142.57 27.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 0.0 110.876 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -70.56 103.19 2.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.787 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.494 HD22 HD13 ' A' ' 401' ' ' ILE . 19.5 tp -109.83 110.48 21.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 62.04 34.4 16.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 80.8 16.28 75.58 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.518 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -140.03 119.57 13.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.31 104.32 2.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.494 HD13 HD22 ' A' ' 396' ' ' LEU . 28.0 pt -79.42 151.06 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.559 ' OE1' HG13 ' A' ' 404' ' ' VAL . 9.6 tm-20 -114.81 132.02 56.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.663 HD12 ' N ' ' A' ' 392' ' ' ASN . 22.6 mt -116.05 134.83 58.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.109 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.559 HG13 ' OE1' ' A' ' 402' ' ' GLU . 14.1 m -147.74 130.62 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.585 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 14.5 m-85 -49.52 105.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.556 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.072 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 25.5 pttm . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.801 0.334 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.2 t -79.96 123.01 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.865 HD21 ' HB1' ' A' ' 384' ' ' ALA . 33.5 mt -102.42 131.23 49.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.948 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.462 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 76.9 t80 -94.78 104.7 16.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.805 HG22 HG12 ' A' ' 403' ' ' ILE . 33.0 t -104.42 130.78 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -132.33 173.35 11.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . 0.49 ' ND2' ' OE1' ' A' ' 399' ' ' GLU . 0.7 OUTLIER 73.78 40.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.888 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 62.1 mt -78.86 159.11 27.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -86.0 -178.74 6.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.075 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -88.39 4.64 45.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 15.9 p -124.47 15.41 8.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.1 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.87 143.6 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.089 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . 0.409 ' H ' HD12 ' A' ' 353' ' ' ILE . 73.7 p -143.3 173.11 11.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -52.93 -48.09 67.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -51.77 -46.18 64.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.862 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.409 HD12 ' H ' ' A' ' 350' ' ' THR . 77.5 mt -64.7 -35.7 75.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.591 ' HB2' HG11 ' A' ' 367' ' ' VAL . 95.6 mt -69.53 -27.4 65.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.469 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 34.2 mt-10 -77.64 -69.19 0.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -46.21 -32.8 3.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' ALA . . . . . 0.564 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -75.77 -49.16 18.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.098 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' PHE . . . . . 0.446 ' C ' HD11 ' A' ' 364' ' ' LEU . 28.7 m-85 -89.73 15.89 8.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 360' ' ' GLN . 9.9 t -98.9 -57.81 2.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.842 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 359' ' ' SER . 24.2 pt20 -35.97 -39.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.892 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.522 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 85.1 m-85 -63.78 -63.4 1.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.39 162.52 29.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.434 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -50.12 127.28 16.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.499 HD21 ' CZ ' ' A' ' 378' ' ' PHE . 32.3 mt -97.66 153.97 17.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -102.06 -49.03 4.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -171.31 164.42 7.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.591 HG11 ' HB2' ' A' ' 354' ' ' LEU . 40.6 t -136.4 125.8 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -112.08 118.95 36.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -91.32 140.52 29.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.93 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.781 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.5 mp -124.24 -174.76 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 370' ' ' LEU . 1.0 OUTLIER -33.69 -69.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -119.6 -38.53 2.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.822 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.781 ' CE2' HD22 ' A' ' 370' ' ' LEU . 5.2 p90 -91.44 -174.95 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.474 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -163.83 162.81 23.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.111 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -112.47 139.26 48.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 6.2 mm -114.11 104.31 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.119 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -84.26 122.78 29.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.499 ' CZ ' HD21 ' A' ' 364' ' ' LEU . 19.8 m-85 -105.12 148.1 27.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -58.46 -36.85 74.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -134.35 155.79 49.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.879 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . 0.416 ' C ' ' HD3' ' A' ' 381' ' ' ARG . 2.4 tmt_? -59.05 -34.56 72.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 384' ' ' ALA . 23.1 t70 -67.01 -60.03 2.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.831 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -37.06 -32.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.487 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . 0.865 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -76.82 -54.95 5.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.859 0.361 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 381' ' ' ARG . 65.1 t -36.79 -39.7 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -69.8 -66.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -53.29 -15.73 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.118 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.56 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.5 ttm -79.6 -63.93 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.457 ' N ' ' HG2' ' A' ' 388' ' ' MET . 6.4 mt-10 -75.2 -0.67 20.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.522 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 28.3 mm-40 -100.19 -35.36 9.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . 0.564 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 9.8 mmm -103.47 -34.61 8.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.679 ' N ' HD12 ' A' ' 403' ' ' ILE . 3.5 t-20 -37.79 99.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 96.04 28.53 9.23 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.452 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 391' ' ' MET . 34.4 mmtt -95.6 147.26 23.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.779 0.323 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.37 78.02 3.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.457 HD22 HD13 ' A' ' 401' ' ' ILE . 21.5 tp -81.87 110.39 17.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 62.19 27.48 16.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.43 21.3 48.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . 0.49 ' OE1' ' ND2' ' A' ' 344' ' ' ASN . 12.7 mm-40 -140.06 126.51 20.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 0.0 110.851 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.47 92.53 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . 0.457 HD13 HD22 ' A' ' 396' ' ' LEU . 28.8 pt -72.41 150.54 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.094 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -115.78 131.35 56.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.805 HG12 HG22 ' A' ' 342' ' ' VAL . 28.0 mt -114.87 124.84 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.164 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 30.7 m -138.03 132.33 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.56 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 17.7 m-85 -49.18 114.11 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.124 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? . . . . . 0 N--CA 1.457 -0.075 0 CA-C-O 120.861 0.362 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 60.2 t -79.86 129.83 36.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.147 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.534 HD21 ' HB1' ' A' ' 384' ' ' ALA . 31.2 mt -110.71 125.03 53.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' A' ' 343' ' ' ARG . 6.3 t80 -86.04 118.84 25.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 403' ' ' ILE . 21.2 t -115.73 130.12 70.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.099 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.473 ' HB3' ' CE1' ' A' ' 341' ' ' PHE . 6.9 ptp180 -128.58 -179.91 5.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.7 t30 65.22 41.92 4.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.606 HD13 ' NZ ' ' A' ' 369' ' ' LYS . 39.4 mt -84.32 136.33 33.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.28 172.48 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.128 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -81.66 11.92 4.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 18.5 p -129.36 11.19 5.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.742 HG12 ' NZ ' ' A' ' 369' ' ' LYS . 84.8 t -85.91 139.61 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.164 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 76.7 p -140.42 157.71 45.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.446 ' HG2' HG12 ' A' ' 367' ' ' VAL . 35.5 mt-10 -43.92 -43.9 6.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -54.36 -42.87 70.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 78.1 mt -68.93 -33.37 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.462 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 95.2 mt -69.22 -30.83 69.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 359' ' ' SER . 51.9 mt-10 -72.72 -72.41 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -44.19 -36.91 2.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' ALA . . . . . 0.467 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -69.42 -51.87 32.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' PHE . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 34.8 m-85 -89.23 15.58 8.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 355' ' ' GLU . 12.3 t -99.66 -51.82 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -40.44 -38.22 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.945 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.531 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 92.0 m-85 -65.59 -62.35 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.19 170.3 31.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -55.77 138.52 47.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.422 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 55.7 mt -107.95 162.64 13.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -111.46 -48.94 3.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.434 ' NH1' ' HB2' ' A' ' 366' ' ' ARG . 1.3 ptp180 -171.23 166.19 7.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.446 HG12 ' HG2' ' A' ' 351' ' ' GLU . 78.6 t -135.67 130.89 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -116.84 116.81 28.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' LYS . . . . . 0.742 ' NZ ' HG12 ' A' ' 349' ' ' VAL . 33.8 tptt -89.12 146.22 24.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.845 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.5 mp -130.58 -174.86 3.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 370' ' ' LEU . 28.8 mtpt -33.64 -62.49 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.488 ' O ' HD12 ' A' ' 345' ' ' LEU . 3.9 m-20 -129.38 -36.05 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.845 ' CE2' HD22 ' A' ' 370' ' ' LEU . 3.7 p90 -92.23 -174.94 3.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.532 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -167.35 153.02 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.106 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -103.01 137.95 40.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.462 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.9 mm -110.33 110.6 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -88.49 121.46 30.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 358' ' ' PHE . 17.3 m-85 -103.24 144.12 31.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.92 -27.89 54.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -142.01 156.3 45.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -61.49 -35.22 77.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 384' ' ' ALA . 27.0 t70 -66.89 -58.74 4.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -38.04 -31.1 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.455 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' ALA . . . . . 0.534 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -77.19 -58.61 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.328 . . . . 0.0 111.079 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 384' ' ' ALA . 57.7 t -36.08 -35.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -73.54 -66.09 0.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -55.51 -17.37 5.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.095 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.561 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.0 ttm -77.3 -63.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.875 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.463 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.4 mt-10 -74.81 0.33 15.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.531 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 30.1 mm-40 -100.21 -36.27 9.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 393' ' ' GLY . 4.0 mmt -102.64 -31.27 10.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.65 ' N ' HD12 ' A' ' 403' ' ' ILE . 6.5 t-20 -39.2 92.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 101.38 33.85 4.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.465 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -100.14 147.19 25.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.878 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.09 80.96 2.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 17.8 tp -90.07 113.88 25.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 62.25 26.39 15.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.939 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 84.83 20.33 58.11 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -140.01 122.18 15.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.921 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.38 92.27 0.8 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 19.4 pt -71.33 147.46 10.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.123 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -113.05 131.37 55.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.656 HG12 HG22 ' A' ' 342' ' ' VAL . 55.7 mt -110.78 136.98 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.124 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 20.2 m -151.76 135.13 7.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.561 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 24.0 m-85 -52.58 117.22 2.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 179.912 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 3.2 m -88.55 42.48 1.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.91 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 25.2 m -41.28 -60.89 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 172.68 -132.44 2.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.495 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 4.4 t -145.27 137.71 25.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 110.844 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.4 t -143.23 160.38 40.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 179.78 -169.14 39.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.5 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -142.47 124.65 15.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.0 110.933 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -131.38 152.59 50.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.131 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -106.71 46.13 0.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.863 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 87.3 t -102.07 137.95 28.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.128 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -99.2 -27.95 13.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 68.5 t -82.66 137.22 21.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.574 HD22 ' HB2' ' A' ' 388' ' ' MET . 56.6 mt -111.48 127.54 55.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.578 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 71.1 t80 -90.65 105.49 17.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.452 ' CG1' HD12 ' A' ' 401' ' ' ILE . 21.6 t -104.86 128.57 58.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -128.44 175.92 8.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.66 36.4 1.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 31.8 mt -75.1 146.63 41.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.627 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -73.19 -179.14 3.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.107 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -85.51 -2.34 58.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 13.1 p -118.49 15.55 13.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.627 HG23 ' HB3' ' A' ' 346' ' ' ALA . 95.7 t -97.25 135.64 30.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.092 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 82.3 p -139.31 175.79 9.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.168 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -54.86 -44.78 74.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -55.53 -44.77 77.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 63.7 mt -68.54 -33.79 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.138 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.454 ' HB2' HG11 ' A' ' 367' ' ' VAL . 89.9 mt -70.75 -27.77 64.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 359' ' ' SER . 72.4 mt-10 -74.21 -71.19 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -41.54 -39.4 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' ALA . . . . . 0.735 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -69.77 -56.31 7.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -83.86 14.46 4.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 355' ' ' GLU . 13.4 t -99.22 -56.83 2.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 359' ' ' SER . 27.2 pt20 -37.67 -38.28 0.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.496 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 84.5 m-85 -63.0 -63.08 1.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.25 167.12 31.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.465 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -52.98 128.83 28.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.454 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 37.5 mt -98.15 157.2 16.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.912 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -106.02 -46.67 4.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -174.9 165.6 3.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 354' ' ' LEU . 78.4 t -135.41 127.85 47.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.118 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -114.69 113.4 24.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -89.0 142.02 27.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.731 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.1 mp -126.91 -174.02 3.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.5 OUTLIER -32.28 -67.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.891 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -124.43 -37.7 2.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.731 ' CE2' HD22 ' A' ' 370' ' ' LEU . 9.1 p90 -93.46 179.64 5.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.508 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -158.21 168.22 27.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.131 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -119.02 128.55 54.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 7.2 mm -102.6 114.59 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -92.66 126.67 37.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 387' ' ' ALA . 21.2 m-85 -109.51 137.73 46.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -54.16 -30.66 50.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -135.87 152.67 51.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 385' ' ' VAL . 6.0 tmm_? -60.64 -28.37 68.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.919 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -71.72 -54.08 11.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . 0.408 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -42.97 -30.82 1.08 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.444 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -77.74 -59.43 2.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.821 0.343 . . . . 0.0 111.082 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 381' ' ' ARG . 95.4 t -37.99 -37.75 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.127 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -71.3 -62.81 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -59.71 -15.67 21.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.574 ' HB2' HD22 ' A' ' 340' ' ' LEU . 8.7 ttm -78.75 -62.39 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.436 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.6 mt-10 -74.92 -0.35 18.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.496 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 14.3 mm-40 -100.03 -38.99 8.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . 0.735 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 4.4 mmt -100.96 -27.66 13.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.934 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.875 ' N ' HD12 ' A' ' 403' ' ' ILE . 1.5 t-20 -38.05 107.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 78.52 38.61 24.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.479 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 21.3 mmtt -100.06 149.05 23.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 110.884 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -75.57 82.18 2.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.88 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.401 HD22 HD13 ' A' ' 401' ' ' ILE . 15.3 tp -89.48 112.6 23.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 62.24 26.63 15.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 88.14 11.31 67.43 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.487 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -130.91 128.91 41.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.888 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.51 98.37 4.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.825 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.452 HD12 ' CG1' ' A' ' 342' ' ' VAL . 20.2 pt -78.1 147.92 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.138 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -109.83 129.72 55.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.875 HD12 ' N ' ' A' ' 392' ' ' ASN . 15.5 mt -113.35 124.12 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.095 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 2.9 m -138.62 135.16 43.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.562 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 10.1 m-85 -51.67 106.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.893 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.578 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . -67.82 156.5 36.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.077 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -76.07 145.11 76.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.628 0.727 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 146.68 61.06 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.688 2.259 . . . . 0.0 112.354 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 90.84 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.701 2.267 . . . . 0.0 112.339 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -131.14 101.95 5.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLN . . . . . 0.495 ' N ' ' OE1' ' A' ' 411' ' ' GLN . 0.1 OUTLIER -140.57 149.15 42.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -173.3 164.1 4.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -121.06 89.34 3.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.11 139.58 30.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -170.31 136.95 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 58.0 ttm-85 -164.46 110.74 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.852 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -149.64 162.48 40.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -145.89 105.84 4.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.153 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -158.71 115.92 2.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -156.12 130.9 9.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -169.01 142.66 2.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -140.53 117.99 11.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.072 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -106.24 80.05 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.103 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 3.7 m -65.87 -55.83 14.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 42.04 82.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.489 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 176.08 7.27 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 24.5 p -169.5 161.07 9.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.815 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 70.1 m -133.9 170.05 16.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.891 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.461 -179.952 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 3.3 m -43.76 145.25 0.7 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 1.4 t -107.13 110.64 22.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -101.12 -130.83 7.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 87.5 p -131.23 49.67 2.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.89 0.376 . . . . 0.0 110.822 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 59.8 p -124.51 126.79 46.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 104.48 68.31 0.74 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 5.7 mtp -116.94 116.97 28.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.802 0.334 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.516 ' HB3' ' CD2' ' A' ' 405' ' ' PHE . . . -120.09 140.98 50.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.511 ' CA ' ' NH2' ' A' ' 381' ' ' ARG . 3.8 ptmm? -86.32 36.08 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.819 HG21 ' O ' ' A' ' 406' ' ' ALA . 61.0 t -106.93 134.74 47.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.087 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -91.74 -35.43 14.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.929 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 65.2 t -69.49 133.22 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.072 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.529 HD21 ' HB1' ' A' ' 384' ' ' ALA . 51.8 mt -105.28 119.2 38.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -85.32 106.18 16.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.776 HG22 HG12 ' A' ' 403' ' ' ILE . 25.4 t -102.1 130.05 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.163 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -131.14 173.29 11.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.73 39.61 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.614 HD13 ' NZ ' ' A' ' 369' ' ' LYS . 38.6 mt -81.24 156.95 25.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.921 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -95.08 161.23 14.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.075 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -63.73 -8.0 9.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 24.9 p -98.84 -9.24 24.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.165 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.543 HG12 ' NZ ' ' A' ' 369' ' ' LYS . 57.7 t -83.15 140.48 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.139 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 78.2 p -144.46 163.03 35.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -40.7 -50.46 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -52.08 -52.24 52.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.903 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 75.2 mt -58.95 -29.08 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.5 ' HB2' HG11 ' A' ' 367' ' ' VAL . 96.1 mt -75.54 -30.65 59.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.472 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 51.3 mt-10 -75.58 -64.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -50.14 -38.67 40.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' ALA . . . . . 0.458 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -69.01 -49.69 55.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' PHE . . . . . 0.422 ' C ' HD11 ' A' ' 364' ' ' LEU . 45.0 m-85 -90.32 14.89 11.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 355' ' ' GLU . 9.0 t -100.06 -51.35 3.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -38.84 -38.7 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.497 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 94.1 m-85 -64.49 -62.72 1.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -153.65 161.31 29.78 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -47.94 129.06 14.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.472 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 40.4 mt -98.31 156.42 16.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -100.55 -50.49 3.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -171.24 165.49 7.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 354' ' ' LEU . 51.1 t -136.93 129.59 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.82 109.02 16.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . 0.614 ' NZ ' HD13 ' A' ' 345' ' ' LEU . 29.5 tptt -82.17 146.16 29.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.703 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.7 mp -128.99 -174.91 3.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.1 OUTLIER -34.4 -67.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -122.3 -37.14 2.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.703 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.8 p90 -94.19 -175.11 3.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.531 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -166.44 161.41 16.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.138 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -110.94 137.3 48.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 5.3 mm -111.16 109.55 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -89.29 121.32 31.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 19.5 m-85 -101.78 149.08 24.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -69.02 -31.76 70.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.847 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -131.05 154.37 48.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.511 ' NH2' ' CA ' ' A' ' 336' ' ' LYS . 8.4 tpp85 -58.13 -37.71 75.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 384' ' ' ALA . 19.6 t70 -66.2 -57.55 7.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . 0.537 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -35.12 -31.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.507 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.529 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -80.88 -66.93 0.82 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.117 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' A' ' 384' ' ' ALA . 58.0 t -36.0 -35.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 384' ' ' ALA . 12.1 tptm -72.92 -61.03 1.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.51 -16.92 41.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.593 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.7 ttm -76.52 -61.27 2.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.436 ' N ' ' HG2' ' A' ' 388' ' ' MET . 13.1 mt-10 -74.17 -4.22 34.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.872 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.497 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 39.0 mm-40 -100.03 -33.02 10.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . 0.503 ' O ' ' CG ' ' A' ' 394' ' ' LYS . 38.2 mmm -101.96 -41.0 6.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.754 ' N ' HD12 ' A' ' 403' ' ' ILE . 5.1 t-20 -34.12 116.61 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 76.63 30.05 56.87 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.46 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.734 ' HE3' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -100.01 141.97 32.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 0.0 110.896 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.49 99.99 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.734 HD13 ' HE3' ' A' ' 394' ' ' LYS . 20.5 tp -106.36 114.31 28.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.968 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . 0.451 ' HG3' HG22 ' A' ' 349' ' ' VAL . 6.2 mm-40 60.88 27.18 17.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.88 16.86 59.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.479 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -140.04 120.74 14.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.91 100.01 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.567 HD12 ' CG1' ' A' ' 342' ' ' VAL . 25.0 pt -75.68 149.72 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -112.44 128.51 56.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.776 HG12 HG22 ' A' ' 342' ' ' VAL . 35.6 mt -111.96 128.97 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.124 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 9.9 m -142.32 132.91 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.152 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.593 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 19.2 m-85 -50.87 110.78 0.46 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.819 ' O ' HG21 ' A' ' 337' ' ' VAL . . . -68.08 158.32 33.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -96.78 144.98 28.8 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.618 0.723 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 151.01 69.2 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.709 2.273 . . . . 0.0 112.402 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 123.02 9.68 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.631 2.221 . . . . 0.0 112.325 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 6.5 t70 58.84 49.61 9.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -42.14 -45.25 3.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.05 109.1 10.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -69.26 121.68 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -148.34 127.41 12.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -163.18 143.62 9.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -147.54 123.55 10.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -116.88 118.84 33.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -146.31 121.34 10.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.081 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -130.49 173.49 10.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 -164.82 131.38 2.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.844 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -101.41 152.49 20.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -131.79 155.66 47.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.078 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -146.23 166.45 26.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.107 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.1 t -168.29 167.36 12.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -150.29 85.07 0.16 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.488 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 163.49 38.12 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 38.9 t -119.74 -47.71 2.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 429' ' ' GLY . 89.0 p -172.49 156.39 3.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 428' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.494 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 91.7 p -160.54 174.8 13.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.884 0.373 . . . . 0.0 110.853 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 65.8 m -77.65 118.28 19.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.85 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 146.84 65.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.524 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 84.1 p -123.15 149.38 44.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 0.0 110.888 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 34.3 t -167.36 138.75 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.825 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 136.74 131.88 3.02 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.467 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 61.1 mmm -99.96 91.46 4.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.872 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -128.86 157.05 42.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -126.21 58.34 1.37 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.558 ' HB ' ' CD1' ' A' ' 405' ' ' PHE . 58.6 t -90.76 132.32 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.78 -27.79 14.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.0 t -85.17 125.68 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.118 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.617 HD12 ' CE1' ' A' ' 378' ' ' PHE . 70.6 mt -103.84 130.35 51.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.946 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -94.74 107.83 19.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.59 HG22 HG12 ' A' ' 403' ' ' ILE . 18.7 t -106.15 130.49 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -130.15 168.24 17.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.3 t30 72.22 54.35 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.466 HD21 HG12 ' A' ' 342' ' ' VAL . 15.6 mt -96.25 145.91 25.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.929 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -81.08 163.12 23.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.053 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -66.83 -4.47 9.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 24.6 p -104.58 6.31 34.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.709 HG12 ' NZ ' ' A' ' 369' ' ' LYS . 58.6 t -94.16 138.09 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.154 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 43.4 p -142.64 159.15 42.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.16 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.4 ' HA ' HD12 ' A' ' 354' ' ' LEU . 53.3 mt-10 -42.73 -41.15 3.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -57.92 -46.93 84.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 73.3 mt -65.56 -30.17 49.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.14 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.513 ' HB2' HG11 ' A' ' 367' ' ' VAL . 83.2 mt -72.94 -31.4 64.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 359' ' ' SER . 21.7 mt-10 -72.07 -67.69 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -50.3 -39.92 46.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' ALA . . . . . 0.463 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -65.71 -51.3 60.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' PHE . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 45.3 m-85 -90.49 14.57 12.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 355' ' ' GLU . 2.1 t -99.8 -57.44 2.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 359' ' ' SER . 19.1 pt20 -35.2 -39.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -64.58 -65.23 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -147.4 163.89 28.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.454 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -52.85 130.72 34.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.469 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 34.2 mt -99.77 158.94 15.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.949 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -108.07 -44.5 4.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -174.16 164.41 4.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.513 HG11 ' HB2' ' A' ' 354' ' ' LEU . 54.2 t -135.51 133.75 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.443 ' O ' ' HB1' ' A' ' 374' ' ' ALA . 39.7 tptt -119.55 123.76 44.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . 0.709 ' NZ ' HG12 ' A' ' 349' ' ' VAL . 24.0 tptt -95.7 146.29 24.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.788 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.8 mp -133.96 -174.74 3.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 370' ' ' LEU . 24.4 tttp -33.57 -68.46 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.886 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.3 -37.13 2.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.788 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.3 p90 -90.94 -175.79 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.968 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 368' ' ' LYS . . . -168.15 147.18 4.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.091 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -95.76 142.23 28.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.6 mm -118.07 106.18 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -84.44 121.48 27.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.847 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.617 ' CE1' HD12 ' A' ' 340' ' ' LEU . 14.4 m-85 -102.61 151.47 22.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -60.57 -35.77 76.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -140.35 153.12 46.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.449 ' O ' HG23 ' A' ' 385' ' ' VAL . 6.5 tmm_? -52.7 -28.43 21.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.877 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 384' ' ' ALA . 12.0 t0 -69.81 -62.21 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . 0.474 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -36.76 -29.62 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.52 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.506 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -79.9 -58.47 3.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 0.0 111.113 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 381' ' ' ARG . 96.3 t -38.39 -38.63 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.151 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -71.93 -64.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -57.04 -15.48 5.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.602 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 9.0 ttm -79.46 -62.91 1.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.442 ' N ' ' HG2' ' A' ' 388' ' ' MET . 9.9 mt-10 -74.86 -0.97 20.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -100.09 -35.04 9.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . 0.47 ' HA ' ' CG ' ' A' ' 394' ' ' LYS . 27.7 mmm -103.91 -37.15 7.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.889 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.821 ' N ' HD12 ' A' ' 403' ' ' ILE . 4.3 t-20 -34.29 101.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 92.22 29.68 11.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.464 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.47 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 8.7 mmtp -94.99 148.2 22.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 0.0 110.854 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.64 80.66 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 15.6 tp -89.12 115.69 26.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.941 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 62.22 25.02 14.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 86.03 20.18 55.96 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.464 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -139.81 125.28 19.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.92 98.21 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 47.2 pt -74.6 153.32 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -117.09 126.61 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.821 HD12 ' N ' ' A' ' 392' ' ' ASN . 23.2 mt -113.06 124.85 70.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.158 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 10.4 m -137.05 133.35 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.602 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 8.3 m-85 -51.26 110.91 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.22 175.95 2.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.068 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -102.43 144.21 28.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.528 0.68 . . . . 0.0 110.933 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 160.27 50.32 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.681 2.254 . . . . 0.0 112.328 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -175.52 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.684 2.256 . . . . 0.0 112.354 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.29 92.75 2.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -104.34 86.38 2.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 77.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -86.76 106.09 17.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.855 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -133.93 155.07 50.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -133.97 115.54 14.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.85 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 41.2 ptt85 -168.48 134.35 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -119.14 130.6 55.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -127.31 110.45 12.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.133 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.83 38.62 2.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -131.14 84.87 2.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -119.72 -44.53 2.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 59.28 47.85 10.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -105.16 -48.1 3.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 18.9 m -119.69 85.45 2.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -120.36 -157.35 10.16 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.511 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 89.63 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.732 2.288 . . . . 0.0 112.34 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 5.0 m -122.02 -177.81 3.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 4.6 t -171.11 148.01 2.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.844 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.511 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 39.0 t -164.08 147.65 9.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.916 0.389 . . . . 0.0 110.828 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 25.4 t -160.63 158.89 29.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.857 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 99.21 107.12 2.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.505 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 1.8 t -151.93 156.34 39.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.916 0.389 . . . . 0.0 110.836 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 58.5 m -74.39 155.18 38.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -143.63 61.89 0.51 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.443 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 63.5 mtp -88.43 90.45 8.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.769 0.319 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -138.79 127.37 23.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.133 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -100.29 42.74 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 91.4 t -103.14 138.27 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 339' ' ' VAL . 0.0 OUTLIER -96.8 -31.05 12.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.427 ' N ' ' HD2' ' A' ' 338' ' ' LYS . 86.4 t -77.18 131.34 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.101 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.878 HD21 ' HB1' ' A' ' 384' ' ' ALA . 43.4 mt -108.26 127.37 53.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.522 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 56.2 t80 -91.27 108.61 20.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.463 HG12 HD21 ' A' ' 345' ' ' LEU . 14.0 t -103.13 134.73 43.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.125 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -134.11 167.13 21.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.84 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . 0.401 ' O ' HG22 ' A' ' 401' ' ' ILE . 3.4 t30 73.23 52.38 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.463 HD21 HG12 ' A' ' 342' ' ' VAL . 22.5 mt -96.22 131.99 42.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.452 ' HB3' ' CB ' ' A' ' 397' ' ' GLU . . . -54.58 -176.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -88.93 5.68 42.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 21.9 p -121.86 13.77 10.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 91.6 t -88.55 138.81 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . 0.432 ' H ' HD12 ' A' ' 353' ' ' ILE . 67.0 p -144.07 167.05 23.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.159 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -50.45 -43.94 55.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.04 -41.9 75.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.432 HD12 ' H ' ' A' ' 350' ' ' THR . 71.3 mt -69.49 -41.48 80.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.557 ' HB2' HG11 ' A' ' 367' ' ' VAL . 92.4 mt -63.37 -32.51 73.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.48 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 46.1 mt-10 -68.21 -73.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -41.48 -39.67 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.957 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' ALA . . . . . 0.652 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -66.7 -54.6 21.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' PHE . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 37.0 m-85 -87.78 14.68 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 355' ' ' GLU . 17.7 t -99.99 -53.25 3.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.848 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -38.68 -38.68 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.505 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 84.3 m-85 -64.08 -62.71 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -151.87 169.78 31.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.525 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -53.86 132.73 42.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.818 0.342 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.48 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 32.9 mt -101.46 160.49 14.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.949 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -110.33 -48.04 3.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -172.97 163.65 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' A' ' 354' ' ' LEU . 71.9 t -134.1 130.07 54.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -111.06 108.41 18.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.866 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . 0.407 ' C ' HD12 ' A' ' 370' ' ' LEU . 19.3 tptp -87.08 137.58 32.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.799 HD22 ' CE2' ' A' ' 373' ' ' TYR . 7.6 mp -126.28 -174.74 3.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 370' ' ' LEU . 30.8 tttm -33.55 -67.73 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.873 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.16 -36.39 2.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.799 ' CE2' HD22 ' A' ' 370' ' ' LEU . 6.5 p90 -93.7 -177.36 4.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -165.79 159.65 16.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.098 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -110.7 131.51 54.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.882 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 3.9 mm -105.26 115.58 47.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -93.54 113.98 26.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.429 ' HE1' HD12 ' A' ' 340' ' ' LEU . 17.4 m-85 -96.06 146.11 24.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.851 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -63.66 -32.81 74.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -131.82 153.31 50.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.409 ' C ' ' HD2' ' A' ' 381' ' ' ARG . 2.0 tmm_? -62.19 -30.66 71.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -71.61 -50.42 30.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -44.8 -31.97 2.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.546 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.878 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -76.57 -63.06 1.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.792 0.33 . . . . 0.0 111.138 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 384' ' ' ALA . 61.3 t -34.92 -36.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . 0.445 ' HE3' ' CG ' ' A' ' 390' ' ' GLU . 17.8 tptt -72.68 -66.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -55.21 -16.87 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.592 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 7.5 ttm -77.65 -61.64 1.93 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.422 ' N ' ' HG2' ' A' ' 388' ' ' MET . 7.3 mt-10 -77.48 -2.06 33.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.505 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 52.9 mm-40 -100.15 -25.89 14.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . 0.652 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 23.4 mmm -112.1 -38.19 4.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.832 ' N ' HD12 ' A' ' 403' ' ' ILE . 7.6 t-20 -35.09 92.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 108.44 23.95 6.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.477 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 391' ' ' MET . 0.3 OUTLIER -90.28 146.9 23.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.774 0.321 . . . . 0.0 110.903 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -78.6 80.26 4.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 19.0 tp -89.19 114.89 26.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.927 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . 0.452 ' CB ' ' HB3' ' A' ' 346' ' ' ALA . 67.4 mm-40 62.49 27.74 16.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 82.45 20.88 61.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.481 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -140.18 122.51 15.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.891 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.38 95.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 344' ' ' ASN . 30.4 pt -72.4 148.7 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.193 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -115.79 130.77 56.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.832 HD12 ' N ' ' A' ' 392' ' ' ASN . 19.7 mt -109.74 138.93 35.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.167 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 17.9 m -149.43 134.61 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.073 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.592 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 15.4 m-85 -54.71 108.7 0.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.854 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.522 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . -69.9 159.14 34.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -82.19 146.88 55.81 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.602 0.715 . . . . 0.0 110.912 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 163.05 39.74 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.694 2.263 . . . . 0.0 112.315 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 176.02 7.3 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.666 2.244 . . . . 0.0 112.381 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.94 131.83 47.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLN . . . . . 0.425 ' C ' ' HD3' ' A' ' 412' ' ' LYS . 1.4 pt20 -138.15 159.51 41.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.425 ' HD3' ' C ' ' A' ' 411' ' ' GLN . 0.0 OUTLIER -168.84 135.97 1.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 14.4 mmm-85 -139.47 149.37 43.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.414 ' C ' ' OE2' ' A' ' 415' ' ' GLU . 14.0 pttp -157.95 150.41 22.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.414 ' OE2' ' C ' ' A' ' 414' ' ' LYS . 7.1 mp0 -138.0 134.73 35.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.94 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -132.2 130.46 41.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.94 121.7 36.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -153.41 172.63 16.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -171.68 164.51 6.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . 0.426 ' CG ' ' N ' ' A' ' 421' ' ' GLN . 12.0 ttp-105 -158.15 165.86 33.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . 0.426 ' N ' ' CG ' ' A' ' 420' ' ' ARG . 8.7 tp60 -108.2 117.27 33.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -86.42 168.05 14.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.081 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -155.12 -179.96 8.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.1 t -142.06 173.52 11.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 155.26 145.92 4.3 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.48 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 171.03 15.26 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.62 2.213 . . . . 0.0 112.351 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 67.9 m -124.79 -60.88 1.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.825 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.8 m 53.11 43.01 32.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.48 -179.999 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 69.0 m -131.66 127.46 37.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 110.9 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 39.2 m -70.0 163.8 25.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 121.36 64.6 0.24 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.468 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 34.1 t -104.86 108.02 19.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.904 0.383 . . . . 0.0 110.878 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 47.8 t -50.12 -52.32 35.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.867 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 64.96 58.69 9.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.477 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 7.7 ttt -80.38 -49.1 11.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.8 0.334 . . . . 0.0 110.867 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -135.13 -175.01 3.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.069 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -107.94 42.11 1.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.11 141.5 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.148 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.76 -32.6 9.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.942 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 90.6 t -79.94 135.94 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.862 HD21 ' HB1' ' A' ' 384' ' ' ALA . 16.5 mt -111.62 127.27 55.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -88.54 113.1 23.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.875 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.558 HG22 HG12 ' A' ' 403' ' ' ILE . 15.8 t -111.43 135.45 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -132.49 170.61 14.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.5 t30 73.46 43.85 0.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 39.0 mt -83.37 127.59 33.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.612 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -49.4 178.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -84.57 -5.34 59.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 25.7 p -117.84 22.46 12.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.612 HG23 ' HB3' ' A' ' 346' ' ' ALA . 64.5 t -96.4 136.64 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.153 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 77.8 p -135.45 178.28 7.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.132 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.87 -40.29 92.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -58.27 -46.54 85.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.86 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.67 -30.82 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.487 ' HB2' HG11 ' A' ' 367' ' ' VAL . 97.0 mt -73.84 -26.87 60.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 359' ' ' SER . 52.6 mt-10 -81.27 -64.77 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -51.05 -25.37 4.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -83.66 -44.83 14.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' PHE . . . . . 0.407 ' C ' HD11 ' A' ' 364' ' ' LEU . 35.9 m-85 -92.03 9.91 31.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 361' ' ' PHE . 92.2 p -95.13 -54.46 3.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.84 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 359' ' ' SER . 26.0 pt20 -34.28 -35.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.462 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 98.2 m-85 -70.97 -68.27 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -145.61 165.48 27.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.461 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -54.37 131.84 42.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.755 0.312 . . . . 0.0 110.909 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.407 HD11 ' C ' ' A' ' 358' ' ' PHE . 86.9 mt -101.32 155.63 17.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -100.88 -42.99 6.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.938 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -174.95 170.08 3.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.487 HG11 ' HB2' ' A' ' 354' ' ' LEU . 35.7 t -140.66 125.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.131 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.434 ' O ' ' HB1' ' A' ' 374' ' ' ALA . 8.7 tmtt? -112.49 123.14 49.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . 0.402 ' C ' HD12 ' A' ' 370' ' ' LEU . 15.7 tptm -97.52 143.52 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.763 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.9 mp -129.1 -174.62 3.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.1 OUTLIER -32.12 -72.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.932 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -120.04 -35.37 3.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.763 ' CE2' HD22 ' A' ' 370' ' ' LEU . 12.4 p90 -94.99 -179.41 4.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 368' ' ' LYS . . . -159.11 167.28 29.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.109 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -118.32 125.39 49.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 5.3 mm -99.18 110.5 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -91.68 120.75 32.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.827 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 358' ' ' PHE . 21.0 m-85 -101.02 154.63 18.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.55 -33.96 73.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -132.13 156.58 46.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.412 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 5.6 tmm_? -61.86 -32.71 73.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.15 -52.08 26.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -42.69 -32.84 1.42 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.543 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.862 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -77.73 -64.35 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.789 0.328 . . . . 0.0 111.092 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.43 ' C ' ' O ' ' A' ' 384' ' ' ALA . 68.2 t -35.39 -32.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.122 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 384' ' ' ALA . 15.5 tptm -74.8 -61.89 1.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.92 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.07 -14.68 25.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.57 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.4 ttm -78.65 -60.18 2.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.906 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -73.23 -3.15 25.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.462 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 4.4 mm-40 -100.41 -39.43 7.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . 0.513 ' HB2' HD11 ' A' ' 403' ' ' ILE . 49.8 mmm -99.76 -19.73 16.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 388' ' ' MET . 0.8 OUTLIER -43.92 119.46 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 56.36 37.25 73.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.445 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.433 ' HD2' ' C ' ' A' ' 395' ' ' ASP . 0.0 OUTLIER -100.09 150.78 22.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.78 0.324 . . . . 0.0 110.911 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . 0.433 ' C ' ' HD2' ' A' ' 394' ' ' LYS . 24.7 t0 -71.12 105.92 3.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 38.4 tp -119.39 115.48 24.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 59.77 36.95 22.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 77.0 9.56 86.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.501 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -135.31 124.39 24.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.893 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.79 106.12 6.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.931 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.497 HD12 ' CG1' ' A' ' 342' ' ' VAL . 21.7 pt -83.12 147.11 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -109.56 128.58 55.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.558 HG12 HG22 ' A' ' 342' ' ' VAL . 44.1 mt -110.71 142.55 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.11 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 403' ' ' ILE . 9.6 m -157.01 134.12 2.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.57 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 27.0 m-85 -53.32 111.04 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.72 157.68 34.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.113 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -89.92 143.89 30.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.54 0.686 . . . . 0.0 110.941 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 147.84 63.75 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.723 2.282 . . . . 0.0 112.342 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -39.38 6.48 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.643 2.228 . . . . 0.0 112.332 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.41 125.25 1.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -87.42 114.99 24.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.42 ' HD2' ' C ' ' A' ' 412' ' ' LYS . 1.5 pptp? -118.49 155.17 31.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.908 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -173.88 119.3 0.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.83 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -174.61 148.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.932 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.67 -176.41 3.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -146.31 159.15 43.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -95.84 134.17 39.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -93.4 169.44 10.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -147.96 -177.18 5.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.894 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -125.01 171.48 10.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -165.65 114.25 0.99 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -90.19 175.55 7.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.062 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -170.02 172.88 6.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.082 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 26.9 p -172.59 161.98 5.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 173.51 84.63 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.445 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -174.17 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.712 2.275 . . . . 0.0 112.34 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 8.3 t -172.86 176.35 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 83.8 p -146.8 166.48 26.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.507 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 2.0 t -155.58 153.42 30.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.883 0.373 . . . . 0.0 110.844 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 76.1 p -168.71 118.14 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.821 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 54.58 -156.84 7.02 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 42.0 t -123.5 113.23 18.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 0.0 110.875 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 59.9 p -90.64 124.64 35.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.834 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 73.66 50.39 11.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.524 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 12.3 ptp -67.87 128.36 36.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -132.78 157.14 45.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.113 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -120.45 28.37 8.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 58.9 t -83.6 130.51 35.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.081 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.93 -25.14 17.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.16 136.63 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.101 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.845 HD21 ' HB1' ' A' ' 384' ' ' ALA . 53.1 mt -112.9 128.9 56.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -92.59 108.26 19.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.66 HG22 HG12 ' A' ' 403' ' ' ILE . 48.7 t -106.0 127.27 61.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.176 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -126.51 173.44 9.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.24 39.19 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.581 HD21 HG12 ' A' ' 342' ' ' VAL . 48.7 mt -78.22 121.78 24.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -50.26 172.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.078 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -83.34 15.63 2.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 63.1 p -132.29 19.27 4.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.161 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 350' ' ' THR . 67.0 t -97.71 158.06 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . 0.5 ' N ' HG12 ' A' ' 349' ' ' VAL . 21.2 p -156.19 165.54 36.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.411 ' HG2' HG12 ' A' ' 367' ' ' VAL . 58.4 mt-10 -49.69 -44.51 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -56.96 -45.61 82.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 67.0 mt -64.43 -31.81 55.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.121 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.547 ' HB2' HG11 ' A' ' 367' ' ' VAL . 88.6 mt -73.49 -26.09 60.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 359' ' ' SER . 90.6 mt-10 -81.82 -66.88 0.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.899 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -49.72 -23.41 1.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -85.86 -45.75 11.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.078 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' PHE . . . . . 0.429 ' O ' HD21 ' A' ' 364' ' ' LEU . 36.1 m-85 -92.49 11.47 26.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 355' ' ' GLU . 95.7 p -100.09 -24.48 14.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.866 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -63.6 -31.71 72.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.563 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 93.6 m-85 -74.95 -61.95 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.859 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -148.65 162.45 28.87 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.521 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -52.18 129.19 27.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.429 HD21 ' O ' ' A' ' 358' ' ' PHE . 38.7 mt -97.7 154.63 17.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -101.85 -42.75 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.925 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.477 ' CZ ' ' HB2' ' A' ' 366' ' ' ARG . 2.4 ptm85 -174.1 164.89 4.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.859 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.547 HG11 ' HB2' ' A' ' 354' ' ' LEU . 46.3 t -136.53 124.68 34.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -117.79 107.94 14.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . 0.462 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 12.3 tttm -88.17 140.43 29.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.757 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.4 mp -118.18 -174.21 2.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 370' ' ' LEU . 9.2 ttpt -31.97 -69.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -118.12 -39.32 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.757 ' CE2' HD22 ' A' ' 370' ' ' LEU . 5.4 p90 -91.61 -174.96 4.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.462 ' CB ' ' HA ' ' A' ' 369' ' ' LYS . . . -162.48 167.96 22.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.103 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -121.92 121.51 37.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.845 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.512 HD11 HD22 ' A' ' 354' ' ' LEU . 6.7 mm -97.06 111.86 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -91.19 124.09 35.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.835 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 387' ' ' ALA . 23.6 m-85 -105.28 152.16 23.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.99 -35.59 80.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -129.65 153.43 48.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.859 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.411 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 5.9 tmm_? -60.08 -32.91 71.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -70.08 -51.36 32.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.843 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -42.82 -33.76 1.71 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.43 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.845 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -76.52 -56.94 4.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.812 0.339 . . . . 0.0 111.071 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 80.6 t -38.47 -39.87 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.094 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -70.76 -65.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -55.05 -16.62 3.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.174 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.597 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.5 ttm -78.54 -62.84 1.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.448 ' N ' ' HG2' ' A' ' 388' ' ' MET . 9.0 mt-10 -75.92 -0.55 21.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.563 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 56.3 mm-40 -100.08 -34.6 10.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . 0.43 ' HG2' ' CE2' ' A' ' 361' ' ' PHE . 4.9 mmt -104.52 -31.15 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.904 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.749 ' N ' HD12 ' A' ' 403' ' ' ILE . 3.9 t-20 -36.68 97.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 95.46 38.26 4.8 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.522 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -100.1 147.66 25.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.888 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -75.53 75.19 2.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.451 HD22 HD13 ' A' ' 401' ' ' ILE . 17.6 tp -79.75 111.17 15.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.933 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 62.4 25.31 15.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . 0.44 ' C ' ' OE1' ' A' ' 399' ' ' GLU . . . 89.77 14.62 59.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.495 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . 0.44 ' OE1' ' C ' ' A' ' 398' ' ' GLY . 15.8 mp0 -133.38 126.15 30.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.808 0.337 . . . . 0.0 110.86 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.72 97.34 2.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.451 HD13 HD22 ' A' ' 396' ' ' LEU . 18.1 pt -76.9 151.7 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -114.77 132.18 56.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.749 HD12 ' N ' ' A' ' 392' ' ' ASN . 31.6 mt -115.27 121.34 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.135 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 15.3 m -136.19 132.58 49.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.597 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 7.4 m-85 -51.07 117.47 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -77.21 169.64 17.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.098 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -80.49 154.26 73.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.601 0.715 . . . . 0.0 110.904 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 147.15 62.01 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.729 2.286 . . . . 0.0 112.341 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -3.68 12.51 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.633 2.222 . . . . 0.0 112.352 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -156.31 -179.8 8.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -142.76 138.24 30.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -116.65 118.44 32.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -153.02 116.9 4.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.855 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -170.18 143.78 2.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -163.74 117.93 1.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.4 147.41 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -137.89 178.65 6.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.934 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -156.03 121.88 4.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -123.7 154.06 39.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 8.4 ttm-85 -165.73 105.63 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -138.54 167.93 20.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -165.39 130.69 2.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.107 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -158.6 117.1 3.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.067 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 60.7 p -131.29 126.66 35.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -131.74 83.77 0.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.499 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 427' ' ' SER . 53.2 Cg_endo -69.81 132.39 23.15 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.621 2.214 . . . . 0.0 112.332 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 426' ' ' PRO . 69.4 m 34.79 44.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.853 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 23.2 t -79.64 109.25 13.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.823 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.452 179.979 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 7.2 t -164.5 114.42 1.18 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.876 0.369 . . . . 0.0 110.883 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 7.6 t -151.82 142.2 22.49 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.856 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 154.42 -135.88 4.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 38.2 t -73.12 121.5 20.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 110.841 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 69.6 m -118.17 82.19 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.851 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -122.24 170.47 15.11 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.478 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -64.31 137.59 57.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.804 0.335 . . . . 0.0 110.842 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -112.92 81.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.08 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -69.9 83.91 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 57.4 t -124.59 136.46 60.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -101.39 -32.93 10.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 98.5 t -78.53 133.15 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.079 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.541 HD21 ' HB1' ' A' ' 384' ' ' ALA . 55.1 mt -109.72 128.59 55.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 75.1 t80 -93.79 102.83 14.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.578 HG22 HG12 ' A' ' 403' ' ' ILE . 33.0 t -102.06 133.85 44.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.106 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -132.77 168.79 17.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.865 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 74.76 52.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.503 HD22 HG11 ' A' ' 349' ' ' VAL . 41.9 mt -97.38 148.11 23.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -85.79 169.53 13.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.137 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -71.12 -1.98 14.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 40.6 p -106.16 0.51 25.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.503 HG11 HD22 ' A' ' 345' ' ' LEU . 86.8 t -93.91 130.45 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.119 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 68.9 p -132.83 165.65 24.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.124 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -47.42 -41.97 21.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -57.39 -47.44 81.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 66.5 mt -65.64 -28.82 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.555 ' HB2' HG11 ' A' ' 367' ' ' VAL . 95.1 mt -74.58 -28.93 61.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -78.56 -63.32 1.43 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.821 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 35.8 mmtt -53.36 -34.71 58.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' ALA . . . . . 0.463 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -71.43 -45.53 62.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -92.64 13.07 21.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 361' ' ' PHE . 1.5 t -97.62 -53.69 3.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 359' ' ' SER . 15.4 pt20 -36.57 -32.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.576 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 90.5 m-85 -71.04 -66.04 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -147.61 179.05 24.8 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -61.95 129.86 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 110.865 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.453 HD21 ' CZ ' ' A' ' 378' ' ' PHE . 32.1 mt -101.21 152.12 21.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -100.37 -47.0 5.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -174.31 168.74 3.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' A' ' 354' ' ' LEU . 41.9 t -139.56 131.62 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.153 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.14 123.48 44.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -96.19 143.51 27.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.902 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.926 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.4 mp -127.73 -174.6 3.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 370' ' ' LEU . 0.8 OUTLIER -33.31 -66.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -124.51 -36.78 2.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.926 ' CE2' HD22 ' A' ' 370' ' ' LEU . 9.7 p90 -92.86 179.75 5.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.439 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -160.32 161.43 33.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -112.2 136.57 51.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 5.0 mm -110.52 109.62 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.128 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -89.43 123.27 33.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.501 ' CE1' HD12 ' A' ' 340' ' ' LEU . 15.6 m-85 -105.56 140.72 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -56.72 -33.98 67.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.842 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -131.42 149.12 52.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.412 ' NH1' ' CG2' ' A' ' 385' ' ' VAL . 0.0 OUTLIER -57.06 -32.89 66.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -69.41 -53.1 21.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -41.29 -32.24 0.67 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.531 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.541 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -77.63 -58.78 3.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 111.119 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.412 ' CG2' ' NH1' ' A' ' 381' ' ' ARG . 57.6 t -38.52 -35.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -74.57 -64.32 1.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -58.25 -15.53 10.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.4 ttm -78.76 -63.07 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.439 ' N ' ' HG2' ' A' ' 388' ' ' MET . 14.6 mt-10 -73.52 1.41 9.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.576 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 43.7 mm-40 -100.12 -41.77 6.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . 0.489 ' O ' ' N ' ' A' ' 393' ' ' GLY . 8.1 mmm -99.91 -27.39 13.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.821 ' N ' HD12 ' A' ' 403' ' ' ILE . 5.1 t-20 -37.19 92.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.849 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 97.7 38.84 4.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.497 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.418 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 24.8 mmtm -100.04 148.29 24.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.739 0.304 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -75.9 77.69 2.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.417 HD22 HD13 ' A' ' 401' ' ' ILE . 15.6 tp -82.3 111.5 18.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 62.61 25.42 15.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . 0.43 ' C ' ' OE1' ' A' ' 399' ' ' GLU . . . 90.49 12.83 60.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . 0.43 ' OE1' ' C ' ' A' ' 398' ' ' GLY . 1.8 mp0 -131.76 129.55 40.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.943 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.49 97.43 3.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.417 HD13 HD22 ' A' ' 396' ' ' LEU . 20.7 pt -76.16 147.47 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -113.22 130.47 56.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.821 HD12 ' N ' ' A' ' 392' ' ' ASN . 11.7 mt -113.1 126.72 70.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.121 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 30.1 m -140.48 134.03 33.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.064 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 14.3 m-85 -50.95 110.1 0.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.857 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.579 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . -66.66 151.38 47.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -76.77 143.81 71.95 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.626 0.726 . . . . 0.0 110.875 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 151.5 69.56 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.697 2.264 . . . . 0.0 112.354 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -40.56 5.12 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.255 . . . . 0.0 112.33 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -40.75 142.26 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.874 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -154.1 129.09 9.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -125.06 128.85 49.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -160.33 106.17 1.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -76.62 99.46 5.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -149.63 169.47 20.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 1.2 ppt_? -159.99 149.75 18.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -172.15 135.63 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -169.93 136.38 1.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -173.66 152.25 2.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.947 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -159.36 152.37 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -172.72 139.74 0.93 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -171.26 163.56 7.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -112.03 179.05 4.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.094 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 11.6 t -160.88 175.58 12.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -129.97 89.73 0.3 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.459 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 125.78 12.55 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.698 2.266 . . . . 0.0 112.315 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 2.3 m -167.99 151.82 6.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.844 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 98.6 p -74.28 160.03 31.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.904 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.516 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 79.0 p -49.47 128.76 17.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 0.0 110.858 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 68.2 m -121.65 141.27 51.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 144.63 -116.67 0.96 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.48 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 34.0 p 43.99 41.21 3.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.369 . . . . 0.0 110.831 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 36.9 t -105.62 93.63 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.845 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -97.06 161.51 21.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.506 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 2.8 ttt -136.12 113.54 10.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.343 . . . . 0.0 110.87 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.521 ' HB3' ' CD2' ' A' ' 405' ' ' PHE . . . -150.33 157.75 43.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -94.75 74.44 3.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 406' ' ' ALA . 93.7 t -140.11 138.34 37.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.412 ' HB3' ' NH1' ' A' ' 381' ' ' ARG . 10.5 ptpt -94.15 -33.75 13.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.22 121.87 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.083 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.426 HD21 ' HB1' ' A' ' 384' ' ' ALA . 78.5 mt -98.81 121.75 41.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -88.31 106.56 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.66 HG22 HG12 ' A' ' 403' ' ' ILE . 47.2 t -105.16 135.33 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -134.73 167.64 20.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.84 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 24.7 t30 74.59 49.99 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.49 HD21 HG12 ' A' ' 342' ' ' VAL . 14.5 mt -92.53 130.24 38.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.06 -179.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.101 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -87.15 6.5 32.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 22.2 p -124.15 15.88 9.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.171 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 55.3 t -91.98 134.93 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.151 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 58.4 p -136.98 161.0 37.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.145 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -47.02 -42.93 19.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -56.76 -40.42 75.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.884 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 83.0 mt -72.17 -29.55 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.539 ' HB2' HG11 ' A' ' 367' ' ' VAL . 85.3 mt -74.73 -28.04 60.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 359' ' ' SER . 45.3 mt-10 -72.26 -70.09 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -42.08 -44.1 3.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' ALA . . . . . 0.821 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -63.38 -57.05 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.097 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' PHE . . . . . 0.486 ' O ' HD21 ' A' ' 364' ' ' LEU . 41.0 m-85 -85.09 16.08 3.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 355' ' ' GLU . 5.4 t -100.07 -59.27 1.74 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.851 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 359' ' ' SER . 21.7 pt20 -36.82 -40.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 92.8 m-85 -62.36 -61.83 2.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.39 161.79 29.59 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.474 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.28 128.63 22.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 0.0 110.876 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.486 HD21 ' O ' ' A' ' 358' ' ' PHE . 49.6 mt -98.81 152.95 19.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -101.45 -47.64 4.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -170.17 166.02 9.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.841 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.539 HG11 ' HB2' ' A' ' 354' ' ' LEU . 60.1 t -137.49 123.64 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -105.73 111.34 23.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -91.02 136.48 33.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.851 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.9 mp -124.73 -174.82 3.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 370' ' ' LEU . 7.9 mmtm -32.9 -71.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.09 -37.88 3.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.851 ' CE2' HD22 ' A' ' 370' ' ' LEU . 8.4 p90 -91.67 -179.8 5.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.951 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -165.55 160.47 17.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.053 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -111.69 135.51 52.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 7.5 mm -108.88 106.97 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.099 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -87.58 120.29 28.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.535 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 23.6 m-85 -99.74 158.6 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -79.91 -32.07 40.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -128.22 152.91 47.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.414 ' HB2' ' NH1' ' A' ' 381' ' ' ARG . 0.0 OUTLIER -59.14 -34.08 71.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.855 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 384' ' ' ALA . 10.3 t70 -70.74 -54.95 9.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -37.81 -30.75 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.449 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.426 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -81.28 -65.92 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.492 HG22 ' HZ ' ' A' ' 405' ' ' PHE . 58.4 t -36.4 -36.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.124 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -72.88 -61.83 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -60.3 -15.66 27.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.076 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.591 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.5 ttm -77.97 -61.18 2.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.417 ' N ' ' HG2' ' A' ' 388' ' ' MET . 16.4 mt-10 -74.89 -0.73 19.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.515 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 7.4 mm-40 -100.15 -37.41 8.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.839 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . 0.821 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 17.8 mmm -101.66 -34.04 9.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.858 ' N ' HD12 ' A' ' 403' ' ' ILE . 5.2 t-20 -34.0 93.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 98.17 39.47 3.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.414 ' CG ' ' HA ' ' A' ' 391' ' ' MET . 2.0 mmmp? -99.92 147.51 25.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.886 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -75.76 69.47 2.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.851 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.582 HD22 HD13 ' A' ' 401' ' ' ILE . 14.8 tp -74.93 113.12 11.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 61.94 27.33 16.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 85.31 21.26 55.14 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.533 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -140.1 125.91 19.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.87 0.367 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.37 96.92 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.582 HD13 HD22 ' A' ' 396' ' ' LEU . 33.4 pt -74.61 148.36 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -110.35 131.27 55.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.858 HD12 ' N ' ' A' ' 392' ' ' ASN . 36.1 mt -116.06 127.61 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 11.1 m -141.11 134.24 30.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.175 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.591 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 6.3 m-85 -52.49 108.73 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.464 ' O ' HG21 ' A' ' 337' ' ' VAL . . . -63.31 174.86 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.11 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -88.13 143.91 33.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.619 0.723 . . . . 0.0 110.896 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 148.55 65.43 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.681 2.254 . . . . 0.0 112.359 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 151.26 69.13 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.672 2.248 . . . . 0.0 112.392 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.83 92.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -90.71 -53.38 4.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -38.11 151.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -167.24 168.28 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.874 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -170.35 138.03 1.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.17 129.0 7.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.81 134.63 20.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -166.31 157.99 13.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -142.09 119.45 11.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.156 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.39 150.92 12.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.911 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 10.9 tpt85 -166.74 119.16 0.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -153.92 156.2 37.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -174.89 112.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -130.98 140.36 50.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 38.0 m -163.89 177.2 8.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.84 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 180.0 141.38 4.62 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.473 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -175.65 1.21 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.712 2.275 . . . . 0.0 112.379 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 50.4 m -155.73 164.72 38.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.822 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 37.1 p -115.53 -61.22 1.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.511 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 1.9 t -162.92 159.17 23.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 0.0 110.849 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 23.0 t -166.2 145.71 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.813 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -140.49 45.52 0.98 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.487 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 8.3 t -118.33 119.07 33.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.895 0.378 . . . . 0.0 110.888 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.8 t -85.47 93.12 8.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.861 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -143.37 132.45 4.98 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.496 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.47 -21.78 19.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.824 0.345 . . . . 0.0 110.868 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -133.7 174.17 10.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.074 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.432 ' HD2' ' NH1' ' A' ' 381' ' ' ARG . 34.5 mttm -124.79 69.9 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.534 HG11 ' O ' ' A' ' 406' ' ' ALA . 74.4 t -54.64 139.64 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.19 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -93.15 -32.08 14.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.1 122.34 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.641 HD21 ' HB1' ' A' ' 384' ' ' ALA . 48.6 mt -96.52 134.67 39.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -99.19 107.9 20.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.727 HG12 HD21 ' A' ' 345' ' ' LEU . 29.8 t -103.71 131.81 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.147 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -130.92 172.39 12.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.901 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.7 t30 72.54 33.27 1.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.727 HD21 HG12 ' A' ' 342' ' ' VAL . 17.8 mt -76.63 125.47 29.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.01 176.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.053 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -82.73 9.95 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 20.6 p -125.78 9.7 7.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 90.8 t -92.57 139.17 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . 0.446 ' H ' HD12 ' A' ' 353' ' ' ILE . 55.5 p -143.89 171.59 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -50.7 -50.98 53.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -50.28 -39.18 44.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 350' ' ' THR . 74.2 mt -73.94 -35.71 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.59 ' HB2' HG11 ' A' ' 367' ' ' VAL . 96.7 mt -69.29 -26.26 64.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.481 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 44.9 mt-10 -76.43 -71.49 0.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -42.43 -35.72 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' ALA . . . . . 0.684 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -72.81 -55.72 6.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.145 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' PHE . . . . . 0.408 ' O ' HD21 ' A' ' 364' ' ' LEU . 41.2 m-85 -84.17 14.12 4.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 355' ' ' GLU . 18.0 t -99.65 -52.95 3.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -39.46 -37.24 0.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.575 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 93.6 m-85 -66.38 -62.58 1.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -150.53 161.85 29.11 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -53.15 122.77 10.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 110.937 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.481 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 32.0 mt -90.4 166.59 13.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -114.2 -44.78 3.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.501 ' HG3' ' CD2' ' A' ' 377' ' ' HIS . 18.5 ptt180 -173.01 166.53 5.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.59 HG11 ' HB2' ' A' ' 354' ' ' LEU . 89.7 t -139.81 123.83 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -107.17 120.1 41.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . 0.422 ' C ' HD12 ' A' ' 370' ' ' LEU . 16.1 tptp -91.73 142.28 27.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.768 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.4 mp -129.57 -174.57 3.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 370' ' ' LEU . 1.9 mptp? -33.33 -73.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -119.27 -29.66 5.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.768 ' CE2' HD22 ' A' ' 370' ' ' LEU . 3.8 p90 -97.99 -175.0 3.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.569 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -168.52 153.48 6.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.09 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -100.61 146.12 27.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 6.5 mm -118.87 110.81 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . 0.501 ' CD2' ' HG3' ' A' ' 366' ' ' ARG . 55.1 m-70 -89.46 126.1 35.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.819 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.458 ' CZ ' HD21 ' A' ' 364' ' ' LEU . 20.1 m-85 -108.4 139.41 43.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -58.52 -29.44 66.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -134.62 143.76 47.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.432 ' NH1' ' HD2' ' A' ' 336' ' ' LYS . 3.8 tmm_? -52.13 -34.56 45.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -67.35 -56.53 9.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . 0.426 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -37.74 -32.47 0.11 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.537 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.641 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -77.43 -62.81 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.803 0.335 . . . . 0.0 111.122 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 384' ' ' ALA . 54.8 t -36.72 -39.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.133 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . 0.416 ' HA ' ' NZ ' ' A' ' 386' ' ' LYS . 0.1 OUTLIER -71.23 -65.67 0.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -53.84 -19.27 4.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.14 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.7 ttm -74.97 -63.74 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.465 ' N ' ' HG2' ' A' ' 388' ' ' MET . 5.5 mt-10 -73.71 1.56 10.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.575 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 3.0 mm-40 -99.67 -39.66 8.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . 0.684 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 5.9 mmm -101.36 -29.95 11.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.744 ' N ' HD12 ' A' ' 403' ' ' ILE . 4.4 t-20 -34.17 96.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 94.11 38.43 5.13 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.525 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -99.62 147.2 25.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -76.51 76.44 3.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.468 HD22 HD13 ' A' ' 401' ' ' ILE . 17.6 tp -81.48 113.92 19.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 61.99 24.92 14.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 88.09 20.23 50.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -140.06 126.6 20.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 110.924 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.6 99.28 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.468 HD13 HD22 ' A' ' 396' ' ' LEU . 20.9 pt -77.15 148.59 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -109.95 129.9 55.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.744 HD12 ' N ' ' A' ' 392' ' ' ASN . 24.3 mt -113.3 129.21 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 34.2 m -146.68 135.27 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.089 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 15.9 m-85 -52.69 120.06 5.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.534 ' O ' HG11 ' A' ' 337' ' ' VAL . . . -79.83 135.16 36.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.042 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -63.81 146.13 97.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.529 0.68 . . . . 0.0 110.914 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 146.13 59.44 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.672 2.248 . . . . 0.0 112.407 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -6.26 18.14 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.69 2.26 . . . . 0.0 112.377 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -111.31 156.96 20.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -129.13 176.09 8.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -138.13 144.2 40.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . 0.46 ' HD3' ' N ' ' A' ' 413' ' ' ARG . 1.3 mpp_? -107.28 174.12 6.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -142.3 140.38 32.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -128.11 169.47 14.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.34 167.33 23.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -154.58 161.89 41.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -125.65 155.12 41.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.097 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -104.04 -25.26 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? 41.85 52.6 4.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -119.27 142.81 47.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -174.26 178.92 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -170.42 176.03 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.118 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 19.9 m -158.46 175.82 13.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.874 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -162.12 149.15 17.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.487 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -174.89 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.676 2.251 . . . . 0.0 112.361 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 21.3 t -172.91 -176.62 1.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 85.9 p -128.05 -53.82 1.3 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.861 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.471 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 34.8 p -101.25 90.65 4.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.873 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 24.4 m -83.25 113.55 20.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.854 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 70.43 163.1 4.44 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 34.1 t -95.62 145.93 24.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 0.0 110.872 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 2.1 m -134.07 47.1 2.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -91.42 -139.59 8.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.25 127.99 34.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.831 0.348 . . . . 0.0 110.824 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -126.38 -176.89 3.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.132 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.498 ' C ' ' NH2' ' A' ' 381' ' ' ARG . 1.1 mptp? -101.95 79.11 1.86 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.589 ' O ' ' CE1' ' A' ' 405' ' ' PHE . 41.3 t -135.87 138.11 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.14 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -91.22 -33.66 15.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 77.9 t -74.79 123.24 29.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.107 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.411 HD21 ' HB1' ' A' ' 384' ' ' ALA . 48.9 mt -99.06 123.4 43.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -91.54 106.36 18.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.66 HG22 HG12 ' A' ' 403' ' ' ILE . 11.9 t -103.51 138.24 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.152 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -136.03 168.4 19.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 5.9 t30 73.2 54.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 31.1 mt -94.99 137.77 33.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.88 172.52 1.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.107 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -79.38 1.16 26.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 5.7 p -118.04 13.54 13.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.183 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 45.5 t -97.25 140.46 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 64.6 p -140.35 172.48 12.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.151 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -51.49 -45.89 62.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -54.87 -46.62 74.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 72.5 mt -64.32 -28.84 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.156 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.512 ' HB2' HG11 ' A' ' 367' ' ' VAL . 96.4 mt -76.59 -27.61 55.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 359' ' ' SER . 54.2 mt-10 -77.45 -65.69 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -46.47 -37.52 7.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' ALA . . . . . 0.692 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -72.17 -49.83 32.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.099 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' PHE . . . . . 0.546 ' O ' HD21 ' A' ' 364' ' ' LEU . 39.6 m-85 -88.17 13.03 12.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 355' ' ' GLU . 5.3 t -98.89 -52.64 3.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . 0.411 ' HG3' ' N ' ' A' ' 361' ' ' PHE . 18.2 pt20 -38.59 -40.14 0.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 390' ' ' GLU . 93.5 m-85 -64.0 -62.44 1.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -149.55 169.36 29.79 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -59.61 127.34 31.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 358' ' ' PHE . 81.4 mt -95.99 156.37 16.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -104.99 -41.73 5.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -174.93 165.9 3.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.512 HG11 ' HB2' ' A' ' 354' ' ' LEU . 33.9 t -139.48 124.6 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.155 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -109.5 114.98 29.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . 0.443 ' C ' HD12 ' A' ' 370' ' ' LEU . 19.1 tptp -90.89 144.28 25.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.852 HD22 ' CE2' ' A' ' 373' ' ' TYR . 7.0 mp -130.92 -174.69 3.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 370' ' ' LEU . 16.1 tttm -33.09 -68.02 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.4 -37.56 2.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.852 ' CE2' HD22 ' A' ' 370' ' ' LEU . 9.7 p90 -92.23 179.8 5.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -160.86 161.54 31.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.078 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -112.42 125.37 54.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 6.1 mm -101.32 121.29 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -100.94 124.38 46.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.56 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 26.5 m-85 -106.64 133.78 50.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -53.9 -32.57 53.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -128.51 151.18 49.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.498 ' NH2' ' C ' ' A' ' 336' ' ' LYS . 11.5 tpp85 -58.41 -36.31 73.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 384' ' ' ALA . 14.6 t70 -68.23 -55.48 12.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -37.97 -31.15 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.506 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 385' ' ' VAL . . . -80.87 -63.96 1.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.855 0.359 . . . . 0.0 111.155 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.53 HG22 ' HZ ' ' A' ' 405' ' ' PHE . 79.7 t -36.82 -35.42 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . 0.436 ' HE2' ' CG ' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -72.02 -60.02 2.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.888 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -62.21 -17.37 58.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.594 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.1 ttm -75.39 -60.9 2.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.887 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.435 ' N ' ' HG2' ' A' ' 388' ' ' MET . 11.1 mt-10 -74.48 -0.79 18.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 361' ' ' PHE . 33.8 mm-40 -99.98 -37.93 8.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.913 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . 0.692 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 12.3 mmm -99.9 -29.22 12.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.751 ' N ' HD12 ' A' ' 403' ' ' ILE . 2.7 t-20 -41.24 111.79 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.845 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 75.49 28.84 60.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.507 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.477 ' CG ' ' O ' ' A' ' 391' ' ' MET . 0.0 OUTLIER -97.71 142.79 29.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -68.73 99.89 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.535 HD22 HD13 ' A' ' 401' ' ' ILE . 21.6 tp -105.46 109.67 21.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 61.6 32.63 18.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 83.28 15.99 70.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -139.82 120.09 13.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.871 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.75 106.02 3.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.535 HD13 HD22 ' A' ' 396' ' ' LEU . 23.7 pt -79.25 161.08 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.132 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -123.75 125.61 45.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.751 HD12 ' N ' ' A' ' 392' ' ' ASN . 25.0 mt -111.16 135.51 50.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.128 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 6.9 m -150.16 130.96 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.132 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.594 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 15.5 m-85 -51.53 108.95 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.512 ' O ' HG11 ' A' ' 337' ' ' VAL . . . -62.95 153.14 34.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.064 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . 0.421 ' HG3' ' N ' ' A' ' 408' ' ' PRO . 4.4 tttp -78.9 142.63 60.68 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.588 0.709 . . . . 0.0 110.891 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . 0.421 ' N ' ' HG3' ' A' ' 407' ' ' LYS . 54.0 Cg_endo -69.71 148.63 65.84 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.737 2.291 . . . . 0.0 112.365 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -19.07 36.48 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.714 2.276 . . . . 0.0 112.294 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -61.98 153.15 30.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.849 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -126.12 164.48 20.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -153.07 122.08 6.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -109.87 121.19 44.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.882 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -120.89 134.85 55.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -116.16 -175.73 2.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -156.07 130.35 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.869 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -80.81 122.23 26.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -112.93 174.17 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.102 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 8.0 pm0 -112.85 -176.57 2.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.945 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -165.96 108.14 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -98.68 153.27 18.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -107.39 178.17 4.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.081 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -173.54 177.42 2.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.105 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.5 t -163.99 153.52 14.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -157.32 144.7 10.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.511 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -172.69 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.678 2.252 . . . . 0.0 112.373 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 86.2 p -150.24 139.11 20.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 23.3 m -70.63 -59.66 2.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.444 179.961 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.474 -0.251 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 29.8 t -47.83 144.16 3.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.881 0.372 . . . . 0.0 110.825 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 84.9 p -147.76 177.17 9.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 173.3 66.99 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.481 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 65.4 m -109.76 120.46 42.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.904 0.383 . . . . 0.0 110.853 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 73.3 m -137.41 117.42 13.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.896 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.6 175.88 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.5 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 15.0 mtt -141.34 157.82 44.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.767 0.318 . . . . 0.0 110.912 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -156.52 132.75 9.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.115 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 88.57 4.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 55.2 t -135.92 127.86 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -93.81 -27.56 16.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 95.5 t -81.5 121.13 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.765 HD12 ' CE1' ' A' ' 378' ' ' PHE . 60.5 mt -100.66 121.94 42.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.944 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.402 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 89.2 t80 -85.54 108.25 17.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.829 HG22 HG12 ' A' ' 403' ' ' ILE . 43.4 t -106.69 133.64 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.123 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.437 ' NH1' ' HB2' ' A' ' 343' ' ' ARG . 3.0 ptm85 -131.66 172.18 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.835 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.1 t30 72.7 37.45 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.519 HD21 HG12 ' A' ' 342' ' ' VAL . 17.5 mt -77.34 144.79 37.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.903 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.447 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -73.89 179.05 4.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -83.49 2.55 36.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 69.5 p -120.64 11.55 11.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 346' ' ' ALA . 97.6 t -95.58 132.16 40.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.129 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 70.5 p -139.39 165.57 26.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.164 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.4 ' HA ' HG11 ' A' ' 367' ' ' VAL . 41.6 mt-10 -41.2 -44.31 2.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.882 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -55.29 -59.21 5.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 80.4 mt -55.73 -31.75 30.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.126 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.437 HD22 HD11 ' A' ' 376' ' ' ILE . 93.1 mt -71.43 -26.15 62.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.496 ' O ' ' CB ' ' A' ' 359' ' ' SER . 27.0 mt-10 -83.71 -53.92 5.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . 0.439 ' O ' ' NE2' ' A' ' 360' ' ' GLN . 74.0 mttt -57.55 -20.44 32.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' ALA . . . . . 0.695 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -93.26 -44.45 8.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.111 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' PHE . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 41.2 m-85 -93.25 18.03 10.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 355' ' ' GLU . 3.3 t -100.06 -61.84 1.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 356' ' ' LYS . 2.4 pm0 -37.68 -37.84 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.51 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 70.0 m-85 -62.71 -58.74 6.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -155.46 162.83 31.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.483 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -55.07 123.59 14.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.432 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 60.0 mt -91.36 178.21 6.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -131.76 -44.02 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -173.97 165.96 4.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 351' ' ' GLU . 64.6 t -138.07 134.48 44.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.428 ' O ' ' HB1' ' A' ' 374' ' ' ALA . 7.0 tptm -118.85 117.72 29.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . 0.518 ' C ' HD12 ' A' ' 370' ' ' LEU . 14.3 tptm -93.51 144.29 25.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.809 HD22 ' CE2' ' A' ' 373' ' ' TYR . 8.0 mp -130.87 -174.44 3.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 370' ' ' LEU . 20.8 tttp -31.53 -64.78 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -128.36 -37.26 1.84 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.809 ' CE2' HD22 ' A' ' 370' ' ' LEU . 14.1 p90 -92.53 179.18 5.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 368' ' ' LYS . . . -159.1 171.89 19.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.069 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -124.06 127.73 48.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.839 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.437 HD11 HD22 ' A' ' 354' ' ' LEU . 4.4 mm -101.2 109.31 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.161 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -85.79 110.46 19.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.765 ' CE1' HD12 ' A' ' 340' ' ' LEU . 17.9 m-85 -92.95 143.31 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -55.32 -33.1 63.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -141.43 162.66 34.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.511 ' O ' HG23 ' A' ' 385' ' ' VAL . 4.0 tmm_? -63.62 -33.0 74.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -65.47 -58.84 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.824 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -42.17 -28.6 0.53 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.452 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -80.18 -60.38 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 0.0 111.092 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 381' ' ' ARG . 60.6 t -37.44 -35.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . 0.421 ' HA ' ' NZ ' ' A' ' 386' ' ' LYS . 0.0 OUTLIER -73.83 -63.25 1.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -59.65 -14.41 13.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.563 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.7 ttm -80.28 -62.24 1.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.859 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.422 ' N ' ' HG2' ' A' ' 388' ' ' MET . 11.9 mt-10 -75.05 -3.19 31.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.51 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 28.2 mm-40 -100.16 -29.38 12.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.822 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . 0.695 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 5.0 mmt -107.92 -41.98 4.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.77 ' N ' HD12 ' A' ' 403' ' ' ILE . 26.2 t-20 -34.21 93.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.856 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 103.64 28.44 5.99 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.51 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 391' ' ' MET . 1.1 mmmm -98.54 146.31 25.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.771 0.319 . . . . 0.0 110.918 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -74.35 78.6 1.86 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.872 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.466 HD22 HD13 ' A' ' 401' ' ' ILE . 19.0 tp -86.23 113.22 22.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 62.34 25.1 14.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.31 17.98 58.04 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.483 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -138.64 124.26 19.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.28 92.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.466 HD13 HD22 ' A' ' 396' ' ' LEU . 20.7 pt -71.56 146.13 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.154 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -111.76 130.84 55.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.829 HG12 HG22 ' A' ' 342' ' ' VAL . 20.9 mt -115.04 126.47 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.43 136.82 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.132 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.563 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 13.1 m-85 -54.56 110.61 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.825 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.402 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . -68.75 131.98 46.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.116 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -54.15 150.19 16.42 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.585 0.707 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 148.66 65.97 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.657 2.238 . . . . 0.0 112.345 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 93.72 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.701 2.267 . . . . 0.0 112.364 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 38.9 p30 -74.29 175.1 7.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.858 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -162.12 161.94 28.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.27 -64.82 1.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -173.09 157.14 3.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.404 ' C ' ' HD2' ' A' ' 414' ' ' LYS . 1.2 tmmm? -102.59 107.69 18.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.96 141.31 31.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.408 ' HD3' ' C ' ' A' ' 416' ' ' ARG . 0.6 OUTLIER -140.81 163.73 32.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.851 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 25.4 tptt -113.64 158.02 21.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -172.23 120.29 0.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.129 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.03 155.83 42.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -112.67 138.75 49.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.848 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -147.97 149.14 31.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.887 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -147.33 167.6 23.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -160.74 169.11 23.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 68.5 p -163.91 178.88 7.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 179.78 146.0 6.66 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.445 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -176.36 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.758 2.305 . . . . 0.0 112.346 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 83.9 p -133.77 173.81 11.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.809 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.5 t -150.96 175.38 12.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.875 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.435 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 36.4 p -144.94 134.46 23.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 110.856 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 13.6 t -153.29 119.91 5.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 100.47 69.69 0.89 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 36.2 p -73.22 130.19 39.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.883 0.373 . . . . 0.0 110.862 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 t -61.08 -54.67 41.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 76.92 83.54 0.5 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.44 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 8.9 mmt -104.4 -52.65 2.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.754 0.311 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -157.39 131.96 8.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.057 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -75.7 104.82 6.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.939 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.474 ' HB ' ' CD1' ' A' ' 405' ' ' PHE . 55.5 t -133.69 134.93 56.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.137 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -94.29 -31.39 14.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.924 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 64.6 t -79.1 123.92 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 72.0 mt -104.19 125.48 50.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 72.0 t80 -90.04 106.66 18.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.527 HG22 HG12 ' A' ' 403' ' ' ILE . 22.3 t -104.31 137.68 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.163 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -136.34 169.25 17.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.3 t30 74.16 46.81 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.901 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 48.5 mt -83.88 135.91 34.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.944 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.3 179.8 0.54 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -85.81 5.97 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 49.8 p -123.43 11.61 9.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 350' ' ' THR . 87.5 t -90.81 153.01 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . 0.415 ' N ' HG12 ' A' ' 349' ' ' VAL . 77.6 p -153.96 173.18 16.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -58.55 -35.85 72.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.6 -40.71 92.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 68.9 mt -69.16 -28.66 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.503 ' HB2' HG11 ' A' ' 367' ' ' VAL . 94.6 mt -72.39 -31.47 65.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 359' ' ' SER . 64.8 mt-10 -72.18 -74.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -42.05 -34.55 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' ALA . . . . . 0.486 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -73.01 -52.13 15.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' PHE . . . . . 0.438 ' C ' HD11 ' A' ' 364' ' ' LEU . 38.3 m-85 -88.06 15.11 7.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 360' ' ' GLN . 82.7 p -97.23 -56.39 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 359' ' ' SER . 26.4 pt20 -35.16 -42.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 87.9 m-85 -61.42 -68.36 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -146.51 165.03 28.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.489 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -54.72 127.65 29.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.828 0.347 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.438 HD11 ' C ' ' A' ' 358' ' ' PHE . 78.7 mt -96.35 156.41 16.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -103.36 -42.42 5.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -174.59 169.43 3.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 354' ' ' LEU . 48.9 t -140.65 126.02 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.123 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -119.73 104.86 10.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . 0.482 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 20.2 tttm -82.81 152.75 25.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.879 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.9 mp -130.51 -174.8 3.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 370' ' ' LEU . 16.9 tptm -33.26 -68.8 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -118.66 -39.06 3.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.879 ' CE2' HD22 ' A' ' 370' ' ' LEU . 7.0 p90 -92.9 -178.94 4.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 369' ' ' LYS . . . -158.02 168.16 27.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.061 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -121.28 128.3 52.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 7.4 mm -103.7 113.7 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -92.52 123.71 36.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 387' ' ' ALA . 20.4 m-85 -105.77 145.61 30.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.64 -33.73 74.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -132.29 159.09 40.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.418 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 0.4 OUTLIER -65.24 -28.91 69.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 384' ' ' ALA . 23.5 t0 -70.77 -61.07 1.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -36.89 -30.37 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.509 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 382' ' ' ASP . . . -76.91 -63.22 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.346 . . . . 0.0 111.07 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 384' ' ' ALA . 89.5 t -36.46 -35.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.095 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -63.13 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -59.21 -16.16 19.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.515 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.7 ttm -77.75 -61.64 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.421 ' N ' ' HG2' ' A' ' 388' ' ' MET . 14.6 mt-10 -75.22 0.31 16.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.491 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 32.4 mm-40 -100.07 -36.58 9.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . 0.5 ' O ' ' N ' ' A' ' 393' ' ' GLY . 3.6 mmt -102.95 -30.32 10.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.812 ' N ' HD12 ' A' ' 403' ' ' ILE . 7.0 t-20 -42.54 91.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 100.82 30.46 6.09 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.462 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 391' ' ' MET . 22.1 mmtt -100.0 148.43 24.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.743 0.306 . . . . 0.0 110.943 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -74.15 85.49 1.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.905 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.558 HD22 HD13 ' A' ' 401' ' ' ILE . 21.8 tp -93.34 112.34 24.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 62.48 26.94 16.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 86.35 18.39 59.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -140.09 126.0 19.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.882 0.373 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.0 93.51 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.558 HD13 HD22 ' A' ' 396' ' ' LEU . 25.9 pt -71.02 149.32 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.085 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -113.51 131.7 55.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.812 HD12 ' N ' ' A' ' 392' ' ' ASN . 30.9 mt -113.3 133.46 59.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.14 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 5.1 m -145.72 132.83 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.515 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 7.1 m-85 -53.7 109.45 0.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.55 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . -71.63 147.23 47.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.094 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -66.85 145.52 98.94 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.571 0.7 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . 0.413 ' HA ' ' HD2' ' A' ' 409' ' ' PRO . 53.6 Cg_endo -69.71 113.36 3.34 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.7 2.267 . . . . 0.0 112.341 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 408' ' ' PRO . 54.1 Cg_endo -69.7 101.87 0.95 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.702 2.268 . . . . 0.0 112.362 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -157.22 137.89 13.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -106.14 101.32 10.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -128.83 145.17 51.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . 0.424 ' HG2' ' N ' ' A' ' 414' ' ' LYS . 50.7 ttp180 -154.94 155.34 34.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.424 ' N ' ' HG2' ' A' ' 413' ' ' ARG . 11.3 tptp -139.97 121.84 15.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -144.54 143.67 30.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.914 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -171.29 151.36 3.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -159.0 139.45 12.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.912 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -155.94 157.27 35.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -134.46 171.56 14.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -135.69 172.45 12.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -110.03 149.09 30.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -97.5 159.83 14.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.031 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -113.13 162.6 15.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.3 p -124.94 168.48 13.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.834 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -173.87 146.44 8.77 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.502 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 117.33 5.02 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.707 2.271 . . . . 0.0 112.322 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 2.9 m -60.37 -55.17 36.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.855 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 9.3 m -99.45 153.7 18.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.466 -179.982 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 45.9 p -55.38 134.0 50.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.866 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 70.6 p -101.67 139.2 37.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -86.12 139.32 16.77 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.448 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 14.0 m -39.36 105.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 110.845 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 45.3 t -39.57 153.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 159.62 99.47 0.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.483 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 27.5 mtt -68.16 119.24 12.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.743 0.306 . . . . 0.0 110.839 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -169.67 148.92 3.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.073 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -122.56 91.33 3.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.4 133.07 69.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.12 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -94.54 -31.4 13.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.891 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 58.3 t -80.65 132.74 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.649 HD21 ' HB1' ' A' ' 384' ' ' ALA . 33.4 mt -110.74 127.38 55.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -90.39 114.08 26.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.664 HG22 HG12 ' A' ' 403' ' ' ILE . 22.0 t -111.59 131.62 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -130.0 170.14 14.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.2 t30 74.81 41.21 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.54 HD12 ' NZ ' ' A' ' 369' ' ' LYS . 44.1 mt -80.27 133.6 36.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.551 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -56.17 -177.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.498 ' OD1' HG23 ' A' ' 348' ' ' THR . 11.6 p30 -91.67 11.59 23.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.908 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . 0.498 HG23 ' OD1' ' A' ' 347' ' ' ASN . 51.4 p -135.04 17.71 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.551 HG23 ' HB3' ' A' ' 346' ' ' ALA . 71.4 t -95.48 136.92 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.103 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 76.9 p -135.79 170.52 15.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.133 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -52.49 -46.05 66.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -52.59 -42.97 64.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 77.6 mt -70.94 -27.46 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.178 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.549 ' HB2' HG11 ' A' ' 367' ' ' VAL . 97.8 mt -73.99 -31.5 62.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 359' ' ' SER . 24.4 mt-10 -74.73 -64.83 0.96 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.939 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -44.36 -40.34 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' ALA . . . . . 0.787 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -71.26 -55.79 7.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.092 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' PHE . . . . . 0.409 ' O ' HD21 ' A' ' 364' ' ' LEU . 45.3 m-85 -81.77 13.95 2.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.864 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 355' ' ' GLU . 7.2 t -100.03 -54.17 2.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.828 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -39.65 -36.02 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 81.1 m-85 -65.52 -63.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.19 168.74 31.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.479 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -53.37 129.12 30.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 110.906 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.476 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 32.7 mt -99.54 163.35 12.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -111.93 -48.68 3.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -172.82 165.91 5.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 354' ' ' LEU . 93.7 t -134.45 127.41 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.147 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -110.83 114.19 27.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . 0.54 ' NZ ' HD12 ' A' ' 345' ' ' LEU . 16.3 tptp -89.97 138.76 31.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.87 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.718 HD22 ' CE2' ' A' ' 373' ' ' TYR . 7.7 mp -125.49 -174.83 3.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 370' ' ' LEU . 3.2 mptp? -33.7 -70.81 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.94 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -119.01 -38.26 3.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.838 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.718 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.9 p90 -91.78 -175.79 4.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.947 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -164.95 158.26 16.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -109.63 133.57 52.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 3.7 mm -107.41 107.48 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -85.5 117.88 24.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.562 ' CE1' HD12 ' A' ' 340' ' ' LEU . 16.2 m-85 -99.42 146.13 26.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -57.72 -36.48 72.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -133.18 160.34 37.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.409 ' HD2' ' C ' ' A' ' 381' ' ' ARG . 1.6 tmm_? -63.92 -35.27 80.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 384' ' ' ALA . 11.5 t0 -65.77 -58.58 5.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -38.62 -30.67 0.1 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.466 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.649 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -76.95 -58.91 3.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.317 . . . . 0.0 111.091 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.4 t -37.9 -37.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.122 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . 0.431 ' HA ' ' NZ ' ' A' ' 386' ' ' LYS . 0.1 OUTLIER -72.3 -65.36 0.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.84 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -56.14 -16.57 5.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.106 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.535 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.5 ttm -78.52 -64.13 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.465 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.1 mt-10 -73.86 0.83 12.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.914 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.489 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 57.5 mm-40 -100.14 -39.91 7.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . 0.787 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 5.9 mmm -100.11 -30.12 12.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.777 ' N ' HD12 ' A' ' 403' ' ' ILE . 5.5 t-20 -42.03 94.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 100.61 30.38 6.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.503 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.0 147.74 25.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.329 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . 0.414 ' C ' ' OD1' ' A' ' 395' ' ' ASP . 31.2 t0 -75.35 88.63 2.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.875 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 29.2 tp -94.73 110.17 22.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.984 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 63.35 24.95 14.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.47 18.95 51.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.448 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -139.94 125.59 19.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.9 94.05 2.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 20.1 pt -71.5 148.14 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -112.04 130.3 55.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.879 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.777 HD12 ' N ' ' A' ' 392' ' ' ASN . 27.2 mt -112.43 131.24 64.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.096 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 22.1 m -144.8 136.58 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.535 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 12.2 m-85 -54.17 116.0 2.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.2 147.22 46.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.098 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -77.12 143.95 70.81 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.564 0.697 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 132.37 23.26 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.355 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 172.01 13.38 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.709 2.272 . . . . 0.0 112.349 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -45.69 132.17 8.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.87 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -49.96 144.68 6.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 4.6 tppt? -77.61 -60.66 2.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 9.0 ttm105 -169.54 160.31 8.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.85 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -131.27 123.85 29.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -114.5 156.21 25.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -143.6 141.19 30.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -166.45 149.28 6.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -166.15 149.16 7.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -158.69 138.18 11.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.95 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -91.63 144.25 25.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -86.36 158.71 19.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -141.07 177.28 8.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.105 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -114.82 159.93 20.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 96.0 p -168.37 171.2 9.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -131.29 157.34 22.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.516 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 153.91 68.45 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.721 2.28 . . . . 0.0 112.321 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 1.1 t -163.96 157.88 19.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 13.5 m 57.48 53.45 7.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.48 -179.973 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 12.7 t -109.82 -63.96 1.31 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.902 0.382 . . . . 0.0 110.838 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 32.9 m -113.16 94.93 5.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.894 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -96.88 139.81 14.7 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.465 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 1.9 t -113.26 130.84 56.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.903 0.382 . . . . 0.0 110.855 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 37.6 m -96.54 149.18 22.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -120.84 129.79 7.99 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.494 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' MET . . . . . 0.752 ' O ' HG23 ' A' ' 337' ' ' VAL . 16.6 mmt -121.05 157.46 29.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 110.884 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 336' ' ' LYS . . . 35.34 37.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.082 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 335' ' ' ALA . 35.2 mtmt 34.48 45.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 334' ' ' MET . 58.3 t -48.73 136.89 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.117 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -105.48 -30.09 9.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.0 t -79.48 138.98 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.798 HD21 ' HB1' ' A' ' 384' ' ' ALA . 47.4 mt -114.01 130.84 56.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.475 ' HB3' HG23 ' A' ' 404' ' ' VAL . 56.2 t80 -92.19 107.98 19.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.464 HG22 HG12 ' A' ' 403' ' ' ILE . 21.7 t -105.09 136.36 39.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -135.78 173.36 11.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.0 t30 68.89 52.1 0.54 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.434 HD21 HG12 ' A' ' 342' ' ' VAL . 18.0 mt -94.94 121.15 36.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.889 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -46.26 173.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -80.78 13.79 2.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 38.6 p -128.19 5.58 5.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 51.0 t -88.92 140.41 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.107 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 68.0 p -143.71 170.56 15.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.134 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -49.47 -41.86 41.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -59.31 -39.0 81.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 77.0 mt -73.64 -29.38 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.526 ' HB2' HG11 ' A' ' 367' ' ' VAL . 89.7 mt -74.26 -27.48 60.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 359' ' ' SER . 38.0 mt-10 -80.2 -66.87 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -48.7 -25.54 1.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' ALA . . . . . . . . . . . . . . . -83.91 -47.47 11.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' PHE . . . . . 0.438 ' O ' HD21 ' A' ' 364' ' ' LEU . 35.4 m-85 -90.76 12.89 17.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 355' ' ' GLU . 99.2 p -99.64 -46.93 5.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -41.75 -30.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.513 ' CE1' ' CB ' ' A' ' 390' ' ' GLU . 98.4 m-85 -75.43 -73.92 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -135.56 174.4 21.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.476 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -60.16 133.88 56.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.792 0.33 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.438 HD21 ' O ' ' A' ' 358' ' ' PHE . 50.0 mt -103.74 153.36 20.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -103.5 -47.42 4.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -173.47 165.08 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.849 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' A' ' 354' ' ' LEU . 51.4 t -136.58 132.57 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.72 107.79 15.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . 0.4 ' C ' HD12 ' A' ' 370' ' ' LEU . 19.5 tptp -83.43 143.36 30.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.889 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.2 mp -128.59 -174.27 3.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.941 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 370' ' ' LEU . 21.6 mtpp -32.48 -64.15 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.47 -33.77 2.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.889 ' CE2' HD22 ' A' ' 370' ' ' LEU . 3.8 p90 -93.74 -176.04 3.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.508 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -166.81 160.49 14.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.123 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -111.57 134.85 52.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.464 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 3.6 mm -109.76 116.05 51.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -92.13 121.16 33.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 20.0 m-85 -106.57 127.67 53.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -42.52 -35.82 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -134.28 157.6 45.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -34.57 74.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 384' ' ' ALA . 27.1 t0 -65.67 -57.4 8.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . 0.459 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -38.97 -29.15 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.798 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -82.07 -58.86 2.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 111.122 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 94.1 t -38.16 -39.66 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.109 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -68.62 -60.56 2.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.07 -14.35 47.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.085 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 7.6 ttm -79.43 -59.67 2.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -75.09 -3.43 32.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.513 ' CB ' ' CE1' ' A' ' 361' ' ' PHE . 6.2 mm-40 -100.07 -37.18 9.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . 0.498 ' O ' ' CG ' ' A' ' 394' ' ' LYS . 69.8 mmm -99.91 -25.13 14.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 388' ' ' MET . 1.4 t-20 -42.04 118.84 1.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 63.69 32.68 84.98 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.467 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 391' ' ' MET . 0.0 OUTLIER -96.75 145.2 26.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.757 0.313 . . . . 0.0 110.91 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -68.48 108.22 3.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.561 HD22 HD13 ' A' ' 401' ' ' ILE . 21.1 tp -119.51 111.45 18.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 62.01 37.06 15.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.893 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 76.72 11.17 85.58 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.492 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -137.27 121.08 17.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.368 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.34 116.04 8.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.561 HD13 HD22 ' A' ' 396' ' ' LEU . 17.3 pt -90.99 147.55 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.113 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.737 ' OE2' HG13 ' A' ' 404' ' ' VAL . 13.9 tm-20 -111.23 133.13 53.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 392' ' ' ASN . 22.6 mt -116.92 134.69 59.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.127 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.737 HG13 ' OE2' ' A' ' 402' ' ' GLU . 3.9 m -144.92 140.59 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 14.9 m-85 -61.0 105.01 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -62.44 166.47 5.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 408' ' ' PRO . 0.2 OUTLIER -72.38 143.73 85.88 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.527 0.68 . . . . 0.0 110.927 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . 0.474 ' N ' ' HG3' ' A' ' 407' ' ' LYS . 53.9 Cg_endo -69.65 153.69 69.11 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.722 2.281 . . . . 0.0 112.382 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -32.37 18.52 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.647 2.231 . . . . 0.0 112.367 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -97.16 132.38 42.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.856 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.93 86.74 2.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -55.67 134.47 51.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -102.01 111.22 23.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -100.56 143.33 30.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -136.02 152.71 51.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -124.64 171.29 10.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.857 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.04 169.39 10.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -131.39 147.07 52.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.092 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -127.93 166.1 18.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.03 116.73 20.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -174.09 118.99 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -168.05 167.02 12.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -163.74 169.17 18.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 93.6 p -168.51 176.72 5.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.54 68.75 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -178.45 2.36 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.685 2.257 . . . . 0.0 112.336 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 1.9 m -166.74 137.18 3.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.913 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.2 m -38.25 154.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.453 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 24.2 t -163.93 147.67 9.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.0 110.908 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 2.5 t -110.08 168.79 9.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.837 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -118.17 132.74 9.98 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 3.4 m -146.05 176.61 9.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 110.869 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 77.9 p -159.21 152.77 22.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.915 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 79.55 127.3 0.59 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.508 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 1.1 tpt -103.62 89.2 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.78 0.324 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -132.86 166.64 21.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.62 16.42 9.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 56.8 t -50.94 129.2 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -93.86 -31.88 14.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.83 130.83 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 388' ' ' MET . 63.0 mt -106.27 124.62 49.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.458 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 46.8 t80 -88.69 107.28 18.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.433 HG12 HD21 ' A' ' 345' ' ' LEU . 20.6 t -101.98 134.73 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.126 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -134.54 170.35 15.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.823 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.1 t30 72.91 39.12 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.433 HD21 HG12 ' A' ' 342' ' ' VAL . 31.1 mt -79.93 154.45 28.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -93.08 163.17 13.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -65.51 -7.29 13.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 81.9 p -103.53 -0.13 30.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.135 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 96.0 t -91.97 132.27 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.087 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . 0.497 ' H ' HD12 ' A' ' 353' ' ' ILE . 67.8 p -134.62 170.3 16.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -50.97 -44.95 60.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -56.61 -41.2 76.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.933 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.497 HD12 ' H ' ' A' ' 350' ' ' THR . 73.2 mt -70.46 -30.25 42.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.138 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.449 ' HB2' HG11 ' A' ' 367' ' ' VAL . 97.2 mt -73.5 -30.13 62.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 359' ' ' SER . 49.4 mt-10 -75.64 -67.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -47.87 -36.44 12.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.848 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' ALA . . . . . 0.515 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -70.96 -49.77 41.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' PHE . . . . . 0.442 ' O ' HD21 ' A' ' 364' ' ' LEU . 39.6 m-85 -88.9 12.78 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.88 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 355' ' ' GLU . 40.4 t -99.26 -53.41 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -37.96 -31.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 91.5 m-85 -71.98 -63.11 1.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -149.55 171.12 29.71 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.465 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -58.62 128.26 36.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 0.0 110.917 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.442 HD21 ' O ' ' A' ' 358' ' ' PHE . 33.7 mt -97.35 171.48 8.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.956 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -120.52 -45.69 2.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.403 HH11 ' CD2' ' A' ' 377' ' ' HIS . 9.1 ptm180 -173.84 165.03 4.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.858 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.449 HG11 ' HB2' ' A' ' 354' ' ' LEU . 40.4 t -137.12 137.37 46.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.415 ' O ' ' HB1' ' A' ' 374' ' ' ALA . 7.9 tmtm? -125.07 120.32 31.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.864 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -94.44 140.92 29.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.873 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.692 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.8 mp -124.47 -174.71 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 370' ' ' LEU . 19.3 tttp -33.11 -65.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -125.67 -37.44 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.864 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.692 ' CE2' HD22 ' A' ' 370' ' ' LEU . 3.5 p90 -92.41 -174.8 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 368' ' ' LYS . . . -164.69 163.66 21.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -116.15 129.6 56.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.901 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.1 mm -104.52 119.45 53.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.127 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . 0.403 ' CD2' HH11 ' A' ' 366' ' ' ARG . 75.3 m-70 -98.3 121.89 40.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.493 ' CE2' ' O ' ' A' ' 383' ' ' GLY . 21.5 m-85 -102.75 149.9 24.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.76 -29.19 70.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.858 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -136.23 160.54 38.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.892 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.443 ' O ' HG23 ' A' ' 385' ' ' VAL . 7.0 tmm_? -65.05 -29.41 70.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -73.13 -54.09 9.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . 0.493 ' O ' ' CE2' ' A' ' 378' ' ' PHE . . . -40.17 -30.76 0.28 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.45 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -80.13 -63.87 1.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 111.104 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 381' ' ' ARG . 52.6 t -37.08 -35.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.131 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -61.5 1.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -60.88 -16.12 38.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.098 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.52 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.3 ttm -78.13 -62.21 1.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.444 ' N ' ' HG2' ' A' ' 388' ' ' MET . 18.5 mt-10 -74.5 1.22 12.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.554 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 4.4 mm-40 -100.07 -39.08 8.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . 0.515 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 10.6 mmm -102.7 -30.76 10.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.78 ' N ' HD12 ' A' ' 403' ' ' ILE . 5.7 t-20 -34.35 93.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 98.81 37.23 4.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -99.97 148.34 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.328 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -76.06 77.95 2.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.861 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.509 HD22 HD13 ' A' ' 401' ' ' ILE . 16.6 tp -83.36 110.54 18.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.979 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 63.04 29.67 16.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 84.18 20.68 58.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -140.09 126.7 20.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.83 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.43 97.84 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.509 HD13 HD22 ' A' ' 396' ' ' LEU . 22.2 pt -77.79 146.38 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -112.12 131.69 55.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.882 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.78 HD12 ' N ' ' A' ' 392' ' ' ASN . 13.5 mt -112.04 132.45 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.101 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 13.7 m -145.69 134.06 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.52 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 16.2 m-85 -51.5 111.13 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.844 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . -65.76 150.26 48.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.128 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -73.33 141.13 80.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.582 0.706 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 160.31 50.17 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.67 2.247 . . . . 0.0 112.375 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 141.29 44.84 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.702 2.268 . . . . 0.0 112.323 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -119.99 128.11 53.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.868 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -152.8 154.67 35.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.943 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -136.48 159.41 41.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.863 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -149.39 156.0 41.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.858 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.63 139.91 1.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -101.49 155.55 18.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.886 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -133.47 134.08 43.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.835 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -137.9 135.38 36.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -144.85 163.34 34.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.132 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -129.3 177.03 7.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 8.6 ptt-85 -149.51 158.18 43.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -144.7 149.01 34.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -129.75 177.56 7.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.094 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -163.09 173.06 13.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.079 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 65.3 m -147.52 176.03 10.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -151.55 145.54 13.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.503 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 172.79 12.0 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.669 2.246 . . . . 0.0 112.349 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 26.6 m -114.17 -56.01 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.859 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 14.5 m 54.38 42.78 31.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.489 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 26.0 m -115.19 172.25 7.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.854 0.359 . . . . 0.0 110.874 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 20.0 t -144.2 131.11 20.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.855 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -96.55 -153.57 29.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.491 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 2.5 m -73.11 171.89 12.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 110.851 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 12.6 t -116.53 110.34 18.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.856 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -111.23 106.38 2.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 32.6 mtt -106.57 41.33 1.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.793 0.33 . . . . 0.0 110.86 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -123.5 175.12 6.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.104 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -108.43 94.2 4.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.935 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 44.6 t -143.94 131.01 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.128 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -92.92 -32.28 14.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 91.6 t -75.7 124.9 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.533 HD21 ' HB1' ' A' ' 384' ' ' ALA . 91.4 mt -104.97 116.67 32.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -82.79 109.33 16.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.723 HG22 HG12 ' A' ' 403' ' ' ILE . 24.4 t -108.3 132.26 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -130.72 177.17 7.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 68.94 43.79 1.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 33.6 mt -83.39 141.26 31.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.41 -178.16 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.095 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -88.87 2.95 52.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 61.4 p -120.08 13.87 12.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.186 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 73.6 t -92.83 150.47 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 75.5 p -149.13 170.04 19.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -52.07 -44.85 64.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -54.61 -52.12 63.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 77.8 mt -58.07 -33.1 45.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.521 ' HB2' HG11 ' A' ' 367' ' ' VAL . 87.4 mt -73.85 -26.63 60.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.918 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.47 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 31.7 mt-10 -78.92 -63.29 1.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -51.35 -41.33 60.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' ALA . . . . . 0.581 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -65.85 -49.73 67.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.055 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' PHE . . . . . 0.444 ' O ' HD21 ' A' ' 364' ' ' LEU . 41.2 m-85 -89.08 16.82 6.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.888 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 360' ' ' GLN . 12.2 t -99.95 -57.15 2.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 359' ' ' SER . 24.0 pt20 -37.68 -39.42 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.914 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.548 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 71.6 m-85 -62.83 -63.41 1.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -150.88 166.45 30.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.499 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -54.88 125.53 20.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 0.0 110.916 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.47 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 34.3 mt -94.12 154.32 17.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -103.63 -44.9 4.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -174.92 163.6 3.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.521 HG11 ' HB2' ' A' ' 354' ' ' LEU . 51.8 t -135.14 124.06 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.34 106.97 13.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . 0.487 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 17.6 tttm -84.14 150.43 25.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.879 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.4 mp -127.97 -174.33 3.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 370' ' ' LEU . 9.7 ttmt -32.58 -67.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.04 -38.68 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.843 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.879 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.8 p90 -91.94 -176.39 4.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.487 ' CB ' ' HA ' ' A' ' 369' ' ' LYS . . . -160.88 166.86 27.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -119.53 131.9 55.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.41 HD11 HD22 ' A' ' 354' ' ' LEU . 7.2 mm -107.79 110.31 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.132 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -88.9 125.64 35.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.517 ' CE1' HD12 ' A' ' 340' ' ' LEU . 20.0 m-85 -108.8 134.59 51.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.87 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -46.66 -36.55 7.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -133.29 158.84 41.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -62.29 -36.56 82.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 384' ' ' ALA . 26.4 t70 -63.48 -59.5 4.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 382' ' ' ASP . . . -36.89 -31.78 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.533 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -76.06 -61.24 2.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 111.093 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 384' ' ' ALA . 66.7 t -35.79 -33.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.088 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 384' ' ' ALA . 0.0 OUTLIER -75.3 -65.15 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 179.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -58.0 -14.77 7.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.1 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.59 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 8.8 ttm -80.23 -62.38 1.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.874 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.423 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.0 mt-10 -75.63 -1.64 25.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.548 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 69.0 mm-40 -100.14 -32.28 10.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . 0.581 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 19.5 mmm -106.2 -37.94 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.896 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.863 ' N ' HD12 ' A' ' 403' ' ' ILE . 7.0 t-20 -33.9 93.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.927 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 103.92 27.02 6.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.481 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 391' ' ' MET . 14.1 mmmt -90.76 146.72 23.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.792 0.33 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.72 72.41 3.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.897 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 15.8 tp -75.84 111.82 11.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 62.49 24.99 14.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . 0.446 ' C ' ' OE1' ' A' ' 399' ' ' GLU . . . 89.75 14.39 59.66 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.508 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . 0.446 ' OE1' ' C ' ' A' ' 398' ' ' GLY . 2.5 mp0 -132.88 127.71 34.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.87 0.367 . . . . 0.0 110.849 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.46 96.81 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 20.4 pt -74.67 148.9 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.11 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -112.58 129.71 56.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.863 HD12 ' N ' ' A' ' 392' ' ' ASN . 27.3 mt -113.91 126.47 71.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.141 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.65 136.28 46.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.149 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.59 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 9.0 m-85 -54.9 112.61 1.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.22 167.93 16.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.104 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.67 149.39 35.66 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.605 0.717 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 129.01 16.88 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.73 2.286 . . . . 0.0 112.32 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -25.59 28.43 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.685 2.257 . . . . 0.0 112.332 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.52 158.85 9.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -152.14 120.79 6.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -172.87 131.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 6.1 ttt-85 -128.99 147.0 50.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -120.29 166.97 12.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -164.79 119.96 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -124.24 176.26 6.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.828 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -167.17 105.7 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -133.25 129.08 37.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.053 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -118.56 139.36 51.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -154.28 146.54 23.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -143.51 166.29 25.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -164.36 169.52 17.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -149.08 142.71 25.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 17.4 t -143.2 146.82 34.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.85 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -154.85 90.62 0.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.513 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -177.29 1.82 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.657 2.238 . . . . 0.0 112.314 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 5.9 t -147.76 164.84 32.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.3 m -81.39 174.01 11.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.859 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.493 179.983 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 21.5 t -108.41 120.9 43.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.89 0.376 . . . . 0.0 110.897 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 6.5 t -137.88 136.54 37.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -105.99 115.51 4.83 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.437 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 84.3 p -80.71 -40.75 24.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 0.0 110.836 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 333' ' ' GLY . 3.8 t -119.84 92.56 3.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 332' ' ' SER . . . 35.43 -113.64 0.14 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.447 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 52.9 mtt -134.08 101.84 5.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.297 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -78.41 172.14 14.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 5.4 ptpt -121.82 111.14 16.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.552 ' HB ' ' CD1' ' A' ' 405' ' ' PHE . 48.2 t -151.04 129.36 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.118 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 8.8 pttm -94.03 -32.6 13.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 67.7 t -79.61 118.81 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.147 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.572 HD21 ' HB1' ' A' ' 384' ' ' ALA . 46.1 mt -99.2 131.02 45.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -92.92 105.17 17.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.53 HG22 HG12 ' A' ' 403' ' ' ILE . 20.8 t -104.17 131.83 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -133.21 173.73 11.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 73.06 35.47 0.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.427 HD21 HG12 ' A' ' 342' ' ' VAL . 21.4 mt -76.63 139.18 40.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.428 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -67.52 -178.93 0.97 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -85.7 -0.26 54.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 17.2 p -117.64 14.94 14.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.159 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.428 HG23 ' HB3' ' A' ' 346' ' ' ALA . 96.0 t -96.52 133.73 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.127 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 39.8 p -134.39 169.01 17.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.116 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -51.7 -41.66 61.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -57.47 -43.87 84.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 66.5 mt -67.7 -29.56 45.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.55 ' HB2' HG11 ' A' ' 367' ' ' VAL . 96.0 mt -72.78 -32.01 65.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.908 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.477 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 16.1 mt-10 -73.14 -69.85 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . 0.471 ' HE3' ' N ' ' A' ' 356' ' ' LYS . 0.7 OUTLIER -43.25 -39.11 2.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' ALA . . . . . 0.561 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -69.59 -56.02 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' PHE . . . . . 0.426 ' O ' HD21 ' A' ' 364' ' ' LEU . 42.7 m-85 -83.96 14.54 4.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 355' ' ' GLU . 11.7 t -100.01 -52.39 3.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -40.35 -37.63 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.533 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 79.9 m-85 -65.7 -62.75 1.34 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.94 162.22 29.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.507 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -49.0 130.85 18.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 0.0 110.917 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.477 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 36.2 mt -101.21 155.02 18.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -100.12 -47.86 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -173.52 167.44 4.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.55 HG11 ' HB2' ' A' ' 354' ' ' LEU . 83.2 t -136.87 133.42 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.34 118.51 31.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 12.9 tptp -92.66 141.33 28.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.758 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.5 mp -126.39 -174.65 3.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 370' ' ' LEU . 1.3 mppt? -33.51 -68.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -122.27 -37.67 2.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.758 ' CE2' HD22 ' A' ' 370' ' ' LEU . 6.7 p90 -92.64 -176.39 4.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.503 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -163.87 161.84 23.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -112.4 134.68 53.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.7 mm -108.56 109.11 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.151 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -88.42 120.67 30.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.808 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.508 ' CE1' HD12 ' A' ' 340' ' ' LEU . 17.9 m-85 -101.92 147.53 26.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.54 -33.7 75.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -132.71 153.97 50.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -61.78 -31.01 71.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.99 -51.18 27.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -43.18 -36.67 2.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.501 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.572 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -72.11 -59.32 2.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.865 0.364 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.478 HG22 ' HZ ' ' A' ' 405' ' ' PHE . 86.1 t -36.41 -37.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.8 tptt -72.56 -66.01 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . . . -56.3 -15.87 4.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 7.5 ttm -78.94 -60.15 2.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -78.2 -2.5 38.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.533 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 65.0 mm-40 -100.07 -21.62 15.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . 0.561 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 10.9 mmm -116.8 -39.12 3.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.845 ' N ' HD12 ' A' ' 403' ' ' ILE . 27.5 t-20 -33.23 93.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 103.73 29.93 5.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 391' ' ' MET . 14.8 mmmt -96.2 146.4 24.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.729 0.299 . . . . 0.0 110.914 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.66 74.05 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.625 HD22 HD13 ' A' ' 401' ' ' ILE . 15.6 tp -76.41 110.65 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 62.28 24.96 14.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.66 13.84 57.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.478 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -133.56 130.53 38.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 0.0 110.889 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.3 93.57 2.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.625 HD13 HD22 ' A' ' 396' ' ' LEU . 20.2 pt -72.06 145.47 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -108.72 130.2 55.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.845 HD12 ' N ' ' A' ' 392' ' ' ASN . 24.7 mt -115.52 127.82 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.1 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.27 140.07 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 7.7 m-85 -58.16 108.95 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.5 156.49 36.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -81.13 146.54 58.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.549 0.69 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 131.94 22.35 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.723 2.282 . . . . 0.0 112.345 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -35.82 12.05 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.653 2.235 . . . . 0.0 112.361 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.66 113.99 21.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -113.28 79.14 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -108.98 122.06 46.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -73.89 99.04 3.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -121.93 112.84 18.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -149.77 165.81 31.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -140.14 151.3 45.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . 0.415 ' C ' ' HD3' ' A' ' 417' ' ' LYS . 2.5 tmtt? -159.33 129.78 5.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -168.01 143.79 3.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.165 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -165.67 140.46 4.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.884 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -149.94 152.41 34.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -95.25 156.29 16.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.961 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -117.19 172.53 7.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.08 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -172.33 164.56 5.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.2 t -159.27 173.28 16.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 176.72 147.46 6.56 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.486 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 142.64 48.34 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.705 2.27 . . . . 0.0 112.335 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 6.2 m -134.11 -62.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 5.0 m -137.6 140.09 40.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.864 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.488 -179.952 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 77.0 p -107.5 158.42 17.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.883 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 5.5 t 41.94 42.08 2.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -143.28 89.56 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.484 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 1.2 t -170.04 126.66 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.377 . . . . 0.0 110.851 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 48.0 t -104.92 81.55 1.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . -135.23 103.73 0.48 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.462 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 29.5 mmt -78.13 121.05 23.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.783 0.325 . . . . 0.0 110.881 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -115.47 122.68 46.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.101 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -85.22 43.91 1.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 406' ' ' ALA . 94.7 t -93.32 133.3 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.177 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -93.06 -33.27 14.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.95 122.45 27.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.153 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.645 HD21 ' HB1' ' A' ' 384' ' ' ALA . 29.3 mt -102.33 122.85 45.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 52.7 t80 -85.64 111.29 19.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.608 HG22 HG12 ' A' ' 403' ' ' ILE . 46.3 t -106.22 141.51 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.117 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -140.74 168.21 20.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 75.05 45.34 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 54.0 mt -81.08 137.97 35.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.655 ' HB3' HG23 ' A' ' 349' ' ' VAL . . . -62.31 -175.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.085 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -89.86 -4.84 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.851 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 80.5 p -118.71 19.26 13.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.655 HG23 ' HB3' ' A' ' 346' ' ' ALA . 81.5 t -94.74 152.57 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.091 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . 0.403 ' N ' HG12 ' A' ' 349' ' ' VAL . 82.2 p -155.45 175.44 13.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -57.28 -45.82 83.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.926 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -53.4 -43.59 68.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 349' ' ' VAL . 70.7 mt -67.72 -38.81 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.498 HD22 HD11 ' A' ' 376' ' ' ILE . 88.1 mt -64.28 -25.41 68.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.961 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 359' ' ' SER . 37.2 mt-10 -76.94 -71.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -44.2 -33.17 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' ALA . . . . . 0.621 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -74.39 -52.47 12.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.128 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' PHE . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 41.7 m-85 -88.27 13.57 11.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 355' ' ' GLU . 11.8 t -100.03 -58.22 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 359' ' ' SER . 20.7 pt20 -34.96 -39.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 89.6 m-85 -63.41 -63.91 1.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -149.83 166.47 29.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.81 129.98 31.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.917 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.418 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 27.8 mt -98.36 161.51 13.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.869 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -109.71 -46.28 3.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -174.32 165.27 4.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.471 HG11 ' HB2' ' A' ' 354' ' ' LEU . 53.2 t -135.75 132.57 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.108 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.77 108.25 10.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . 0.467 ' HA ' ' CB ' ' A' ' 374' ' ' ALA . 8.3 tttm -87.77 147.28 25.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.774 HD22 ' CE2' ' A' ' 373' ' ' TYR . 5.6 mp -126.33 -173.52 2.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.486 ' C ' ' O ' ' A' ' 370' ' ' LEU . 32.4 ttmt -30.35 -65.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -125.72 -37.96 2.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.861 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.774 ' CE2' HD22 ' A' ' 370' ' ' LEU . 4.5 p90 -90.93 -176.25 4.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 370' ' ' LEU . . . -162.78 160.93 25.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.086 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.401 ' CZ ' ' HD1' ' A' ' 341' ' ' PHE . 12.7 m-85 -116.28 121.86 43.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.498 HD11 HD22 ' A' ' 354' ' ' LEU . 5.3 mm -96.62 122.26 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -100.09 123.19 44.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 358' ' ' PHE . 19.9 m-85 -105.3 147.71 27.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -64.28 -35.01 79.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -130.99 147.46 52.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.457 ' NH1' ' CG2' ' A' ' 385' ' ' VAL . 0.0 OUTLIER -55.54 -32.07 62.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.826 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 384' ' ' ALA . 7.1 t70 -68.74 -60.6 2.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 382' ' ' ASP . . . -36.35 -33.81 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.491 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.645 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -74.07 -63.8 1.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 111.065 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.457 ' CG2' ' NH1' ' A' ' 381' ' ' ARG . 92.5 t -35.43 -35.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . 0.48 ' HE3' ' CG ' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -71.92 -60.56 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -62.1 -17.73 58.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.135 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.585 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 7.4 ttm -75.24 -59.1 2.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.401 ' N ' ' HG2' ' A' ' 388' ' ' MET . 7.3 mt-10 -77.69 -3.04 39.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.48 ' CG ' ' HE3' ' A' ' 386' ' ' LYS . 28.5 mm-40 -100.09 -29.21 12.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.884 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . 0.621 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 7.4 mmm -108.0 -28.92 9.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.663 ' N ' HD12 ' A' ' 403' ' ' ILE . 2.6 t-20 -43.74 111.56 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 78.81 24.71 61.67 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 391' ' ' MET . 0.0 OUTLIER -93.62 142.57 27.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 0.0 110.876 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -70.56 103.19 2.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.787 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.494 HD22 HD13 ' A' ' 401' ' ' ILE . 19.5 tp -109.83 110.48 21.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 62.04 34.4 16.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 80.8 16.28 75.58 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.518 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -140.03 119.57 13.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.31 104.32 2.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.494 HD13 HD22 ' A' ' 396' ' ' LEU . 28.0 pt -79.42 151.06 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.559 ' OE1' HG13 ' A' ' 404' ' ' VAL . 9.6 tm-20 -114.81 132.02 56.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.663 HD12 ' N ' ' A' ' 392' ' ' ASN . 22.6 mt -116.05 134.83 58.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.109 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.559 HG13 ' OE1' ' A' ' 402' ' ' GLU . 14.1 m -147.74 130.62 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.585 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 14.5 m-85 -49.52 105.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.556 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . -64.21 145.37 56.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.072 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -66.49 153.13 93.72 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.616 0.722 . . . . 0.0 110.896 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 127.9 15.27 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.633 2.222 . . . . 0.0 112.374 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -3.55 12.22 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.745 2.297 . . . . 0.0 112.368 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -152.48 159.27 43.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -101.2 94.82 6.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.959 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -98.47 104.74 16.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -142.15 113.58 7.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -127.66 100.81 6.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -56.38 160.66 2.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.63 166.51 21.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.828 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -170.26 144.53 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -121.26 156.23 32.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.082 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -156.95 153.13 27.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -169.1 174.69 6.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.83 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -155.53 142.13 18.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.908 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -128.84 162.25 27.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.1 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -152.76 134.96 14.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.101 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 23.3 t -119.95 171.43 8.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -156.39 145.64 12.55 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.476 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 110.99 2.68 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.723 2.282 . . . . 0.0 112.346 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 1.4 t -82.25 142.43 32.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 5.5 m -77.74 167.77 21.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.486 179.997 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 97.7 p -126.87 -46.8 1.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.856 0.36 . . . . 0.0 110.828 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 34.8 m -136.17 121.1 18.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -171.95 143.44 7.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.492 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 73.2 p -130.8 132.99 45.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.87 0.367 . . . . 0.0 110.855 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.4 m -126.91 110.86 13.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 90.89 -170.54 34.89 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.49 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 9.0 mmt -85.13 162.35 19.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.329 . . . . 0.0 110.844 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -79.61 -55.86 4.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.096 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -76.13 74.83 2.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.525 ' HB ' ' CD1' ' A' ' 405' ' ' PHE . 80.7 t -126.08 133.13 69.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -95.23 -31.8 13.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.913 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 88.2 t -79.96 123.01 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.865 HD21 ' HB1' ' A' ' 384' ' ' ALA . 33.5 mt -102.42 131.23 49.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.948 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.462 ' HB2' ' HB2' ' A' ' 406' ' ' ALA . 76.9 t80 -94.78 104.7 16.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.805 HG22 HG12 ' A' ' 403' ' ' ILE . 33.0 t -104.42 130.78 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -132.33 173.35 11.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . 0.49 ' ND2' ' OE1' ' A' ' 399' ' ' GLU . 0.7 OUTLIER 73.78 40.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.888 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 62.1 mt -78.86 159.11 27.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -86.0 -178.74 6.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.075 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -88.39 4.64 45.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 15.9 p -124.47 15.41 8.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.1 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.87 143.6 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.089 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . 0.409 ' H ' HD12 ' A' ' 353' ' ' ILE . 73.7 p -143.3 173.11 11.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -52.93 -48.09 67.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -51.77 -46.18 64.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.862 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.409 HD12 ' H ' ' A' ' 350' ' ' THR . 77.5 mt -64.7 -35.7 75.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.591 ' HB2' HG11 ' A' ' 367' ' ' VAL . 95.6 mt -69.53 -27.4 65.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.469 ' HA ' ' CD1' ' A' ' 364' ' ' LEU . 34.2 mt-10 -77.64 -69.19 0.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -46.21 -32.8 3.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' ALA . . . . . 0.564 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -75.77 -49.16 18.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.098 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' PHE . . . . . 0.446 ' C ' HD11 ' A' ' 364' ' ' LEU . 28.7 m-85 -89.73 15.89 8.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 360' ' ' GLN . 9.9 t -98.9 -57.81 2.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.842 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 359' ' ' SER . 24.2 pt20 -35.97 -39.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.892 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.522 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 85.1 m-85 -63.78 -63.4 1.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.39 162.52 29.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.434 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -50.12 127.28 16.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.499 HD21 ' CZ ' ' A' ' 378' ' ' PHE . 32.3 mt -97.66 153.97 17.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -102.06 -49.03 4.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -171.31 164.42 7.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.591 HG11 ' HB2' ' A' ' 354' ' ' LEU . 40.6 t -136.4 125.8 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -112.08 118.95 36.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -91.32 140.52 29.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.93 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.781 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.5 mp -124.24 -174.76 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 370' ' ' LEU . 1.0 OUTLIER -33.69 -69.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -119.6 -38.53 2.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.822 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.781 ' CE2' HD22 ' A' ' 370' ' ' LEU . 5.2 p90 -91.44 -174.95 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.474 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -163.83 162.81 23.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.111 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -112.47 139.26 48.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 6.2 mm -114.11 104.31 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.119 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -84.26 122.78 29.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.499 ' CZ ' HD21 ' A' ' 364' ' ' LEU . 19.8 m-85 -105.12 148.1 27.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -58.46 -36.85 74.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -134.35 155.79 49.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.879 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . 0.416 ' C ' ' HD3' ' A' ' 381' ' ' ARG . 2.4 tmt_? -59.05 -34.56 72.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 384' ' ' ALA . 23.1 t70 -67.01 -60.03 2.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.831 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -37.06 -32.31 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.487 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.865 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -76.82 -54.95 5.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.859 0.361 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 381' ' ' ARG . 65.1 t -36.79 -39.7 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -69.8 -66.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -53.29 -15.73 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.118 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.56 ' SD ' ' CE2' ' A' ' 405' ' ' PHE . 8.5 ttm -79.6 -63.93 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.457 ' N ' ' HG2' ' A' ' 388' ' ' MET . 6.4 mt-10 -75.2 -0.67 20.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.522 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 28.3 mm-40 -100.19 -35.36 9.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . 0.564 ' CE ' ' HB1' ' A' ' 357' ' ' ALA . 9.8 mmm -103.47 -34.61 8.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.679 ' N ' HD12 ' A' ' 403' ' ' ILE . 3.5 t-20 -37.79 99.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 96.04 28.53 9.23 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.452 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 391' ' ' MET . 34.4 mmtt -95.6 147.26 23.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.779 0.323 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.37 78.02 3.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.457 HD22 HD13 ' A' ' 401' ' ' ILE . 21.5 tp -81.87 110.39 17.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 62.19 27.48 16.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.43 21.3 48.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . 0.49 ' OE1' ' ND2' ' A' ' 344' ' ' ASN . 12.7 mm-40 -140.06 126.51 20.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 0.0 110.851 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.47 92.53 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.457 HD13 HD22 ' A' ' 396' ' ' LEU . 28.8 pt -72.41 150.54 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.094 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -115.78 131.35 56.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.805 HG12 HG22 ' A' ' 342' ' ' VAL . 28.0 mt -114.87 124.84 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.164 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 30.7 m -138.03 132.33 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.56 ' CE2' ' SD ' ' A' ' 388' ' ' MET . 17.7 m-85 -49.18 114.11 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 341' ' ' PHE . . . -75.98 161.84 28.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.124 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -73.85 147.29 86.27 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.546 0.688 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 146.84 61.82 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.686 2.257 . . . . 0.0 112.374 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -17.53 37.23 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.673 2.248 . . . . 0.0 112.33 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -113.88 120.01 39.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -109.59 130.09 55.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.935 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.407 ' HG3' ' N ' ' A' ' 413' ' ' ARG . 25.3 tptt -69.01 151.81 46.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . 0.407 ' N ' ' HG3' ' A' ' 412' ' ' LYS . 20.0 ptp180 -110.32 149.01 30.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -130.01 154.27 47.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -150.76 118.45 6.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -90.41 155.79 18.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -124.54 -178.32 4.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -137.64 143.74 41.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.074 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -102.21 175.69 5.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 11.2 ptt-85 -97.51 177.09 5.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.04 162.6 40.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.905 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -123.55 172.0 9.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -143.26 167.66 21.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.077 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 69.6 m -129.62 170.8 13.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.849 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -118.04 126.01 6.7 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.489 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -172.21 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.708 2.272 . . . . 0.0 112.356 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 64.8 p -147.96 175.46 10.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 52.8 p -124.63 175.34 7.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.496 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 30.2 p -146.21 131.15 18.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 110.848 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 83.1 p -55.6 168.51 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.903 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -115.9 152.28 18.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.493 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 70.8 m -78.7 150.18 32.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 0.0 110.873 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 2.9 m -90.01 124.57 34.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 58.86 85.6 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.476 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' MET . . . . . . . . . . . . . 9.2 ttt -94.47 -54.73 3.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.758 0.313 . . . . 0.0 110.89 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -155.13 140.41 17.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.085 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 75.59 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 86.3 t -133.47 133.1 57.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.198 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -91.69 -28.81 17.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 60.2 t -79.86 129.83 36.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.147 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.534 HD21 ' HB1' ' A' ' 384' ' ' ALA . 31.2 mt -110.71 125.03 53.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' A' ' 343' ' ' ARG . 6.3 t80 -86.04 118.84 25.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 403' ' ' ILE . 21.2 t -115.73 130.12 70.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.099 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.473 ' HB3' ' CE1' ' A' ' 341' ' ' PHE . 6.9 ptp180 -128.58 -179.91 5.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.7 t30 65.22 41.92 4.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.606 HD13 ' NZ ' ' A' ' 369' ' ' LYS . 39.4 mt -84.32 136.33 33.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.28 172.48 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.128 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -81.66 11.92 4.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' THR . . . . . . . . . . . . . 18.5 p -129.36 11.19 5.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.742 HG12 ' NZ ' ' A' ' 369' ' ' LYS . 84.8 t -85.91 139.61 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.164 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . . . . . . . . . 76.7 p -140.42 157.71 45.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.446 ' HG2' HG12 ' A' ' 367' ' ' VAL . 35.5 mt-10 -43.92 -43.9 6.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -54.36 -42.87 70.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 78.1 mt -68.93 -33.37 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.462 ' HB3' ' CD1' ' A' ' 376' ' ' ILE . 95.2 mt -69.22 -30.83 69.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 359' ' ' SER . 51.9 mt-10 -72.72 -72.41 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -44.19 -36.91 2.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' ALA . . . . . 0.467 ' HB1' ' CE ' ' A' ' 391' ' ' MET . . . -69.42 -51.87 32.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' PHE . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 378' ' ' PHE . 34.8 m-85 -89.23 15.58 8.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 355' ' ' GLU . 12.3 t -99.66 -51.82 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -40.44 -38.22 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.945 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.531 ' CE1' ' HB3' ' A' ' 390' ' ' GLU . 92.0 m-85 -65.59 -62.35 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -152.19 170.3 31.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -55.77 138.52 47.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.422 ' CD1' ' HA ' ' A' ' 355' ' ' GLU . 55.7 mt -107.95 162.64 13.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -111.46 -48.94 3.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.434 ' NH1' ' HB2' ' A' ' 366' ' ' ARG . 1.3 ptp180 -171.23 166.19 7.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.446 HG12 ' HG2' ' A' ' 351' ' ' GLU . 78.6 t -135.67 130.89 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -116.84 116.81 28.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' LYS . . . . . 0.742 ' NZ ' HG12 ' A' ' 349' ' ' VAL . 33.8 tptt -89.12 146.22 24.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.845 HD22 ' CE2' ' A' ' 373' ' ' TYR . 6.5 mp -130.58 -174.86 3.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 370' ' ' LEU . 28.8 mtpt -33.64 -62.49 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.488 ' O ' HD12 ' A' ' 345' ' ' LEU . 3.9 m-20 -129.38 -36.05 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.845 ' CE2' HD22 ' A' ' 370' ' ' LEU . 3.7 p90 -92.23 -174.94 3.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.532 ' HA ' HD13 ' A' ' 370' ' ' LEU . . . -167.35 153.02 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.106 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -103.01 137.95 40.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.462 ' CD1' ' HB3' ' A' ' 354' ' ' LEU . 4.9 mm -110.33 110.6 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -88.49 121.46 30.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 358' ' ' PHE . 17.3 m-85 -103.24 144.12 31.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.92 -27.89 54.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -142.01 156.3 45.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -61.49 -35.22 77.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 384' ' ' ALA . 27.0 t70 -66.89 -58.74 4.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -38.04 -31.1 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.455 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.534 ' HB1' HD21 ' A' ' 340' ' ' LEU . . . -77.19 -58.61 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.328 . . . . 0.0 111.079 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 384' ' ' ALA . 57.7 t -36.08 -35.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -73.54 -66.09 0.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -55.51 -17.37 5.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.095 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.561 ' SD ' ' CZ ' ' A' ' 405' ' ' PHE . 9.0 ttm -77.3 -63.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.875 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.463 ' N ' ' HG2' ' A' ' 388' ' ' MET . 8.4 mt-10 -74.81 0.33 15.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.531 ' HB3' ' CE1' ' A' ' 361' ' ' PHE . 30.1 mm-40 -100.21 -36.27 9.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 393' ' ' GLY . 4.0 mmt -102.64 -31.27 10.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.65 ' N ' HD12 ' A' ' 403' ' ' ILE . 6.5 t-20 -39.2 92.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 391' ' ' MET . . . 101.38 33.85 4.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.465 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -100.14 147.19 25.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.878 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.09 80.96 2.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 17.8 tp -90.07 113.88 25.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 62.25 26.39 15.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.939 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 84.83 20.33 58.11 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -140.01 122.18 15.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.921 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.38 92.27 0.8 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 19.4 pt -71.33 147.46 10.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.123 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -113.05 131.37 55.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.656 HG12 HG22 ' A' ' 342' ' ' VAL . 55.7 mt -110.78 136.98 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.124 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 20.2 m -151.76 135.13 7.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.561 ' CZ ' ' SD ' ' A' ' 388' ' ' MET . 24.0 m-85 -52.58 117.22 2.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -74.61 161.36 29.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -89.68 143.83 30.95 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.611 0.719 . . . . 0.0 110.864 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 159.58 52.85 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.678 2.252 . . . . 0.0 112.337 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 150.29 67.94 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.635 2.224 . . . . 0.0 112.328 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -86.03 125.05 33.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -159.82 135.78 8.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -121.24 161.42 21.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . 0.413 ' NH1' ' HB3' ' A' ' 413' ' ' ARG . 4.9 mmm180 -123.07 -52.07 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -52.64 161.44 0.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -161.86 155.93 21.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.866 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -143.82 165.17 28.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . 0.457 ' HG2' ' N ' ' A' ' 418' ' ' ALA . 9.1 ttmm -165.91 145.47 6.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.457 ' N ' ' HG2' ' A' ' 417' ' ' LYS . . . -146.65 171.69 14.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.069 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -169.47 139.27 2.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -122.72 170.1 10.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -127.69 176.14 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -165.57 166.71 17.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.061 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -137.09 152.54 50.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 3.8 m -163.83 162.85 23.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . -150.73 146.05 14.63 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.481 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 171.78 13.84 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.724 2.282 . . . . 0.0 112.308 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 53.4 m -98.7 -44.01 6.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.843 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 27.8 m -146.51 166.35 26.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.486 -179.959 . . . . . . . . 0 0 . 1 stop_ save_